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Abstract 
 
Faecal egg count (FEC) directed targeted anthelmintic treatment programmes and 
regular efficacy testing using the faecal egg count reduction test (FECRT) have been 
advocated to support evidence-based helminth control in horses. One major hurdle to 
their widespread application is that horse owners/managers and those that prescribe 
anthelmintics may have insufficient knowledge on which to base evidence-based 
protocols. The ultimate aim of this study was to create a framework for a decision 
support system (DSS) to support evidence-based helminth control in horses. To create 
the framework, the diagnostic performance of FEC and FECRT methodologies were 
evaluated. In addition, the efficacy of the three licensed anthelmintic classes was tested 
in several equine populations. The prevalence and distribution of helminths was 
determined in these populations, and an analysis undertaken to investigate factors 
associated with different levels of strongyle egg shedding in individuals. The 
consistency of egg shedding patterns in individuals over time was evaluated and the 
resource implications of following a FEC directed targeted treatment investigated. The 
FEC analysis findings support the rationale of FEC directed targeted anthelmintic 
treatments in horses to reduce treatment frequency in order to mitigate the impact of 
anthelmintic resistance. Moreover, the results show that such a strategy may be cost 
effective. The efficacy studies revealed that the macrocyclic lactone anthelmintics were 
highly effective in reducing strongyle egg output at two weeks after treatment, but 
further studies are required to analyse the strongyle egg reappearance period after 
treatment with these anthelmintics. In summary, this study validates the use of FEC 
directed treatment protocols in the field and the next step will be to use the derived 
information to design user-friendly online support tools. 
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Introduction 
Gastrointestinal helminths present a serious challenge to the health and welfare of 
equids worldwide. With virtually all grazing equids at risk of infection (Nielsen et al., 
2006), there is a need for control strategies that help reduce the threat of clinical 
disease. As early as the 1600’s, products were being administered to horses in order to 
‘control’ worms (Poynter and Hughes, 1958) and since the early 1900’s and the advent 
of scientific testing, a number of anthelmintic compounds, with increasing spectrum, 
efficacy and safety have been developed and licensed for use in horses (Lyons et al., 
1999). To break nematode life cycles and reduce pasture contamination, interval 
dosing treatment programmes were suggested (Drudge and Lyons, 1966); however, 
while the frequent administration of anthelmintics has significantly reduced parasite-
associated morbidity (Matthews, 2014), it is widely believed to have contributed to the 
development of anthelmintic resistance, particularly in cyathostomins (Kaplan, 2002, 
2004), and as such, these approaches to parasite control are no longer sustainable. As 
helminth infections and worm egg excretion are highly over-dispersed amongst horses 
(Relf et al., 2013), targeted treatment programmes are being advocated to reduce 
anthelmintic use and hence selection pressure for drug resistance. As part of targeted 
treatment programmes, faecal egg count (FEC) analysis is increasingly being used to 
direct treatment decisions (Matthews, 2014). The major caveat to the application of 
targeted treatment programmes is that many horse owners/managers have 
insufficient knowledge on which to base such protocols (Stratford et al., 2014a; 
Matthews, 2014). For example, often they have little idea of the relative contribution 
that individual horses make to pasture contamination or of the true drug sensitivity of 
the parasite population. Furthermore, advice is seldom sought from veterinary 
surgeons and often, when it is, the information provided is based on out-dated 
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concepts (e.g. interval treatment protocols developed in the 1970’s) (Matthews, 2014). 
The aim of this project is to build a framework for sustainable helminth control for 
horse owners, Suitably Qualified Persons (SQP), veterinary pharmacists and veterinary 
surgeons to use to help them to develop rational parasite control programmes on an 
evidence basis. Such a system will be underpinned by tools such as the FEC to promote 
the targeted treatment of horses in the field and will help sustain the effectiveness of 
the currently available anthelmintic classes. 
1.1 Equine helminths 
There are several gastrointestinal helminth species that can affect horses; they can be 
broadly categorised into the following classes; Nematoda and Cestoda. In addition, 
there are nematode species that can affect the lungs, and the trematode, Fasciola 
hepatica, that can affect the liver but these infections are seldom seen in horses. For 
this reason, the focus of this thesis will be on gastrointestinal nematodes and cestodes, 
in particular the small strongyles because of their prevalence and potential 
pathogenicity.   
1.1.1 Nematodes 
Cyathostomin spp. are by far the most prevalent group of nematodes found in equids 
(Herd, 1990a; Herd, 1990b; Lyons et al., 2000; Nielsen et al., 2006) and have been 
recognised as the main contributor of worm eggs shed in faeces (Herd et al., 1981; 
Stratford et al., 2014a). Presently, these are considered the most important parasite 
species to affect equids (Love et al., 1999; Matthews, 2008); this is due to their high 
prevalence, potential pathogenicity and ability to develop anthelmintic resistance 
(Lester and Matthews, 2014). There are more than 50 recognised cyathostomin species 
(Lichtenfels et al., 2008), with most horses infected with between five and 10 common 
species (Ogbourne 1976; Reinemeyer, 1986). Most infections are well tolerated; 
 4 
 
however the most serious consequence of cyathostomin infection is the mass 
emergence of encysted cyathostomin larvae from the large intestinal wall, which can 
result in larval cyathostominosis, a colitis characterized by diarrhoea, rapid weight loss 
and ventral oedema, which can be fatal in up to 50% of cases (Love and McKeand, 
1997; Hillyer and Mair, 1997; Love et al., 1999). Cyathostomins are commonly referred 
to as small strongyles; adult worms are less than 1.5cm in length. They undergo a 
direct lifecycle and do not require an intermediate host (Figure 1.1). Infective larvae 
(L3) are ingested by the horse from pasture and develop and mature in the large 
intestine to adulthood. Adult females may start to lay eggs within 5 - 6 weeks of 
infection and oviposit in the caecum and large colon (Reinemeyer, 1986). Eggs are 
passed via faeces onto pasture, where their hatching and development is influenced by 
climatic conditions. Under optimum conditions (25 - 33˚C; Ogbourne, 1972; Mfitilodze 
et al., 1987) eggs may hatch and develop into infective third stage larvae (L3) within 3 - 
4 days (Ogbourne, 1972). Once the eggs hatch, the first stage larvae (L1) undergo two 
parasitic moults to become infective third stage larvae (L3). L1 and L2 stages, survive 
by ingesting bacteria and organic material from the environment (Rupashinge and 
Ogbourne, 1978). L2 then moult to become L3, which have a protective sheath that is 
formed from the cuticle of the L2. This is thought to help to protect them from adverse 
environmental conditions such as freezing and desiccation. However, as the L3 cannot 
ingest nutrients they must survive on lipids stored within intestinal cells (Reinemeyer, 
1986). The L3 can persist for long periods of time in faeces, and can survive for up to 
14 – 21 weeks during summer months as the faeces protect the larvae from desiccation 
(Mfitilodze et al., 1988; Reinemeyer, 1986). Rainfall is necessary for L3 to migrate from 
faeces to herbage (English, 1979; Ogbourne, 1973; Ludwig, 1982; Craig et al., 1983; 
Mfitilodze et al., 1988; Reinemeyer, 1986). During periods of prolonged hot weather, 
L3 perish on pasture within weeks, as a higher temperature leads to an increase in 
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Ingested L3 are thought to exsheath in the small intestine and penetrate mucosal cells 
at the base of the glands of Lieberkuhn in the caecum and colon, and, depending on the 
species, may be found in the mucosa or submucosa (Tiunov, 1953; Mathieson, 1964; 
Reinemeyer, 1986). A cyst is formed around the developing larvae, by fibroblast 
accumulation (Mathieson, 1964) and L3 can moult to L4 within 6 - 12 days of infection 
(Tiunov, 1953). The L4 subsequently emerge from the cysts and enter the lumen of the 
caecum or colon; the time that this takes is thought to vary considerably (Reinemeyer, 
1986). The presence of L4 in the gut lumen has been reported to follow a seasonal 
distribution in the UK, with a peak in the late winter/early spring and late 
summer/early autumn (Ogbourne, 1976; Dowdall et al., 2002). In many cases, after 
ingestion, encysted larvae enter a state of prolonged development in the gut wall and 
this has been measured from four months to periods of up to two years (Reinemeyer et 
al., 1986). In the UK, larval encystment has been observed to occur predominantly 
during the winter months when it is presumed that conditions for larval development 
on pasture are less favourable (Herd and Willardson, 1985). In this country, it has been 
reported that up to 90% of the total cyathostomin burden may exist as encysted larvae, 
with several million present in individual horses (Murphy and Love, 1997; Dowdall et 
al., 2002). The emergence of larvae from the intestinal wall is thought to be influenced 
by environmental conditions, host immunity and/or worm population density, and 
may also coincide with the removal of adults from the lumen following anthelmintic 
dosing (Gibson, 1960; Smith, 1976). The emergence of encysted stages and their 
subsequent development to adulthood has been proposed as responsible for the spring 
rise of FEC observed in April and May in temperate climates, coincident with a rise in 
environmental temperature, which favours larval development on pasture 
(Reinemeyer, 1986). The exact mechanisms triggering the mass emergence of encysted 
larvae are still largely unknown, but when larvae emerge in large numbers from the 
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caecal and colon wall, this can cause an intense inflammatory reaction, leading to a 
potentially fatal syndrome called ‘larval cyathostominosis’. The emergence of larvae 
can severely damage the gut wall, causing diarrhoea, oedema, anorexia, acute weight 
loss, pyrexia and protein losing enteropathy (Giles et al., 1985; Love et al., 1999; Lyons 
et al., 2000). In temperate climates, cases of larval cyathostominosis are usually seen 
between January and May, and usually in horses under the age of five (Reinemeyer, 
1986; Reid et al., 1995). Figure 1.2a shows a three year-old mare that presented with 
larval cyathostominosis in April 2011 to the Equine Hospital at the Royal (Dick) School 
of Veterinary Studies (R(d)SVS) (Case Number 1.1). Clinical signs the horse presented 
with included; chronic diarrhoea, with larvae visible in the faeces, anorexia and 
pyrexia. Unfortunately, the mare did not respond to treatment with anthelmintics, 
fluids and corticosteroids and was euthanased. Upon post mortem examination, there 
was pronounced thickening and oedema of the ventral colon (Figure 1.2b), and many 
larvae visible on the mucosa, highlighting the real threat of larval cyathostominosis in 
young horses that have not been treated appropriately with anthelmintics. 
  
Figure 1.2 The image on the left (a) shows a three year-old mare (Case Number 1.1) 
that presented with larval cyathostominosis. The image on the right (b) shows 
pronounced thickening and oedema of the ventral colon at post mortem as a result of 
the mass emergence of cyathostomin larvae. 
 
a b 
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The equine intestinal immune response to cyathostomin infection is poorly 
understood. Collobert-Laugier et al. (2007) suggested that intestinal mast cell 
responses were involved in the acquisition of immunity (Collobert-Laugier et al., 2007). 
Further studies identified a linear correlation observed between magnitude of caecal 
cyathostomin burden and specific mast cell populations, indicating little association 
with immunity (Pickles et al., 2010). Davidson et al. (2005), measured cytokine 
responses in cyathostomin infected horses. In these studies, interleukin-4 (IL-4) and 
interleukin-10 (IL-10) were cited as indicators of a T helper cell (Th) 2 response and 
tumour necrosis factor- α (TNF-α) and interferon- γ (IFN-γ) as indicators of Th1 type 
responses. These authors found a significant correlation between IL-4 and IL-10 levels 
with numbers of cyathostomin EL3 and developing larvae and no correlation between 
larval numbers and IFN-γ levels. TNF-α was identified at a few sites in the caecum of 
horses with inflammatory enteropathy associated with emerging/emerged larvae, but 
this cytokine was not detected at sufficient sites for the observation to be significant. 
From the results, it was concluded that Th2 responses predominate in mucosal 
cyathostomin infections prior to larval reactivation (Davidson et al., 2005). However, 
this was a small study in a limited number of horses, and further work is required to 
understand the host immune response to cyathostomin infection and to understand 
the role it plays in larval encystment and subsequent re-emergence. All published 
studies available indicate that immunity is relatively slow to develop and requires 
prolonged exposure to cyathostomin challenge and heavy worm burdens may be seen 
in horses of all ages (Klei and Chapman, 1999). However, strongyle egg shedding tends 
to be higher in younger horses compared to adult horses (von Samson -Himmelstjerna 
et al., 2007; Relf et al., 2013). Understanding the equine intestinal immune response to 
cyathostomins is essential for developing effective control programmes (Klei and 
Chapman, 1999; Pickles et al., 2010).  
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The large strongyles form a clinically significant group of helminths that can affect 
horses, and historically, were the focus of parasite control programmes (Drudge and 
Lyons, 1966). However, their prevalence has diminished significantly over the past 20 
years due to intensive anthelmintic worming regimens and the introduction of the 
broad-spectrum macrocyclic lactone (ML) class of anthelmintics (Love et al., 1999; 
Nielsen et al., 2012a). The large strongyles, so named because adults of certain species 
can reach 5 cm in length, are large dark-red bursate nematodes that undergo a direct 
lifecycle. The main species are Strongylus vulgaris, Strongylus edentatus, Strongylus 
equinus (Figure 1.3) and Triodontophorus spp. S. vulgaris (Looss, 1900) is the most 
pathogenic of these species. Infective L3 are ingested from pasture and enter the 
intestinal mucosa where they moult to L4 in the submucosa (Duncan, 1974b). From 
there, they enter small arteries and migrate to the predilection site of the cranial 
mesenteric artery and its main branches (Duncan and Pirie, 1972), where they dwell 
for approximately four months (Wetzel, 1940). The larvae return to the intestinal wall 
via the arterial lumen. The prepatent period is 6 - 7 months (Duncan and Pirie, 1972). 
Migrating larvae are responsible for major pathology, where thrombus formation can 
occur around the larvae (Duncan, 1974b). Thrombolic emboli may detach causing 
damage to smaller arteries and arterioles downstream (Enigk, 1950), leading to 
localised ischemia and subsequent infarction and necrosis to areas of the large 
intestine (Enigk, 1950; Duncan and Pirie, 1972), resulting in a painful thromboembolic 
colic. Clinical signs include; tachycardia, profuse sweating and endotoxic shock (Enigk, 
1950; Drudge and Lyons, 1966; Duncan and Pirie, 1972). In acute cases the prognosis is 
poor (Drudge and Lyons, 1966). S. vulgaris was once highly prevalent, with prevalence 
reported to be 80% - 100% (Bollinger, 1870; Robertson, 1939; Slocombe and McCraw, 
1975; Tolliver et al., 1987; Nielsen et al., 2012). In the 1960’s, interval dosing protocols 
were recommended to reduce transmission (Drudge and Lyons, 1966) and as a result, 
 10 
 
the prevalence of this parasite has decreased significantly to individual prevalence 
rates below 5% (Höglund et al., 1997; Craven et al., 1998; Lind et al., 1999; Boxell et al., 
2004) and is rarely observed in populations of horses that receive regular anthelmintic 
treatment. The focus of parasite control then shifted to the small strongyles (Herd, 
1990a; Love; Nielsen et al., 2012a). Strongylus edentatus larvae have been reported to 
cause diarrhoea, peritonitis, colic and death (Wetzel, 1952; Wetzel and Kersten, 1956; 
Phillips and Koltviet, 1958; Slocombe and McGraw, 1975). Infective larvae are ingested 
from pasture and penetrate veins in the intestinal mucosa where they travel to the liver 
(McCraw and Slocombe, 1974). Here, the larvae moult to L4. Migration through the 
liver can cause mononuclear cells and eosinophils to accumulate leading to foci and 
tortuous tracks which can give a rough and mottled appearance to the liver, with 
pronounced thickening (Wetzel and Kersten, 1956). Larvae exit the liver to their 
predilection site of the hepatic ligaments and the flank. The hepatic ligaments may 
become thickened and fibrosed and the flanks may look oedematous and thickened 
(McCraw and Slocombe, 1974). The final moult occurs after approximately four 
months, where the L5 migrate subperitoneally, to the large intestinal wall. Larvae 
returning to the caecum and ventral colon can form purulent nodules and 
haemorrhagic foci, which subsequently rupture releasing young adults into the lumen 
(McCraw and Slocombe, 1974). Less is known about S. equinus, but the pathology and 
clinical signs are similar to those reported for S. edentatus (Wetzel, 1940; McCraw and 
Slocombe, 1974; Slocombe, 1985). Ingested L3 penetrate the wall of the caecum and 
ventral colon, causing the formation of nodules, where they moult to L4. Larvae then 
use the peritoneal cavity to migrate to the liver, where they then migrate through the 
liver parenchyma for six weeks or more (Wetzel, 1940; McCraw and Slocombe, 1974). 
Following migration through the liver, L4 and L5 may be found in the pancreas. Here, 
they can become encased in a fibrous capsule, causing the pancreas to become firm and 
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nodular, resulting in a disruption to lobular architecture, a reduction in parenchyma 
and atrophy of secretory cells (McCraw and Slocombe, 1974). 
 
 
 
 
 
 
Figure 1.3. A photograph showing the buccal capsule of Strongylus vulgaris at x 100 
magnification. Arrow A points to the leaf crown and B points to the teeth (H. E. Lester) 
 
Triodontophorus spp. are a group of non-migratory large strongyles. Pathology is 
caused by damage to the caecum and colon wall from the ingestion of plugs of mucosa 
by feeding adult parasites; in particular Triodontophorus tenuicollis, which feeds in 
groups and may cause large deep ulcers (Slocombe, 1985). 
The ascarid, Parascaris equorum is regarded as the most important parasite of young 
equids (Drudge and Lyons, 1966; Clayton, 1986; Reinemeyer, 2009). It is a ubiquitous 
nematode, found in the small intestine of young horses worldwide (Reinemeyer, 2009; 
2012). Larvae emerge from the ingested egg into the alimentary tract, after which they 
undergo hepato-tracheal migration before arriving at the predilection site of the small 
intestine, approximately one month later as L4 (Clayton and Duncan, 1977). The larvae 
then mature in the small intestine and can achieve patency within 75 -80 days post-
infection (Clayton and Duncan, 1977). Adult females are highly fecund and are capable 
A 
B 
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of producing 200,000 eggs per day, which are passed in faeces (Clayton, 1986). Second 
stage larvae (L2) then develop in the eggs which have been measured as infective in 10 
days at 25 - 35°C (Clayton, 1986). Larvated eggs can survive in the environment for five 
to 10 years providing a persistent source of environmental contamination (Clayton, 
1986). The L2 emerging from ingested eggs migrate through the liver causing focal 
haemorrhages and eosinophillic tracts to the lungs where they cause mucous 
formation and eosinophilic alveolitis, bronchiolitis and bronchitis (Nichols et al., 1978; 
Slocombe, 1985). Heavy burdens may lead to intestinal impaction or perforation of the 
intestine (Slocombe, 1985). Clinical signs include a transitory cough with purulent 
nasal discharge, poor growth, emaciation, a pot-bellied appearance, poor coat, dullness, 
inappetence, lassitude and death (Clayton, 1986; Slocombe, 1985; Reinemeyer, 2009; 
Reinemeyer, 2012). Protective immunity to P. equorum is thought to develop on 
exposure and after six months of age (Clayton and Duncan, 1979a): infections are 
seldom seen in horses above the age of two (Reinemeyer, 2012). However, older horses 
that have not been exposed when younger can harbour patent infections at low levels 
(Gawor, 1996; Kornas et al., 2006; Hinney et al., 2011a). Studies have reported the 
prevalence of P. equorum within populations of young horses to range from 22.4% to 
80% (Gawor, 1996; Hinney et al., 2011; Laugier et al., 2012; Relf et al., 2013). 
Trichostrogylus axei (Cobald, 1879) is a nematode found in the stomach of horses and 
ruminants (Slocombe, 1985). It is not considered to be highly pathogenic unless 
present in vast numbers, where it can cause profuse diarrhoea, especially in foals 
(Leland et al., 1961; Slocombe, 1985). T. Axei eggs are undistinguishable from strongyle 
eggs under microscopic examination; therefore determination of prevalence by FEC 
analysis is not possible. 
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Strongyloides westeri is a fine hair-like worm that dwells in the small intestine of foals 
and weanlings (Lyons et al., 1973). This nematode can be parasitic or free-living (Lyons 
et al., 1973). The parasitic phase is exclusive to female worms. The L3 can become 
parasitic, infecting the host by skin penetration or ingestion (Greer et al., 1974). They 
then migrate via the venous system and develop into adult females in the small 
intestine. In the small intestine, the females produce larvated eggs through 
parthenogenesis, and the eggs are then passed in faeces (Lyons et al., 1973; Greer et al., 
1974). The prepatent period for S. westeri is 8 - 14 days (Lyons et al, 1973). Foals are at 
risk immediately after birth as inhibited larvae can become mobilized from the ventral 
abdominal wall of the mother and infect the foal by vertical transmission through milk 
(Greer et al., 1974). Clinical signs include diarrhoea, anorexia, dullness and poor 
growth rates and are unusual but may be seen in very young animals (Lyons et al., 
1973). Mature parasites found in the duodenum and proximal jejunum may cause 
inflammation with oedema and erosion of epithelium if present in large numbers and 
cause catarrhal enteritis with impairment of digestion and absorption (Lyons et al, 
1973). A recent study investigating helminth egg excretion in populations of 
Thoroughbred horses in the UK detected S. westeri eggs on 45% (9/20 yards) of the 
yards tested and reported that 8% of the overall horse population tested positive and 
1% were measured as excreting ≥200 EPG (Relf et al., 2013). 
 
The equine pinworm, Oxyuris equi, is fairly common but of limited pathogenic 
significance in the intestine (Reinemeyer, 2012). Erosion of the mucosa may occur in 
heavy infections and an inflammatory response may be seen (Enigk, 1949). Eggs are 
ingested and larvae are released into the small intestine. They then travel to the large 
intestine and migrate to mucosal crypts in the caecum and colon, where they develop 
into L4 (Enigk, 1949). The L4 emerge and feed on the mucosa before reaching maturity. 
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The adults are found in the lumen of the dorsal and descending colons. After 
fertilisation, gravid females migrate to the hosts’ anus, and, extruding their anterior 
end lay their eggs around the perianal area. Allergens in the proteinaceous liquid in 
which the eggs are laid, cause intense anal pruritis and tail-rubbing (Reinemeyer, 
2012). The reported prepatent period is five months (Hasslinger, 1990). There have 
been no recent studies performed in the UK looking into the prevalence of this parasite.  
 
Dictyocaulus arnfieldi is the only lungworm found in equids (Round, 1976). This 
parasite is relatively common in donkeys (Matthews and Burden, 2013), where large 
numbers of parasites can accumulate in the lungs without causing clinical disease 
(Boyle and Houston, 2006). Patent infection in horses is rare; however, infection can 
lead to a persistent cough, increased respiratory rate and nasal discharge (Veneziano et 
al., 2011). D. arnfieldi undergoes a direct life cycle, with a reported prepatent period of 
approximately 12 weeks (Round, 1976; Clayton and Duncan, 1981). Eggs containing L1 
are laid by adult females residing in the lung bronchi, where they ascend the 
mucociliary apparatus, up the trachea. They are then swallowed, and eggs and L1 are 
passed in faeces (MacKay and Urquhart, 1979; Burks, 1998; Boyle and Houston, 2006). 
Migrating larvae and adult worms in the parenchyma and bronchi may result in an 
immune-mediated bronchopneuemonia (Beech, 1979). Adult parasites cause chronic 
catarrhal bronchitis with hyperplasia, thickened epithelium as well as focal oedema 
and haemorrhage (Beech, 1979; Boyle and Houston, 2006). This can lead to an 
increased risk of secondary bacterial infections (Burks, 1998; Boyle and Houston, 
2006). Infection is more common in horses that are co-grazed with donkeys in cold, 
wet climates (Beech, 1979). Clinical signs in horses can develop within 12 days of 
infection (MacKay and Urquhart, 1979) and are usually seen in adult horses rather 
than foals (Clayton and Duncan, 1981). Typically, coughing, exercise intolerance and 
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bilateral mucopurulent nasal discharge are seen, the latter is particularly noted if there 
is a concurrent secondary bacterial infection (Boyle and Houston, 2006). The 
prevalence of lungworm in UK equid populations is largely unknown due to a lack of 
recent published literature. 
1.1.2 Cestodes 
 
Historically in the UK, equine tapeworm infections were considered to be of little 
clinical relevance, and were rarely associated with disease (Soulsby, 1968; Proudman 
and Trees, 1999). A number of reports emerged in the 1980’s, citing circumstantial 
evidence of an association between Anoplocephala spp. and interssusception of the 
ileocaecal region, caecal rupture and spasmodic colic (Barclay et al., 1982; Beroza et al., 
1983; Cosgrove et al., 1986; Owen et al., 1989; Proudman and Edwards, 1993; 
Proudman et al., 1998; Proudman and Trees, 1999). There are three species of equine 
tapeworm belonging to the family Anoplocephalidae, these are: Anoplocephala 
perfoliata (Goeze, 1782), Anoplocephala magna (Abilgarrd, 1978) and 
Anoplocephaloides mamillana (formerly Paranoplocephala mamillana). A. perfoliata is 
the most common tapeworm found in equids (Proudman et al., 1998; Reinemeyer, 
2012). A. magna is the largest and is found in the posterior small intestine. A. 
mamillana the smallest and is found in the anterior small intestine and occasionally in 
the stomach (Proudman and Trees, 1999). The life cycle is indirect, requiring an 
intermediate forage mite host to complete its lifecycle. Each species possesses a scolex 
for attachment to the intestinal mucosa and a flattened strobila comprised of 
proglottids, through which nutrients are absorbed. The proglottids contain both male 
and female reproductive organs and the most posterior proglottid becomes gravid, 
containing embryonated eggs. The gravid proglottid then detatches and is passed in 
faeces releasing embryonated eggs, which can survive for up to 9 months on pasture 
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(Dunn, 1978). Embryonated eggs are ingested by the intermediate oribatid forage mite 
and develop into infective immature cysticercoids, which contain the scolex. This stage 
of development takes approximately 2 - 4 months (Bashkirova, 1941). Oribatid mites 
are ingested and are digested, releasing the cysticercoids. The scolex attaches to the 
intestinal mucosa, where proglottids grow from the base of the scolex and mature in 6 - 
10 weeks (Arundel, 1985). At the site of attachment, A. perfoliata cause ulceration of 
the mucosa and submucosa, leading to localised inflammation which may involve the 
entire thickness of the caecal wall (Bain and Kelly, 1977; Pavone et al., 2011). It is 
believed that the local inflammation interferes with gut motility, leading to an 
increased chance of interssusception and spasmodic colic (Lee and Tatchell, 1964; Bain 
and Kelly, 1977; Burns et al., 1990; Summers et al., 1995; Pavone et al., 2011). A recent 
post mortem study performed on 31 horses in Italy found a significant relationship 
between parasite burden and histopathological lesions in the mucosa and submucosa, 
with hypertrophy of circular muscle (Pavone et al., 2011). In addition, horses with a 
moderate-to-high infection expressed degenerative regressive changes in neuronal 
cells in the intestines with a decreased number of myenteric ganglia and neuronal cells; 
supporting the theory that infection with A. perfoliata interferes with gut motility 
(Pavone et al, 2011). The presence of local fibrous connective tissue can mechanically 
constrict the ileocaecal orifice, which can also lead to intestinal impaction (Reinemeyer 
and Nielsen, 2009). Complete protective immunity does not develop against tapeworm 
species and horses in the UK are at risk of infection throughout their lives (Ihler et al., 
1995; Nilsson et al., 1995; Rehbein et al., 2013). 
1.1.3 Trematodes 
 
Fasciola hepatica is a common zoonotic trematode found worldwide (Rojo-Vazquez et 
al., 2012; Gordon et al., 2013), and is responsible for economic losses in food-producing 
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animals due to reduced growth, fertility and milk yield, death and the condemnation of 
livers at slaughter (Mezo et al., 2011; Sargison and Scott, 2011; Borji et al., 2012; 
Gordon et al., 2013). Recently, an increase in the prevalence and incidence of F. 
hepatica has been observed in the UK in ruminants, with parasite distribution 
increasing from the west of the country, eastwards (Mitchell, 2002; Gordon et al., 
2013). This has been attributed to the warmer winters and wetter summers that have 
occurred, which are favourable climatic conditions for the propagation of the 
intermediate snail host, Galba truncatula (Kenyon et al., 2009; Taylor, 2012; Gordon et 
al., 2013). F. hepatica has a wide host range, which includes equids. A study looking at 
experimental infection of horses with liver fluke concluded that the horse exhibits 
resistance to the establishment of F. hepatica infection, and found that the majority of 
parasites were eliminated or immobilized at an early stage of infection (Nansen et al., 
1974). In addition, plasma aminotransferase levels were within a normal range 
throughout infection indicating limited damage to the liver parenchyma by migrating 
immature fluke and, neither eosinophilia nor precipitating antibodies were detected 
suggesting that the antigenic stimulus was insignificant and/or transient (Nansen et al., 
1975). In contrast, in 38 cases, F. hepatica infection has been associated with clinical 
signs in horses that had been co-grazing with cattle and sheep known to harbour liver 
fluke (Owen, 1977). The horses showed signs of lowered performance and/or a loss of 
condition, capricious appetite and acute diarrhoea (Owen, 1977). A recent coprological 
survey in donkeys in the UK also estimated the prevalence in these hosts at 
approximately 4% (Matthews and Burden, 2013). Earlier studies reported that 33 - 
91% of donkeys examined excreted F. hepatica eggs (Pankhurst, 1963; Kearney, 1974). 
In the same studies, prevalence in horses was recorded at 0.1 - 77% (Pankhurst, 1963; 
Kearney, 1974). Interestingly, the latter study was performed in the west of Ireland, 
which has been recognised as an endemic focus for liver fluke, with prevalence 
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reported to be high in cattle (Ross, 1966; Murphy et al., 2006). However, there is 
paucity of information regarding the prevalence of this parasite in horses, but there 
have been several reports of disease and this is usually associated with co-grazing with 
infected livestock or deer (Rehbein et al., 2002). 
Of all the helminth species to affect equids, the cyathostomins are now the focus of 
control programmes (with the exception of foals). This is due to their high prevalence, 
potential pathogenicity and ability to develop anthelmintic resistance. However, when 
considering equine parasite control, it is necessary to consider other helminth species. 
To do this, it is necessary to have up-to-date epidemiological information and validated 
tools for their detection. 
1.2 Detection of parasites in equids 
 
The detection and enumeration of parasite eggs and larvae in faeces has formed the 
cornerstone of diagnostic parasitology since the methodology for identifying human 
hookworm infection was first described (Stoll, 1946). Since then, a number of faecal 
egg count (FEC) methodologies for detecting and enumerating parasite eggs in faeces 
have been published. Such methodologies range from a simple direct smear (Beaver, 
1950) to more complicated methods involving centrifugation and flotation. The most 
widely used standard quantitative technique is the McMaster (McM) method (Gordon 
and Whitlock, 1939; Pereckiene et al., 2007; Rinaldi et al., 2014). This method or 
related modifications (Henriksen and Aagaard, 1976; MAFF, 1986; Dunn and Keymer, 
1986; Thienpont et al., 1986; Gronvold, 1991; Kassai, 1999) are relatively easy to 
perform and are used widely worldwide. FEC analyses give an approximate estimation 
of levels of egg excretion and do not provide an accurate reflection of total nematode 
burden within individuals (Shaw and Dobson, 1995; Nielsen et al., 2010; Lester and 
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Matthews, 2014). In essence, they can only indicate a patent infection, and are of no use 
in detecting prepatent infection such as migrating or encysted larval stages, which are 
often responsible for the major pathology associated with infection (Andersen et al., 
2013). Further, traditional FEC methods do not reliably detect tapeworm, pinworm, 
fluke or lungworm eggs (Lester and Matthews, 2014). There are 64 strongyle species 
that can infect equids, 50 of which are small strongyle species and these eggs cannot be 
differentiated morphologically (Andersen et al., 2013) and, as such, coproculture of 
eggs to the L3 stages is necessary to differentiate between large and small strongyles; 
however, this does not permit differentiation of small strongyles to species level 
(Andersen et al., 2013). 
The majority of FEC methods are based on flotation, and relies on the use of solutions 
of specific gravity that act to separate the nematode eggs from debris. The eggs are 
then quantified under a microscope, usually at x 40 magnification.  Each test differs in 
diagnostic sensitivity, the time required to perform the test, the type of laboratory 
equipment required and the level of expertise needed to execute the technique with 
accuracy (Table 1.1).  ‘Detection limit’ is the term used to describe the diagnostic 
sensitivity of the FEC method.  If the egg detection limit is high, the method will not be 
particularly sensitive to changes in egg abundance (Morrison, 2004) below or around 
the detection limit and is more likely to give false negative results.  A lower detection 
limit means that the method is more sensitive, as one uses a lower (or no) 
multiplication factor for the conversion of the number of eggs seen to provide an 
estimation of EPG.  Larger multiplication factors artificially inflate the variance 
observed in the FEC, leading to more varied results (Torgerson et al., 2012) and so it is 
considered best practice to use a method with a lower detection limit, particularly 
when assessing efficacy of anthelmintics (Kaplan and Nielsen, 2010; Vidyashankar et 
al., 2012).
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Table 1.1. The detection limit, equipment, approximate cost of equipment, time taken/sample, ease of method and number of steps taken for 
each faecal egg count method method. 
 
 
a Bartley and Elsheikha, 2011 
b Innovis Ltd 
c Contact Professor Giuseppe Cringoli for information 
d MAFF, 1986 
e Zoetis UK Ltd 
* a-d FWEC methods are quantitative and give and EPG estimate, method e is qualitative and gives a positive or negative result 
FWEC method Detection limit 
of test* 
Special 
equipment 
needed 
Cost of 
equipment 
Time taken:  
from weighing 
out subsample to 
FWEC result 
Relative ease of 
method (based 
on number of 
steps, expertise 
required) 
Number of steps 
in protocol from 
weighing 
subsample to 
result 
Centrifugal-
flotationa 
1-9 EPG Miller eye piece 
graticule, 
centrifuge, 
cuvettes, 
polymer tubes 
 
Approximately 
£500 (not 
including 
centrifuge or 
microscope) 
~10-15 min Complex 7 
FECPAKb 
 
20 EPG FECPAK system £760 ~5-10 min Moderate 4 
miniFLOTACc 5 EPG FLOTAC device  
 
NA* 12-15 min Easy 5 
McMasterd 
 
15-100 EPG McMaster slides £15 to 150/slide ~5-10 min Easy 4 
Ovatece Only recorded as 
+ or - 
Ovatec devices £95 for 50 tests ~10 min Easy 6 
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The McMaster method and its modifications (Gordon and Whitlock, 1939; MAFF, 1986) 
are the most widely used standard quantitative tests for estimating the number of 
strongyle eggs in equine faecal samples.  These are relatively quick and straightforward 
to perform and are the method currently recommended by the World Association for 
the Advancement of Veterinary Parasitology (WAAVP) for determining anthelmintic 
efficacy in domestic species (Coles et al., 1992).  The modified McMaster method 
(MAFF, 1986) is based on the flotation-dilution principle and assumes that eggs are 
randomly distributed in solution, if the sample has been well-mixed prior to dispensing 
the filtrate into the ‘McMaster’ counting slide (Torgerson et al., 2012).  If the faecal 
suspension is allowed to sit in saturated salt solution for a time prior to loading of the 
slide, eggs will float to the surface and will no longer be randomly distributed.  By not 
mixing the faecal suspension and removing only the surface layer, relatively more eggs 
will be placed into the slide, overestimating EPG and leading to an inaccurate result.  In 
the authors’ experience, this is a relatively common error in practice.  A number of 
modifications of the McMaster method exist; two recent studies have attempted to 
determine which of these is the most accurate and reliable (Table 1.2). Both studies 
found that McMaster adaptations that use a larger amount of faeces and a lower 
dilution ratio (i.e. g of faeces/ml of water) and subsequently, a lower multiplication 
factor when converting the number of eggs seen into an estimation of EPG, gave more 
reliable results with increased diagnostic sensitivity (Table 1.2).   
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Table 1.2. Results from two studies that investigated different modifications of the McMaster method. Study 1 (Vadlejch et al., 2011) compared 
seven published modifications and Study 2 (Pereckiene et al., 2007) evaluated which of three McMaster modifications was the most reliable. 
Study Details Methods investigated Vol. of 
faeces 
(g) 
Vol. of 
water 
(ml) 
Centrifugation 
(min:rpm) 
Flotation 
solution 
(specific 
gravity) 
Flotation 
time 
(min) 
Multiplication 
factor 
Detection 
Limit 
(EPG) 
Major findings 
1 Comparison of 
modifications of 
the McM methods 
for counting 
Ascaris suum eggs 
in pig faeces 
1. Henriksen & Aagaard 
(1976) 
4 56 7:1200  NaCl + 
sugar 
(1.27) 
2-3 20 20 When counting all chambers, 
methods 1, 2, 5 and 6 showed 
100% sensitivity. Method 7 
showed the least sensitivity 
(83.3%).  Method 7 was the easiest 
and quickest to perform but the 
least sensitive, Method 1 was the 
most complex and most sensitive.  
Counting  eggs in the chambers 
increased sensitivity of all 
methods 
2.Kassai (1999) 3 42 3 :1500  NaCl (1.2) 3 50 50 
3.Urquhart et al. (1996) 3 42 2 :2000  NaCl (1.2) 2-3 50 50 
4.Urquhart et al. (1996) 3 42 None NaCl (1.2) 2-3 50 50 
5.Gronvold (1991) 4 56 None NaCl (1.2) 2-3 50 50 
6.Gronvold (1991) 4 56 None NaCl + 
sugar 
(1.27) 
2-3 50 50 
7.Thienpont et al. 
(1986) 
2 60 None NaCl (1.2) 2-3 100 100 
2 Investigation of 
sensitivity and 
reliability of three 
different McM 
techniques for 
counting 
Teladorsagia 
circumcincta eggs  
8.Wetzel (1951) 2 60 None NaCl (1.2) 2-3 67 67 Method 10 demonstrated the 
greatest sensitivity and reliability 
compared to the other methods. 
9.Zajicek (1978) 1 15 2:2000 MgSO4 + 
Na2S2O3 
(1.28) 
(Breza, 
1959) 
5 33 33 
10.Roepstorff and 
Nansen (1998) 
4 56 5:1200  NaCl + 
glucose 
(1.3) 
3-5 20 20 
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The FECPAKTM (Innovis UK Ltd) method was developed in New Zealand initially as an 
on-farm tool for assessing sheep FEC (Presland et al., 2005).  Here, 10g faeces are 
examined and there is no centrifugation step (Table 1.1). The number of eggs seen is 
multiplied by a factor of 20 to provide an EPG estimate.   When the FECPAK method 
was compared with the modified McMaster method for counting nematode eggs in 
equine faecal samples, the former was found to display higher sensitivity and shown to 
be less likely to provide an underestimate of mean EPG for data with similar 
characteristics of mean EPG and sample variation in their study (Presland et al., 2005).   
Centrifugal-flotation methods (Christie and Jackson, 1982; Egwang and Slocombe, 
1982; Bartley and Elsheika, 2011) have detection limits down to 1 EPG.  These methods 
are technically more complex than the others outlined in Table 1.1 and require more 
specialist equipment.  
FLOTACTM (Cringoli, 2010) apparatus, including mini-FLOTAC and fill-FLOTAC, offer 
sensitive FEC methods.  The standard FLOTAC method requires investment in 
specialist equipment, and requires two-weeks’ training at the FLOTACTM laboratory 
based at University of Naples (for further information contact Professor G. Cringoli: 
cringoli@unina.it).  Several studies have been performed to evaluate FLOTAC for 
estimating nematode eggs and larvae in the faeces of different host species (Cringoli, 
2010; Cringoli et al., 2010; Rinaldi et al., 2011; Levecke et al., 2012b).   In each, a 
greater level of diagnostic sensitivity was achieved in comparison to the other methods 
investigated.  For example, the diagnostic accuracy of a simple flotation, McMaster and 
FLOTAC FEC methods for counting helminth eggs in sheep faeces was investigated.  
The study reported a lower coefficient of variation in FLOTAC compared to the other 
methods, emphasizing the potential higher accuracy of this method (Rinaldi et al., 
2011). The major limitations of the FLOTAC method are the number of steps required 
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to process one sample and the requirement of a centrifuge, which means each sample 
takes a relatively long time to analyse, and this is not always practical if high volumes 
of samples have to be processed. The mini-FLOTAC is an alternative; less specialist 
equipment is required and there is no centrifugation step, making it less complex to 
perform.  For equine samples, it has been proposed that 45 ml of saturated salt solution 
be added to 5 g of well-mixed faeces, before loading into a mini-FLOTAC chamber.  
After 10 min, the sample can be read.  The detection limit can be adapted by counting 
different areas of the slide and a detection limit of 5 EPG has been reported [G. Coles, 
pers. comm.].  The mini FLOTAC system will be available commercially in the near 
future for use in practice, but further validation is required to investigate 
reproducibility for its use with equine faecal samples.  
The OvatecTM (Zoetis UK Ltd) system provides a relatively quick method to examine 
whether or not nematode eggs are present.  The output of this method is a ‘positive’ or 
‘negative’ result rather than an EPG estimate.  If no eggs are observed, this system 
reports a 95% certainty that the FEC of the sample is less than 150 EPG and 100% 
certainty that it is less than 250 EPG (Ronsyn et al., 2012).  A relatively small amount of 
faeces is examined (less than 3 g), which is likely to render this method inaccurate.  In 
this context, it has been shown that the larger the volume of equine faeces examined in 
the FEC test, the lower the variability in the true mean count of a sample (Denwood et 
al., 2012).  Thus, whilst Ovatec may be useful for identifying medium to high FEC, due 
to its current inherent lack of sensitivity, is not recommended for assessing 
anthelmintic efficacy. 
Several studies have compared relative values of the different FEC methodologies.  
Most recently, a study investigating bias, accuracy and precision of the modified 
McMaster (10 EPG detection limit), Cornell-Wisconsin (CW, 1 EPG detection limit) and 
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FLOTACTM (1 EPG detection limit) methods with regard to the outcome of faecal egg 
count reduction test data in cattle found that FLOTACTM gave the most precise results, 
whilst the McMaster and Cornell-Wisconsin (CW) methods gave similar, but less 
precise results (Levecke et al., 2012b).  FEC methods with the same detection limit (for 
example, FLOTAC and CW, detection limit = 1EPG) do not necessarily have an equal 
level of precision, with differences due to the egg recovery method.  For example, in the 
CW method, eggs are recovered by placing a cover slip onto the meniscus of the 
flotation solution, which may result in a loss of eggs through spillage.  In addition, the 
area for eggs to float onto for counting is smaller with CW and if egg density is high, 
eggs may be stacked in multiple layers, reducing the number counted, therefore 
producing an inaccurate estimate of EPG (Levecke et al., 2012b).  
There are a number of factors that affect the variability of FEC data, which in turn 
impact the precision of the result. These can broadly be split into biological factors and 
technical factors. Biological factors include, faecal consistency, fluctuation in egg 
shedding over time, worm fecundity and host immunity. Technical factors include the 
underlying Poisson distribution of egg count data, aggregation of eggs in faeces, storage 
and handling of the faecal samples and the faecal egg count method used. Studies have 
shown that faecal consistency affects the variability of FEC, whereby diarrhoea 
increases faecal moisture and may dilute the number of eggs observed (Le Jambre et 
al., 2007), leading to a lower observed FEC. In a number of host–parasite systems, it has 
been reported that parasite eggs are not laid at a constant rate and diurnal fluctuations 
in egg excretion over time have been observed (Engels et al., 1996; Yu et al., 1998; 
Giver et al., 2000; Oju and Mpoame, 2006). Typically, parasite eggs are shed at a higher 
rate during the day compared to the night (Villanоuna et al., 2006; Dolnik et al., 2011; 
Coelho et al., 2013), and this impacts variability of FEC as the concentration of eggs 
differs over time leading to differences in observed FEC depending on the time of day 
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the sample is collected, therefore, samples taken for FEC should be taken at the same 
time of day to reduce potential variation. 
Density dependent fecundity is commonly observed in helminth species (Anderson and 
May, 1985). Typically, egg output decreases as parasite burden increases and a greater 
degree of variation in fecundity is observed at low worm burdens (Kotze and Kopp, 
2008). However, density dependent effects are not common to all helminth species, for 
example Haemonchus contortus in sheep (Coyne et al., 1991) and Trichostrongylus 
tenuis in red grouse (Shaw and Moss, 1989) do not exhibit density dependent 
fecundity. It has been suggested that density dependent fecundity results from 
competition between parasites, host immunity and direct parasite-parasite 
interactions (Anderson and May, 1985; Keymer, 1982). A recent study investigated the 
fecundity of 10 common cyathostomin species by extracting eggs from the uterus of 
mature female worms and found that Cylicocyclus insigne and C. nassatus were the most 
fecund species (average of 445 and 212 eggs, respectively), while C. leptostomum and C. 
longibursatus were the least fecund (average 63 and 49 eggs, respectively) and a 
positive correlation between worm size and fecundity was observed (Kuzmina et al., 
2012). 
Host immunity can influence FEC via the preventing the establishment of incoming 
larvae, inhibiting or delaying maturation of larvae to the adult stage, and the 
subsequent reduction in the size of the adult females (Smith et al. 1983a, b, 1984; Stear 
et al. 1995; Garnier et al., 2015).   
 
The Poisson distribution describes the underlying distribution of count data, where the 
mean and variance are equal (Torgerson et al., 2012). In terms of FEC, fixed weights of 
faeces are mixed with a fixed volume of flotation solution and a known volume of the 
diluted faecal suspension is placed into a counting slide. The number of eggs observed 
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in the counting slide are then multiplied by the appropriate egg detection limit to 
estimate the number of egg per gram (EPG). Eggs within the slide should follow a 
Poisson distribution if the sample has been well mixed. The egg detection limit is 
dependent on the dilution factor of faeces and the volume of faecal suspension counted. 
However, when raw egg counts are transformed to EPG estimates, inflated variance 
between repeated counts of the same sample is observed because the multiplication 
factor/egg detection limit artificially inflates the variance (Torgerson et al., 2012). For 
example, five raw egg counts from drawn from a Poisson distribution with a mean of 4 
eggs would be 0, 4, 6, 2, and 3. If each if the counts are multiplied by an egg detection 
limit of 50 EPG the observed EPG values would be 0, 200, 300, 100 and 150 EPG, 
demonstrating the variability in FEC. This variability is due to the Poisson process, 
which is inflated by the multiplication factor (Torgerson et al., 2012). As such, FEC 
methods that use a lower multiplication factor/egg detection limit produce less 
variable FEC. 
Nielsen et al. (2010) investigated the effect of storage factors on strongyle FEC in 
horses and found that optimum counts could be achieved if faeces were <12 hours old 
and if the sample was refrigerated after collection and processed within five days 
(Nielsen et al., 2010).FEC method.  
A major caveat to the application of FEC is the evidence that there is no significant 
positive relationship between cyathostomin worm burden (including the larval stages) 
and faecal egg count (FEC) (Dowdall et al., 2004; Nielsen et al., 2010; Kuzmina et al., 
2012), and that horses measured as shedding 100 EPG may harbour more than 
100,000 worms (Nielsen et al., 2010). That said, these studies have been focussed on 
horses less than two years of age, which are more likely to have higher burdens of 
encysted larvae (Lyons et al., 2011), which will have impacted the results as the 
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immature stages do not lay eggs. To date, there have been no recent studies looking at 
the relationship between worm burden and FEC in adult horses. In adult horses 
however, the relationship between adult worm burden and FEC could be influenced by 
immune responses. For example, in sheep, immunity to the nematode Teladorsagia 
circumcincta results in a reduction in the size of adult female worms (Smith et al., 1983; 
Stear et al., 1995), which results in a reduction in fecundity (Stear and Bishop, 1999), 
therefore, adult female worms may be present but may not be detected if they are 
laying fewer eggs. This phenomenon however, has not been demonstrated in 
cyathostomins.   
In support of FEC, strongyle egg shedding has been shown to be consistent in adult 
horses over time (Dopfer et al.,2004; Nielsen et al., 2006), thus supporting the rationale 
for targeting treatments in adult  horses. Furthermore, Nielsen et al. (2010) reported 
that horses with a FEC of up to 500 EPG had significantly higher strongyle worm 
counts, supporting the usage of treating horses with FEC in this range and 
demonstrates that deworming horses with high FEC can potentially reduce the level of 
environmental contamination. 
 
Currently, there are no non-invasive methods for the detection of cyathostomin 
encysted larvae (EL) (Matthews, 2014). A routine diagnostic test would help to identify 
the horses with high EL burdens, which may have low or negative FEC, and would aid 
the identification of horses requiring larvicidal anthelmintic treatment. Recently, 
serum IgG(T) responses to two larval native antigen complexes (of 20 and 25 kDa in 
size) were observed to be significantly higher in clinical cases than in cyathostomin-
naïve or negative animals, and in experimentally infected animals, anti-25 kDa complex 
IgG(T) levels correlated positively with field exposure to cyathostomin species, 
burdens of EL3 and total mucosal parasites (Dowdall et al., 2002; Dowdall et al., 2003; 
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Dowdall et al., 2004). In addition, antigen-specific IgG(T) responses were significantly 
higher in infected compared to uninfected horses (p=0.0001 and 0.002 for anti-25 and 
anti-20 kDa responses, respectively) in naturally infected horses, whose parasite 
burdens were quantified at post mortem. In infected horses, anti-25 kDa IgG(T) levels 
correlated positively with mucosal and luminal burdens (p<0.05) (Dowdall et al., 
2004). The antigens were shown to be specific to cyathostomins and cross reactivity 
between other helminth species was limited (Dowdall et al., 2003). Recently, genes 
encoding two antigenic proteins, that are produced by EL cyathostomins; gut 
associated larval antigen (Cy-GALA) (McWilliam et al., 2010) and cyathostomin 
immunodiagnostic antigen (Cy-CID, Matthews, pers. comm.) have been isolated and the 
proteins expressed in Escherichia coli. These proteins exhibit no cross reactivity to 
serum from horses specifically infected with other non-cyathostomin helminth species, 
and antiserum raised to one Cy-GALA, does not bind to extracts from other helminth 
species (McWilliam et al., 2010). It is anticipated that a diagnostic ELISA based on 
detection of antibodies to a cocktail of these recombinant proteins will be developed 
for commercial use in the next 3 years (Matthews, 2014), with further development 
focussing on increasing cyathostomin species coverage for the proteins Cy-GALA and 
Cy-CID, to ensure that the assay is sensitive to the presence of less common 
cyathostomin species. 
There is no validated FEC method for the detection of Oxyuris equi as adult female 
worms lay their eggs around perineum, so eggs are not consistently detected in faeces. 
The recommended method for the identification of O. equi eggs is the tape test, 
whereby sticky tape (i.e. Sellotape®) is pressed around the perineum and then removed 
carefully and examined under a microscope for the presence of the distinctive eggs 
(Reinemeyer, 2012). 
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Tapeworm eggs are not reliably detected by the traditional FEC methods outlined 
above, (Nilsson et al., 1995). FEC counts performed by the McMaster method give low 
sensitivity (8 – 61%) for tapeworm (Proudman and Edwards, 1992; Abbott and 
Barrett, 2010). Modifications by using a larger amount of faeces (30 - 40 g) have been 
suggested (Proudman and Edwards, 1992; Ihler et al., 1995; Nilsson et al., 1995; Meana 
et al., 1998; Kjaer et al., 2007), and by adopting a more sensitive method (i.e. 
centrifugal-flotation) (Proudman and Edwards, 1992). Sensitivity using these 
modifications has been reported to range between 37 to 61% and a specificity of 98% 
(Proudman and Edwards, 1992; Ihler et al., 1995; Nilsson et al., 1995; Meana et al., 
1998; Proudman and Trees, 1999). However, other reports suggest that there is no 
clear relationship between adult tapeworm burden and FEC (Meana et al., 1998). An 
ELISA for the detection of A. perfoliata specific antibody responses is commercially 
available (Diagnosteq, Liverpool, UK). This serological assay detects IgG(T) antibodies 
against 12 and 13 kDa excretory/secretory (ES) antigens (Proudman and Trees, 1996). 
Proudman and Trees (1996) demonstrated a correlation between ELISA optical density 
(Od) and A. perfoliata infection intensity, and reported that horses with high infection 
intensity (in this case, Od > 0.6) were at greater risk of tapeworm-associated colic. The 
sensitivity and specificity of this ELISA was reported as ~70% and ~95%, respectively 
(Proudman and Trees, 1996; Traversa et al., 2008). Od in the range of 0.2 and 0.6 are 
difficult to interpret as one study found that 66% of tapeworm-negative horses had an 
ELISA Od of 0.2 or more (Kjaer et al., 2007), demonstrating that the circulating 
antibodies from a previous infection results in a lack of sensitivity. The tapeworm 
ELISA has been available for over ten years 
(http://www.liv.ac.uk/diagnosteq/tapeworm_test.htm) and has proved useful as a 
monitoring tool, but is not widely used due to the associated cost. A lack of diagnostic 
sensitivity has been observed due to the long half-life of antigen-specific 
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immunoglobulin in equine serum in response to infection and this must be taken into 
consideration when interpreting the test (Abbott and Barrett, 2010). If the deworming 
history of a horse is unknown and tapeworm infection is suspected, rising Od levels in 
serial blood samples over a 2-month period is likely to indicate infection (Abbott and 
Barrett, 2010). Recently, a diagnostic ELISA test that measures tapeworm antibodies in 
saliva has been developed and is available to buy commercially in the UK (Equisal: 
http://equisal.co.uk/The-Test). This test costs £17.95 (price at time of writing this 
thesis), does not require a veterinary surgeon, and therefore could be a more 
favourable option to the horse owner. The information associated with the test 
currently claims that it is able to identify a negative/low burden or a moderate/high 
burden with 83% sensitivity and 85% specificity. This was determined by comparing 
the results of the test with the number of adult tapeworm recovered at post mortem in 
104 horses. (http://equisal.co.uk/WebRoot/Store5/Shops/d7497350-0c56-4e11-
a207-b31ca0b55b54/MediaGallery/Equisal_Vets_lft_A5_single_page.pdf). At the time 
of writing, there were no peer-reviewed scientific publications available to support 
these data. A coproantigen ELISA, able to detect ES antigens in horse faeces as been 
developed (Kania and Reinemeyer, 2005), and has demonstrated a positive correlation 
between antigen concentration and the number of adult tapeworm (Skotarek et al., 
2010) giving a reported sensitivity and specificity of 74% and 92%, respectively. This 
test is not available commercially as yet. A PCR-based assay has been proposed for the 
detection of tapeworm infections based on the amplification of Internal Transcribed 
Spacer 2 (ITS2) of parasite rDNA, which has been identified as a genetic marker for the 
detection of A. perfoliata in horse faeces (Drogemuller et al., 2004; Traversa et al., 
2008). Initial reports are promising, but more work is required to validate this method 
(Traversa et al., 2008; Andersen et al., 2013). 
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The detection of F. hepatica eggs is commonly based on a standard sedimentation FEC 
technique (McCaughey and Hatch, 1964; Gordon et al., 2013). In addition, standard FEC 
techniques such as the McM and centrifugation-flotation techniques can be used with 
saturated zinc sulphate as the flotation medium as this offers a lower specific gravity 
(1.18), which enables the flotation of larger eggs (MAFF, 1986). The test is confounded 
by the long prepatent period (9 to 15 weeks) of this helminth species and sporadic egg 
shedding observed due to the fact that adult fluke lay their eggs in the gall bladder 
(Chowaniec and Darski, 1970; Mezo et al., 2004; Valero et al., 2009; Gordon et al., 
2013). Recently, a coproantigen ELISA based on a monoclonal antibody (MM3 MAb) 
that detects cathepsin L protease, secreted from the luminal surface of the fluke’s gut 
(Mezo et al., 2004; Muino et al., 2011) has been developed and is available 
commercially for use in ruminants (BIO-X Diagnostics, Belgium). In sheep, claims have 
been made that this test is able to detect a single, live fluke (Mezo et al., 2004). 
Moreover, following experimental infection, liver fluke were detected five weeks post-
infection (Mezo et al., 2004; Flanagan et al., 2011; Gordon et al., 2012), indicating value 
in detecting immature infections before they reach patency, which will help to reduce 
damage caused by migrating immature fluke. There is a lack of information regarding 
the detection of fluke infections in equids, as such investigations into FEC methods and 
the usefulness of the coproantigen ELISA are warranted, particularly because of the 
rise of prevalence of F. hepatica in ruminant species (Mitchell, 2002; Gordon et al., 
2013) and the increased number of reports of suspected failure of the anthelmintic 
triclabendazole (TCBZ), which has been confirmed in sheep (Gordon et al., 2012; 
Winkelhagen et al., 2012) and in cattle (Olaechea et al., 2011). TCBZ is the only 
flukicide with activity against all stages of liver fluke, most importantly the immature 
stages (Fairweather et al., 2012). Little is known about the clinical significance of F. 
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hepatica in horses and donkeys and a rise in prevalence and infection intensity of this 
helminth could potential have a bearing on their health and welfare. 
The Baermann technique is routinely used for the detection of D. arnfieldi (Boyle and 
Houston, 2006). The eggs when laid, are embryonated, and can hatch rapidly liberating 
L1, so FEC methods are less useful. Detection via faecal examination in the horse can be 
inaccurate as patent infections are seldom seen, but the inflammatory process 
associated with immature larvae can cause disease without a patent infection (Boyle 
and Houston, 2006). 
Many of the recommended FEC techniques for the identification of equine helminth 
infection have not been fully validated or optimised. If such techniques are to underpin 
evidence-based parasite control programmes there is a need to ensure that 
recommended methods are fit for purpose. 
1.3 Control of parasites in equids: anthelmintics 
 
Certain species of gastrointestinal helminths are ubiquitous in grazing equids 
(Andersen et al., 2013) and infection can potentially lead to clinical disease (Nielsen et 
al., 2014). Consequently, there is a need for their control. As early as the 1600’s a 
variety of different organic and non-organic substances such as hen’s eggs, the 
intestines of young hen’s and pigeons, human faeces, aniseed, aloes, liquorice, linseed 
and vitriolated mercury were administered to horses for the control of intestinal 
parasites (Poynter, 1958). In 1915, the oil of chenopodium was recommended, and 
excellent results versus strongyles were reported when used in combination with 
linseed oil after the horse had been fasted for 36 hours prior to treatment (Lyons et al., 
1999). Later, Colonel Floyd Sager, wrote in his book, in which he recorded anecdotes 
from his 60 years as an equine practitioner, that following treatment with oil of 
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chenopodium, horses would lose weight and not be able to eat or drink for 3 - 4 days 
post-treatment (Lyons et al., 1999), indicating the questionable safety of such 
compounds. Since the early 1900’s and the advent of the scientific testing of drugs to 
assess efficacy and safety, 25 anthelmintic compounds have been developed and 
licensed for the control of gastrointestinal helminths (Table 1.3). 
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Table 1.3. The history of anthelmintic compounds licensed for use in horses and their claimed activity against different 
gastrointestinal parasite species 
Year Class Compound/s Activity Reference/s 
1917 Carbon disulphide Carbon disulphide* Ascarids 
Bots 
Hall, 1917 
1940 Phenothiazine Phenothiazine* Strongyles  Habermann et al., 1941 
1950 Piperazines Piperazines* 
Used with carbon 
disulphide 
 
Used with 
phenothiazine 
 
Ascarids, bots, pinworm, strongyles 
Increased activity versus large strongyles and phenothiazine-
resistant small strongyles 
 
 
 
 
Drudge et al., 1963 
1960’s Organophosphates Trichlorfon* Ascarids, bots, mature pinworm  
 Dichlorvos* Ascarids, bots, large and small strongyles, pinworm  
1960’s Benzimidazoles Thiabendazole* 
Cambendazole* 
Fenbendazole 
Mebendazole* 
Oxfendazole* 
Oxibendazole* 
Ascarids, pinworm, strongyles Drudge et al., 1963 
Colglazier et al., 1977 
1970’s Tetrohydropyrimidines Pyrantel tartrate 
 
Pyrantel pamoate 
 
At double the 
nematocidal dose 
 
Ascarids, Strongylus vulgaris, small strongyles, pinworm 
Ascarids, small strongyles, pinworm, Strongylus vulgaris and 
Strongylus equinus 
Anoplocephala perfoliata 
Cornwell and Jones, 1968 
Lyons et al., 1975 
 
 
 
 
Slocombe, 1979 
1980’s Macrocyclic lactone 
(avermectin) 
Ivermectin Ascarids, bots, small and large strongyles, pinworm  Klei et al., 1993; Xiao et al., 1994; 
DiPietro et al., 1989 
 
1997 Macrocyclic lactone 
(milbemycin) 
Moxidectin Ascarids, bots, adult and larval stages of large strongyles, adult, 
EL3 and developing stages of small strongyles, pinworm 
Monahan et al., 1995, 1996; DiPietro et 
al., 1997; Duncan et al., 1998; Bairden et 
al., 2001; Bairden et al., 2006 
* compound no longer licensed for use in horse
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1.3.1 Anthelmintics 
 
Carbon disulphide was the first compound to be tested and developed for use against 
ascarids and bots (Hall, 1917) and over the years there have been a number of 
anthelmintic compounds discovered, tested and licensed for use against equine 
parasites. Currently there are three classes of broad-spectrum anthelmintic licensed 
for use in horses in the UK; these are the benzimadazoles (BZ), tetrahydropyrimidines 
(THP) and the macrocyclic lactones (ML). The ML group is split into two ML derivatives 
known as the avermectins and the milbemycins, to which ivermectin (IVM) and 
moxidectin (MOX) belong, respectively. Praziquantel (PRZ) is a narrow-spectrum 
anthelmintic specifically licensed for use against cestodes. 
Anthelmintics may be effective against one or more parasitic stages. For example they 
may possess adulticidal activity, i.e. they are effective against the adult worm 
population, larvicidal activity, i.e. they are effective against the larval stages and 
ovicidal, i.e. they are effective against the eggs. The effect of anthelmintics on different 
parasite stages has implications for control.   
1.3.3.1 Benzimidazoles 
 
BZ inhibit the synthesis of microtubules in nematodes (Lacey, 1990). By binding to the 
nematode β-tubulin subunit, BZ prevent dimerization and subsequent polymerisation 
during microtubule assembly (Lacey, 1990). The progressive loss of microtubule 
function disrupts cell division, depletes energy stores and causes starvation (Prichard, 
1990). Fenbendazole (FBZ) is the only BZ licensed for use in horses in the UK. Initial 
controlled efficacy studies found that FBZ administered orally as a single dose (5mg/kg 
body weight (bwt)) was 100% effective against adult cyathostomins (Colglazier et al., 
1977) (Table 1.4), while a dose of 7.5 mg/kg bwt administered for five consecutive 
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days reported >95% efficacy against total musosal larvae and >91% efficacy against 
EL3 (Bairden et al., 1998). In addition, FBZ was reported to be completely effective 
against adult O. equi and, 50% against L4 (Colglazier et al., 1977) and highly effective 
against P. equorum (Malan et al., 1981). 
1.3.3.2 Tetrahydropyrimidines 
The THP class of anthelmintics includes the pyrantel (PYR) salts pyrantel embonate 
and pyrantel tartrate, with the former being licensed for use in the UK. PYR is a 
depolarizing neuromuscular blocker that exerts a cholinergic action causing paralysis 
by massive contraction of the parasite musculature (Brady and Nichols, 2009). 
Through mimicking acetylcholine action, it changes the permeability of the post-
synaptic membranes leading to sustained muscle contraction (spastic paralysis) 
(Elsheikha et al, 2011). PYR was shown to eliminate 89 - 96% of adult cyathostomins, 
when administered orally at a dose-rate of 19 mg/kg bwt (Lyons et al., 1974) but was 
not effective against mucosal stages. At the same dose rate, PYR was reported to be 
>90% effective against adult O. equi and P. equorum (Lyons et al., 1974). In addition, 
PYR given at 38 mg/kg is highly effective against A. perfoliata (Slocombe, 1979) (Table 
1.4).  
1.3.3.3 Macrocyclic lactones 
 
The introduction of the ML class marked a key step in the control of parasites as these 
compounds possess broad-spectrum anti-nematode and -arthropod activity but they 
are not effective against tapeworm or fluke species (Schumacher and Taintor, 2008), 
because these helminths lack the high affinity binding site for ML (Neal, 2002). ML are 
highly lipohilic and are excreted in bile and eliminated in faeces (Zulalian et al., 1994). 
The ML were originally thought to potentiate the action of the inhibitory 
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neurotransmitter gamma-aminobutyric acid (GABA) by blocking the hyperpolarisation 
of nematode somatic muscle by opening GABA-gated chloride channels (Holden-Dye 
and Walker, 1990), although this hypothesis has yet to be supported (Martin et al., 
2002). It is thought that the ML probably act by binding to and permanently opening 
glutamate-gated chloride channels found only in the neurones and monocytes of 
invertebrates (Cully et al., 1994). This causes the influx of chloride ions leading to 
neuromuscular paralysis (flaccid paralysis) and death (Cully et al., 1994). IVM, an 
avermectin, was the first ML to be licensed for use in horses in 1981, and, at a dose rate 
of 0.2 mg/kg, was demonstrated to have high efficacy (>99%) against adult 
cyathostomins and luminal larvae (98%), but showed little activity against EL3, even at 
an elevated dose rate of 1 mg/kg (Klei et al., 1993; Xiao et al., 1994). IVM was also 
effective (>90% efficacy) at killing adult and immature stages of O. equi, adult large 
strongyle species (including arterial and tissue larval stages), adult, L3 and L4 stages of 
P. equorum (DiPietro et al., 1989), adult S. westeri, adult and immature D. arnfieldi, 
adult T. axei and oral and gastric stages of Gasterophilus spp (Coles et al., 2003). MOX, a 
milbemycin, was first introduced to the market in 1997 (Schumacher and Taintor, 
2008), and is indicated for use for the control of adult and larval stages of large and 
small strongyles, including EL3, P. equorum (Monahan et al., 1995), T. axei, and G. 
intestinalis (Coles et al., 1993). MOX has demonstrated good efficacy (>95%) against 
adult and larval stages of S. vulgaris, S. equinus and S. edentatus (Monahan et al., 1995). 
Early studies investigating efficacy against cyathostomin mucosal larvae found MOX to 
be ineffective (Xiao et al., 1994; Monahan et al., 1995, 1996). These data were in 
contrast to later studies that reported 90.8% efficacy against cyathostomin EL3 
(Bairden et al., 2001, 2006; Reinemeyer et al., 2003) and 99.9% against other 
developing stages of these parasites (Bariden et al., 2001). The discrepancy in reported 
efficacy against cyathostomin mucosal larval stages is possibly explained by differences 
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in the interval between dosing and necropsy, with the earlier studies performing 
necropsy two weeks post-treatment, which is believed to be too short a time to allow 
elimination of mucosal larvae (Monahan and Klei, 2002; Matthews, 2008), therefore 
the results obtained in the study by Bairden et al. (2001) would appear to be more 
accurate. MOX has persistent activity, with prolonged plasma bioavailability (Perez et 
al., 1999), and may provide protection from cyathostomin reinfection for 2 - 3 weeks 
post-administration (Vercruysse et al., 1998). There have been concerns over the 
safety of MOX, for use in foals and debilitated horses, and since it became licensed, 
there have been several adverse drug reactions reported (Hampshire et al., 2004). MOX 
is 100 times more lipophilic than IVM (Hayes, 1994), and may become highly 
concentrated in the serum of equids with little body fat. In this situation, MOX may 
cross the blood-brain barrier, leading to toxicity (Johnson et al., 1999; Muller et al., 
2005). Reported clinical signs of MOX toxicity include dyspnoea, depression, ataxia, 
weakness, seizures and coma (Johnson et al., 1999; Hampshire et al., 2004; Muller et al., 
2005). Given that MOX is the only anthelmintic effective with larvicidal activity and 
given that the pathogenic risk of the larval stages, MOX should be considered for use 
for the control of cyathostomins despite the apparent safety risks. To mitigate against 
this, if MOX is to be used in foals and equids with little body fat, it is essential that the 
correct dose is administered based on an accurate body weight.  
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Table 1.4. Summary of the mode of action, dose rate and delivery route and efficacy claims for each of the broad-spectrum 
anthelmintics licensed for use in horses in the UK 
Anthelmintic Mode of action Recommended dose 
rate and delivery 
route 
Efficacy claim Reference/s 
Fenbendazole Binds to the 
nematode β-
tubulin subunit, 
disrupting 
microtubule 
assembly leading to 
starvation 
5 mg/kg per os 
 
 
 
 
7.5 mg/kg per os for 
5 consecutive days 
100% efficacy vs. cyathostomins 
100% vs. adult pinworm 
95-100% vs. L4 pinworm 
100% vs. Parascaris equorum 
 
90.7% vs. luminal cyathostomins 
95.3% vs. mucosal larvae 
99.4% vs. LL3 and D4 
91.5% vs. EL3 
 
80% and 100% vs. migrating S. vulgaris and S. edentatus  
95% vs. mucosal small strongyles 
100% vs. adult small and large strongyles 
 
Colglazier et al., 1977 
 
 
Malan et al., 1981 
 
Duncan et al., 1998 
 
 
 
 
Duncan et al., 1980 
Pyrantel  Mimics 
acetylcholine 
action, changing 
the permeability of 
the post-synaptic 
membranes leading 
to sustained muscle 
contraction 
(spastic paralysis) 
19 mg/kg per os 
 
 
 
 
38 mg/kg per os 
89-96% vs. adult cyathostomins 
>90% vs. O. equi and P. Equorum 
 
 
 
Highly effective vs. A. Perfoliata 
Lyons et al., 1974 
 
 
 
 
 
Slocombe, 1979 
Ivermectin MLs bind to 
glutamate-gated 
chloride channels 
causing the influx 
of chloride ions 
leading flaccid 
0.2 mg/kg per os >99% vs. adult cyathostomins; 98% vs. luminal 
cyathostomin larvae 
>90% vs. adult and immature stages of O. equi 
>90% vs. adult, arterial and tissue stages of large 
strongyles 
>90% vs. adult L3 and L4 P. equorum, adult S. westeri, T. 
Klei et al., 1993; Xiao et 
al., 1994 
DiPietro et al., 1989 
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paralysis and death 
 
axei and adult and immature D. Arnfieldi 
 
Moxidectin Flaccid paralysis – 
see above 
0.4 mg/kg per os 90-100% vs. adult and larval stages of large strongyles, 
adult ascarids, cyathostomins, T. axei and S. westeri 
90.8% vs. cyathostomin EL3 
99.9% vs. other developing stages of cyathostomin 
Monahan et al.,1995, 
1996; Coles et al., 1998; 
Bairden et al., 2001, 
2006; Reinemeyer et al., 
2003 
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1.3.3.4 Narrow-spectrum 
 
PRZ exerts its effect by primarily by invoking tetanic contractions of parasite 
musculature and intense irreversible focal vacuolization and disintegration of the 
tegument (Elsheikha et al, 2011). The damage is probably caused by interaction with 
phospholipids and proteins that create an imbalance in the ion transport of cations 
through the tegument. This affects metabolism and leads to strong contraction of the 
tegument muscles leading to paralysis (Elsheikha et al, 2011). PRZ has been licensed 
for concomitant use with IVM and MOX. 
1.3.3.5 Herbal preparations 
 
In the UK, there is an herbal preparation (Verm-X) that claims to offer ‘natural control 
and daily protection’. However, apart from claiming ‘veterinary approval’ there have 
been no formal registration type efficacy studies performed to substantiate efficacy of 
this product in equids. An efficacy study in nine donkeys using Verm-X reported no 
reduction in strongyle egg count after treatment and concluded that this product 
should not be used for the control of strongyles (Bernard and van Doorn, 2011). 
Further, a comparative study that examined the efficacy of the Verm-X preparation for 
chickens and flubendazole against four species of chicken nematode, found that Verm-
X efficacy against adult worms ranged from <0 - 11% and was not significantly 
different to the untreated control group (Squires et al., 2012). 
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1.4 Anthelmintic resistance 
Anthelmintic resistance (AR) in nematodes is well documented (Kaplan and Nielsen, 
2010). AR is defined as ‘when a greater frequency of individuals in a parasite 
population, usually affected by a dose or concentration of a compound, is no longer 
affected, or a greater concentration of drug is required to reach a certain level of 
efficacy’ (Pritchard et al., 1980). The first case of AR reported in cyathostomins was to 
phenothiazine in the late 1950’s (Drudge and Elam, 1961), and since then, AR to all 
four modern, broad-spectrum anthelmintic compounds used in equids has been 
identified (Stratford et al., 2011). AR arises through genetic polymorphisms, which are 
selected for over time and are passed on to subsequent generations (Pritchard et al., 
1980). The most serious consequence of resistance is complete treatment failure 
leading to persistent infection and, when high burdens are present, clinical disease. 
A reduction in anthelmintic efficacy may be identified in vivo by the faecal egg count 
reduction test (FECRT), which is considered the gold standard for determination of 
anthelmintic efficacy in domestic species (Coles et al., 1992). FECRT datasets derived 
from horses are often characterised by low precision and poor reproducibility (Craven 
et al., 1999).  Currently, there are no clearly defined guidelines regarding appropriate 
cut-off limits for determining efficacy for the anthelmintic classes used in horses 
(Vidyashankar et al., 2012). The WAAVP initially defined the threshold for resistance as 
a FECR of less than 95% reduction in FEC taken 10 days apart using arithmetic group 
means (Coles et al., 1992).  However, this singular cut-off value did not take into 
consideration differing original efficacies of the various anthelmintic classes in 
anthelmintic-sensitive nematode populations at the time of licensing, leading to the 
potential for misclassification of sensitivity. Recently, FECR cut-offs have been 
recommended for the different anthelmintic compounds used in horses; for example, 
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90% for FBZ (and other BZ anthelmintics) and PYR and 95% for ML anthelmintics 
(Kaplan and Nielsen, 2010).  A mean population FECRT above these cut-offs indicates 
acceptable efficacy, whilst a mean FECRT below these thresholds indicates  AR (Kaplan 
and Nielsen, 2010).  In cases of suspected AR, where the overall group mean FECR is 
close to the threshold for resistance and this is due to effect of FECR observed in one or 
two individuals, the test should be repeated in these individuals to rule out possible 
under-dosing or administration error in the initial study (Stratford et al., 2013).   The 
use of 95% confidence limits (CL) has been suggested to provide a better indication of 
the range of the FECRT data (Vidyashankar et al., 2007).  Some recent studies have 
used both the FECR and 95% lower CL (LCL) to determine the presence or absence of 
AR (Craven et al., 1998; Ihler et al., 1995; Osterman Lind et al., 2007).  
The standard method of FECR analysis (Coles, 1992) currently used in efficacy studies 
worldwide involves calculation of the group arithmetic mean before and after 
treatment to estimate arithmetic mean percentage FECR, from which, 95% CL are then 
derived.  However, this method makes the assumption that FEC data are normally 
distributed, which may affect statistical validity, and lead to inaccurate inferences 
regarding the presence, or absence, of resistance.  To overcome the problem of over 
dispersion in faecal worm egg excretion amongst horses, log and arcsine 
transformations have been suggested (Fulford, 1994; Pook et al., 2002). Arcsine 
transformation of individual FECR has been reported to reduce variation in efficacy 
calculations as demonstrated when applied to field data, this method generated LCL 
closer to the mean in comparison with the WAAVP method (Pook et al., 2002).  Non-
parametric bootstrapping has been suggested as an alternative method as it does not 
require underlying knowledge of the distribution of the data, however, it assumes the 
data obtained are representative of the whole population (Vidyashankar et al., 2007).  
Bayesian methods such as the profile-likelihood method (Torgerson et al., 2005) and 
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Markov chain Monte Carlo (MCMC) (Denwood et al., 2010) have also been proposed to 
account for the variability in FECRT data.  The MCMC has been reported to outperform 
non-parametric bootstrapping when sample size is small and  the pre-treatment FEC is 
low (Denwood et al., 2010). These methods are associated with increased power and a 
reduced chance of incorrectly rejecting the null hypothesis.  However, they are 
computationally intensive, requiring a high level of statistical knowledge and the ability 
to use the statistical modelling package R.  
These issues highlight the potential for inappropriate data analysis that may lead to 
misclassification of resistance in equine worm populations and clearly a validated, 
standardised and easily computable method of FECR data analysis is required. 
Another method for identifying a reduction in anthelmintic efficacy is to measure the 
strongyle egg reappearance period (ERP). The ERP is the time post-anthelmintic 
treatment that helminth egg shedding remains negligible, or below a certain threshold 
(Duncan, 1985), and varies with each anthelmintic class. The ERP in anthelmintic-
sensitive populations can vary but have been previously generally specified as 6 - 8 
weeks for BZ, 6 weeks for PYR (Borgsteede et al., 1993; Herd and Gabel, 1990b; 
Mercier et al., 2001). For the MLs, an ERP of between 8 and 12 weeks was observed for 
IVM (Borgsteede et al., 1993; Boersema et al., 1996) and between 12 and 25 weeks for 
MOX (diPietro et al., 1997; Demeulenaere et al., 1997). The initial ERP were 
determined when each of the drugs were first introduced and based on the assumption 
that helminth populations were sensitive to that specific compound. It is widely 
accepted that a decreased ERP is the first indicator of resistance (Sangster, 2001), but 
the definition and interpretation of ERP differs. Some studies define ERP as the week of 
the first positive FEC post-treatment (Little et al., 2003; Lyons et al., 2008). Others 
define ERP as a fixed threshold of the mean egg count such as 100 or 200 EPG 
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(Boersema et al., 1996; Mercier et al., 2001) or use FECRT to calculate weekly efficacy 
and use a designated threshold to define the ERP (Tarigo-Martinie et al., 2001; von 
Samson-Himmelstjerna et al., 2007). Ideally, a FECRT should be followed by measuring 
the ERP, that way if egg shedding resumes earlier than the expected ERP this could act 
as an early indicator of a lack of efficacy and decisions about the future use of that 
particular anthelmintic can be made. 
BZ were first introduced in the 1960s. Since then, reduced efficacy against 
cyathostomins has been reported in more than 21 countries (Lyons et al., 1999; Kaplan 
et al., 2004). Studies have reported the prevalence of FBZ resistance to be >70% of 
premises tested (Fisher et al., 1992; Craven et al., 1998; Lind et al., 2007) and, in some 
areas, the prevalence measured approaches 100% (Kaplan, 2004). Many researchers 
believe that FBZ resistance is ubiquitous in cyathostomin populations (Kaplan et al., 
2004; Lind et al., 2007; Traversa et al., 2009). Compared to the situation with FBZ, 
identification of cyathostomin resistance to PYR has been less frequently reported, 
although the phenomenon is common in certain countries such as the USA (Kaplan et 
al., 2004). However, the true prevalence of PYR resistance may be underestimated due 
to a lack of studies in the field (Stratford et al., 2011). The ML class dominate the 
equine anthelmintics market worldwide (Nielsen et al., 2006; Comer et al., 2006; Lind 
et al., 2007; Allison et al., 2011). Reduced efficacy of IVM has been measured in 
cyathostomins in the UK (Traversa et al., 2007), the US (Lyons et al., 2008) and 
Germany (von Samson-Himmelstjerna et al., 2007). A recent multinational study 
performed in UK, Germany and Italy reported IVM resistance (FECR<95%) on 3% of 
farms, with on one farm, resistance demonstrated to all three classes in small 
strongyles (Traversa et al., 2009). There have been several reports of a reduction in the 
strongyle ERP following IVM administration in Europe, Brazil and the USA (von 
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Samson-Himmelstjerna et al., 2007; Molento et al., 2008; Lyons et al., 2008). For 
example, Lyons et al. (2008) reported a strongyle ERP of four weeks following IVM 
treatment in 27 yearlings and 19 foals on 6 yards in Kentucky. The same authors 
performed a follow-up study looking into the probable reasons for the observed ERP 
by performing critical tests, which involve counting and identifying worms that 
survived treatment. In this study, the researchers necropsied four yearlings that had 
previously been enrolled as foals in the study above (Lyons et al., 2008) and had been 
born and raised under the same conditions and grazed on the same pasture (Lyons et 
al., 2009). In three horses that were necropsied six days post-treatment, efficacy (as 
measured by a reduction of >90%) versus cyathostomin fourth stage larvae (L4) was 36 
– 80%, whilst efficacy against adult cyathostomins was 99 – 100%. The authors 
concluded that the probable reason for the observed reduction in IVM ERP in the 
previous study was due reduced efficacy of IVM versus L4 and L5 allowing these stages 
to survive treatment and resume maturation and egg laying much sooner than when 
the anthelmintic was first licensed (Lyons et al., 2009). The first report of potential 
cyathostomin resistance to MOX was reported in donkey populations on a welfare 
sanctuary in the UK (Trawford et al., 2005; 2012). Here, there had been a history of use 
of a MOX formulation licensed for use in cattle, which had been administered orally to 
the donkeys. In two trials, the first of which monitored strongyle ERP over the grazing 
season following MOX treatment, a mean strongyle ERP of eight weeks was measured. 
In a second trial, two groups were studied; one in which FEC were measured 14 days 
after administration and the other 25 days post-treatment. Mean reductions in 
strongyle FEC in these two trials were 77 and 87%, respectively. The authors 
concluded that the effect was likely to be attributed to using a MOX formulation not 
licensed in donkeys as this could have affected pharmacokinetics of the compound 
leading to sub-optimal concentrations of the anthelmintic at the site of action 
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(Trawford et al., 2005). A recent study in Kentucky reported a shortened strongyle 
MOX ERP of five weeks in 15 yearling horses which had naturally acquired infections 
(Rossano et al., 2010), while a another in which MOX and IVM were evaluated found 
the strongyle ERP to be as low as 4 and 6 weeks, respectively (van Doorn et al., 2014). 
Similarly a mean strongyle ERP following MOX administration has been reported as 
four weeks in Brazil (Molento et al., 2008). Generally, there is little strongyle ERP data 
available and as such, there is a real need to generate additional data to further assess 
the effectiveness of the MLs across regions.  
Ivermectin resistance in P. equorum was first recorded in 2002 in Europe (Boersema et 
al., 2002) and Canada (Hearne and Peregrine, 2003; Slocombe et al., 2007). The FECRT 
study carried out by Boersema et al. (2002) was in response to a report of failure of ML 
in controlling P. equorum on a stud farm. Here, seven foals that tested positive for P. 
equorum eggs by FEC were treated with MOX; 19 days later FEC were performed to 
reveal that the MOX did not reduced pre-treatment FEC by >90% in any foal. Two foals 
with the highest FEC were treated with IVM and the FEC were not reduced >90 % at 19 
days post-treatment indicating resistance (Boersema et al., 2002). In 2003, a further 
report of IVM resistance was made (Hearne and Peregrine, 2003). Here, 16 
Thoroughbred foals with low to medium P. equorum FEC were treated with IVM. Post-
treatment FEC at 13 days post-treatment revealed that FEC had increased in seven 
foals and remained the same in one. A further 21 foals were treated with IVM and 12 
had a positive FEC 13 days post-treatment (Hearne and Peregrine, 2003). 
Subsequently, a critical test was performed using the isolate from the Canadian FECRT 
study (Kaplan et al., 2006). Here, 11 foals that had been raised helminth free were 
inoculated orally with larvated eggs at six weeks to three months of age. They were 
treated with IVM and necropsied 13 days post-treatment. The results revealed that IVM 
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did not significantly reduce the pre-treatment FEC and on average only reduced worm 
number by 26%, (Kaplan et al., 2006). Subsequently, there have been several reports of 
ML resistance in P. equorum in young horses (Craig et al., 2007; Slocombe et al., 2007; 
von Samson-Himmelstjerna et al., 2007; Veronesi et al., 2009), which is of concern 
given the potential pathogenicity of this helminth. It has been suggested that the 
development of IVM resistance in ascarids may be attributable to the heavy use of this 
compound in young foals and weanlings on horse farms (Kaplan, 2004; Reinemeyer, 
2012). There have been anecdotal reports of ML treatment failures against O. equi 
(Durham and Coles, 2010; Rock et al., 2013) and recently, Wolf et al. (2014) reported 
continuous O. equi egg shedding in two groups of horses following MOX treatment. In 
one horse, continuous egg shedding was recorded 13 weeks post-treatment. Due to the 
long prepatent period of this parasite (quoted as 4.5 months), post-treatment egg 
shedding was not attributed to new infections. To date there have been no reports of 
AR in the large strongyle or tapeworm species. 
Taken together, the evidence summarised above suggests that AR is an increasing 
problem in the helminth species that affect equids, based on the current guidelines for 
classifying resistance. This is of particular concern as there are no new anthelmintic 
classes likely to become available in the short to medium term for horses, and it is now 
essential to preserve efficacy of the currently effective ones, particularly MOX, which is 
the only anthelmintic effective against larval stages of cyathostomins. The primary aim 
of control regimens should focus on the preservation of anthelmintic-sensitive 
nematode populations and this needs to be balanced with minimising the risk of 
parasite-associated disease. 
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1.4.1 Factors affecting anthelmintic efficacy in equids 
 
The current opinion of many parasitologists is that one of the most important factors 
associated with the development of AR is the proportion of parasites in refugium (van 
Wyk, 2001; Kaplan, 2004). Parasites in refugia include stages in the host that are 
potentially not exposed to anthelmintics (i.e. encysted cyathostomin larvae), free-living 
stages on pasture and parasites in untreated hosts (Nielsen et al., 2014a; Nielsen et al., 
2014b). Maximising levels of refugia includes reducing the frequency of treatments, 
especially when levels are presumed to be low on pasture (i.e. during cold winters or 
hot summers or clean, non-grazed pasture). Using FEC to identify horses that are 
shedding moderate-to-high numbers of eggs in their faeces, and targeting treatments to 
these individuals while leaving low egg shedders untreated provides refugia (Kaplan 
and Nielsen, 2010). It has been proposed that nematodes that exist in refugia are not 
exposed to selection pressure for AR and thereby provide a source of susceptible 
alleles that in the next generation would act to ‘dilute’ resistant alleles in the 
population that are theoretically selected for in worms that survive treatment 
(Sangster, 2001; van Wyk, 2001, Nielsen et al., 2007).  The concept of maintaining a 
population of helminths in refugia, thus providing a pool of anthelmintic susceptible 
genotypes was originally suggested in the 1980’s (Martin et al., 1981), and is central to 
current recommendations for the management of anthelmintic resistance worldwide 
(van Wyk, 2001; Pomroy, 2006; Waghorn et al., 2008). However, evidence 
demonstrating the effectiveness of this strategy is scant in horses, with experiments to-
date conducted in small ruminants. In sheep, Martin et al. (1981) demonstrated that 
development of thiabendazole resistance could be slowed by exposing smaller 
proportions of each generation of Haemonchus contortus to anthelmintic treatment. In 
further studies (Leathwick et al., 2006a; Leathwick et al., 2006b; Waghorn et al., 2011), 
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it was reported that leaving up to 20% of lambs untreated with anthelmintic could 
delay resistance development. The main caveat in leaving a proportion of lambs 
untreated was the increase in pasture contamination leading to a reduction in 
productivity as FEC analysis was not performed to identify high egg shedding animals. 
In horses, targeted approaches that have been proposed are based on the 
measurement of individual FEC to identify moderate-to-high egg shedders, so that 
anthelmintics can be targeted appropriately. This is not as practical in ruminant 
species, as often, there are hundreds of animals per flock/herd, which are rarely 
handled individually, whereas horses are usually kept in small groups and are handled 
daily making collecting faeces from individuals more achievable. 
 
Anthelmintic exposure selects for the survival of individuals possessing alleles that 
reduce susceptibility to a particular anthelmintic class. Resistance can only occur when 
the relevant allele(s) are present in the population (Sangster, 2001). Parasitic 
nematodes have high levels of genetic diversity (Gilleard and Beech, 2007) and large 
population sizes, which means that within populations, resistance-conferring alleles 
may be present in sensitive populations even if they have not been previously exposed 
to a particular anthelmintic (Matthews, 2008). A simple mutation can lead to a switch 
from a susceptible genotype to a resistant one when an alteration in nucleotide 
sequence at a single site (known as a single nucleotide polymorphism (SNP)) occurs 
(Matthews, 2008), as is the case with resistance to the BZ class of anthelmintics. Once 
such a SNP is present in a population, each time a horse is treated with the same 
anthelmintic, the majority of worms that survive are resistant and subsequent 
treatments will eventually lead to a higher proportion of the population with the 
resistant genotype. It is the current opinion that resistance is a permanent trait and 
resistant genotypes do not revert to susceptibility even when a population has not 
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been exposed to the associated anthelmintic class for a number of years (Jackson and 
Coop, 2000). However, evolutionary pressure could result in a loss of resistance if 
resistance was not a favourable trait for survival. 
There is evidence to suggest that anthelmintics are not as effective when used in 
younger horses. Early studies conducted on a Thoroughbred breeding farm between 
1982 and 1988 found that oxbendazole (OXB), PYR and IVM were significantly less 
effective when administered to yearlings compared to adult mares (Herd and Gabel, 
1990b). Here, the authors measured how effective each anthelmintic was at 
suppressing strongyle FEC output at for four-week intervals for OXB and PYR and 
eight-week intervals for IVM. Acceptable efficacy was classified as the mean FEC being 
measured as less than 100 EPG at the defined interval. OXB was found to be 
significantly (p<0.05) less effective at suppressing FEC in yearlings compared to mares. 
PYR was administered on 10 occasions, and on each occasion, the mean FEC exceeded 
100 EPG in the yearlings but not the mares. IVM was administered on four occasions 
and a significant (p=0.001) group mean reduction in IVM efficacy was observed in 
mares compared to the yearlings (Herd and Gabel, 1990b). A recent study conducted 
on UK Thoroughbred studs, reported that PYR was effective in two groups of mares 
(group mean FECR 98% - 99%), compared to five groups of yearlings in which efficacy 
ranged from 0 - 73% (Relf et al., 2014). A reason for the observed reduced efficacy in 
younger horses is the fact that younger horses lack acquired immunity, which allows a 
greater accumulation of encysted cyathostomins (Lyons et al., 2009). When 
anthelmintics such as BZ, PYR and IVM are administered, which do not possess high 
efficacy against these stages, once luminal adult worms have been eliminated, encysted 
stages may emerge and resume development and eggs are seen in faeces sooner 
compared to adult horses, which harbour fewer encysted stages (Herd, 1986; Herd and 
Gabel, 1990b). A study looking at PYR efficacy on 64 Danish horse farms also found that 
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PYR ‘efficacy’ increased with age and that, as pre-treatment egg counts increased, 
pyrantel efficacy appeared to decrease (Nielsen et al., 2013). It is well documented that 
strongyle FEC are higher in younger horses compared to adult horses (Relf et al., 2013). 
However, Nielsen et al. (2013) proposed that the explanation for the observed lack of 
efficacy in younger horses with a higher FEC is technical not biological, as using a FEC 
method with an egg detection limit of 20 EPG, a horse with a 200 EPG count treated 
with a drug with a 90% efficacy will be likely to exhibit 0 EPG post-treatment, because 
the low level egg count is likely to go undetected due to a lack of FEC method 
sensitivity. However, if a horse has a pre-treatment FEC of 1000 EPG as measured 
using the same FEC method and is treated the same drug, eggs are likely to be detected 
post-treatment leading to a lower observed efficacy. 
The rotation of anthelmintic classes over time was originally advocated to reduce 
selection pressure to any one class (Drudge and Lyons, 1966). The rationale being, by 
using an anthelmintic with a different mode of action, any parasites surviving the 
previous treatment will be killed. Two rotation plans have been advocated; slow 
rotation, where a single anthelmintic class is used for a year and fast rotation, whereby 
the class is rotated after each deworming occasion. The majority of studies looking into 
anthelmintic rotation and the effect it has on resistance levels have been performed in 
sheep and goats (Martin et al., 1981; Lawrence et al., 2006; Hughes et al., 2007). These 
studies found that fast rotation of classes may mask the emergence of AR. In horses, 
slow rotation could be challenging, especially in light of the high levels of resistance to 
FBZ in cyathostomins, and increasing reports of resistance to PYR in these nematodes, 
making rotation difficult (Kaplan and Nielsen, 2010). 
The dose and move strategy, whereby animals are treated with anthelmintic and then 
moved immediately to ‘clean’ pasture with low levels of parasite infestation has been 
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recognised for many decades and widely advocated as a control practice in many 
species, including horses (Brunsdon, 1980). The rationale being that grazing animals 
will have a reduced exposure to challenge with larvae, resulting in a slower rate of 
reinfection after anthelmintic treatment (Brunsdon, 1980). Clean pastures can be 
maintained by management practices such as re-sowing grass, grazing with alternative 
stock classes, or resting pastures (Brunsdon, 1980; Barger, 1999). However, it has been 
recognised that ‘dose and move’ strategies can place strong selection for resistant 
parasites, because worms surviving treatment become the major source of subsequent 
contamination of clean pasture (Le Jambre, 1978; Cawthome and Whitehead, 1983; 
Michel, 1985; Taylor and Hunt, 1988; Taylor and Hunt, 1989; Martin, 1989) and levels 
of refugia are diminished. Despite this, the practice has been widely implemented, 
particularly in small ruminants (Martin, 1989; Anderson, 1990; van Wyk, 2001; Besier 
and Love, 2003). Evidence of AR in sheep was found to be associated with treatment 
prior to movement to ‘clean’ pastures (Vlassoff and Kettle, 1980; Cawthome and 
Whitehead, 1983; Martin et al., 1985; Taylor and Hunt, 1988). Modelling studies have 
also indicated the selective potential of treatment prior to movement onto low-
contamination pastures (Leathwick et al., 1995; Barnes et al., 1995), but the most 
compelling evidence suggesting that dose and move strategies increase resistance have 
come from field studies in sheep. In a study by Martin (1989), lambs were treated with 
an anthelmintic in late spring followed by a move to ‘clean’ pasture, and subsequently 
received two further treatments with the same anthelmintic in summer. Changes in the 
levels of AR in parasite populations in those lambs, as measured by the Egg Hatch Test 
(EHT), were compared with lambs that were moved to clean pasture but not treated 
with anthelmintic. The authors found that levels of resistance increased dramatically 
after even a single treatment associated with a move to clean pasture (Martin, 1989). 
Two recent studies in New Zealand have provided further evidence. In the first, the 
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authors found that when 100 % of lambs were treated prior to a move onto clean 
pasture, levels of resistance in the resulting larval populations on pasture increased 
compared to when 10 – 20% of lambs were left untreated (Waghorn et al., 2008). In the 
second study, lambs were treated and moved to pastures prepared with differing levels 
of contamination with infective stage nematode larvae. The authors found that 
following treatment, moving lambs onto pastures with the lowest levels of 
contamination resulted in significantly higher levels of resistance compared with 
moving onto pastures with larger levels of contamination (Waghorn et al., 2009). These 
studies provide evidence that dose and move strategies increase the development of 
resistance and support the notion of maintaining levels of parasite refugia. There are 
no data to demonstrate the impact of dose and move strategies on the development of 
resistance in equine parasites, but given that the biology of equine strongyles and ovine 
trichostrongyles is similar it could be postulated that reducing levels of refugia after 
treatment of horses could lead to the same observations. 
1.5 Control of equine parasites 
Due to the prevalence of helminths in equids and the pathogenic potential of certain 
species, control is necessary to protect their health. To break transmission of 
helminths, control methods broadly fall into two categories; anthelmintic 
administration and environmental control. Multiple anthelmintic dosing regimens have 
been recommended in the past namely, interval dosing, strategic- and targeted dosing 
reviewed by (Proudman and Matthews, 2000). Moreover, various management 
practices have been suggested to reduce the build up of parasite eggs and infective 
larvae in the environment (Drudge, 1966; Herd , 1993): for example, the regular 
removal of dung from pastures (Herd, 1993). 
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Interval dosing regimens were first proposed in the 1960’s and were based on the 
application of broad-spectrum anthelmintics to all horses in a population at regular 
intervals (Drudge and Lyons, 1966). These programmes were designed to reduce the 
morbidity and mortality associated with infection with S. vulgaris, which was present 
at high prevalence at the time. The treatment intervals were designed around the ERP 
identified at the time each anthelmintic was first licensed with the aim of eliminating 
nematode egg excretion and pasture contamination. This approach successfully 
reduced large strongyle and other worm related disease in horses (Kaplan, 2002); 
however, it is believed that this approach has significantly contributed to, and 
accelerated, the rate of development of AR. Strategic dosing was first suggested in the 
1980’s (Reinemeyer, 1986) and promotes the administration of anthelmintics at 
specific times of year based on knowledge of helminth epidemiology and life cycles, 
with the overall aim of disrupting seasonal transmission (Proudman and Matthews, 
2000). While this approach might be considered to offer a more rational approach than 
interval dosing, it does not consider the distribution of parasites amongst host 
populations, or different levels of nematode egg excretion between individuals, nor 
does it address changes in weather, which can cause early or late peak pasture 
infectivity (Proudman and Matthews, 2000). Targeted dosing relies on administering 
anthelmintics at the most appropriate time of year, whilst considering the life cycle and 
epidemiology of parasites and taking into account variation in nematode egg excretion 
amongst individuals. This approach includes the measurement of individual FEC of 
horses within populations at specific times of the year to facilitate targeting of 
anthelmintics to only those excreting moderate-to-high levels of nematode eggs in their 
faeces (Duncan and Love, 1991; Gomez and Georgi, 1991). Helminth infections tend to 
be highly over-dispersed amongst hosts (Crofton, 1971; Anderson and May, 1978; 
Shaw and Dobson, 1995; Shaw et al., 1998), and equine nematode infections are no 
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exception (Kaplan and Nielsen, 2010; Relf et al., 2013). This has been demonstrated in 
a recent study looking at helminth egg excretion on UK Thoroughbred stud farms. Here, 
Relf et al. (2013) reported that 11% of 1,221 horses tested by FEC analysis were 
responsible for excreting 80% of eggs detected in samples collected over the sampling 
frame. Such levels of over-dispersion provide an opportunity for sustainable control via 
targeted anthelmintic therapy (Sangster, 1999). The EPG threshold value used to 
prompt treatment is usually between 200 - 500 EPG (Uhlinger, 1993; Larsen et al., 
2011). Some studies have provided evidence that horses tend to sustain strongyle egg 
shedding status; i.e. those that shed high numbers of eggs in their faeces when first 
assessed often have higher FEC than co-grazing horses over time, despite similar levels 
of parasite exposure (Nielsen et al., 2006; Becher et al, 2010). For targeted treatment 
protocols to be successful, it is necessary to understand the factors that affect strongyle 
egg shedding. Such knowledge will facilitate decision making and create optimum 
protocols to determine frequency of FEC testing and to identify risk factors associated 
with increased egg shedding so that only horses that require treatment are targeted. 
Major caveats to the application of a FEC directed targeted treatment programme 
include the fact that FEC do not detect encysted cyathostomin larvae and do not 
reliably detect tapeworm eggs. Because of the potential pathogenicity of cyathostomin 
EL, the current recommendation is that all horses should receive an anthelmintic with 
larvicidal activity (i.e. moxidectin) and PRZ for tapeworm in late autumn or early 
winter in the UK (Matthews, 2008). Further, reducing anthelmintic treatment 
frequency and in low egg shedding horses, totally withholding anthelmintic treatment, 
creates a risk for the re-emergence of S. vulgaris and other large strongyle species 
(Nielsen et al., 2012). A recent study conducted on 42 horse farms in Denmark looked 
at the prevalence of S. vulgaris at individual horse level and farm level by culturing the 
faeces of 662 horses. They found that at individual level and farm level, the prevalence 
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of S. vulgaris was significantly higher on farms that practiced FEC directed strategic 
treatments compared to farms that treated at regular intervals (Nielsen et al., 2012). 
This highlights the need for routine surveillance of S. vulgaris when following FEC 
directed targeted treatment programmes especially if anthelmintics are totally 
withheld from ‘low shedding’ individuals. 
1.5.1 Parasite management practices 
 
A number of studies have shown that many horses are dewormed too frequently and 
that veterinarians have become dissociated from equine parasite control practices 
(Matthews, 2008; Stratford et al, 2011). In racing yards in the UK, Earle et al. (2002) 
found that only 29% of racing yard trainers involved a veterinary surgeon in their 
deworming programmes (Earle et al., 2002) and in a later survey, 84% of horses from 
Thoroughbred training yards were found to be administered with an anthelmintic even 
when a FEC performed prior to treatment was shown to be less than 50 EPG (Comer et 
al., 2006). A questionnaire study conducted in Ireland reported that of 55 yard owners 
questioned, none of the respondents left any animals untreated, 72% administered 
anthelmintics based on a treatment interval of <8 weeks, indicating that if they were 
administering MLs, they would be treating horses within the standard ERP, thus 
potentially exerting a strong selection pressure for resistance (O’Meara and Mulachy, 
2002). Further, only 40% of recipients owned an accurate weighing device, which 
could lead to inaccurate dosing and could potentially lead to parasites being exposed to 
a sub-lethal dose of anthelmintic, thus increasing selection pressure for resistance 
(Stratford et al., 2014a). In a more recent study carried out on 61 UK Thoroughbred 
studs, the authors found that despite many respondents indicating a high level of 
concern about AR, many were not aware of the risk factors for development of 
resistance (Relf et al., 2012). In the preceding 12 months, 98% of respondents stated 
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that they had administered an ML, and 100% of respondents administered 
anthelmintics on an interval basis. None of the yards performed any regular FEC 
analysis (Relf et al., 2012). Considering that some respondents were administering up 
to nine ML treatments per year, there will clearly be selection pressure for AR. An 
online study performed in the UK targeting the general horse owning population 
(Allison et al., 2011) found that <60% of respondents (n = 574) believed that their 
current programme was not as effective as it could be. In this study, 49% of the horses 
were kept on livery yards and the owners indicated that they followed a deworming 
regime imposed by the yard manager. In total, 40% of owners indicated that were ‘not 
happy’ with the imposed programme. Further, 84% of owners stated that they were 
aware of AR, 89% stated that they would be interested in finding out if their horses are 
affected by AR, and 83% said they would be willing to pay two pounds or more per 
month to regularly check for resistance, which is encouraging. However, while 94% of 
respondents believed their horses were reasonably or well protected from worms, only 
25% wanted to reduce the amount of anthelmintic they used and only 31% followed a 
FEC directed regimen (Allison et al., 2011). A recent questionnaire study conducted in 
Scotland (Stratford et al., 2014a) reported that ML or related combination products 
were most commonly administered and that treatments licensed for use against 
cyathostomin EL and tapeworms were administered to horses by 80% and 90% of 
respondents (n = 193), respectively (Stratford et al., 2014a). In this study, it appeared 
from the responses that veterinarians had the greatest influence on control practices 
(40% of 193 respondents), which contrasts to the findings of the earlier study by 
Allison et al. (2011). While 40% respondents believed they practiced ‘targeted dosing’, 
this was not associated with delaying treatment beyond the standard ERP of the 
anthelmintic used (Stratford et al., 2014a). 
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The evidence from these questionnaire studies indicates that horse owners are 
becoming increasingly aware of the issue of AR and the need to adopt more sustainable 
approaches to control. Nevertheless, it was clear from the results that the majority are 
confused by these concepts and few are actually following robust FEC directed targeted 
treatment programmes. The challenge now is to educate and encourage those that 
prescribe anthelmintics to support the application of FEC directed targeted 
programme, and to convince horse owners to deviate from traditional approaches to 
control. A greater emphasis needs to be placed on diagnostic tests such as the FEC and 
FECRT to identify which horses need treatment and to improve surveillance of AR. 
1.5.1.1 Dung removal 
 
The regular removal of dung from pasture has been advocated to help reduce pasture 
contamination (Herd, 1993; Herd and Coles, 1995). The rationale being to remove 
strongyle larvae before they develop into L3, which migrate from the faeces onto the 
pasture (Mathee et al., 2004). This approach, in conjunction with reducing the 
frequency of anthelmintic treatments, is now widely recommended to reduce selection 
pressure for AR (Corbett et al., 2014). A recent study, conducted at the Donkey 
Sanctuary in the UK, investigated the effectiveness of dung removal methods to control 
small strongyle burdens in donkeys (Corbett et al., 2014). Here, faecal samples and 
pasture samples were collected on a monthly basis for seven months from donkeys 
managed under three different pasture management strategies. The results revealed 
that twice weekly removal of faeces from pastures, either by manual or automated 
means, significantly reduced the number of strongyle eggs shed in faeces of co-grazed 
donkeys (Corbett et al., 2014). It has been suggested that regular dung removal may 
reduce refugia, which may lead to an increase in the likelihood of AR (Nielsen et al., 
2007) however; further research is needed to investigate this. The study by Corbett et 
 61 
 
al. (2014) was conducted in donkeys, which only received anthelmintic treatment if 
their egg count exceeded 2000 EPG (i.e. higher that the arbitrary 200 EPG threshold 
currently recommended for horses) therefore, studies need to be performed in horses 
to evaluate how effective dung removal is and to determine suitable EPG thresholds for 
anthelmintic treatment for animals that graze pastures which are regularly cleaned. 
1.5.1.2 Co-grazing with ruminants 
 
Allowing ruminants to co-graze with horses has been recommended as a way to reduce 
pasture contamination (Herd, 1986). Few nematode species are shared between horses 
and ruminants, with the exception of Trichostrongylus axei, which is of little pathogenic 
significance to equids. A caveat to this approach is the increasing prevalence of F. 
hepatica in ruminants (Mitchell, 2002; Gordon et al., 2013). F. hepatica has a wide host 
range, including humans and equids. Currently, routine surveillance of F. hepatica in 
equids is not performed and further, routine FEC analysis will not reliably detect fluke 
eggs. There is a lack of information on the prevalence of F. hepatica and the clinical 
significance of fluke in equids in the UK and, in light of the increased prevalence of this 
trematode, there is a need for further research. In addition, there are no licensed 
flukicides available for use in equids in the UK, with treatment only allowed by a 
veterinary surgeon under the ‘cascade’ option: a legal flexibility that allows veterinary 
surgeons to prescribe an unlicensed product in the absence of a suitable licensed 
product. In areas where fluke prevalence is high and in areas where the intermediate 
snail host is found, ruminants should be tested and treated with an appropriate 
anthelmintic before being turned out with horses or donkeys or used in rotational 
grazing plans with horses (Matthews and Burden, 2013).  
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1.5.1.3 Quarantine 
 
Newly introduced horses have the potential to disseminate anthelmintic resistant 
parasites and should be treated with an effective broad-spectrum anthelmintic with 
activity against encysted cyathostomin and large strongyle larvae (Kaplan, 2002; 
Matthews, 2008, 2011; Lester and Matthews, 2014). It has been suggested that after 
quarantine treatment, horses should not be turned out onto pasture for 72 h, to ensure 
all eggs have been excreted in faeces (Nielsen et al., 2010). This is viewed as best 
practice and should be recommended. To date, there have been no studies conducted 
to investigate the impact of not quarantining horses in terms of spreading resistant 
nematodes, but data from surveys in New Zealand indicated that sheep farms that had 
introduced large numbers of purchased stock were significantly more likely to test 
positive for IVM resistance than those that did not (Lawrence et al., 2006; Hughes et al., 
2007). In a further study, on sheep farms in Western Australia, the prevalence of IVM 
resistance was linked with failure of farmers to quarantine-treat stock after purchase 
(Suter et al., 2004). These data support the view that failure to adequately quarantine-
treat animals is responsible for the dissemination of anthelmintic resistant nematodes 
(Coles and Roush, 1992).  
1.6 Project aims 
 
The evidence presented in this Chapter, indicates that of all the helminth species to 
affect horses, the cyathostomins present the greatest challenge while, in foals, P. 
equorum is the greatest threat. The frequent, prophylactic administration of 
anthelmintics has contributed to the development of widespread resistance in 
cyathostomins and P. equorum and recent evidence suggests that resistance to MLs in 
O. equi is a potential issue and chemical options for control are becoming limited and 
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unsustainable. With no new anthelmintic classes likely to be licensed for use, in the 
near future, control programmes must be designed to preserve efficacy of the currently 
effective ones. The primary aim of control programs must now be the preservation of 
anthelmintic-sensitive nematode populations, coupled with minimising the risk of 
parasite-associated disease. FEC directed targeted treatment programmes and regular 
efficacy testing have been advocated; however, if FEC are to become the cornerstone of 
control, there is a need to optimise the methodologies to ensure that they are fit for 
purpose. Results from questionnaire studies have demonstrated a large gap in 
knowledge regarding evidence-based helminth control. In light of the aforementioned 
issues, there is a real need to build a supportive framework for sustainable helminth 
control for horses.  
The aim of this study was to do this by investigating the following areas: 
1. Assessing sources of variation in equine FEC, which underpin anthelmintic-
targeted treatment programmes and anthelmintic efficacy evaluation, with the 
aim of producing guidelines to reduce variation and improve accuracy of these 
tests. 
2. Studying in detail, efficacy of commonly used anthelmintics in populations of 
horses to determine the current prevalence of AR in the UK. 
3. Investigating the true value the FECRT by comparing different methodologies 
to determine which is the most accurate and reliable to ensure that resistance 
is not misclassified. 
4. Identifying risk factors associated with nematode egg excretion. This was 
achieved by comparing FEC test results with questionnaire study answers on 
relevant management practices. 
5. Undertaking studies into the practical utility of these protocols in the field. 
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The information derived from the above areas was then used to build a framework 
for a decision support system (DSS) to facilitate sustainable helminth control in 
future. 
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CHAPTER 2: Performance of faecal egg 
count methods for the detection of equine 
parasites 
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2.1 Introduction 
 
There are a number of underlying factors that can lead to variability in faecal egg count 
(FEC) data. Biological factors include; fluctuation in egg excretion over time (Oju & 
Mpoame, 2006; Rinaldi et al., 2009), faecal consistency (Uhlinger, 1993; Le Jambre et 
al., 2007; Turner et al., 2010) and differences in the biotic potential of different parasite 
species (Mfitilodze and Hutchinson, 1987). Technical factors include; aggregation of 
eggs within faeces (Yu et al., 1998; Denwood et al., 2012), variation in the collection, 
storage and handling of samples (Nielsen et al., 2010b), the Poisson process as well as 
the type of FEC method used (Mes, 2003; Cringoli et al., 2004; Pereckiene et al., 2007; 
Vadlejch et al., 2011; Levecke et al., 2012a; Torgerson et al., 2012). Each of these factors 
forms the potential for aggregation of helminth eggs at each level, potentially leading to 
variability in faecal egg count (FEC) data and this may confound interpretation of the 
data. Downstream consequences might include under- or over-estimating the 
requirement for treatment, leading to unnecessary treatments or not treating horses 
that require treatment and/or the misclassification of anthelmintic efficacy i.e. 
classifying a drug as efficacious when it’s not or misclassifying a drug as resistant . If 
FEC analysis is to underpin evidence-based helminth control in horses, there is a need 
to investigate sources of variation to ensure that recommended methods are fit for 
purpose and minimise potential misclassification. 
2.2 Aims and objectives 
 
Here, technical factors associated with FEC variability were investigated, namely, the 
distribution of strongyle eggs in equine faeces at different levels where egg aggregation 
could occur. The levels investigated were the entire faecal motion, between faecal 
boluses, within boluses at individual bolus level and the distribution of eggs in 
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suspension. The biotic potential was not investigated here as there are over 50 species 
of cyathostomin (Lictenfels et al., 2008), each with varying biotic potential (Kuzmina et 
al., 2012) and there is no way of differentiating between cyathostomin species using 
FEC analysis. Two FEC methods were compared, the McMaster (McM) technique 
(Gordon & Whitlock, 1939), which is the most widely used technique in practice and a 
centrifugal-flotation (CF) technique (Christie and Jackson, 1982), which offers 
increased diagnostic sensitivity to assess the impact of variability on decisions to 
administer anthelmintics and on estimates of efficacy. Practical solutions are proposed 
to reduce FEC variability in practice in support of targeted anthelmintic use and 
efficacy monitoring. 
2.3 Materials and methods 
 
2.3.1 Faecal sample collection and storage 
 
All faecal samples were obtained from freshly voided material. A minimum of three 
faecal boli from each sample were collected and placed into a zip-lock bag, expelling as 
much air as possible before sealing. All samples were stored at approximately 4°C until 
being processed and analysed, which occurred within four days of collection to 
minimise the degradation of nematode eggs in the samples (Nielsen et al., 2010b). 
2.3.2. Faecal egg counting techniques 
 
2.3.2.1 McMaster method 
 
A McM technique (Gordon and Whitlock, 1939), described in the Ministry of 
Agriculture, Fisheries and Food technical manual (MAFF, 1986), was employed. In 
brief, the method involved adding 3 g faeces to 42 ml of saturated sodium chloride 
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solution (NaCl; specific gravity 1.204; MAFF, 1986) homogenising and then pouring the 
faecal suspension over a sieve (1mm aperture) into a beaker. Two different volumes of 
faecal suspension were examined using a standard McM slide (Fig. 2.1), either 1.0 ml 
(two entire chambers) resulting in an egg detection limit (dl) of 15 eggs per gram 
(EPG) (McM15) or 0.3 ml (two grids), resulting in an egg dl of 50 EPG (McM50). The 
total number of eggs counted using each variation of the method was recorded 
separately. 
 
 
 
 
 
 
 
Figure 2.1. The dimensions of a standard McMaster slide: C = chamber (1 chamber = 
0.5 ml) G = grid (1 grid = 0.15 ml) (modified from MAFF, 1986) 
 
2.3.2.2. Centrifugal-flotation method 
 
A modification of a CF method described by Christie and Jackson (1982), with an egg dl 
as low as 1 EPG was used for investigations into egg distribution. In brief, each gram of 
faeces was thoroughly mixed with 10 ml tap water. From this, a 10 ml aliquot was 
dispensed over a 1 mm sieve and washed through with a further 5 ml tap water. The 
resulting suspension was poured into plastic polymer tubes (Beckman Coulter Ltd. UK) 
and then centrifuged (203 x g for 2 min). After centrifugation and removal of the 
supernatant, the faecal pellet was re-suspended in 10 ml saturated NaCl solution 
(specific gravity 1.204; MAFF. 1986) and centrifuged at 203 x g for 2 min. Artery 
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forceps were used to clamp the tube just below the meniscus, isolating the eggs from 
the sample, and the contents above the forceps poured into a cuvette. The cuvette (2.5 
ml volume, Sigma-Aldrich® Co. UK) was inverted to ensure even distribution of the 
eggs and topped up with NaCl solution and then a lid applied. The cuvette was 
positioned horizontally under a compound microscope (x 40 total magnification) and, 
using a Miller square eyepiece graticule (Graticules Ltd. UK) (Fig. 2.2), eggs were 
enumerated depending on egg density. Where eggs were present at low density (i.e. ~< 
25 eggs in the cuvette), all eggs in the cuvette were counted, and no multiplication 
factor was used equating to an egg dl of 1 EPG. If eggs were at a moderate density (i.e. 
~25 - 50 eggs in the cuvette), two traverses of the cuvette were counted using the large 
square of the Miller eyepiece graticule, equating to a third of the total cuvette volume 
(Fig. 2.3A). The number of eggs in each traverse were added together and multiplied by 
a factor of three to give an EPG estimate, equating to an egg dl of 3 EPG. When eggs 
were at high density (i.e. ~> 50 eggs in the cuvette), two whole traverses of the cuvette 
were counted using the smaller square of the eyepiece, equating to one ninth of the 
total cuvette volume (Fig. 2.3B). The total number of eggs in two traverses were then 
added together and multiplied by a factor of nine to give EPG estimate equating to an 
egg dl of 9 EPG. Parasite eggs were differentiated into the following types: strongyles, 
Parascaris equorum, Oxyuris equi, Anoplocephala spp. and Strongyloides westeri 
(Thienpont, 1986). 
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Figure 2.2. Diagrammatic representation of Miller square eyepiece graticule (7 x 7 
mm), the small square is exactly 1/3 of the width of the larger square. The large square 
was used when the egg density was moderate, resulting in a detection limit of 3 eggs 
per gram (EPG). The small square was used when the egg density was high, giving a 
detection limit of 9 EPG 
 
Figure 2.3. Diagrammatic representation of the different areas examined depending on 
the egg density in the cuvette. A = medium egg density, here the number of eggs seen in 
two traverses (traverse 1 (T1) and 2 (T2)) using the large square of the Miller eye piece 
were recorded and multiplied by 3. B = high egg density, here the number of eggs seen 
in two traverses using the small square of the Miller eye piece were recorded and 
multiplied by 9 (adapted from Bartley and Elsheikha, 2011) 
 
2.3.3 Populations of equids used for the provision of faeces for 
analysis 
 
The populations of horses used in the different analyses were selected 
opportunistically and were not consistent between investigations. Faecal samples used 
for investigations into the distribution of strongyle eggs in faeces (Section 2.3.4) were 
collected from three horses (H1, H2 and H3) resident at the equine hospital at the 
Royal (Dick) School of Veterinary Studies (R(d)SVS), University of Edinburgh. These 
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samples were collected in October 2011. The horses were selected on the basis of 
having positive FEC during initial screening. The horses were aged between 5 and 15 
years. The samples used for investigations into the distribution of strongyle eggs at 
cuvette level (Section 2.3.5) were collected from 31 donkeys resident at the Donkey 
Sanctuary, Sidmouth, Devon, UK. The samples were collected in August 2013 and 
posted to Moredun Research Institute. All samples were analysed within 4 days of 
collection. All donkeys were over the age of 5 years (5 – 32 years), and were managed 
under the same conditions. The faecal samples used for studies into the effect of mixing 
(Section 2.3.6) and subsample size (Section 2.3.7) on the variance in FEC were collected 
from a population of ponies from Dartmoor and transported to Moredun Scientific for 
use in a clinical trial. Entire faecal motions were collected on a single occasion from 
seven ponies (designated H4, H5, H6, H7, H8, H9 and H10) in June 2012. The ponies 
were approximately 6 months old and had not received anthelmintic treatment prior to 
faecal collection. The ponies were maintained together and were housed at the time of 
sampling. The samples used for investigating the effect of FEC method on decisions for 
targeted treatment (Section 2.3.8) and the effect of FEC method on the estimated 
anthelmintic efficacy using the faecal egg count reduction test (FECRT) (Section 2.3.9) 
were collected from 13 horse yards (designated Yard 1 to 13). All yards were based in 
the southeast of England and were approached to participate in this study through the 
Bell Equine Veterinary Clinic, Kent, and the House and Jackson Veterinary Clinic, Essex, 
between March and December 2012. Further information about these horses can be 
found in Chapter 3, Section 3.3.1. 
2.3.4 Distribution of strongyle eggs in faeces 
 
The spatial distribution of strongyle eggs in faeces was investigated, as aggregation or 
clumping could be an important source of variation (Denwood et al., 2012; 
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Vidyashankar et al., 2012; Torgerson et al., 2012). The errors arising through the FEC 
process follow a hierarchical structure (Figure 2.4). Each different level was 
investigated as a potential source of variation. Single, entire motions were collected 
from three horses (designated H1, H2 and H3, respectively) residing at the equine 
hospital at the R(d)SVS, once a day at approximately the same time for three 
consecutive days, with the exception of one horse (H1), which was discharged from the 
hospital before the third day. Each motion was divided into individual boli and two, 1 g 
subsamples were taken from each; one from the surface and one from the centre, and 
analysed separately using the CF method. The remainder of each motion was 
thoroughly mixed by hand until all the boluses had been broken down and a 10 g 
subsample was taken from each and analysed twice by CF to give an estimation of the 
average FEC from well mixed faeces for each horse on each occasion. 
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Figure 2.4. The proposed hierarchical levels that could potentially lead to variation 
during faecal egg count analysis. Count (C1 and C2) refer to the two traverses made 
when egg density is >25 eggs per cuvette 
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2.3.5 The distribution of strongyle eggs at cuvette level 
 
The accuracy of the density dependent variations in dilution factor inherent to the CF 
method depends on the assumption that eggs are randomly distributed across the 
counting surface of the cuvette. To check this assumption, freshly voided faecal 
samples were collected from 31 donkeys resident at the Donkey Sanctuary, Sidmouth, 
Devon. The samples were well mixed before a 10 g subsample was taken for analysis 
by CF. For each sample, using the large square of the Miller eye piece, the number of 
eggs in five traverses of the cuvette, were recorded separately. Each cuvette was 
counted a second time and all eggs present in the cuvette were counted (1 EPG egg dl), 
then the number of eggs detected in a third of the cuvette were counted (3 EPG egg dl) 
and finally the number of eggs in a ninth of the cuvette (9 EPG egg dl). 
2.3.6 The effect of mixing samples on the variance of strongyle FEC 
 
Entire faecal motions were collected on a single occasion from four ponies (designated 
H4, H5, H6, H7) harbouring naturally acquired infections that were resident at the 
Moredun Research Institute. These ponies were from Dartmoor; they were 
approximately 6 months old and had not received anthelmintic treatment prior to 
faecal collection. The ponies were maintained together and were housed at the time of 
sampling. All motions were observed being voided and collected when fresh. From 
each entire motion, a total of 10 subsamples were randomly taken (i.e. by eye) for CF 
analysis (10 g per subsample) and a further 10 subsamples were randomly selected for 
McM analysis (3 g per subsample). The remainder of each unmixed motion was then 
thoroughly mixed manually and subsamples taken again as described above. For CF, 
the actual number of eggs observed in each cuvette was recorded. For samples 
analysed by McM, the actual number of eggs seen in the two grids (McM50) and the 
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two chambers (McM15) of a McM slide were recorded separately and no multiplication 
factor was applied. 
2.3.7 Effect of sample size on mean and variance of strongyle FEC 
 
Initial faecal sample size taken from an entire motion prior to taking a subsample for 
FEC analysis could have an effect on variance and repeatability of FEC results, the 
hypothesis being that a larger sample would be more representative of the entire faecal 
motion. Freshly voided entire motions were collected on one occasion from the three 
ponies (designated H8, H9 and H10, respectively) resident at the Moredun Research 
Institute. From each entire motion, three sample sizes were taken (3 x 7 g, 3 x 10 g and 
3 x 15 g). The remainder of each motion was mixed and further samples taken (3 x 7 g, 
3 x 10 g and 3 x 15 g). From each sample size, a 3 g subsample was taken and one McM 
slide per subsample was analysed. The actual number of eggs observed in each grid 
and in each chamber of the slide was recorded. 
2.3.8 The effect of faecal egg count method on decisions for targeted 
treatment 
 
Personnel at 13 equine yards (Yard 1-13) in the southeast of England were asked to 
submit faecal samples from all horses resident on each yard between March and 
December 2012. Large (~200 g), freshly voided, unmixed samples were collected from 
each horse and placed into sealed bags, carefully ensuring the removal of as much air 
as possible. Samples were sent to the laboratory by post within 24 h of collection. Once 
received, each sample was thoroughly mixed by hand and one 10 g and one 3 g 
subsample taken and analysed by CF and McM50, respectively. 
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2.3.9 The effect of faecal egg count method on the outcome of 
anthelmintic efficacy using the faecal egg count reduction test 
 
Faecal samples were obtained from all equids at each yard (Yard 1 to 13) once the 
minimum strongyle egg reappearance period (ERP) of the previously administered 
anthelmintic had passed. The standard minimum ERP used were as follows: 6 weeks 
for fenbendazole (FBZ) and pyrantel embonate (PYR), 8 weeks for ivermectin (IVM) 
and 13 weeks for moxidectin (MOX) (Herd and Gabel, 1990b, Borgsteede et al., 1993, 
Mercier et al., 2001, Stratford et al., 2011). Horses for which strongyle FEC of 50 EPG 
(counted by the CF method) were included and administered per os with anthelmintic 
on Day 0 at the following dose rates; FBZ (Panacur® equine paste, MSD Animal Health; 
7.5mg/kg body weight (BW)), PYR (Strongid-P™, Elanco animal Health; 19mg/kg BW), 
IVM (Eqvalan® oral paste for horses, Merial Animal Health; 0.2mg/kg BW) or MOX 
(Equest®, Zoetis Animal Health; 0.4mg/kg BW). Each horse received a dose appropriate 
for 110% of individual body weight, as estimated by weigh tape, to minimise the risk of 
under-dosing (Stratford et al., 2014b). Each individual was treated by their owner and 
monitored immediately afterwards to ensure that the paste/gel was ingested. All 
horses on the same yard received the same class and batch of anthelmintic. Faecal 
samples were collected on Day 0 immediately prior to anthelmintic administration and 
then at 14 days post-treatment (Stratford et al., 2014b). Each faecal sample was 
analysed by CF, McM15 and McM50. Testing of anthelmintic classes was performed in 
succession on several populations, starting with FBZ, followed by PYR, then IVM and 
finishing with MOX. 
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2.4 Statistical analyses 
2.4.1 Distribution of eggs in faeces 
 
If helminth eggs are randomly distributed within faeces then the number of eggs 
observed in serial randomly selected subsamples should follow a Poisson distribution 
(Denwood et al., 2012; Torgerson et al., 2012). The Poisson distribution (Equation 2.1) 
can be expressed as a discrete probability distribution, in which the probability of 
finding s eggs in a fixed volume of faeces is a function of the mean number of eggs per 
unit volume, m. A feature of the Poisson distribution is that the variance equals the 
mean. If variance exceeds the mean, this indicates over-dispersion (OD) or clumping of 
eggs (Hilborn and Mangel, 1997). The Poisson distribution is described by: 
𝑷𝒓(𝐙 = 𝒔) =
𝒆−𝒎𝒎𝒔
𝒔!
 
The mean, variance, variance to mean ratio, and coefficient of variation (CV; i.e. 
standard deviation divided by mean) were calculated for each entire motion, between 
boli, between subsamples and between counts at cuvette level (Figure 2.4) for each 
horse on each day. The distribution of eggs at each level was tested for OD by 
multiplying the variance to mean ratio by the number of degrees of freedom, and 
comparing the result with the chi-square distribution (Bliss and Fisher, 1953; Morgan 
et al., 2005). Where OD was confirmed (p<0.05), the negative binomial distribution 
(NBD) was fitted to the data by maximum likelihood estimation (MLE) (Williams and 
Dye, 1994; Shaw et al., 1998; Morgan et al., 2005) to give estimates of the mean, m, and 
the aggregation factor, k. The NBD is a discrete probability distribution, which is used 
to describe the amount of aggregation or OD in data, where decreasing values of k 
correspond to increasing levels of OD (Lloyd-Smith, 2007). The variance of the NBD is 
equal to (µ + µ2/k), so as k increases, (effectively k ≥c.10) the variance approaches the 
(Equation 2.1) 
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-k 
s 
mean and the distribution approaches the Poisson (Bolker, 2008). Here, the NBD is 
used to identify sources of supra-Poisson variability in FEC; thus, the likelihood of 
individual FEC (Z) from the multiple subsamples throughout the entire motion, given a 
combination of m and k was estimated using the formula in Equation 2.2 where 𝛤 
represents the gamma function. The point likelihoods for each FEC were multiplied and 
the log of this value was multiplied by -1. This value was minimised by changing m and 
k iteratively in turn using the Solver function in Excel (Torgerson et al., 2005; Morgan 
et al., 2005). Ninety-five percent confidence bounds for estimates of m and k were 
calculated by identifying the corresponding values for the negative log-likelihood plus 
1.92 (Hilborn and Mangel, 1997). 
 
Pr(𝑍 = 𝑠) =
𝛤(𝑘+𝑠)
𝛤(𝑘)𝑠!
 (
𝑚
𝑘+𝑚
) (1 +
𝑚
𝑘
) 
 
The chi-square goodness of fit test was used to assess whether the data adequately 
fitted the NBD (Shaw et al., 1998). The starting point for estimation of k was the 
corrected moment estimate (Smith and Guerrero, 1993) using Equation 2.3, where m is 
the mean, v is the variance, and n is the sample size: 
𝑘 =
𝑚2− (
𝑣
𝑛
)
𝑣−𝑚
 
The actual number of eggs seen, as opposed to the EPG estimations following a 
multiplication factor, was used for both the MLE and the initial calculation for OD to 
reduce the inflation of variance introduced by a multiplication factor (Torgerson et al., 
2012). 
(Equation 2.2) 
(Equation 2.3) 
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The relationship between the mean number of eggs and k at each level was 
investigated by Poisson regression with a zero intercept using the “glm” function in 
RStudio version 2.15.1. All models were then plotted using ‘ggplot2’ (Wickham, 2012). 
 2.4.2. The distribution of strongyle eggs at cuvette level 
 
The distribution of eggs within the cuvette was investigated because with the CF 
method, when egg density is medium-high, not all eggs in the cuvette are counted, and 
if eggs are clumped in suspension within the cuvette this could lead to erroneous FEC 
results. Initially, the distribution of eggs in the cuvette was investigated by multiplying 
the mean to variance ratio of the number of eggs detected in each of the five traverses 
for each sample by the number of degrees of freedom, and comparing the result with 
the chi-square distribution (Bliss and Fisher, 1953; Morgan et al., 2005). Significant OD 
was present when p< 0.05. To investigate whether counting either a third (3 EPG 
detection limit) or a ninth (9 EPG detection limit) of the cuvette area was as accurate as 
counting all eggs in the cuvette (1 EPG detection limit), the total number of eggs 
counted in the cuvette (1 EPG) was divided by 3 and 9 and rounded to the nearest 
integer to give the expected (E) number of eggs seen in a third and a ninth of the 
cuvette, respectively. This was compared with the observed (O) number of eggs 
recorded when a third (3 EPG) and a ninth (9 EPG) of the cuvette was counted, using 
the chi-squared test (χ2) (Equation 2.4). The relationship between the 1 EPG count and 
the 3 and 9 EPG counts was analysed by Poisson regression. 
 
χ2 =∑
(𝑶−𝑬)𝟐
𝑬
 
(Equation 2.4) 
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2.4.3 The effect of mixing and of sample size on the variance of 
strongyle faecal egg count 
 
To examine the effect of mixing samples and the effect of sample size on the variance 
and OD of strongyle FEC for each set of counts from each horse, the mean and variance 
and CV were calculated and used to test for OD as described in Section 2.3.1. The 
relationship between mean and k in the unmixed and mixed samples was investigated 
by Poisson regression (See Section 2.4.1) 
2.4.4 The effect of faecal egg count methodology on decisions for 
targeted treatment 
 
The effect of FEC methodology on decisions for targeted treatment was examined for 
each yard and each FEC method. Thus, the yard mean EPG and variance were 
calculated and the NBD fitted to each dataset to gain an estimate of k (as described in 
Section 2.4.1). In addition, the percentage of horses exceeding the set threshold for 
treatment (set at 200 EPG) was calculated and a binomial test using the prop.test 
function in RStudio performed to investigate whether there was a significant (p<0.05) 
difference between the percentage of horses exceeding the 200 EPG threshold 
depending on which FEC method was used.  
2.4.5 The effect of faecal egg count methodology on the outcome of 
anthelmintic efficacy using the faecal egg count reduction test 
 
FECR datasets derived from the English yards (Yards 1- 11) and used in Chapter 3 were 
also used for this analysis. On these particular yards, screening samples on Day 0, and 
follow-up samples on Day 14, were collected and analysed by CF, McM15 and McM50 
following the methods outlined in Section 2.3.5. For each yard, the Day 0 and Day 14 
FEC derived from each FEC method were used to estimate the percentage reduction in 
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FEC using the World Association for the Advancement of Veterinary Parasitology 
(WAAVP) recommended formula (Equation 2.5). 
 
(
(𝐷𝑎𝑦 0 𝐹𝐸𝐶 − 𝐷𝑎𝑦 14 𝐹𝐸𝐶)
𝐷𝑎𝑦 0 𝐹𝐸𝐶
)  ×  100 
 
The relationship between Mean Day 0 and Mean Day 14 FEC by treatment for McM50, 
McM15 and CF was investigated by Poisson regression (See Section 2.4.1) 
2.5 Results 
 
2.5.1 The distribution of strongyle eggs in faeces 
 
Entire motions were collected from H1, H2 and H3 at approximately the same time 
each day for three consecutive days, with the exception of H1, which was discharged 
from the equine hospital on Day 2. The mixed average EPG estimated from 10 g of 
faeces are shown for each individual in Table 2.1. The number of boli examined from 
each entire motion differed on each occasion, and ranged from 19 to 30. The mean 
number of eggs observed from the two subsamples taken from each boli (edge and 
centre) ranged from 17 to 40 (Table 2.1). 
Significant OD of strongyle eggs was observed between counts performed on each 
entire motion, confirming that eggs are clumped within faeces. Values for k ranged 
from 5.4 to 12.4 and values for CV ranged between 0.3 and 0.5 (Table 2.1). Significant 
OD was observed in strongyle egg counts for each bolus within an entire motion when 
the mixed average EPG was less than 50 EPG, suggesting that clumping occurs at bolus 
level when egg density is low. The values for k ranged between 10.6 and 97.0 and the 
CV ranged from 0.2 to 0.4. Significant OD was observed between the two 1 g 
(Equation 2.5) 
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subsamples taken from each bolus for each horse on each day. Values for k ranged 
between 10.6 and 28.5, and the CV ranged from 0.2 to 0.4. When egg density in the 
faeces collected was moderate-to-high (H1 on Days 1 and 2 and in H2 and H3 on Day 
3), either a 3rd or a 9th of the total cuvette volume was counted. Here, the number of 
eggs seen in two traverses, using the small square of the Miller eye piece to count a 3rd 
of the cuvette or the number of eggs seen in two traverses using the small square to 
count a 9th of the cuvette, were recorded as count one and count two separately. There 
was significant OD of strongyle eggs between the two counts at cuvette level. Values for 
k ranged between 12.7 and 25.4 and the CV ranged between 0.4 and 0.5. 
The results show that in the entire motion and on days where two counts at cuvette 
level were made, the p-values and k were low, and the CV was greater compared to 
between boli and between samples. Each measure of OD was in agreement, suggesting 
that OD of strongyle eggs occurs throughout the entire motion and at cuvette level. The 
CV was greater throughout the entire motion in all horses on all days compared to 
between boli and between samples. On days where egg density was high and two 
counts of the cuvette were made, the CV was the same as in the entire motion (Figure 
2.5).  A Poisson regression model with k as the response variable and the mean number 
of eggs as the explanatory variable (Figure. 2.6; Table 2.2) showed that the values for k 
were significantly (p<0.01) lower in the entire motion compared to between boli and 
between samples, indicating that the greatest degree of aggregation occurred at motion 
level, followed by sample level, with the least aggregation observed at bolus level. 
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Table 2.1. Tests for over-dispersion of strongyle eggs within faeces at each level for each horse on each day where faecal egg counts were 
measured by the centrifugal-flotation technique 
    Entire motion Between boli Between samples Between counts 
Horse Day Mixed 
Av. 
EPG 
(10g)* 
No. of boli 
examined 
on each 
occasion 
Mean 
no. of 
eggs 
** 
p*** K cv p*** k cv p*** k cv p*** k cv 
H1 D1 248a 29 40 <0.001 8.7 0.4 0.2 60.5 0.3 <0.001 25.0 0.3 <0.001 12.7 0.4 
D2 356a 22 39 <0.001 10.9 0.4 0.2 75.0 0.3 0.0007 28.5 0.3 <0.001 14.5 0.4 
 
H2 
D1 35b 21 27 <0.001 10.1 0.4 <0.001 11.2 0.3 0.031 11.2 0.3 **** **** **** 
D2 18b 19 22 <0.001 6.3 0.5 <0.001 10.6 0.4 <0.001 10.6 0.4 **** **** **** 
D3 56c 26 17 <0.001 7.6 0.5 0.2 97.0 0.4 0.0004 17.4 0.4 0.004 12.8 0.5 
 
H3 
D1 45b 23 29 <0.001 5.4 0.5 <0.001 14.7 0.4 <0.001 14.7 0.4 **** **** **** 
D2 39b 24 23 <0.001 12.4 0.3 <0.001 47.0 0.2 0.0292 28.0 0.2 **** **** **** 
D3 71c 30 22 <0.001 7.3 0.4 0.2 84.0 0.3 0.0003 17.8 0.3 0.0085 25.4 0.4 
* Average eggs per gram (EPG) determined by taking a 10g well mixed subsample from the remainder of each motion, after sub-sampling as described in the methods section. 
a multiplication factor of 9 used to calculate EPG,  b no multiplication factor used all eggs counted, c multiplication factor of 3 used to calculate EPG 
k – aggregation factor cv - coefficient of variance, **Actual number of eggs seen in the cuvette either by counting all eggs (low egg density), all eggs seen in 1/3rd of the cuvette (moderate egg 
density) or all eggs seen in 1/9th (high egg density) *** Variance to mean ratio x degrees of freedom and compared result with chi-square distribution to test for significance. If <0.05 there was 
over-dispersion, **** Egg density low so all eggs within cuvette counted so OD between counts not tested 
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Figure 2.5. The coefficient of variation (CV) of repeated strongyle egg counts taken 
from the entire motion, between boli, between samples (two samples per bolus) and 
between counts for each horse (H1, H2 and H3) on each day as measured by 
centrifugal-flotation 
 
 
Figure 2.6. Poisson regression model with zero intercept for the mean number of eggs 
versus k for the entire motion, between boli and between samples 
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Table 2.2.  Poisson regression model of the mean number of eggs versus k for the 
entire motion, between boli and between samples 
 
Factor Coefficient Standard 
error 
Z value p  
Mean 0.004610 0.005122 0.90 0.368 Null deviance
: 3342.86  on 
24  df* 
Residual devi
ance:  212.39 
 on 20  df 
 
Motion 3.785172 0.150206 25.20 <0.001 
Boli 2.013215 0.186461 10.80 <0.001 
Sample 2.824145 0.163089 17.32 <0.001 
*degrees of freedom 
 
2.5.2. The performance of the centrifugal-flotation method 
 
The number of eggs seen in each traverse (T1 to T5) in the analysis of 31 cuvettes was 
recorded (Table 2.3). The distribution of eggs between the five traverses for each 
sample was calculated to test for OD. No significant OD was observed between 
traverses for any of the samples. There was no significant difference between the 
expected number of eggs and the observed number of eggs detected for each detection 
limit (Table 2.4). The EPG estimates for 1, 3 and 9 EPG detection limit for each sample 
are shown in Figure 2.7. Poisson regression models with 3 EPG as the response 
variable and 1 EPG as the explanatory variable (Fig. 2.8a) and 9 EPG as the response 
variable (Fig 2.8b) showed that the model coefficient was smaller for 3EPG compared 
to 9EPG (0.005 and 0.05, respectively) suggesting that  there is a larger unit increase 
between 1EPG and 9EPG than 3EPG. 
 
 
Table 2.3. Number of eggs counted in each traverse of the cuvette (T1 – T5), for 31 
independent samples. The distribution of eggs between each traverse was tested for 
over-dispersion (OD) by multiplying the variance to mean ratio by the number of 
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degrees of freedom, and comparing the result with the chi-square distribution. OD was 
confirmed when p<0.05 
Sample T1 T2 T3 T4 T5 Mean Variance p-value 
1 0 0 0 0 0 0.0 0 1.00 
3 0 1 2 0 0 0.6 0.8 0.25 
3 1 0 0 1 1 0.6 0.3 0.096 
7 3 2 2 2 3 2.4 0.3 0.97 
7 7 12 15 11 6 10.2 13.7 0.25 
8 15 12 19 22 13 16.2 17.7 0.36 
9 14 10 14 9 9 11.2 6.7 0.70 
10 12 7 9 6 15 9.8 13.7 0.23 
11 14 16 17 12 20 15.8 9.2 0.68 
13 28 28 26 18 19 23.8 24.2 0.40 
14 18 19 25 20 27 21.8 15.7 0.58 
15 28 35 26 31 29 29.8 11.7 0.80 
17 37 29 36 28 18 29.6 58.3 0.069 
18 32 24 30 34 34 30.8 17.2 0.69 
20 30 27 28 31 30 29.2 2.7 0.98 
23 46 46 48 43 47 46.0 3.5 0.99 
24 58 55 49 44 42 49.6 47.3 0.43 
25 59 62 63 53 54 58.2 20.7 0.84 
28 71 53 58 63 65 62.0 47.0 0.60 
29 63 62 65 61 79 66.0 55.0 0.50 
29 78 69 88 76 83 78.8 51.7 0.62 
30 74 67 85 77 70 74.6 48.3 0.62 
31 74 81 101 72 87 83.0 136.5 0.16 
 
 
 
 
 
 
 
 
 
 
Table 2.4. The actual number of eggs counted using 1 egg per gram (EPG) detection 
limit for samples 1 to 31. The expected (E) number of eggs at 3 EPG and 9 EPG was 
calculated by dividing the number of eggs seen at 1EPG detection limit by 3 by 9, 
respectively. For 3 EPG detection limit and 9 EPG detection limit the chi-squared test 
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(χ2) was used to determine whether observed number of eggs differed significantly 
from that predicted (p <0.05) 
 
Sample 
Actual eggs 
at 1EPG 
Expected 
(E) no. of 
eggs at 
3EPG 
Observed 
(O) no. of 
eggs at 
3EPG  
(𝑶 − 𝑬)𝟐
𝑬
 
 
Expected 
(E) no. of 
eggs at 
9EPG 
Observed 
(O) no. of 
eggs at 
9EPG 
(𝑶 − 𝑬)𝟐
𝑬
 
 
1 0 0 0 0 0 0 0 
2 2 1 1 1 0 0 0 
3 3 1 1 0 0 0 0 
4 3 1 1 0 0 1 4 
5 12 4 4 0 1 2 1 
6 27 9 11 0 3 4 1 
7 55 18 14 0 6 5 0 
8 53 18 19 0 6 7 0 
9 61 20 20 0 7 6 0 
10 55 18 23 1 6 6 0 
11 88 29 36 0 10 12 0 
12 118 39 45 0 13 11 0 
13 126 42 41 0 14 12 0 
14 111 37 46 0 12 14 0 
15 154 51 50 0 17 16 0 
16 142 47 53 0 16 19 0 
17 167 56 67 0 19 19 0 
18 166 55 60 0 18 21 0 
19 169 56 75 1 19 19 0 
20 176 59 58 0 20 31 1 
21 242 81 78 0 27 22 0 
22 206 69 81 0 23 32 1 
23 246 82 88 0 27 28 0 
24 263 88 98 0 29 34 0 
25 317 106 106 0 35 31 0 
26 283 94 120 1 31 50 1 
27 354 118 123 0 39 42 0 
28 344 115 142 0 38 47 0 
29 429 143 111 0 48 48 0 
30 405 135 146 0 45 49 0 
31 415 138 125 0 46 58 1 
   
χ2 5 
 
χ2 10 
   
p 1 
 
p 0.99 
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Sample number 
 
 
 
Figure 2.7. The estimated strongyle eggs per gram (EPG) when performing egg counts by the centrifugal-flotation method and applying 
three different egg detection limits (1 EPG, 3 EPG and 9 EPG) to each sample (1 – 31) 
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Figure 2.8. Poisson regression with zero intercept of the egg counts derived from 31 
horses as measured by 1 egg per gram (EPG) detection limit vs. 3 EPG (A: 1EPG = 
2.9684493+0.0052001 p<0.001) and 1 EPG vs. 9 EPG (B: 1EPG = 1.8042202 + 0.056348 
p<0.001) using the centrifugal flotation method 
 
 
B 
A 
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2.5.3. The effect of mixing samples on variance and over-dispersion 
of strongyle faecal egg counts 
 
The effect of mixing faeces before taking a subsample for FEC analysis on variance and 
OD of eggs in 10 subsamples taken from H4 to H7 was investigated. For the samples 
counted by CF, in H4 and H6, 1/3 of the total cuvette volume was counted and in H5 
and H7, 1/9 of the cuvette was counted. In H4 and H6, the mean total number of eggs 
counted in 10 samples by CF was less than in H5 and H7 and as such, the variance was 
greater in H5 and H7 (Table 2.5). For all horses, in the unmixed samples, the variance 
and CV were greater and k lower compared to the mixed samples. The CV ranged 
between 0.24 and 0.35 in the unmixed samples, and between 0.09 and 0.20 in the 
mixed samples, and k ranged from 10.1 to 37.5 in the unmixed and 80 to 124 in the 
mixed samples. All measures of OD were in agreement showing that mixing reduced 
OD in strongyle FEC performed by CF. 
Using McM, the total numbers of eggs seen either in two grids or two chambers of a 
McM slide were recorded (Table 2.5). The CV was greater in the unmixed samples 
compared to the mixed, where CV ranged from 0.34 to 0.69 and 0.16 and 0.53, 
respectively. Values for k were lower in the unmixed samples compared to the mixed 
samples, where k ranged between 3.88 to 100 and 12 to 344, respectively. In the 
chamber, variance was greater in the unmixed samples (range, 4 to 819) compared to 
the mixed samples (range, 1 to 94); the CV was greater in the unmixed compared to the 
mixed (0.31 to 0.40 and 0.11 to 0.39, respectively). Again, values for k were lower in 
the unmixed samples when compared to the mixed samples and ranged from 7.96 to 
348 and 38 to 961, respectively. 
These results demonstrate that mixing reduces the OD of strongyle eggs using each 
counting method. The lowest CV values were observed in the counts performed by CF 
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compared to McM, and within McM, the lowest CV values were recorded for counts 
made when the whole chamber areas were counted (Figure 2.9). 
 
 92 
 
 
 
 
 
 
 
 
 
 
 
 
 
a 
1/3rd of the cuvette was counted 
b 1/9th of the cuvette was counted
 
 
 
            
  
  Unmixed   Mixed   
    Horse Mean Variance CV p k Mean Variance CV P k 
C
F
 
Total eggs 
observed in 
cuvette 
H4a 31 127 0.35 <0.001 12.2 42 69 0.20 <0.001 80 
H5b 52 284 0.32 <0.001 10.1 63 80 0.14 <0.001 316 
H6a 28 52 0.26 <0.001 37.5 25 16 0.15 <0.001 926 
H7b 61 207 0.24 <0.001 21.8 69 36 0.09 <0.001 1245 
 M
cM
 No of eggs in 
grid 
H4 4 5 0.64 0.16 9.70 6 9 0.53 0.11 12 
H5 24 184 0.56 <0.001 3.88 32 27 0.16 0.53 320 
H6 2 2 0.68 0.59 100 2 1 0.40 0.91 332 
H7 20 47 0.34 0.01 17.8 20 10 0.16 0.83 344 
No of eggs in 
chamber 
H4 13 19 0.32 0.18 55.5 9 12 0.39 0.21 38 
H5 71 819 0.40 <0.001 7.96 55 94 0.18 0.07 93 
H6 5 4 0.38 0.66 348 5 1 0.15 0.1 360 
H7 66 431 0.31 <0.001 13.4 42 20 0.11 0.91 961 
Table 2.5. The effect of mixing prior to taking subsamples from entire motions collected from four horses on the mean, variance, 
coefficient of variation (CV) and over-dispersion of strongyle eggs when faecal egg counts were performed by either centrifugal-flotation 
(CF) or McMaster (McM) 
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Figure 2.9. The effect of mixing faeces on the coefficient of variation (CV) between 10 
subsamples performed by McMaster and centrifugal-flotation (CF) methods on faecal 
samples collected from horses H4 to H7 
 
The Poisson regression models for unmixed and mixed samples (Figure 2.10, Table 
2.6) revealed that mixing reduced OD. In the unmixed samples, as mean increased, k 
decreased indicating increased OD. In contrast, in the mixed samples, as mean 
increased, k increased indicating reduced OD. In the unmixed samples, the greatest 
OD was observed with the CF method compared to the mixed samples, where the 
greatest OD was observed in the grid.  
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Table 2.6. Poisson regression model for unmixed and mixed samples 
  Coefficients Standard Er
ror 
Z value p  
Unmixed Intercept 5.28600 0.17323 30.515 <0.001 Null devi
ance: 114
4.27  on 
11  df* 
Residual 
deviance:
  256.56  
on  8  df 
 
CF -0.05978 0.00395 -15.134 <0.001 
Eggs in Cha
mber 
0.55494 0.15363 3.612 <0.05 
Eggs in Gri
d 
-1.19864 0.17472 -6.861 <0.001 
Mixed Intercept 0.0093989 0.0008092 11.61 <0.001 Null devi
ance: 548
87.6  on 
12  df 
Residual 
deviance:
  3328.6  
on  8  df 
 
CF 5.9834045 0.0468663 127.67 <0.001 
Eggs in Cha
mber 
5.6135021 0.0368771 152.22 <0.001 
Eggs in Gri
d 
5.3821551 0.0341615 157.55 <0.001 
 
*df = degrees of freedom 
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Figure 2.10. Poisson regression with zero intercept for the mean and predicted 
values of k for Centrifugal Flotation (CF) and McMaster faecal egg counting techniques 
(Number of eggs in the chamber and the grid) when samples were unmixed (A) and 
mixed (B) 
 
 
 
 
 
Unmixed 
Mixed 
A. 
B. 
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2.5.4. Effect of subsample size on variance and over-dispersion of 
strongyle eggs 
 
The effect of three different subsample sizes (7 g, 10 g and 15 g) on the mean, 
variance, CV and OD of eggs seen was calculated from FEC performed using McM. The 
variance and CV decreased and p-values and k were higher in the mixed samples 
compared to the unmixed subsamples from each horse and for each subsample size in 
both the grid and the chamber (Table 2.7). The CV was lower when the whole 
chamber was counted compared to the grid only (Fig 2.11). This was observed over 
all subsample sizes. No significant OD was observed in either the mixed or unmixed 7 
g subsamples in the grid or the chamber. In the sample from H10, OD was detected in 
10 g unmixed subsamples in the chamber, and in H9 and H10, OD was observed in 15 
g unmixed subsamples in the chamber. No significant OD was detected between any 
of the mixed subsamples. Increasing subsample size reduced CV in the unmixed 
subsamples from H8 in the grid, and for all unmixed subsamples in the chamber. With 
the mixed subsamples, CV decreased with sample size in the samples collected from 
H9 in the grid and for H8 and H9 in the chamber. In total, CV was reduced by 
increasing sample size in 7 out of 12 subsamples. 
The Poisson regression models of the mean number of eggs versus k for 7, 10 and 15 g 
subsamples taken from unmixed and mixed faeces (Table 2.8, Figure 2.12) showed 
that in both unmixed and mixed samples, k increased with the mean. In the unmixed 
samples, values for k were lower in 10 g subsamples compared to 7 and 15 g 
subsamples, indicating that increasing sample size in unmixed samples does not 
reduce OD. In the mixed samples, the mean and k were lower for the 7 g subsamples 
compared to 10 and 15 g subsamples.
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Table 2.7. Effect of sample size on variance, coefficient of variation (CV) and over-dispersion of strongyle eggs between faecal samples 
collected from horses H8 to H10 when performing faecal egg counts by the McMaster technique by counting the number of eggs in both 
grids of the McMaster slide or both chambers of the McMaster slide 
 
   
Unmixed Mixed 
   
Mean Variance CV p k Mean Variance CV p k 
 7
 g
 
No of 
eggs in 
grids 
H8 21 37 0.29 0.17 121 23 16 0.18 0.49 343 
H9 5 14 0.81 0.05 4.69 8 14 0.45 0.18 41.8 
H10 21 28 0.25 0.26 186 18 1 0.06 0.95 355 
No of 
eggs in 
chambers 
H8 64 149 0.19 0.1 101 68 56 0.11 0.44 360 
H9 25 70 0.34 0.06 22.4 23 34 0.26 0.23 120 
H10 63 36 0.1 0.64 1110 62 1 0.02 0.98 1305 
 1
0
 g
 
No of 
eggs in 
grids 
H8 25 54 0.29 0.12 51.5 20 2 0.08 0.89 357 
H9 7 8 0.43 0.29 161 8 2 0.2 0.74 343 
H10 16 30 0.35 0.14 49.7 17 4 0.12 0.79 352 
No of 
eggs in 
chambers 
H8 72 193 0.19 0.07 80.6 68 16 0.06 0.79 1325 
H9 25 9 0.12 0.07 356 21 4 0.1 0.83 356 
H10 54 400 0.37 <0.001 12.9 59 2 0.03 0.96 1246 
 1
5
 g
 
No of 
eggs in 
grids 
H8 24 39 0.26 0.2 101 20 32 0.25 0.19 157 
H9 5 13 0.72 0.07 6.65 10 4 0.2 0.67 344 
H10 27 148 0.45 0.004 7.76 16 3 0.11 0.83 352 
No of 
eggs in 
chambers 
H8 75 181 0.18 0.09 107 70 17 0.06 0.78 1336 
H9 19 0 0 1 357 27 0 0.02 0.99 365 
H10 80 52 0.09 0.52 1282 55 10 0.06 0.83 1077 
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Figure 2.11. Effect of sample size and mixing on the coefficient of variation (CV) 
between faecal egg counts (FEC) performed by the McMaster method when the 
number of eggs in two grids or the number of eggs in both chambers of the McMaster 
slide were enumerated for faecal samples collected from horses H8 to H10 
 
Table 2.8 Poisson regression model with zero intercept for the mean number of eggs 
and predicted values of k for 7, 10 or 15g subsamples using the McMaster faecal egg 
counting technique when samples were unmixed and mixed  
 Intercept Coefficients Standard Er
ror 
Z value p  
Unmixed Mean 3.6437501 0.0489210 74.78 <0.001 Null devi
ance: 43
489.6  on
 18  df* 
Residual 
deviance:
  4290.4  
on 14  df 
 
7g 0.0277752 0.0006468 42.94 <0.001 
10g 0.7007891 0.0447970 15.64 <0.001 
15g 0.7864260 0.0452819 17.37 <0.001 
Mixed Mean 0.0277752 0.0006468 42.94 <0.001 Null devi
ance: 69
23.7  on 
17  df 
Residual 
deviance:
 4290.4  
on 14  df 
 
7g 3.6437501 0.0489210 74.48 <0.001 
10g 4.3445392 0.0459458 94.56 <0.001 
15g 4.4301761 0.0398336 111.22 <0.001 
 *degrees of freedom    
0
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0.4
0.5
0.6
0.7
0.8
0.9
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Figure 2.12. Poisson regression with zero intercept for the mean number of eggs and 
predicted values of k for 7, 10 or 15g subsamples using the McMaster faecal egg 
counting technique when samples were unmixed (A) and mixed (B) 
 
 
 
Unmixed 
Mixed 
B. 
A. 
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2.5.5. The effect of FEC methodology on decisions for targeted 
treatment 
 
The impact of FEC method on the mean, variance, k, number of horses and percentage 
of horses with the FEC of ≥200 EPG was recorded for Yards 1 to 13 (Table 2.9). The 
number of horses tested on each yard ranged from 12 to 43 individuals. The mean 
EPG across the yards was 166 EPG (range = 32 - 777 EPG) when FEC analysis was 
performed by McM, compared to 94 (range = 19 - 482 EPG) by CF. The variance 
between horses within yards was greater in FEC performed by McM when compared 
to CF. Distribution (k) of FEC between horses within yards, differed between method, 
where values for k were lower on average for FEC performed by McM compared to CF, 
(0.07; range = 0.03 – 0.17 and 0.19; range 0.06 – 0.38, respectively). The Poisson 
regression model of group mean EPG versus k showed that k was significantly 
(p=0.026) lower when McM was used (Figure 2.13). 
These factors had a bearing on the number and percentage of horses meeting a ≥200 
EPG threshold set for anthelmintic treatment. On average, 58 (22%) horses would 
have required anthelmintic treatment when the McM method was used to estimate 
FEC compared to 31 (11%) horses when FEC were performed by the CF method. On 
7/12 yards, significantly more horses met the threshold for treatment when McM was 
used compared to CF (Table 2.9). Overall, significantly more (p<0.001) horses 
required treatment when FEC were performed by McM compared to CF. 
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Table 2.9. The effect of faecal egg count (FEC) method (McMaster or Centrifugal-flotation) on the mean, variance and distribution of FEC 
between horses on each yard (k) on the number of horses with a FEC of more than 200 eggs per gram (EPG) and the percentage of horses 
with a FEC of more than 200 EPG from faecal samples collected from 13 different yards. A binomial test to compare two proportions was 
applied to test for significance (p<0.05) between the percentage of horses meeting the 200 EPG threshold for treatment depending on 
which FEC method was used 
 
McMaster Centrifugal-flotation 
Yard n Mean EPG Variance k 
no. > 
200 
EPG 
% 
> 200 
EPG Mean EPG Variance k 
no. > 
200 
EPG 
% 
> 200 
EPG 
 
 
p 
1 18 175 105956 0.09 6 33 79 24228 0.26 2 11 0.002 
2 22 32 8701 0.03 2 9 32 7555 0.1 2 9 1.000 
3 17 269 394453 0.05 6 28 132 95183 0.2 3 17 0.015 
4 22 120 200157 0.03 2 9 61 36733 0.06 1 5 0.124 
5 43 256 115977 0.17 17 55 114 22307 0.38 10 23 0.0004 
6 25 128 104808 0.05 4 16 84 42662 0.14 3 12 0.285 
7 15 777 1037810 0.14 8 53 482 472264 0.23 7 47 0.744 
8 31 29 4962 0.03 3 10 20 1804 0.1 0 0 <0.001 
10 21 88 25726 0.10 4 19 57 11606 0.12 3 14 0.344 
11 31 28 4828 0.03 3 10 20 1755 0.15 0 0 <0.001 
12 12 42 6288 0.05 2 16 19 1124 0.14 0 0 0.008 
13 16 53 6156 0.08 1 6 23 888 0.34 0 0 0.053 
Totals 273 *166 *167985 *0.07 58 *22 *94 *59842 *0.185 31 *11 <0.001 
* Average 
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Figure 2.13. Poisson regression with a zero intercept of Mean eggs per gram (EPG) 
and k for faecal egg counts performed on 13 groups of horses by the centrifugal 
flotation method (CF: Model, k = 0.001190 + -1.811762) and the McMaster method 
(McM: Model, k = 0.00190 + -2.881568)  
 
2.5.6. The effect of faecal egg count methodology on the outcome of 
tests of anthelmintic efficacy against strongyles 
 
A total of 33 FECRT were conducted on 205 individual horses between March and 
December 2012. MOX FECRT were conducted on 6 yards (n = 43 horses); IVM on 8 
yards (n = 56 horses); PYR on 10 yards (n = 43 horses) and FBZ on 9 yards (n = 63 
horses) (Table 2.10). Faecal samples were collected from all horses on Day 0 prior to 
anthelmintic administration and on Day 14. Each sample was analysed by the McM 
method using two different egg detection limits (50 and 15 EPG) and by the CF 
method, and the percentage reduction in FEC calculated from the EPG estimates 
derived from each FEC method (see methods Section). All of the MOX FECRT gave a 
yard mean average of 100% strongyle egg reduction, regardless of FEC method, and 
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the strongyle population on each yard was classified as sensitive. With the IVM 
FECRT, a mean faecal egg count reduction (FECR) of >90% was obtained at all sites; 
however, the average yard FECR differed depending on FEC method. For FEC analysed 
by McM50, the estimated FECR ranged from 95.9% to 100%; for McM15 this ranged 
from 95.7% to 100% and for CF FECR, this value was between 99.9% and 100%. The 
PYR FECRT yielded different results regarding the classification of resistance status 
between FEC methods on two yards. On Yard 3, the outcome of the PYR FECRT, where 
FEC were analysed by McM50 was classified as resistant (FECR = 89%), McM15 was 
classified as susceptible (FECR = 92%) and CF was classified as resistant (FECR = 
87%). On Yard 5, the outcome of the PYR FECRT was classified as resistant when 
McM50 was used to determine FEC (FECR = 86%), and susceptible when McM15 and 
CF were used (FECR = 98% and 99%, respectively). For yards where FBZ was tested, 
all FEC methods classified the resident strongyle populations as FBZ-resistant (Fig. 
2.14). 
Generally, the mean pre- and post-treatment EPG was higher for FEC performed my 
McM50 compared to McM15, and both McM detection limits gave higher mean EPG 
compared to the CF method. For faeces collected at Day 14 after PYR treatment, when 
eggs were detected, the mean EPG was higher using McM50 methodology compared 
to McM15 methodology and, again, both McM methods calculated a greater mean Day 
14 EPG estimate compared to the CF method. On three occasions, the McM50 method 
failed to detect eggs in samples in which eggs were detected using the CF method and 
on two occasions the McM15 method failed to detect eggs in samples in which eggs 
were detected using the CF method. This had a bearing on the outcome of the FECRT: 
where the mean Day 14 FEC was 0 for both McM methods, the calculated FECR was 
100%, while the corresponding FECR calculated using the CF method were below 
100%. 
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The Poisson regression models for Mean Day 0 as the explanatory variable and Mean 
Day 14 as the response variable by anthelmintic for each FEC method show that there 
is no relationship between Day 0 mean and Day 14 mean when IVM or MOX  are used 
regardless of the FEC method used (Figure  2.15 a-c). However, there was a significant 
positive relationship between mean Day 0 FEC and mean Day 14 when PYR (p<0.001) 
and FBZ (p<0.001) were used for all three FEC methods (Figure 2.15 a-c) and as the 
Mean Day 0 FEC increased, the mean Day 14 increased, leading to lower estimates of 
efficacy.
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McM50 McM15 CF 
 
Yard 
Mean 
Day 0 
EPG 
Mean 
Day 14 
EPG 
% 
Efficacy 
Mean 
Day 0 
EPG 
Mean 
Day 14 
EPG 
% 
Efficacy 
Mean 
Day 0 
EPG 
Mean 
Day 
14 
% 
Efficacy 
 1 386 0 100 335 0 100 344 0 100 
 2 620 0 100 477 0 100 449 0 100 
MOX 4 1064 0 100 744 0 100 318 0 100 
 7 1389 0 100 962 0 100 369 0 100 
 8 358 0 100 240 0 100 224 0 100 
 10 330 0 100 216 0 100 260 0 100 
 1 616 10 98.0 541 6.0 98.9 445 0.0 100 
 3 462 4 99.2 251 4.6 98.2 345 0.2 99.9 
 4 1188 0 100 1039 0.0 100 357 0.0 100 
IVM 5 306 13 95.9 264 11.3 95.7 177 0.0 100 
 6 314 0 100 230 0.0 100 93 0.0 100 
 7 2469 0 100 2040 0.0 100 651 0.0 100 
 8 1117 0 100 725 0.0 100 296 0.0 100 
 10 1140 0 100 927 0.0 100 344 0.0 100 
 1 986 0 100 836 0 100 227 8 97 
 2 350 0 100 435 0 100 183 3 98.4 
 3 1183 125 89 917 73 92 238 31 87 
 4 1050 100 90.5 1025 90 91.2 310 31 90.0 
PYR 5 1250 0 100 880 5 99.4 419 8 98.2 
 7 1900 88 95.4 1579 64 96.0 484 19 96.1 
 8 920 50 97.8 753 15 98.0 242 5 98.0 
 9 553 13 86 523 9 98 319 5 99 
 10 625 50 92 626 26 95.8 229 11 95.4 
 11 793 57 92 663 30 94 374 17 95 
 1 1263 863 31.7 1091 726 30.8 324 209 57.2 
 2 450 410 8.9 396 312 21.2 251 106 57.9 
 4 742 442 40.4 653 413 36.8 365 261 28.5 
FBZ 5 713 925 -29.8 439 791 -80.3 461 218 52.7 
 7 533 508 4.7 435 355 18.4 263 228 13.1 
 8 1080 950 12.0 930 795 6.7 255 264 -3.3 
 9 867 497 42.6 743 400 46.2 512 263 48.6 
 10 913 688 25 724 521 28 216 106 51 
 11 957 593 38 748 441 41 426 304 29 
Table 2.10. The effect of faecal egg count (FEC) method (McMaster (McM) with an egg 
detection limit of 50 eggs per gram (EPG) (McM50), and 15 EPG (McM15) and by centrifugal-
flotation (CF) on the outcome of estimates of faecal egg count reduction (FECR; % efficacy) 
derived from yard mean Day 0 EPG and yard mean Day 14 EPG from samples collected from 
horses on Yards 1 to 11. Anthelmintics moxidectin (MOX), ivermectin (IVM), pyrantel (PYR) 
and fenbendazole (FBZ) were administered on each yard on separate occasions. On each 
occasion, horses on the same yard received the same anthelmintic. For MOX and IVM, the 
threshold set for anthelmintic susceptibility was a FECR of >95%. For PYR and FBZ, the 
threshold was >90%. Results that were classified as resistant are highlighted 
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Figure 2.14. The effect of faecal egg count method (McMaster (McM) egg detection limit 50 eggs per gram (EPG) (McM50), McM egg 
detection limit 15 EPG) or centrifugal-flotation)) on the interpretation of faecal egg count reduction tests (FECRT) (% faecal egg count 
reduction (FECR)) conducted using moxidectin (MOX), ivermectin (IVM), pyrantel embonate (PYR) and fenbendazole (FBZ) on Yards 1 to 
11. The threshold for anthelmintic susceptibility for MOX and IVM was >95% as shown by the dashed line and for PYR and FBZ; the 
threshold for anthelmintic susceptibility was > 90% as represented by the solid black line
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Figure 2.15. Poisson regression with a zero intercept for the Mean Day 0 faecal egg 
count (FEC) versus the Mean Day 14 FEC when FEC were performed by A. centrifugal 
flotation (CF), B. McMaster with an egg detection limit of 15 eggs per gram (EPG) and C. 
McMaster with an egg detection limit of 50 EPG for each anthelmintic (fenbendazole, 
FBZ; ivermectin, IVM; moxidectin, MOX and pyrantel, PYR) 
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2.6 Discussion 
 
A single FEC is often used as a basis for making decisions on whether or not to 
administer anthelmintic to horses (Uhlinger, 1993). If FEC are to form the foundation 
of evidence-based helminth control, there is a need to ensure that related 
methodologies and procedures, including pre-analytic factors such as sample collection 
and storage are optimised. Despite the limitations of FEC analysis, it is currently the 
only tool available for implementing targeted anthelmintic treatments and for routine 
monitoring of efficacy (Nielsen et al, 2014; Matthews, 2014). Here, it was demonstrated 
that strongyle eggs were over-dispersed in horse faeces. Thorough mixing prior to sub-
sampling reduced variance and over-dispersion of eggs and the use of a FEC method 
with a lower egg dl reduced variance between samples/tests. The FEC method used 
influenced decisions for anthelmintic treatment, with more horses exceeding a 200 
EPG threshold when FEC were analysed by the MCM50 method compared to the more 
sensitive CF method. When determining anthelmintic efficacy, different assumptions 
were made depending on the FEC method used. When efficacy was high (IVM & MOX) 
or when it was very low (FBZ), all FEC methods generated the same assumptions, but 
when anthelmintic efficacy was around the accepted threshold, then the FEC method 
implemented had an impact and disagreements between classifications were found. 
The results presented here clearly show that strongyle eggs are clumped within faeces 
to varying degrees at entire motion level, bolus level, sample level and cuvette level. 
The most important level was the entire motion as OD seen at each level contributed to 
the OD seen throughout the entire motion. However, estimated values for k at each 
level were >5.4 indicating a Poisson distribution. As k increases, the variance 
approaches the mean and the distribution approaches the Poisson distribution (Bolker, 
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2008). The level of OD of eggs within faeces was low but accumulates at several levels 
leading to supra-Poisson variation. Hence, effective mixing reduces variance arising 
from multiple levels of low OD within faecal boluses and entire motions. Denwood et al. 
(2012) investigated sources of variability arising in equine FEC analysis and found that 
the major sources of variation could be attributed to the aggregation of eggs within 
faeces and variations in egg concentration between entire faecal motions. The greatest 
amount of variance could be explained between samples taken from the same animal, 
but they reported that taking a larger sample and mixing it thoroughly could reduce 
this variance. These findings are in agreement with the results obtained in the present 
study, where mixing prior to taking a subsample for analysis reduced variance and OD 
in egg counts carried out by McM and CF methods. Another study found that mixing 
composite sheep faecal samples reduced OD; however, the faecal samples were 
collected from different individuals showing a higher level of OD compared to the 
individual horse samples analysed in this study (Morgan et al., 2005). A study looking 
at the distribution of Ascaris lumbricoides eggs in human faeces found that mixing 
faeces prior to taking a subsample for analysis reduced variance in observed FEC, and 
found that when a smaller amount of faeces was examined, a greater degree of error 
was observed (Sinniah, 1982). Another, more recent study looking at the distribution 
of Shistosoma mansoni and hookworm eggs in human stool samples found that mixing 
samples reduced intra-sample variance (Krauth et al., 2012). Conversely, a study 
examining the distribution of strongyle and Parascaris equorum eggs in horse faeces 
using a combined sedimentation-flotation method found the distribution of these eggs 
to be randomly distributed, and found that mixing did not improve reproducibility of 
results (Kuhnert-Paul et al., 2012). A likely reason for the latter observations is that the 
researchers examined three, 10 g subsamples per entire motion, compared to the 
present study, where 1 g subsamples were analysed from multiple boli. The large 
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amount of faeces analysed would therefore account for lower variance, as it has been 
demonstrated that increasing the amount of faeces examined significantly reduces 
sample variance (Denwood et al., 2012). In effect, by taking larger subsamples, OD 
within those subsamples is eliminated by mixing during the FEC process. 
It was observed that, when multiplication factors were used (i.e. when egg density was 
higher), OD was observed at cuvette level. This is likely to be due to eggs not being 
randomly distributed once in the cuvette. It has been documented that helminth larvae 
clump in suspension if not well mixed (Schnyder et al., 2011) and, even though the 
suspension may have been thoroughly mixed prior to being placed in the cuvette, a 
degree of clumping may have occurred. To test this, the distribution of eggs at cuvette 
level was investigated. The results found that the eggs were randomly distributed at 
cuvette level, and no significant OD was observed in the number of eggs seen in each 
traverse of the cuvette. In terms of the number of eggs seen when counting a third or a 
ninth of the cuvette, there was no significant difference between the expected and 
observed egg counts. The Poisson regression models suggest that there was a 
significant positive relationship between the 1 EPG and 3 EPG and 9 EPG detection 
limits. As a larger number of eggs are counted, and a multiplication factor used, 
variance will be inflated (Torgerson et al., 2012). Alternatively, due to the high egg 
density, errors in counting may occur, the likelihood being that not all eggs are 
counted, so a lower EPG is estimated compared to when a third or a ninth of the 
cuvette is counted. In the study conducted by Denwood et al. (2012), the authors 
concluded that the McM method was not associated with high level of variance, and 
overall, gave a low CV. However, they counted between 6 and 10 McM chambers per 
sample. With more independent counts made and a lower detection limit used, the 
variance would become smoothed and therefore lower. As Morgan et al. (2005) point 
out, when counting nematode eggs in sheep faeces, the increased precision gained by 
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filling and counting more slides if offset by increased effort and diminishing returns if 
more than four chambers are counted. However, in practice, technicians are unlikely to 
count more than one slide, but reducing variance and increasing diagnostic sensitivity 
they can be achieved by taking a subsample from a well mixed sample and counting the 
number of eggs in two chambers opposed to the grids alone. 
Variation between replicate samples using the McM method has been observed (Stear 
et al., 2006). Mes (2003) found that variance was larger in FEC performed by McM 
compared to a sugar-salt flotation method. In the present study, 3 g of faeces were used 
for the McM method compared to 10 g in the CF method. Three grams of faeces is the 
most commonly used amount when using the McM method (MAFF, 1986). However, a 
number of modifications of the McM method exist. Two recent studies have attempted 
to determine which of these is the most accurate and reliable (Pereckiene et al., 2007; 
Vadlejch et al., 2011). Vadlejch et al. (2011) evaluated seven different McM methods by 
comparing the results of estimated EPG of Ascaris suum eggs in 30 pig faecal samples, 
while the study by Pereckiene et al. (2007) compared the reliability of three methods 
by preparing sheep faeces that was artificially spiked with Teladorsagia circumcincta 
eggs at three different concentrations (low (20 EPG), intermediate (50 – 200 EPG) and 
high (500 EPG)). For each concentration, 30 replicates were analysed and the ratio of 
samples that detected eggs within both a ±10% and ±20% tolerance limit was 
calculated. Both studies found that McMaster adaptations that use a larger amount of 
faeces and a lower dilution ratio (i.e. g of faeces/ml of water) and subsequently, a lower 
multiplication factor when converting the number of eggs seen into an estimation of 
EPG, give more reliable results and better sensitivity. When small amounts of faeces are 
examined, the increased multiplication factor renders the EPG estimate less precise 
(Cringoli et al., 2004; Mes, 2003; Vadlejch et al., 2011). In the present study, the sample 
size from which the subsample is taken for analysis was observed to impact variance in 
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FEC in mixed subsamples but not in unmixed subsamples in this study in agreement 
with results from other studies. These results indicate that taking a larger mixed 
subsample will decrease OD but in unmixed samples, the degree of OD will not be 
reduced by increasing sample size. 
Previously, FEC derived by the FLOTAC method (which has a 1 EPG detection limit) 
have been shown to give empirically lower variability compared to McM methods 
(Presland et al., 2005; Schnyder et al., 2011). Whilst the CF method employed here 
differs from the FLOTAC method, both offer greater analytical sensitivity. Both utilise 
more faeces per test and use lower multiplication factors. In agreement with this, it has 
been observed that when the multiplication factor is low, there is a substantial 
reduction in errors associated with EPG (Torgerson et al., 2012). 
Screening faecal samples analysed by the McM50 method gave consistently higher 
estimations of the group mean and greater variance compared to the CF method, and 
gave consistently lower values for k indicating greater apparent OD. This is because the 
samples analysed by the McM method gave more negative results but a higher overall 
mean, which generate lower values for k compared to CF. The CF method gave fewer 0 
EPG readings due to the ability to detect eggs at lower density. For this reason, the 
percentage of horses meeting the threshold for anthelmintic treatment was 
consistently greater when FEC were analysed by the McM method, resulting in more 
horses appearing to need treatment, assuming that a threshold of 200 EPG is a 
reasonable indication for the necessity of treatment. The 200 EPG threshold is an 
arbitrary number widely used to select adult horses for anthelmintic treatment 
(Kaplan and Nielsen, 2010). In theory, this threshold could be increased adult horses 
grazing low risk pastures. For example, if the threshold was increased to 500 EPG, very 
few adult horses would require treatment in the population of horses screened in this 
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study using either FEC method rendering the choice of FEC method a moot point and 
on the flipside, if the threshold was lowered to 100 EPG the number of horses requiring 
treatment would increase regardless of which FEC method was used. At the current 
threshold of 200 EPG using McM50 to select horses for treatment, more horses would 
require treatment, potentially leading to an increased number of unnecessary 
treatments, theoretically resulting in fewer parasites within the entire population in 
refugia and increased selection pressure for resistance. 
Overall, the outcome of FECRT using each of the FEC methods was in broad agreement, 
and when an anthelmintic is highly efficacious (MOX/IVM) or not efficacious (FBZ), the 
FEC method used had no bearing on the interpretation of the FECRT. However, when 
anthelmintic efficacy approached the threshold of sensitivity/resistance (as in the case 
of PYR treatment on two yards), the FEC method used impacted the interpretation of 
the FECRT and disagreements in the classification were observed. Here, the McM15 
method was in disagreement with the other two methods when one set of FECRT data 
were analysed; here indicating PYR to be efficacious compared to the McM50 and CF (1 
EPG detection limit) methods. Likewise, the McM50 method indicated one population 
to be PYR resistant when the other two methods indicated sensitivity to PYR. As 
controlled efficacy trials were not undertaken, the true PYR sensitivity status of these 
strongyle populations remains unknown. In practice, retesting would be recommended 
to monitor efficacy of PYR if the compound is used subsequently. Efficacy studies 
performed around the time of licensing of PYR indicated that in drug-sensitive 
populations reductions in FEC ranged between 94 - 100% after treatment, with 
substantial variability in efficacy observed amongst farms (Lyons et al., 1975; Nielsen 
et al., 2013). As such, PYR FECR data should be interpreted with care (Nielsen et al., 
2013). However, since 95% confidence intervals were not calculated here, conclusions 
about classifying resistance can’t be made. Previous studies have alluded that using 
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McM for assessing anthelmintic efficacy may lead to erroneous results when 
interpreting FECRT data, particularly when animals are shedding a low number of eggs 
(El-Abdellati et al., 2010; Levecke et al., 2012a; Levecke et al., 2012b) resulting in an 
increased likelihood of falsely declaring anthelmintic efficacy (false negative result). A 
recent study compared three FEC techniques (Cornell-Wisconsin (1EPG detection 
limit), FLOTAC (1 EPG) and McM (10 EPG)) for bias, accuracy and precision of FECRT 
results in cattle and found that methods with the same detection limit gave different 
levels of accuracy and precision (Levecke et al., 2012b). The McM and Cornell-
Wisconsin techniques were less accurate compared to FLOTAC and as a result 
significantly underestimated FECR where baseline FEC were low and more efficacious 
drugs were used. However, for all FEC methods, the precision and accuracy of FECRT 
increased when the pre-treatment mean increased and FEC methods utilising a low egg 
dl were used. The authors concluded that the precision of FECRT is affected by the FEC 
methodology used and that levels of egg excretion should be considered when 
interpreting the FECRT (Levecke et al., 2012b).  
In the present study, when IVM and MOX were administered there was no relationship 
between Day 0 mean FEC and Day 14 mean FEC. The probable reason for this 
observation being that these products are still highly efficacious. When FBZ and PYR 
were administered, the Day 0 14 FEC increased with the Day 0 FEC regardless of the 
FEC method used, indicating that the higher the pre-treatment mean, the lower the 
FECR will be.  However, the effect was lower when CF and McM15 were used compared 
to McM50. The same observation was made in a recent study, where a hierarchical 
model was used for evaluating PYR efficacy data. Here, the authors found that as the 
group mean pre-treatment FEC increased, PYR efficacy decreased. They concluded that 
this was likely to be due to the FEC method used rather than underlying biological 
issues; for example, using a FEC method with a detection limit of 20 EPG, on a horse 
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with a pre-treatment FEC of 200 EPG, that was then treated with PYR with a known 
efficacy of 90%, the post-treatment FEC is likely to be 0 EPG resulting in an observed 
FECR of 100%, compared to a horse with a pre-treatment FEC of 1000 EPG, which, 
when treated with the same drug is likely to show a positive FEC post-treatment, giving 
a lower estimated % FECR (Nielsen et al., 2013). The statistical reasoning behind such 
findings has recently been discussed by Torgerson et al. (2012), and the Poisson 
process can describe variance observed in FEC. Even if faeces have been well mixed to 
ensure that eggs are evenly distributed, using a FEC method offering an analytical 
sensitivity of 1 EPG, when FEC is 1 or 2 EPG, diagnostic sensitivity will be 63% and 
86%, respectively, due to the Poisson error (Torgerson et al., 2012). This demonstrates 
that erroneous declarations of efficacy are more likely when using a single McM count 
at an analytic sensitivity of 50 EPG. When an observed egg count of 0 is derived by McM 
with a sensitivity of 50 EPG, 95% lower and upper confidence limits of 0 and 184.5 
EPG, respectively, are given (Torgerson et al., 2012). The confidence bounds decrease 
with increased analytical sensitivity such that a 0 EPG count derived using a 
multiplication factor of 10 gives lower and upper 95% CLs of 0 and 36.9 EPG, 
respectively (Torgerson et al., 2012). This has implications when assessing efficacy, as 
negative counts on Day 14 post-treatment may not actually be negative, thus falsely 
declaring an anthelmintic to be efficacious. 
Although the McM technique is the most widely used method for FEC analysis 
(Presland et al., 2005; Pereckiene et al., 2010; Denwood et al., 2012), it would appear 
that there is little appreciation of statistical processes underlying variation in this 
method. Many studies report FEC data using the McM method at a detection limit of 50 
EPG, but counting a larger volume of faecal suspension, which will achieve an egg dl of 
15 EPG, and provides a simple way to increase analytical sensitivity, if laboratories are 
unwilling to change to other more sensitive methodologies such as the CF method.   
 116 
 
The volume of faecal suspension examined in a McM slide will affect the reliability of 
the EPG estimate (Cringoli et al., 2004). In addition, researchers have suggested that 
multiple counts be performed per sample to reduce variability (Vidyashankar et al., 
2007; Denwood et al., 2012). By performing more counts and taking an average, 
variation is smoothed (Morgan et al., 2005). However, this is often impractical. There 
are a number of biological factors that can influence FEC. These include; parasite 
biology including fecundity, parasite density and prepatent period and host biology, 
including physiological status, immunity, management factors, pre-exposure to 
parasite challenge, nutrition, anthelmintic treatments (Gasbarre et al., 1996; 
Pereckiene et al., 2007; Gates and Nolan, 2009; Vadlejch et al., 2011).  
The k values obtained from the screening FEC between horses on the same yard were 
lower (0.03 – 0.26) compared to the k values obtained in the faecal motion (6.3 – 12.4), 
between boli (10.6 – 84) or between samples (10.6 – 28.5), indicating that the greatest 
degree of variation is observed between horses than at any of the other levels 
investigated. Egg excretion between horses is highly aggregated (Relf et al., 2013) as a 
host population is unlikely to be homogeneous, and will differ in terms of age, sex, 
immune status and susceptibility (Morril and Forbes, 2012) as such, groups of hosts 
that are not uniform are likely to exhibit higher levels of FEC aggregation (Morgan et 
al., 2005). There are other factors related to parasite biology and epidemiology, such as 
the distribution of the infective stages in the environment (Quenouille, 1949; Shaw et 
al., 1998), seasonality, climatic and temperature dependent effects on parasite 
development both in the environment and within the host (Shaw et al., 1998) and 
density dependent effects within the host (Anderson and May, 1985). To reduce the 
degree of aggregation between horses, in terms of the impact of variation on FEC and 
FECRT, selection criteria are applied, i.e. only horses with a FEC of ≥200EPG are 
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included in a FECRT. While these factors need to be considered, the purpose of the 
present study was to evaluate the factors affecting variance that arise in FEC. 
A limitation to the study was that the horses selected for the different investigations 
were selected opportunistically and were not consistent between studies. As such, 
between horse variation was not accounted for and this could have impacted on the 
variability of the observed results. However, since the studies into the variability 
arising in equine FEC were focussed on technical factors and the results demonstrated 
that strongyle eggs in faeces followed a Poisson distribution in well mixed faeces, the 
fact that samples were collected from different horses was unlikely to have impacted 
the results. The results did however show that the greatest degree of aggregation was 
observed between individual horses.  
2.7 Conclusions 
 
From these findings, the following acronym DISMIS is suggested giving practical 
solutions to decrease variability in FEC: 
Decrease variability by: 
Increasing sample size - Take at least three individual boli and send for analysis 
(Denwood, 2010; Vidyashankar, 2012). 
Store samples correctly - Place in a zip-lock bag, expel the air before sealing, refrigerate 
at 4˚C and process within 4 days (Nielsen et al. 2010). 
Mix samples thoroughly - Before measuring out the subsample thoroughly mix 
(Section 2.5.3). 
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Increase Sensitivity - Use a FEC method with a low egg detection limit especially when 
assessing anthelmintic efficacy. If using the McM method, count more of the faecal 
suspension by counting all of the eggs present in the two chambers and multiply by 15 
(Sections 2.5.5 – 2.5.6) 
It is important to identify, understand and quantify the inherent sources of variation to 
better understand the underlying statistical processes that underpin FEC when making 
decisions for anthelmintic treatment and assessing the efficacy of these products. This 
research has answered important questions about sources of variation in FEC 
methodology and provides a framework for further analysis by exploring the impact of 
variation on FEC and subsequent decisions for targeted treatment and efficacy through 
statistical modelling. The challenge remains to fully recognise the sources of variation, 
which inevitably arise from the Poisson process during FEC analysis and the OD that 
occurs between horses and individual samples to make accurate estimations of FEC. 
Data such as those presented in this Chapter provide a stronger basis for modelling the 
statistical processes impacting FEC results, and hence designing FEC protocols that are 
fit for purpose and properly interpreted. 
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CHAPTER 3: Efficacy of anthelmintics 
against small strongyles 
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3.1 Introduction 
 
Virtually all grazing horses are at risk of infection from helminths and as such, 
appropriate control measures are necessary. The long term frequent use of 
anthelmintics has contributed to the development and spread of anthelmintic 
resistance (Kaplan, 2002; Kaplan, 2004; Matthews, 2008). However, defining resistance 
is complicated by the fact that there are no published guidelines for the conduct of 
faecal egg count reduction tests (FECRT) or for the interpretation of FECRT results in 
horses, and published studies have used different protocols and different thresholds to 
classify resistance, making comparisons between studies difficult (Stratford et al., 
2014). There are no agreed guidelines regarding optimum group size, the pre-
treatment faecal egg count (FEC) and FEC distribution among the group or which FEC 
method should be used. Most commonly, resistance is defined as a FECRT test <95% 
for the macrocyclic lactones (ML) and <90% for fenbendazole (FBZ) and pyrantel 
(PYR) (Kaplan and Nielsen, 2010), however, these thresholds have been arbitrarily 
chosen and have not been validated against the ‘gold standard’ controlled efficacy test, 
whereby infected horses are dosed with an anthelmintic then slaughtered 10 – 21 days 
later to recover the immature and adult worm burden (Duncan et al., 2002). To account 
for the range of FECRT data, the calculation of lower 95% confidence limits (LCL) have 
been suggested (Vidyashankar et al., 2007; 2012). The suggested thresholds to indicate 
acceptable efficacy are  FECR >95% and LCL >90% for the MLs and FECR >90% and 
LCL >80% for FBZ and PYR (Kaplan and Nielsen, 2010; Vidyashankar et al., 2007; 
2012). Regardless of the limitations of the FECRT, it remains the only tool for the 
evaluation of anthelmintic efficacy in horses under field conditions (Matthews, 2014).  
FBZ resistance  in cyathostomins is widespread, (Kaplan et al., 2004; Osterman-Lind et 
al., 2007; Traversa et al., 2012) and reduced sensitivity of cyathostomins to pyrantel 
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salts is very common in some geographic locales (Kaplan et al., 2004; Comer et al., 
2006; Lind et al., 2007; Traversa et al., 2007). In addition, single cyathostomin 
populations have been identified that exhibit both FBZ and PYR resistance (Kaplan, 
2004; Traversa et al., 2007). A reduction in egg reappearance period (ERP) has also 
been suggested as an early indicator of resistance (Sangster, 1999). A reduction in 
strongyle ERP from over 8 weeks (Borgsteede et al., 1993) down to 4 weeks after IVM 
administration has been described (Lyons et al., 2008b; Molento et al., 2008; von 
Samson-Himmelstjerna et al., 2007) and a shortened strongyle ERP after MOX 
administration has been reported in Kentucky (Rossano et al., 2010). Concurrent 
reduced efficacy of all three broad-spectrum anthelmintic classes has also been 
identified in Brazil (Molento et al., 2008; Canever et al., 2013). 
Encysted larvae (EL3), and play an important role in cyathostomin epidemiology as the 
gradual maturation of these stages in the spring can lead to a significant amount of 
pasture contamination (Herd, 1986), and most importantly are responsible for larval 
cyathostominosis, which can be fatal in up to 50% of cases (Love et al., 1999; Lyons et 
al., 2000). In temperate climates, the disease is most common in winter and spring, and 
in horses less than six years of age (Reid et al., 1995). Stress-induced 
immunosuppression may also be a contributory factor (Mair, 1993), while recent 
administration of an anthelmintic that primarily targets luminal stage cyathostomins 
may precipitate clinical disease (Reid et al., 1995). For these reasons, it is important 
that control strategies are aimed at cyathostomin EL3. Cyathostomin EL3 present a 
considerable challenge when planning control protocols as their identification and 
quantification is problematic. In the UK, there are two anthelmintics licensed for use in 
the treatment of cyathostomin EL; MOX administered as a single dose of 0.4 mg/kg has 
claimed 90.8% efficacy against cyathostomin EL3 and 99.9% against other developing 
larval stages (Bariden et al., 2001) and FBZ administered at 7.5 mg/kg on five 
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consecutive days (5d FBZ) with claimed 91.5% efficacy versus inhibited EL3 and 99.4% 
efficacy versus developing mucosal larval stages (Duncan et al., 1998). These studies 
were conducted over 13 years ago in only 8 – 10 horses and, since then, there have 
been many reports of resistance in cyathostomin populations to FBZ (Fisher et al., 
1992; Kaplan 2004; Osterman-Lind et al., 2007). It has been proposed that where low 
level resistance exists to a single dose of FBZ, a 5d FBZ course might still prove 
efficacious (Blanek et al., 2006), as prolonged exposure of the parasites to an elevated 
dose of FBZ is likely to produce greater efficacy. However, in horses that had been 
previously identified as harbouring FBZ-resistant cyathostomins following a single 
dose of FBZ, continuous egg shedding was observed when the same horses were 
treated with a 5d FBZ course (Chandler et al., 2000; Chandler and Love, 2002; Rossano 
et al., 2010). Despite the high prevalence of FBZ resistance and evidence to suggest that 
5d FBZ is likely to be ineffective at eliminating FBZ-resistant cyathostomins, 5d FBZ is 
still used in the UK to remove EL, especially in debilitated animals in cases of larval 
cyathostominosis, and as a standard quarantine measure (personal communication, 
Claire Stratford, 2012). If 5d FBZ is used and is not effective against luminal or mucosal 
stages, then significant egg shedding will continue leading to pasture contamination 
and reinfection. 
3.2 Aims of Chapter 
 
The main aim here was to determine efficacy of all three classes of anthelmintic against 
strongyle infections in horses based on yards across Eastern Scotland and Southern 
England as up to date information on the performance of these anthelmintics will 
inform the decision support tool and guide control programmes. Secondly, the efficacy 
of 5d FBZ and MOX against strongyles in two populations of horses was compared 
because these are the two anthelmintics licensed for use versus cyathostomin EL, and if 
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significant egg shedding is observed post-treatment, this would indicate that the drug 
had not been effective against the adult worm population, which in turn may indicate a 
lack of efficacy versus the refractory larval stages which are more difficult to kill 
(Matthews, 2014). Again, these data will help to inform the decision support tool and 
guide recommendations for the control of cyathostomin EL. 
3.3 Materials and Methods 
 
3.3.1 Scottish and English study populations 
 
British Horse Society (BHS) approved livery yards were approached using the BHS 
website (www.bhs.org.uk), contacted via email and asked to participate. In addition, 
boarding stables, competition and welfare yards that were clients of the Bell Equine 
Veterinary Clinic (Kent, UK) and House and Jackson Veterinary Clinic (Essex, UK) were 
recruited onto the study. All horses had access to grazing and had been treated with a 
ML within the last 6 months. Each yard was supplied with a questionnaire to complete, 
which provided information on the yard (yard type, acreage, number of horses), 
anthelmintic usage (frequency, last product used, and type of deworming programme) 
and management practices (Appendix 1). 
3.3.2 Study populations used for investigations into the efficacy of 
5d FBZ and MOX 
 
Two studies were conducted to investigate the efficacy of 5d FBZ in two populations of 
horses. For Experiment 1, all equids recruited belonged to a welfare charity and for 
Experiment 2, all equids were residents at the (R(D)SVS) equine hospital. 
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3.3.3 Sample collection 
 
All faecal samples were collected and processed in the same manner. Horse 
owners/yard managers were asked to collect freshly voided from all horses resident on 
each yard. Pre-labeled zip-lock bags were provided for sample collection, identification 
and submission of samples. On the first sampling occasion, the pre-labeled bags were 
left blank for the horse owners to write the name and age of each horse on each bag. On 
subsequent sampling occasions, pre-labeled bags with the horses’ names were 
supplied. Horse owners were asked to collect at least three faecal boli from a freshly 
voided motion and to place these into a zip-lock bag, expelling the air before sealing. 
The samples were sent immediately to Moredun Research Institute and stored at 
approximately 4˚C. All samples were processed within 4 days of collection. Prior to 
processing, all samples were logged onto data capture forms. The date of sample 
arrival, the date of processing, each horse’s name and age were recorded. Samples 
were recorded in batches according to which yard they came from. 
3.3.4 Faecal egg count methodology 
 
A modification of the salt flotation method (Christie and Jackson, 1982), sensitive down 
to 1 egg per gram (EPG), was used as described previously (Section 2.3.2.2). 
 
3.3.5 Larval culture 
 
For 11 of the 16 English yards, positive FEC samples from the first screening occasion 
were pooled and the eggs cultured to third stage larvae (L3). In brief, faecal samples 
from individual horses were formed into fist-sized balls and placed into a 500 ml 
container lined with a polythene bag. A further polythene bag was used to cover the 
container, which was pierced several times before incubation at 22˚C. After 14 days, 
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the container was removed and flooded with tepid water and allowed to stand for 4 h. 
The contents of the container were poured over a filter made from two layers of filter 
paper, the filter then placed on top of a 200 ml jar filled with tepid water, so that the 
filter paper was flush with the water and left overnight so that larvae could migrate 
through the filter paper into the jar. The filter was removed and the contents of the jar 
were siphoned off until approximately 2 cm of liquid remained. This was poured into a 
flask, where it was stored at approximately 4˚C until L3 in the sample were 
enumerated. Strongyle larvae were identified according to MAFF, 1986. On three yards, 
the FEC were too low for culture to be performed and on two other yards, eggs were 
not cultured to L3 due to time constraints. No larval cultures were performed on faeces 
obtained from the Scottish yards. 
3.3.6 Faecal egg count reduction tests (FECRT) Scottish and English 
yards 
 
Faecal samples were obtained from all equids at each site once the minimum ERP of 
the previously administered anthelmintic had passed. The standard minimum ERP 
used were 6 weeks for FBZ and PYR, 8 weeks for IVM and 13 weeks for MOX (Stratford 
et al., 2011b). Horses with strongyle FEC of 50 EPG were included in the FECRT and 
administered per os with anthelmintic on Day 0 at the following dose rates; FBZ 
(Panacur® equine paste)a (7.5 mg/kg), PYR (Strongid-P™)b (19 mg/kg), IVM (Eqvalan® 
oral paste for horses)c (0.2 mg/kg) or MOX (Equest®)d (0.4 mg/kg). Each horse 
received a dose appropriate for 110% of each individual’s body weight, as estimated by 
weigh tape to minimise the risk of under-dosing (Stratford et al., 2014b). Each 
individual was administered with the appropriate anthelmintic by their owner and 
monitored immediately after to ensure that the paste/gel was swallowed. In addition, 
for individuals with a faecal egg count reduction (FECR) indicative of resistance (i.e. a 
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FECR reduction below the designated threshold for efficacy) in populations where the 
mean FECR was above the accepted efficacy threshold, the test was repeated in those 
individuals using the same anthelmintic. This was performed to exclude administration 
or sampling error. In cases where the yard mean FECR indicated anthelmintic 
resistance, all horses with FEC 50 EPG at Day 14 were enrolled onto a FECRT using a 
different anthelmintic class. All animals on the same yard received the same class and 
batch of anthelmintic. Faecal samples were collected on Day 0 immediately prior to 
anthelmintic administration and at 14 days post-treatment. Testing of anthelmintic 
classes was performed in succession in most populations, starting with FBZ, followed 
by PYR, then IVM and finishing with MOX. Because of its effect on cyathostomin EL 
(Bairden et al., 2006), which in the UK are thought to be in highest proportions in the 
autumn/winter months (Ogbourne, 1976), MOX was preferentially tested in these 
seasons. 
3.3.7 FECRT using 5d FBZ in welfare horses and in horses residing at 
an equine hospital 
 
In the first experiment, equids resident at a welfare charity in Scotland were screened 
for the presence of strongyle eggs in faeces. Individual equids with a strongyle FEC of 
≥50 EPG were selected for a 5d FBZ FECRT. FBZ (Panacur Equine Guard, MSD) was 
administered per os at 7.5 mg/kg for five consecutive days at a dose appropriate for 
110% body weight as estimated by weigh tape. Faecal samples were collected prior to 
the first administration (Day 0) and at 14 days after the final FBZ administration (Day 
14). Equids with a FEC of ≥50 EPG at Day 14 of the FECRT were subsequently 
administered with MOX and a FECRT performed. Faecal samples were collected on Day 
0 prior to administration of 0.4 mg/kg MOX and on Day 14. In a second study, horses (n 
= 11) based at the R(D)SVS equine hospital were screened for the presence of strongyle 
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eggs. Those with a FEC of ≥50 EPG were selected and randomly allocated to one of two 
treatment groups; Group 1 received FBZ (Panacur Equine Guard, MSD) administered 
per os at 7.5 mg/kg for five consecutive days and Group 2 received MOX (Zoetis Animal 
Health) per os at a dose of 0.4 mg/kg on Day 4. Doses were appropriate for 110% body 
weight as estimated by weigh tape. Faecal samples were collected prior to the first 
administration (Day 0 and Day 4) and at 14 days after the final FBZ administration 
(Day 19). For both studies, a mean FECR of >90% for 5d FBZ and >95% for MOX was 
noted as acceptable efficacy (Kaplan and Nielsen, 2010a). FECR for both 5d FBZ and 
MOX were calculated using arithmetic means. Estimates of the 95% CL were derived 
from these figures. Eggs were not cultured to third stage larvae. 
3.3.8. Data analysis 
 
3.3.8.1. FECRT 
 
Microsoft® Office Excel® 2007 was used for recording data and analysis. Summary data 
for each yard included median age, age range, interval since last anthelmintic 
treatment, percentage of horses recruited onto the FECRT study, % of horses with FEC 
of ≥200 EPG, mean FEC and range of FEC. FECR was calculated for each group of horses 
using the following formula recommended by the WAAVP (Coles et al., 1992), where 
arithmetic group mean FEC for Day 0 and Day 14 were used to estimate the group 
FECRT (Section 2.4.5, Equation 2.5). 
There are no agreed guidelines regarding appropriate cut-off limits for determining 
efficacy for the anthelmintic classes in horses (Vidyashankar et al., 2012). The 
methodology here followed recently published recommendations; i.e. thresholds 
chosen for establishing appropriate efficacy were arithmetic mean FECR of >95% for 
ML and >90% for BZ/PYR (Kaplan and Nielsen, 2010). In addition, 95% lower 
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confidence limits (LCL) were included to give a more accurate indication of the range of 
the data (Vidyashankar et al., 2007). Non-parametric bootstrapping was used to 
sample with replacement from the observed FECR, and upper and lower 2.5-
percentiles of 10,000 simulations were taken as the 95% confidence limits (Efron, 
1979; Hilborn and Mangel, 1997). PopTools software (CSIRO, Australia) was used for 
bootstrapping (Hood, 2010) and LCL of 90% and 80% were selected for classifying 
resistance for ML and FBZ/PYR, respectively. If % mean FECR and LCL fell below the 
designated cut-offs, anthelmintic resistance was indicated, and if either the % mean 
FECR or the LCL fell below these cut-offs, resistance was suggested. The cut-offs were 
selected on the basis of the differing original efficacies in anthelmintic-sensitive 
strongyle populations of the various active ingredients when they were first registered 
as veterinary medicines (Colglazier et al., 1977; Cornwell and Jones, 1968; Xiao et al., 
1994). 
3.3.8.2. Factors affecting Day 14 FEC 
 
Factors impacting Day 14 FEC were investigated using generalised linear mixed models 
(GLMM) with a negative binomial distribution to account for the aggregation of FEC on 
Day 14. A mixed modelling approach was selected to allow random effects to be fitted 
alongside fixed effects to account for the variation between yards and 
psuedoreplication. All GLMM were run in RStudio 2.15.1 using the ‘glmer.nb function in 
the ‘lme4’ package (Bates et al., 2015). The different factors investigated are outlined in 
Table 3.1. 
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Table 3.1. A summary of the different factors and responses included in the analyses to 
determine factors affecting strongyle egg shedding 
Factor Responses 
 
Yard type Livery, sanctuary, stud 
Country England/Scotland 
Age* Years 
Anthelmintic treatment FBZ, IVM, MOX, PYR 
Day 0 FEC* Eggs per gram 
* continuous variable 
 
Initially, the multivariate model was populated with all explanatory variables; non-
significant factors were removed and the factor with the lowest z value (the ratio of the 
estimated slope to its standard error) was dropped from the models in turn until only 
significant factors (p≤0.05) remained and the minimal adequate model was achieved. 
The significance of removing factors from the model was evaluated using log-likelihood 
ratio tests (LRTs, Zuur et al., 2010; Crawley, 2013). To confirm that the minimal 
adequate model was reasonable, all dropped terms were sequentially reintroduced 
back into the final model to ensure a lack of significant change in explanatory power as 
confirmed by LRTs. Inspecting the model residuals and plotting them against the fitted 
values and against each significant factor allowed model checking. Yard and individual 
were fitted as a random effect to account for the heterogeneity between yards and to 
account for pseudoreplication associated with repeated observations from the same 
individuals. 
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3.4 Results 
 
3.4.1 Study population; profile of horses and yards 
3.4.1.1. Scottish population 
 
FEC analysis was initially performed on 1,359 samples from 15 yards, from March 
2010 to May 2012. Thirteen yards were leisure horse livery yards located in Midlothian 
(Yards 1s - 12s, 15s), and two were welfare establishments located in the Scottish 
Borders (Yard 13s) and Aberdeenshire (Yard 14s) (Figure. 3.1). The majority of equids 
sampled were of mixed breed and were used for pleasure riding or were retired. In 
general, the premises tested had used anthelmintics fairly infrequently in the 
preceding year, with the majority of equids receiving an IVM- or MOX-based 
anthelmintic every 2 - 6 months. All premises, particularly the welfare establishments, 
reported regular introduction of new equids, often with an unknown worming history, 
which could lead to pasture contamination if the new arrivals were not quarantined 
appropriately, or, more importantly, they could harbour resistant worm populations 
and subsequently contaminate the pasture. Efficacy testing with multiple anthelmintic 
classes was performed in succession on a number of these populations. Group sizes for 
FECRT ranged from 3 to 64 equids (median 12), representing 5.3 - 88.9% of each yard 
population tested. Precise ages were provided for 238 equids; 82% of the population 
tested (median 9 years, range 1 to 33). Of the remaining 54 equids, 20 were classified 
as ‘aged’ by the yard owner, meaning greater than 12 years, and 34 had no age 
specified. The average interval between last anthelmintic administered and FEC 
screening was 136 days (range 81 to 240 days) (Table 3.2). 
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Figure 3.1. Map illustrating the geographical locations of the Scottish yards recruited 
for the study (adapted from http://maps.google.co.uk/) 
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Table 3.2. Summary data for each Scottish yard (Yards 1s -15s) including yard type, median age, the last anthelmintic administered (AM) 
and interval since last treatment 
 
 
L = Livery, S = Sanctuary, IVM = ivermectin, MOX = moxidectin, PYR = pyrantel 
NS = Data not supplied  
a 
Interval since last anthelmintic treatment
         Yard        
 1s 2s 3s 4s 5s 6s 7s 8s 9s 10s 11s 12s 13s 14s 15s Totals 
Type of yard L L L L L L L L L L L L S S L  
No. of 
horses 17 79 19 45 35 30 26 21 9 57 28 29 72 57 29 553 
Median age 5 10 15 13 10 14 13 10 12 NS 5 NS 7 7 13 10 
Range (2 -17) (4-20) (4-28) (3-23) (1 -21) (2-22) 4 to 13 (1- 28) (7-25) NS (1-12) NS (1-34) (0.4-23) (5-28) (0.4-34) 
Last AM PYR MOX MOX MOX MOX MOX/PRZ IVM/PRZ NS MOX NS MOX MOX NS IVM MOX  
Interval
a 
(days) 240 180 90 150 81 104 157 NS 204 NS 102 104 NS 93 121 136 
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3.4.1.2. English population 
 
A total of 16 yards were recruited; all were located in the south of England (Figure. 
3.2). Eleven were general boarding stables, two (Yards 4e and 15e) were equine 
welfare/rescue/rehabilitation premises, one (Yard 7e) was a sport horse yard, one 
(Yard 9e) was a non-Thoroughbred stud and one (Yard 10e) was a private yard where 
all horses were owned by one person (Table 3.3). FEC analysis was performed on each 
yard on a minimum of three occasions. In total, 928 faecal samples were collected from 
368 horses between March and December 2012. Ages were provided for 313 horses; 
85% of the population tested (median 12 years, range 1 to 34), with 55 having no age 
specified (Table 3.3). The average number of horses per yard was 23 (range 8 - 48). A 
total of 13 respondents stated that they had previously administered an ML as the last 
treatment to all animals. One (Yard 13e) had stated that they administered a five-day 
course of FBZ (Panacur® Equine Guard, MSD Animal Health) and two (Yards 3e and 
12e) did not provide this information. Eleven (69%) respondents had used an 
anthelmintic with licensed efficacy against encysted larvae (EL); 10 had used MOX and 
one a five-day course of FBZ. The average interval between last anthelmintic 
administered and FEC screening was 129 days (range 76 to 227 days) (Table 3.3). 
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Figure. 3.2. Map illustrating the geographical locations of the English yards recruited for the study 
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Table 3.3. Summary data for each English yard (Yards 1e -16e) including yard type, median age, the last anthelmintic administered (AM) 
and interval since last treatment 
 
        
                  C = Competition, L = Livery, NTBS = Non-Thoroughbred Stud, P = Private, R = Rescue, S = Sanctuary  
                  IVM = ivermectin, MOX = moxidectin, PRZ = praziquantel 
                  NS = Data not supplied  
                        a 
Interval since last anthelmintic treatment 
 Yards  
 1e 2e 3e 4e 5e 6e 7e 8e 9e 10e 11e 12e 13e 14e 15e 16e Totals 
Type of yard L L/C L S L L C L NTBS P L L L L R L  
No. of horses 32 14 18 14 17 14 25 8 23 18 26 43 22 32 48 14 368 
Median age 17 NS NS 7.5 11 15 8 19 NS 17 11 10 12 14 4 12 12.1 
Range 
3 to 
31 NS NS 3 - 34 4 - 19 9 - 21 3 – 15 16 - 28 NS 3 - 25 4 - 25 5 - 19 3 - 30 3 - 29 1 - 17 4 - 19  
Last AM MOX IVM/PRZ NS MOX MOX IVM/PRZ MOX MOX/PRZ IVM MOX/PRZ MOX NS 5DFBZ MOX/PRZ MOX/PRZ MOX  
Interval
a 
(days) 130 148 NS 194 129 171 139 85 89 120 120 NS 76 88 83 227  
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3.4.2 Faecal egg count reduction test results 
3.4.2.1 Scottish FECRT data 
A total of 447 FECRT were performed on 292 equids (Table 3.4) and this was divided 
as follows: FECRT for one (n = 194), two different (n = 55), three different (n = 29) or 
four different (n = 14) anthelmintics. 
Table 3.4. Faecal egg count reduction test (FECRT) summary data for Scottish yards 
indicating number of individual yards and equids tested per yard. The efficacy range 
details the yard arithmetic mean percentage reductions in faecal egg counts (FEC) at 14 
days post-treatment for each anthelmintic tested. The range of 95% Lower Confidence 
Limits (LCL) for all yards for each anthelmintic is also shown. NC = not calculable 
because some Day 14 FEC exceeded Day 0 FEC precluding meaningful calculation of 
95% LCL 
 
 FBZ PYR IVM MOX 
Total yards 7 8 13 10 
Total equids 55 111 163 118 
*FECR range (%) 15.8 - 83.4 90.4 - 99.6 99.5 - 100 99.4 – 100 
95% LCL range 
(%) 
NC 80.9 - 99.4 94.3 - 100 96.1 – 100 
FBZ = fenbendazole, IVM = ivermectin, MOX = moxidectin, PYR = pyrantel 
*calculated from all individual horses from each yard 
 
FBZ efficacy was examined on 7 yards with samples obtained from 55 individuals 
(Table 3.5). On all premises, reduced efficacy was recorded, with mean percentage 
FECR ranging from 15.8 to 83.4% (Figure. 3.3a). For 18% (10/55) of the individual 
horses or ponies tested, Day 14 FEC exceeded Day 0 FEC, precluding calculation of 
meaningful LCL. PYR efficacy was examined on 8 yards using samples derived from 111 
individuals (Table 3.5). On all premises, mean percentage FECR was above the 
designated 90% cut-off, ranging from 90.4 to 99.6% (Figure. 3.3b). The 95% LCL 
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ranged from 80.9 to 99.4%, providing an early indication of resistance in some 
populations. 
IVM efficacy was investigated on 13 yards using samples derived from 163 individuals 
(Table 3.6). On all premises, the mean FECR was above the 95% efficacy cut-off, 
ranging from 99.5 to 100%, indicating acceptable efficacy (Figure. 3.3c). The 95% LCL 
ranged from 94.3 to 100%. MOX efficacy was examined on 10 yards using samples 
from 118 individuals (Table 3.6). On all premises, the mean FECR exceeded the 
designated 95% efficacy cut-off, ranging from 99.4 to 100 % (Figure, 3.3d). The 95% 
LCL ranged from 96.1% to 100% after treatment with MOX. 
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  FBZ PYR 
Yard No. No. 
recruited 
Day 0 FEC [epg] 
Mean (range) 
Day 14 FEC [epg] 
Mean (range) 
FECR 
(%) 
LCL 
(%) 
No. 
recruited 
Day 0 FEC [epg] 
Mean (range) 
Day 14 FEC [epg] 
Mean (range) 
FECR 
(%) 
LCL 
(%) 
    
1s 5 
494 
(198-851) 
287 
(147-426) 41.9 NA 8 
474 
(90-1341) 
45 
(0-239) 91.0 90.4 
2s 14 
227 
(125-747) 
166 
(32-405) 27.0 NA 36 
253 
(2-1472) 
1 
(0-7) 99.6 95.0 
3s 5 
269 
(30-693) 
227 
(8-590) 15.8 NA 9 
113 
(84-207) 
2 
(0-5) 98.7 98.1 
4s 11 
261 
(57-545) 
70 
(2-213) 67.6 NA 11 
107 
(15-548) 
2 
(0-9) 97.8 90.7 
5s 10 
259 
(85-495) 
108 
(26-393) 58.3 NA 17 
193 
(12-563) 
1 
(0-7) 99.6 99.2 
6s 6 
340 
(62-738) 
56.3 
(23-125) 83.4 NA 5 
388 
(47-896) 
2 
(0-8) 99.5 99.4 
7s 4 
166 
(63-246) 
131 
(39-284) 21.1 NA 14 
254 
(2-851) 
3 
(0-25) 98.7 94.5 
8s NP NP NP NP NP 11 
243 
(21-605) 
13 
(0-86) 94.9 80.9 
Total 55     111     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.5.  Faecal egg count reduction test data for fenbendazole (FBZ) and pyrantel (PYR) on individual Scottish yards detailing the number of equids 
recruited (i.e. equids with faecal egg counts (FEC) 50 eggs per gram (EPG) at screening).  Mean strongyle FEC (EPG) are shown for Day 0 and Day 14.  
Arithmetic mean faecal egg count reduction (FECR) (%) and 95% lower confidence limit (95% LCL) (%) are displayed for each population.  NA = not 
applicable because Day 14 FEC exceeded day 0 FEC precluding meaningful calculation of 95% LCL.  NP = not performed 
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Yard No. No. 
recruited 
Day 0 FEC [EPG] 
Mean (range) 
Day 14 FEC [EPG] 
Mean (range) 
FECR 
(%) 
LCL 
(%) 
No. 
recruited 
Day 0 FEC [EPG] 
Mean (range) 
Day 14 FEC [EPG] 
Mean (range) 
FECR 
(%) 
LCL 
(%) 
    
1s 5 
222 
(59-403) 
0 
(0-0) 100 100 5 
145 
(77-287) 
0 
(0-0) 100 100 
2s 39 
415 
(3-1841) 
0.7 
(0-4) 99.8 96.9 45 
200 
(11-675) 
0.1 
(0-2) 100 99.8 
3s 5 
162 
(40-282) 
0 
(0-0) 100 100 8 
370 
(135-801) 
2.4 
(0-16) 99.4 98.6 
4s 10 
156 
(77-296) 
0 
(0-0) 100 100 13 
237 
(6-752) 
0.2 
(0-1) 99.9 96.1 
5s 11 
264 
(101-518) 
0.6 
(0-3) 99.8 99.0 9 
93 
(48-209) 
0.3 
(0-3) 99.6 99.5 
6s 3 
212 
(137-261) 
0 
(0-0) 100 100 3 
166 
(30-338) 
0 
(0-0) 100 100 
7s 4 
106 
(48-189) 
0.5 
(0-1) 99.5 98.4 10 
303 
(29-563) 
0 
(0-0) 100 100 
8s 7 
676 
(216-1742) 
1.9 
(0-6) 99.7 98.7 NP NP NP NP NP 
9s 3 
196 
(86-374) 
0 
(0-0) 100 100 8 
89 
(35-191) 
0 
(0-0) 100 100 
           
Table 3.6.  Faecal egg count reduction test data for ivermectin (IVM) and moxidectin (MOX) on individual Scottish yards detailing the number of 
equids recruited (i.e. equids with faecal egg counts (FEC) 50 eggs per gram (EPG) at screening).  Mean strongyle FEC (EPG) are shown for Day 0 and 
Day 14. Arithmetic mean FECR (%) and 95% LCL (%) are displayed for each population.  NP indicates not performed. 
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  IVM MOX 
 
 
Yard No. No. 
recruited 
Day 0 FEC [EPG] 
Mean (range) 
Day 14 FEC [EPG] 
Mean (range) 
FECR 
(%) 
LCL 
(%) 
No. 
recruited 
Day 0 FEC [EPG] 
Mean (range) 
Day 14 FEC [EPG] 
Mean (range) 
FECR 
(%) 
LCL 
(%) 
10s 3 
83 
(67-92) 
0 
(0-0) 100 100 NP 
 
NP NP NP NP 
11s 6 
608 
(164-1805) 
0.4 
(0-2) 99.9 99.7 NP NP NP NP NP 
12s 3 
112 
(89-156) 
0 
(0-0) 100 100 NP NP 
 
NP NP NP 
13s 64 
650 
(4-2313) 
0.4 
(0-13) 99.9 94.3 NP NP NP NP NP 
14s NP NP NP NP NP 12 
525 
(29-1067) 
0.1 
(0-1) 100 99.2 
15s NP NP NP NP NP 9 
154 
(48-576) 
0 
(0-0) 100 100 
Total 101     110     
Table 3.6. continued. Faecal egg count reduction test data for ivermectin (IVM) and moxidectin (MOX) on individual Scottish yards detailing the number 
of equids recruited (i.e. equids with faecal egg counts (FEC) 50 eggs per gram (EPG) at screening).  Mean strongyle FEC (EPG) are shown for Day 0 
and Day 14. Arithmetic mean FECR (%) and 95% LCL (%) are displayed for each population.  NP indicates not performed. 
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Figure 3.3. Results of faecal egg count reduction tests (FECRT) (arithmetic mean % 
reduction) on 15 yards (1 - 15) following; (a) fenbendazole (FBZ), (b) pyrantel (PYR), 
(c) ivermectin (IVM) or (d) moxidectin (MOX) treatment. Numbers in columns 
represent number of equids sampled. Dashed lines represent efficacy threshold for the 
particular anthelmintic (90% for FBZ and PYR, 95% for IVM and MOX). Solid grey lines 
represent 95% lower confidence limit (LCL) threshold for the particular anthelmintic 
(80% for FBZ and PYR, 90% for IVM and MOX). Error bars representing the 95% lower 
confidence limits (LCL) are included for PYR, IVM and MOX. The 95% LCL have been 
excluded for FBZ as some of the Day 14 FEC exceeded the Day 0 FEC values, preventing 
meaningful calculation 
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(c) IVM 
 
(d) MOX 
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3.4.2.2. English FECRT data 
A total of 404 FECRTs were performed (Table 3.7). All four types of anthelmintic were 
tested (FBZ, PYR, IVM and MOX) on 8 yards (Yards 1e, 4e, 9e, 10e, 11e, 13e, 14e and 
16e); FBZ, PYR and IVM on 2 yards (Yards 7e and 12e); FBZ, PYR and MOX on 2 yards 
(Yards 3e and 5e) and PYR and MOX on 1 yard (Yard 15). Group sizes for FECRT ranged 
from 3 - 27 equids (median 7), representing 16% – 76% of each population tested 
(Table 3.7) 
Table 3.7. Faecal egg count reduction test summary data from English yards indicating 
number of individual yards and equids tested per yard. The efficacy range details the 
yard arithmetic mean percentage reductions in faecal egg counts (FEC) at 14 days post-
treatment for each anthelmintic tested. The range of 95% lower confidence limit (LCL) 
for all yards for each anthelmintic is also shown 
 FBZ PYR IVM MOX 
Total yards 12 12 10 12 
Total equids 101 110 93 100 
*FECR range (%) -3.4 - 65.8 86.8 - 99.5 96.4 – 100 99.9 - 100 
95% LCL range 
(%) 
NC 80.9 - 99.4 94.6 – 100 99.2 - 100 
FBZ = fenbendazole, IVM = ivermectin, MOX = moxidectin, PYR = pyrantel 
*calculated from all individual horses from each yard 
 
Efficacy of FBZ was examined on 12 yards with samples obtained from 101 individuals 
(Table 3.7). On all premises, efficacy was below the designated 90% threshold, with 
mean percentage FECR ranging from 0 - 65.8%. For 19% (n = 19) of the individuals 
tested, Day 14 FEC exceeded Day 0 FEC, precluding calculation of meaningful LCL 
(Figure 3.4a). PYR efficacy was examined on 12 yards using samples derived from 110 
individuals (Table 3.8). On 11 premises, mean percentage FECR was above the 
designated 90% cut-off, ranging from 90.1 to 99.5%. The 95% LCL ranged from 88.3 to 
99.4% (Figure 3.4b). On Yards 4e and 15e, the mean percentage FECR was below the 
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designated cut-off: i.e. FECR of 86.8 and 87.2% were calculated, respectively. However, 
for these tests the 95% LCL did not fall below the designated 80% LCL threshold (81 
and 83.1%, respectively). Evaluation of individual FECR revealed that, on Yard 4e, 
three out of eight individual equids had markedly lower FECR compared to the other 
horses. These horses were retested, and upon retesting the mean FECR was 73.3%, 
95% LCL 46%. On Yard 15e, six out of 27 equids had a FECR below 90% (range 53 - 
87%). Each horse had a high Day 0 FEC (545 - 1112 EPG). These animals were not 
retested. 
Efficacy of IVM was investigated on 10 yards using samples from 93 individuals (Table 
3.9). On all premises, the mean FECR was above the 95% efficacy cut-off, ranging from 
96.4 to 100% (Figure 3.4c). The 95% LCL ranged from 94.6 to 100% after treatment 
with IVM. MOX efficacy was examined on 12 yards using samples from 100 individuals 
(Table 3.9). On all premises, the mean FECR exceeded the designated 95% efficacy cut-
off, ranging from 99.9 to 100% (Figure 3.4d). The 95% LCL ranged from 99.2 to 100% 
after treatment with MOX. 
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 FBZ PYR 
Yard No. No. recruited Day 0 FEC [EPG] 
Mean (range) 
Day 14 FEC [EPG] 
Mean (range) 
FECR (%) LCL (%) No. recruited Day 0 FEC [EPG] 
Mean (range) 
Day 14 FEC [EPG] Mean (range) FECR (%) LCL (%) 
1e 8 318 
(16-1368) 
208 
(1-585) 
34.6 NA 6 311 
(30-707) 
1 
(0-8) 
99.5 99.4 
3e 5 251 
(156-563) 
106 
(0-282) 
57.9 NA 2 189 
(125-252) 
3 
(3-3) 
98.4 97.0 
4e 9 376 
(99-954) 
211 
(0-936) 
43.9 NA 8 238 
(48-423) 
31 
(0-92) 
86.8 81.0 
5e 6 365 
(149-891) 
261 
(5-743) 
28.4 NA 4 246 
(56-783) 
23 
(0-91) 
91.0 90.0 
7e 4 460 
(135-644) 
218 
(56-324) 
52.7 NA 3 370 
(273-450) 
8 
(0-23) 
97.9 91.7 
9e 13 504 
(59-2138) 
279 
(42-1998) 
44.7 NA 13 208 
(39-1053) 
12 
(1-74) 
94.1 91.5 
10e 6 262 
(36-900) 
288 
(25-612) 
13.1 NA 4 484 
(239-954) 
19 
(0-41) 
96.1 91.0 
11e 5 255 
(69-608) 
264 
(89-725) 
-3.4 NA 5 242 
(80-666) 
5 
(1-11) 
98.1 97.0 
12e 18 645 
(33-918) 
368 
(0-671 
43.0 NA 14 319 
(41-833) 
5 
(0-11) 
98.5 93.4 
13e 4 216 
(36-459) 
105 
(60-227) 
51.0 NA 4 226 
(16-378) 
10 
(0-38) 
95.5 92.1 
14e 15 210 
(45-918) 
72 
(0-279) 
65.8 NA 13 98 
(21-329) 
1 
(0-18) 
98.5 96.0 
15e NP NP NP NP NP 27 54 
(99-1229) 
72 
(0-315) 
87.2 83.1 
16e 8 388 
(126-567) 
282 
(117-549) 
27.4 NA 7 374 
(194-563) 
17 
(0-71) 
95.5 88.3 
Total 101     110     
Table 3.8.  Faecal egg count reduction test data for fenbendazole (FBZ) and pyrantel (PYR) on individual English yards detailing the number of equids 
recruited (i.e. equids with faecal egg counts (FEC) 50 eggs per gram (EPG) at screening).  Mean strongyle FECs (EPG) are shown for Day 0 and Day 14.  
Arithmetic mean FECR (%) and 95% lower confidence limit (LCL) (%) are displayed for each population.  NA = not applicable because Day 14 FECs 
exceeded Day 0 FECs precluding meaningful calculation of 95% LCLs.  NP = not performed 
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 IVM MOX 
Yard No. No. recruited Day 0 FEC [EPG] 
Mean (range) 
Day 14 FEC [EPG] 
Mean (range) 
FECR (%) LCL (%) No. 
recruited 
Day 0 FEC [EPG] 
Mean (range) 
Day 14 FEC [EPG] 
Mean (range) 
FECR 
(%) 
LCL (%) 
1 5 
445 
(140-914) 0 (0-0) 100 10 11 
344 
(59-1094) 
0 
(0-0) 100 100 
3 NP NP NP NP NP 4 
523 
(342-657) 
0 
(0-0) 100 100 
4 13 
345 
(42-824) 
0 
(0-2) 99.9 99.6 10 
221 
(63-549) 
0 
(0-0) 100 100 
5 NP NP NP NP NP 7 
318 
(148-567) 
0 
(0-0) 100 100 
7 8 
175 
(68-288) 
8 
(0-20) 96.4 94.6 NP NP NP NP NP 
9 7 
93 
(72-131) 
0 
(0-0) 100 100 14 
518 
(45-1085) 
0 
(0-0) 100 100 
10 8 
1060 
(78-2025) 
0 
(0-0) 100 100 9 
369 
(35-788) 
0 
(0-0) 100 100 
11 6 
296 
(107-518) 
0 
(0-0) 100 100 6 
244 
(84-410) 
0 
(0-0) 100 100 
12 23 
288 
(48-585) 
0 
(0-0) 100 100 NP NP NP NP NP 
13 5 
344 
(95-887) 
0 
(0-0) 100 100 5 
260 
(83-527) 
0 
(0-0) 100 100 
14 18 
440 
(53-2048) 
0 
(0-1) 100 99.8 15 
335 
(42-932) 
0 
(0-0) 100 100 
15 NP NP NP NP NP 12 
231 
(45-878) 
1 
(0-1) 99.9 99.2 
16 NP NP NP NP NP 7 
302 
(77-671) 
0 
(0-0) 100 100 
Total 93     100     
Table 3.9.  Faecal egg count reduction test data for ivermectin (IVM) and moxidectin (MOX) on individual English yards detailing the number of 
equids recruited (i.e. equids with faecal egg counts (FEC) 50 eggs per gram (EPG) at screening).  Mean strongyle FECs (EPG) are shown for Day 0 
and Day 14.  Arithmetic mean faecal egg count reduction (FECR) (%) and 95% lower confidence limit (LCL) (%) are displayed for each population.  
NP = not performed 
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Figure. 3.4. Results of faecal egg count reduction tests (FECRT) (arithmetic mean % 
reduction) on 12 yards (1 - 12) following either; (a) fenbendazole (FBZ), (b) pyrantel 
(PYR), (c) ivermectin (IVM) or (d) moxidectin (MOX) treatment. Numbers on x axis in 
brackets represent number of equids sampled. Dashed lines represent efficacy 
threshold for the particular anthelmintic (90% for FBZ and PYR, 95% for IVM and 
MOX). Solid black lines represent 95% lower confidence limit (LCL) threshold for the 
particular anthelmintic (80% for FBZ and PYR, 90% for IVM and MOX). Error bars 
representing the 95% LCL are included for PYR, IVM and MOX. The 95% LCL have been 
excluded for FBZ as some of the Day 14 FEC exceeded the Day 0 FEC values, preventing 
meaningful calculation 
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(c) IVM 
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3.4.2.3. Factors affecting Day 14 FEC 
 
Plots of  Day 0 FEC versus Day 14 FEC (Figure 3.5a) and horse age versus the Day 14 
FEC (Figure 3.5b) show that as Mean Day 0 increases Mean Day 14 FEC increases and 
as horse age increases, Day 14 FEC decreases. 
The effect of Day 0 FEC on the Day 14 FEC given treatment (Figure 3.6a) demonstrates 
that there is a positive trend when FBZ and PYR were administered indicating that the 
magnitude of the Day 14 FEC is affected by the magnitude of the Day 0 FEC. The effect 
of horse age on Day 14 FEC given treatment shows a negative trend when FBZ and PYR 
are administered (Figure 3.6b). 
The GLMM analyses revealed that country and yard type did not affect Day 0 FEC 
(Table 3.10).  Age had a negative effect on Day 14 FEC but this was not significant (b = -
0.004; p = 0.841). Day 0 FEC had a weak positive effect on Day 14 FEC (b = -0.0008; p = 
0.02). Unsurprisingly, the largest negative effect on Day 14 FEC was observed in the 
MOX treated horses (b = -8.076; p<0.001), followed by IVM (b = -6.407; p<0.001) and 
PYR (b = -2.852, p<0.001) (Table 3.10). 
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Figure 3.5. Plot of Day 0 faecal egg counts (FEC) measured in eggs per gram (EPG 
versus Day 14 FEC (A) and Age versus Day 14 FEC (B) 
 
 
 
B.  
A.  
A. 
A. 
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Figure 3.6. Coplot of Mean Day 0 FEC versus Day 14 FEC (A) and Age versus Mean Day 
14 FEC (B) given treatment (Tx) for fenbendazole (FBZ; bottom left panel), ivermectin 
(IVM; bottom right panel), moxidectin (MOX; top left panel) and pyrantel (PYR; top 
right panel). The red line is a non-parametric smoother to emphasise the contrasting 
trends in each panel 
 
Table 3.10. Generalised linear mixed models (GLMM) of the Day 14 faecal egg count 
(FEC), including Yard as a random effect and country, age, treatment (ivermectin, IVM; 
moxidectin, MOX; pyrantel, PYR) and Day 0 FEC as fixed effects. Included are the 
estimated effect (b), standard error (se) and associated z scores (z), plus the log-
likelihood ratio test statistics for the dropped term. The retained terms form the final 
adequate model  
Explanatory 
variable 
Factor b se z p LRT p 
Dropped 
terms 
       
Country Scotland 0.324 0.666 0.487 0.626 0.752 0.386 
 
Yard type Sanctuary 0.714 1.021 0.7 0.484 0.175 0.675 
Retained 
terms 
       
Age  -0.004 0.018 -0.200 0.841   
Treatment IVM -6.407 0.333 -19.241 <0.001   
 MOX -8.076 0.429 -18.84 <0.001   
 PYR -2.852 0.294 -9.689 <0.001   
Day 0 FEC  0.0008 0.0003 2.237 0.02   
B. 
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3.4.2.4. Efficacy versus Parascaris equorum 
 
The efficacy of FBZ against P. equorum was calculated on two yards (Yards 3e and 9e) 
where ascarid ova were detected on Day 0. A total of 5 FECRT were performed, the 
mean Day 0 FEC were 81 and 27 EPG, respectively, and on each occasion the mean 
FECR was 100%. MOX/PRZ efficacy was examined against P. equorum on one yard 
using five horses (mean Day 0 FEC = 146 EPG, range 5 to 269 EPG). In all horses the 
FECR on Day 14 was 100% (Table 3.11). 
Table 3.11. Faecal egg count reduction test data for fenbendazole (FBZ) and 
praziquantel against ascarids (A) or tapeworm (T). Mean faecal egg count (FEC) 
measured in eggs per gram (EPG) are shown for Day 0 and Day 14. Arithmetic mean 
faecal egg count reduction (FECR) (%) are displayed for each yard 
 
A = Ascarids, T = Tapeworm 
 
3.4.2.5. Larval cultures 
 
On 11 of the 16 yards recruited, positive FEC from the first screening occasion were 
pooled and cultured to generate L3 for classification as large or small strongyles. Of the 
larvae recovered, 94.3% were identified belonging to the cyathostomin group. The 
remaining 5.7% L3 were classified as free-living nematodes. No large strongyle larvae 
were identified in any of the samples examined. 
AM 
Yard 
number No. Horses 
Day 0 FEC 
[EPG] 
mean (range) 
Day 14 FEC 
[EPG] 
mean (range) 
%FECR 
 
FBZ 3e 1 81A 0 100 
FBZ 
9e 4 
27A 
(3 - 47) 0 100 
PRZ 9e 5 
146T 
(5 - 269) 0 100 
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3.4.2.6. Efficacy of 5d FBZ and MOX in two populations of welfare horses and 
horses residing at an equine hospital 
 
In the first study, 69 equids that were resident on a welfare yard in Scotland were 
initially screened by FEC, of which 26 (median age 3.5 years, range 3 months to 23 
years) were measured as excreting ≥50 EPG and were recruited onto a 5d FBZ FECRT. 
The population mean % FECR for 5d FBZ was measured as 44.7% (Table 3.12) at Day 
14 post-treatment. In six (23.1%) individuals, FEC were higher on Day 14 than on Day 
0 of FBZ administration, precluding calculation of 95% LCL. Twelve equids had 
strongyle FEC ≥50 EPG 14 days after 5d FBZ administration and were enrolled onto a 
MOX FECRT (median age 3.5 years, range 3 months to 9 years). The population mean 
FECR after MOX administration was 99.7% (95% LCL = 99.1%) 14 days post-treatment 
(Table 3.12). 
Table 3.12. Population mean percentage faecal egg count reduction (FECR) (%) in 
strongyle FEC after 5 day fenbendazole (5d FBZ) and moxidectin (MOX) 
administration. Included are the group mean strongyle faecal egg count (FEC) 
measured in eggs per gram (EPG) on Day 0 and Day 14, the range of FEC (EPG), the 
group mean faecal egg count reduction (FECR %) and the lower 95% confidence limit 
(95% LCL). NC = not calculable because Day 14 FEC exceeded Day 0 FEC precluding 
meaningful calculation of 95% LCL 
  
 5d FBZ 
(n = 26) 
MOX 
(n = 12) 
 Day 0 Day 14 Day 0 Day 14 
Arithmetic mean 
strongyle FEC 
(EPG) 
412 217 545 0.1 
Range (EPG) 18 - 1701 2 - 1013 29 - 1067 0 – 1 
FECR (%) 44.7 99.7 
95% LCL (%) NC 99.1 
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In a further study, 11 horses, resident at the R(d)SVS equine hospital, were screened 
for the presence of strongyle eggs. The median age of the horses was 12 (range 5 – 16 
years). Of the 11 horses, 10 had a FEC of ≥50 EPG and were randomly allocated to one 
of two treatment groups: Group 1 received 5d FBZ and Group 2 received MOX. On Day 
2, one horse from Group 2 was withdrawn from the study as it had to be euthanased. 
The reason for euthanasia was not attributed to parasitism. The population mean % 
reduction for Groups 1 and 2 was 59.9% (LCL -3.6%) and 100 % (LCL 100%), 
respectively (Table 3.13). 
Table 3.13. Population mean percentage faecal egg count reduction (FECR) (%) in 
strongyle faecal egg count (FEC) after 5 day fenbendazole (5d FBZ) and moxidectin 
(MOX) administration. Included are the group mean strongyle FEC measured in eggs 
per gram (EPG) on Day 0 and Day 14, the range of FEC (EPG), the group mean faecal 
egg count reduction (FECR %) and the lower 95% confidence limit (95% LCL) 
 
 Group 1 
5d FBZ 
(n = 5) 
Group 2 
MOX 
(n = 4) 
 Day 0 Day 14 Day 0 Day 14 
Arithmetic mean 
strongyle FEC 
(EPG) 
292 117 305 0 
Range (EPG) 41 - 810 4 – 200 173 – 648 0 - 0 
FECR (%) 59.9 100 
95% LCL (%) -3.6 100 
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3.5 Discussion 
 
Here, efficacy of anthelmintics against strongyle nematodes in horses in Scotland and 
England was investigated by the FECRT. On all premises tested, there was low efficacy 
of FBZ, consistent with previous reports (Craven et al., 1998; Kaplan et al., 2004; 
Osterman-Lind et al., 2007). The population arithmetic mean FECR ranged amongst 
premises (range -3.4% - 83.4%), but tended to be lower on the English yards (-3.4% - 
65.8%) compared to the Scottish yards (15.8% – 83.4%). This may reflect differences 
in historical use of FBZ, particularly previous inappropriate use; for example, repeated 
under-dosing or high treatment frequency (Stratford et al., 2014b). Alternatively, local 
climate could account for the differences observed. The climate is wetter in Scotland 
compared to the south of England, potentially leading to a larger population of infective 
larvae on pasture in Scotland, thus increasing the population of parasites in refugia, 
which has been demonstrated to slow the development of resistance in sheep 
nematodes (Martin et al., 1981). These results indicate that FBZ should no longer be 
recommended for cyathostomin control on these premises. These results underline 
high levels of a lack of FBZ efficacy compared to the last study performed in Scotland 
20 years ago, when acceptable efficacy (i.e. >90% mean FECR) was identified at 7 out of 
9 premises tested (King et al., 1990). 
Acceptable efficacy of PYR was found on all Scottish premises, with FECR ranging from 
90.4 -99.6%, and LCL ranging from 80.9 to 99.4%. Only on Yard 8s, did the 95% LCL 
approach the designated 80% cut-off. Evaluation of individual FECR on Yard 8s 
revealed a single horse with a markedly lower FECR than the yard mean. This 
individual, who was two years old, was tested on two occasions, and a similar result 
was obtained in both cases. For the control of Schistosoma mansoni, humans often 
receive two treatments, given 40 days apart (Picquet et al., 1998). This approach has 
 
 
156 
 
been shown to be more effective than single treatment alone, particularly in cases 
where there is high infection intensity. This practice is not routinely adopted in the 
treatment of cyathostomins, but could be an effective approach in controlling horses 
with high EL burdens, which would mature after the initial dose, potentially leading to 
an increase in strongyle egg shedding. However, any such treatment would be ‘off-
label’ and would only be allowed by a veterinary surgeon under the ‘cascade’.   
Host age may explain why PYR failed to reduce the pre-treatment FEC by >90% as 
there is previous evidence that anthelmintics are less effective in younger animals 
(Herd and Gabel, 1990). Furthermore, a recent study that examined anthelmintic 
efficacy on UK Thoroughbred stud farms, tested PYR on five studs, using 64 horses; in 
mares, efficacy ranged between 99.4 and 99.8% FECR, while in yearlings efficacy 
ranged between 8% and 73% FECR (Relf et al., 2014). In agreement with this, a recent 
study by Nielsen et al. (2013) found that PYR efficacy increased with increasing age 
and that as pre-treatment FEC increased, PYR efficacy decreased (Nielsen et al., 2013). 
Here, acceptable PYR efficacy was found on 11 of 13 English premises tested. On two 
yards, resistance to PYR was suggested; both however, were used for 
rescue/sanctuary. It is likely that there were frequent movements of animals at these 
properties. Unless strict quarantine measures were employed, there would be an 
increased risk of transmission of anthelmintic resistant small strongyles. Resistance on 
these yards was suspected rather than indicated, and it is possible there were 
difficulties in administering anthelmintics to some individuals rather than this 
representing resistance. The findings here contrast with reports from the USA, where 
PYR resistance was found on 20 - 40.5% farms (Kaplan et al., 2004; Tarigo-Martinie et 
al., 2001). It is likely that the higher prevalence of PYR resistance in the USA is a result 
of its availability as a daily in-feed anthelmintic since the 1990s (Slocombe and de 
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Gannes, 2006; Tarigo-Martinie et al., 2001), likely resulting in a high selection pressure 
for PYR-resistant genotypes (Brazik et al., 2006). 
Acceptable efficacy was demonstrated with both ML anthelmintics; FECR exceeded 
95% reduction in FEC on all premises tested. Recent studies have reported a reduction 
in ERP following IVM treatment in Europe, Brazil and the USA (von Samson-
Himmelstjerna et al., 2007; Molento et al., 2008; Lyons et al., 2008; Relf et al., 2014). In 
a German study, IVM was reported to be efficacious at 14 days post-treatment on 
multiple sites; however, a reduction in strongyle ERP from 8 to 5 weeks on 2 of 6 farms 
was noted (von Samson-Himmelstjerna et al., 2007). Recent studies indicate that MOX 
is still effective at 14 days post-treatment (Becher et al., 2010; Traversa et al., 2009, 
2012), in agreement with the findings of this study. However, in the USA, a shortened 
ERP after MOX administration has been observed (Rossano et al., 2010; Lyons et al., 
2011) and concurrent reduced efficacy of all three anthelmintic classes was indicated 
in Brazil (Molento et al., 2008). In the Brazilian study, only one FECRT was performed 
for each anthelmintic, with group sizes of six horses. With such a limited sample size, 
the findings are not likely to reflect the true resistance status of cyathostomins across 
the whole of Brazil. They failed to mention the age of the horses and the pre-treatment 
FEC, which, as discussed earlier, could have a bearing on efficacy of the anthelmintics 
tested (Nielsen et al., 2013). They also failed to mention the FEC method used, which, 
as reported in Chapter 2 can influence the FECRT. In a more recent study conducted in 
Brazil, 498 horses from 11 yards were used to assess the efficacy of FBZ, PYR, IVM and 
MOX. Each FECRT group consisted of eight horses that were >12 months old and had 
not received anthelmintic treatment in the preceding 60 days (Canever et al., 2013). 
FBZ resistance was reported on all yards tested. PYR resistance was reported on one 
yard and reduced efficacy, measured by a LCL <80%, was identified on three yards. 
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IVM resistance was reported on one yard and resistance to MOX was not observed 
(Canever et al., 2013). Here again, details on the FEC method used were not included, 
nor were any details on the mean pre-treatment FEC published. In addition, on the 
yards where PYR and IVM resistance were observed, the authors did not provide 
details of whether a low FECR was observed in all or just one horse from the test group 
or if the horses were monitored to confirm ingestion of the anthelmintic. Further, the 
animals/groups in which resistance was identified were not retested with the same 
anthelmintic to confirm resistance (Canever et al., 2013). A recent study looking at 
anthelmintic efficacy on UK Thoroughbred studs reported a shortened ERP following 
MOX administration on three yards (n = 35 horses), with eggs reappearing in faeces 4 
weeks post MOX administration, suggesting that the MLs are not working as effectively 
as measured previously (Relf et al., 2014). It is not surprising that a reduction in ERP 
was observed on Thoroughbred stud farms, where populations of small strongyles 
have been under strong selection pressure to develop anthelmintic resistance due to 
practices such as frequent and indiscriminate administration of anthelmintics (Relf et 
al., 2012). Reductions in ERP may be a more sensitive indicator of resistance than FECR 
(Sangster, 1999) and further investigation into ML ERP is warranted to confirm 
continued efficacy of anthelmintics in this class. 
In the present study, FBZ demonstrated good efficacy (≥90%) against P. equorum. In a 
recent study, conducted on UK Thoroughbred studs, FBZ FECRT were conducted in 16 
horses resident on two yards and, on both yards, FBZ demonstrated good efficacy 
(>95% FECR) compared to FECR observed on a further two farms (n = 12 horses) 
where IVM was administered, and the mean % FECR <90%. There have been several 
reports of reduced efficacy of the MLs against P. equorum (Hearne et al., 2003; 
Slocombe et al., 2003; Reinemeyer, 2008) therefore; routine use of ML for the control 
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of P. equorum in foals should be questioned, at least on large stud farms in the UK. 
Further studies are warranted to investigate the efficacy of FBZ against P. equorum, as 
this may be the anthelmintic of choice for use in ascarid control in young horses. 
MOX, IVM and PYR had a significant negative effect on Day 14 FEC. MOX had the 
greatest effect (b = -8.076; p<0.001), followed by IVM (b = -6.407; p<0.001) and PYR (b 
= -2.852; p<0.001), indicating that MOX is more effective at reducing the Day 14 FEC 
compared to IVM and PYR. This finding is likely explained by the original efficacy 
studies, whereby MOX demonstrated 100% efficacy vs. adult cyathostomins, 90.8% 
efficacy vs. EL3 and 99.9% against all other developing cyathostomin larvae (Monahan 
et al., 1995; Bairden et al., 2001; 2006; Reinemeyer et al., 2003), compared to reported 
IVM efficacy of 99% against adults, 98% efficacy against luminal cyathostomin larvae 
(Klei et al., 1993; Xiao et al., 1994), and reported PYR efficacy of 89 – 96% against adult 
cyathostomins (Lyons et al., 1974). Furthermore, IVM and PYR have been licensed for 
longer than MOX, increasing the selection pressure for resistance.  
Day 0 FEC had a significant weak positive effect on Day 14 FEC (b = 0.0008; p = 0.02), 
indicating that the higher the Day 0 FEC, the higher the Day 14 FEC. Age had a weak 
negative effect on Day 14 FEC but this was not significant (b = -0.004, p = 0.841). 
Similar findings were reported in a recent study, where a hierarchical model was used 
for evaluating PYR efficacy data from 64 Danish horse farms (Nielsen et al., 2013). The 
authors found that the group mean pre-treatment FEC had a significant effect on PYR 
efficacy and as the pre-treatment mean increased, PYR efficacy decreased and age had 
a weak negative effect on PYR efficacy with PYR efficacy increasing with age. However, 
this finding was not significant (Nielsen et al., 2013). There is evidence to suggest that 
anthelmintics are not as effective when used in younger horses. Early studies 
conducted on a Thoroughbred breeding farm between 1982 and 1988 found that 
 
 
160 
 
oxbendazole (OXB), PYR and IVM were significantly less effective when administered 
to yearlings compared to adult mares (Herd and Gabel, 1990b). A recent study 
conducted on UK Thoroughbred studs, reported that PYR was effective in two groups 
of mares (group mean FECR 98% - 99%), compared to five groups of yearlings in which 
efficacy ranged from 0 - 73% (Relf et al., 2014). A reason for the observed reduced 
efficacy in younger horses is the fact that younger horses lack acquired immunity, 
which allows a greater accumulation of encysted cyathostomins (Lyons et al., 2009). 
When anthelmintics such as BZ, PYR and IVM are administered, which do not possess 
high efficacy against these stages, once luminal adult worms have been eliminated, 
encysted stages may emerge and resume development and eggs are seen in faeces 
sooner compared to adult horses, which harbour fewer encysted stages (Herd, 1986; 
Herd and Gabel, 1990b). It is well documented that strongyle FEC are higher in younger 
horses compared to adult horses (Relf et al., 2013) 
 Previous studies have used different criteria for determining anthelmintic resistance 
in horses. Lind et al., 2007 used resistance criteria for IVM and FBZ (FECR 95%, LCL 
90%) to describe ‘suspected’ or ‘considered’ resistance; and FECR 90%, LCL 80%, for 
PYR. Tarigo-Martinie et al. (2001), classed an anthelmintic as ‘effective’ if the FECR was 
greater than 90%, ‘equivocal’ if between 80% and 90%, and ‘ineffective’ if less than 
80%. This lack of standardisation makes direct comparison amongst studies difficult, 
limiting the accurate assessment of temporal or geographical variation in efficacy 
(Stratford et al., 2014b). Here, the FECR cut-offs chosen reflected differences in efficacy 
of the anthelmintics in drug-sensitive populations when the products were first 
licensed (Kaplan and Nielsen, 2010), but further work is required to standardise the 
way equine FECRT are conducted and reported. To this end, a working group of 
veterinary parasitologists and equine clinicians have been working towards 
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standardising the FECRT for use in equids, but to date, are yet to produce ratified 
guidelines (Nielsen et al., 2011). The guidelines need to define the number of horses to 
be included in a FECRT, which FEC method to use and the diagnostic sensitivity, what 
the pre-treatment FEC should be for selecting horses for the FECRT, the statistical 
method for estimating efficacy and 95% confidence intervals and clear guidelines on 
how to interpret the results.  
The recruitment of yards through two veterinary practices and the BHS website may 
have introduced a degree of sampling bias, as it could be assumed that BHS yard 
owners are more aware of good parasite management practices and of anthelmintic 
resistance. Therefore these findings may not be fully representative of the entire horse 
population in Scotland and England. That said, there was an element of heterogeneity 
in the yards recruited (i.e. different uses, breeds present and age range). In addition, 
four welfare yards were investigated; which were more likely to harbour a population 
of horses with an unknown, and most likely, infrequent, worming history.  
Efficacy was calculated per yard using the group mean pre- and post-treatment counts. 
This method of analysing the results did not take into account the differences in horse 
age and immunity, grazing history, worming history and other management factors 
between yards. These differences will lead to heterogeneity in FEC among and between 
populations of horses (Morgan et al., 2005), which in turn leads to variation in the 
outcome of FECRT (Denwood et al., 2010). To counter this, the effects of age, Day 0 
mean and treatment on Day 14 FEC were explored through a negative binomial 
generalised mixed model, in which yards were included as a random effect to account 
for the variation between yards. 
In the face of widespread FBZ resistance, it could be argued that MOX remains the only 
anthelmintic with high efficacy versus encysted cyathostomin larvae. The preliminary 
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results here also indicated a lack of efficacy of 5d FBZ in reducing strongyle FEC. These 
results were only capable of determining an effect on egg excretion and previous 
studies have demonstrated poor correlations between the magnitude of FEC and larval 
burdens (Nielsen et al., 2010a), so whether 5d FBZ had any effect on EL burden cannot 
be determined from the data collected here. To definitively assess larvicidal efficacy, 
terminal studies would be required. The development of techniques to determine in 
vivo EL burden (McWilliam et al., 2010; Clements et al., 2012) may assist evaluation of 
treatment efficacy in future. The limitations to such a test would be the length of time 
that IgG(T) circulates post-treatment, which could lead to false positive results. Given 
the high prevalence of FBZ resistance, targeted MOX use should now be recommended 
for the treatment of encysted cyathostomin larvae at the appropriate time of year. 
Presently, some veterinarians prescribe 5d FBZ as a treatment for clinical larval 
cyathostominosis, for treating horses with a high strongyle FEC and as a quarantine 
measure. This may reflect concerns surrounding toxicity of MOX in thin or debilitated 
horses (Johnson et al., 1999; Muller et al., 2005; Schumacher and Taintor, 2008) and 
may also reflect a lack of appreciation of almost ubiquitous FBZ resistance in 
cyathostomin populations. Few studies have reported the outcome of larval 
cyathostominosis cases following MOX treatment. Most publications detailing larval 
cyathostominosis case management were written prior to licensing of MOX (Love and 
McKeand, 1997). In one small study with eight horses in each treatment group, both 
anthelmintics demonstrated adulticidal and larvicidal efficacy evidenced by mucosal 
and luminal worm counts (Steinbach et al., 2006). The data indicated larvicidal death 
occurred sooner following treatment with FBZ compared to MOX, with worm death 
cited as 4 - 6 and 6 - 14 days following treatment, respectively. The different lengths of 
treatment render the data difficult to interpret. Severe mucosal inflammation, 
increased plasma globulin and increased granuloma formation around intact larvae 
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were noted 14 days after 5d FBZ treatment, whereas no substantial intestinal 
histopathological inflammation was observed in MOX-treated horses (Steinbach et al., 
2006). The variations in outcome were thought secondary to differing mechanisms of 
action of the compounds, or differing immunological responsiveness to damaged 
parasites. None of the horses displayed signs consistent with larval cyathostominosis 
prior to treatment, apart from a reduction in weight gain in comparison with a worm-
free control group, and potential safety of administration to clinical cases could not be 
determined (Steinbach et al., 2006). Deprez and Vercruysse, (2003) compared efficacy 
of IVM versus MOX in cyathostominosis cases. Either ML was administered on a 
minimum of one occasion, at the manufacturers recommended dose rate, followed by 
repeat treatments at 7 or 14 days if larvae were identified macroscopically in faeces at 
these time points. Four out of 11 horses in the MOX group received two MOX doses; 
two receiving an additional treatment 7 days later and a further two at 14 days later 
following the initial dose. In comparison, 3 out of 9 horses in the IVM group received 
two MOX doses; three receiving an additional treatment 7 days later and a further two 
at 14 days later. IVM and MOX treatment resulted in elimination of larvae from faeces 
within 1 - 2 weeks; however, there were no significant improvements in body weight 
or clinical parameters over the 3-week observation period and no significant 
intergroup difference. A longer follow-up period would be required for significant 
differences in weight and clinical parameters to be observed. Such results indicate; 
firstly, no significant adverse effects associated with MOX administration in clinical 
cases, and, secondly, prolonged clinical signs, despite apparent anthelmintic efficacy, 
indicate that clinical signs are a result of parasite-induced damage, and that supportive 
care is important. Prior to licensing of MOX in the UK, a treatment regimen comprising 
oral dosing with 5d FBZ followed by IVM on Day 6 of treatment on at least three 
occasions at 10-day intervals was recommended (Love and McKeand, 1997). 
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Considering the high prevalence of FBZ resistance, and the spectrum of activity of MOX, 
revision of these guidelines may be appropriate. Concomitant supportive care 
comprising anti-diarrhoeal agent, fluid-, electrolyte-, oncotic- support and analgesics 
are recommended to reduce intestinal inflammation in cases of colitis (Love and 
McKeand, 1997; Mair et al., 2002). 
3.6 Conclusion 
 
These studies have helped to inform on the current anthelmintic sensitivity status of 
cyathostomin populations in horses in England and Scotland. The observed widespread 
lack of FBZ efficacy in reducing strongyle FEC warrants discussion into the future use 
of this anthelmintic for the treatment and control of cyathostomins. This anthelmintic 
should still be considered for use against other species such as P. equorum, in which 
there appear to be rising levels of resistance to ML products (Boersema et al., 2002; 
Hearn and Peregrine, 2003; von Samson-Himmelstjerna et al., 2007b). Further studies 
are required to look at larger populations of horses in different parts of the UK, and 
different parasite species such as Anoplocephala spp., Oxyuris equi, Strongyloides 
westeri and P. equorum. This study and evidence from many others now suggests that 
horse owners must move towards a more targeted evidence-based approach to 
helminth control. 
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CHAPTER 4: Assessing the performance of 
methods for testing anthelmintic efficacy in 
vivo 
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4.1 Introduction 
 
The faecal egg count reduction test (FECRT) is widely used to estimate anthelmintic 
efficacy against parasitic helminths in vivo (Coles et al., 1992). However, use of the 
FECRT has not been fully validated for use in equids. There are several caveats to its 
application, particularly in horses, but in the absence of validated in vitro and 
molecular tests, the FECRT remains the only available option for the routine evaluation 
and surveillance of anthelmintic efficacy in equids (Kaplan, 2002; Vidyashankar et al., 
2012). Recently, studies have aimed to quantify variability arising through the FECRT 
and have used complex statistical analyses to address the underlying statistical 
limitations arising from equine faecal egg count (FEC) and FECRT data (Torgerson et 
al., 2005; Denwood et al., 2010; Torgerson et al., 2012; Torgerson et al., 2014; Paul et 
al., 2014). However, for many, such computationally and statistically intensive methods 
for determining FECRT are not accessible, as the statistical analyses are run in R, a 
complex statistical package requiring the user to be familiar with programming 
language. As such,  there is a need to assess the performance and limitations of the less 
statistically demanding FECRT method currently recommended by the World 
Association for the Advancement of Veterinary Parasitology (WAAVP) (Coles et al., 
1992;2006) and other less statistically demanding methods cited in the literature 
(Pook et al., 2002; Vidyashankar et al., 2007; 2012), to determine which method 
generates the most reliable estimates of anthelmintic efficacy for use in the field. 
As previously discussed in Chapter 2, there are a number of underlying factors that can 
lead to variability in FEC data. The major findings from the studies in Chapter 2 
demonstrated that strongyle eggs were over-dispersed in faeces (Section 2.5.1), and 
the use of a FEC method with a lower detection limit reduced variance (Section 2.5.3). 
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It was identified that the type of FEC method used also influenced decisions for 
anthelmintic treatment, with more horses found to exceed a 200 EPG threshold when 
FEC were analysed by the McMaster (McM) method compared to a more sensitive 
centrifugal-Flotation (CF) method (Section 2.5.5). When determining levels of 
anthelmintic efficacy in the aforementioned studies, different assumptions were made 
depending on the FEC method used (Section 2.5.6). In summary, when efficacy was 
high (i.e. following IVM or MOX administration) or when it was low (i.e. following FBZ 
administration), all FEC methods generated the same assumptions. However, when 
anthelmintic efficacy was around the threshold (i.e. following PYR administration), 
then the FEC method implemented (McM or CF) had an impact on the classification of 
resistance/susceptibility, and disagreements between methods were observed. 
Results from these empirical datasets warrant further investigation to develop a 
theoretical framework for understanding the optimum diagnostic conditions for 
conducting a FECRT. It is important to be able to discriminate between an anthelmintic 
that is efficacious and one to which there is resistance, and reduce the likelihood of 
misclassification (i.e. either falsely declaring efficacy or falsely declaring resistance). 
Falsely identifying an anthelmintic as efficacious when it is not is problematic because, 
when resistance is identified, an alternative anthelmintic should be administered to 
reduce potential dissemination of resistant alleles through the survival of adult 
parasites and subsequent pasture contamination or through animal movements. It is 
also important to define resistance as early as possible to reduce the potential for 
clinical disease. Once resistance has been identified, this knowledge must be 
disseminated within the scientific and end user communities to inform control 
protocols and potentially incentivise pharmaceutical companies to invest in new 
anthelmintic development. 
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The outcome of a FECRT is classified on the basis of arbitrary thresholds. Typically, 
resistance is declared if the mean percentage reduction in FEC is less than 90% (Coles 
et al., 1992). In the present study, a threshold of 90% was selected for FBZ and PYR and 
95% was selected for IVM and MOX. These were chosen as they reflect differences in 
original efficacy of these anthelmintics in drug-sensitive helminth populations when 
the products were first licensed (Kaplan and Nielsen, 2010). The current lack of 
guidance and rigid thresholds makes the interpretation of FECRT data complicated. For 
example, if an anthelmintic demonstrates 80% efficacy then should that anthelmintic 
be used in the future on the same parasite population?  It must be acknowledged that 
such an approach is based on the presumed efficacy of an anthelmintic rather than its 
‘true’ efficacy, which is unknown (Vidyashankar et al., 2007). Using a single threshold 
for defining efficacy is not a statistically robust approach, as neither the spread of the 
FECRT data is considered nor the impact of outliers on the subsequent classification. As 
such, many researchers include upper and lower confidence intervals (Vidyaskankar et 
al., 2007; Stratford et al., 2014b). Previous studies have used different criteria for 
determining anthelmintic resistance in horse and this lack of standardisation makes 
clear comparison amongst studies challenging by limiting accurate assessment of 
temporal or geographical variation in efficacy (Stratford et al., 2014b). 
Factors affecting the FECRT can be broadly split into those that can be controlled and 
those that cannot. The former include the number of horses included, the FEC method 
used and the egg detection limit of the FEC method utilised, while the latter include the 
mean pre-treatment FEC (EPG), the distribution of FEC between groups of horses (k), 
and true efficacy. The mean pre-treatment FEC and the distribution of FEC can in 
theory be manipulated by modifying selection criteria. Systematic exploration of these 
factors and how they impact the diagnostic performance of the FECRT can realistically 
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only be conducted using a statistical modelling approach (Torgerson et al., 2005; 
Vidyashankar et al., 2007; Dobson et al., 2009, 2012; Calvete and Uriarte, 2013). 
Recently, a study by Calvete and Uriarte (2013) aimed to improve the detection of 
anthelmintic resistance in sheep nematodes by simulating variation across a range of 
parameters including, pre-treatment mean FEC, the distribution of the pre-treatment 
mean FEC, true efficacy, and FEC detection limit. Monte Carlo simulations of all possible 
combinations of parameters were explored. The major limitation of this study was that 
the statistical model was based on prior assumptions and was not validated using 
empirical data obtained in the field. With any simulation approach, it is important to 
parameterise and validate the model with robust data to ensure that model output is as 
accurate as possible and fit for purpose (Sargent, 2013). To this end, the model built for 
the present study was based on the FEC analysis findings of Chapter 2 and FECRT data 
collected in Chapter 3. This enabled a generalisable theoretical framework to be 
developed and validated using a specific set of FEC data collected in support of the 
allied objectives of this thesis.  
4.2 Aims and objectives 
Two methods (non-parametric bootstrapping (Vidyashankar et al., 2007) and arcsine 
transformation of FECRT data (Pook et al., 2002) for estimating anthelmintic efficacy 
were applied to the equine FECRT data presented in Chapter 3 and compared to the 
currently recommended method (WAAVP, Coles et al., 1992) to investigate if the 
method used to estimate mean percentage faecal egg count reduction (FECR) had a 
bearing on the outcome and interpretation of the data in terms of classifying 
anthelmintic efficacy. The arcsine transformation and bootstrap methods were chosen 
as they are better able to deal with FEC data that do not follow a normal distribution, 
and they can be performed relatively simply in Excel opposed to suggested Bayesian 
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methods which require knowledge of R.  As the method suggested by Coles et al. (1992) 
is currently the method recommended by the WAAVP, and as it is the easiest and 
simplest formula available to estimate mean % FECR, its performance was investigated 
further through a simulation approach. The effect of the FEC method used for pre-
treatment and post-treatment samples and the egg detection limit of the method, the 
underlying mean pre-treatment FEC, the underlying distribution of the Day 0 FEC 
(negative binomial parameter, k), the number of horses included in the test and the 
true efficacy of the anthelmintic on the performance of the WAAVP method for 
estimating efficacy was investigated. The overall aim being to produce 
recommendations for interpreting FECRT data that are practical, that take account of 
underlying influences of methods on results and are validated by field data. 
4.3 Materials and methods 
 
4.3.1 Faecal egg count reduction test methods 
 
Three different methods for estimating anthelmintic efficacy were applied to 18 sets of 
FBZ FECRT data, 21 sets of PYR data, 16 sets of IVM FECRT data and 19 sets of MOX 
FECRT data. These datasets were presented in Chapter 3 (Section 3.4.2.2). 
4.3.1.1 Method 1 (WAAVP method) 
 
Percentage FECR was estimated for each group of horses using the following formula 
recommended by the WAAVP (Coles et al., 1992) (Equation 4.1), where arithmetic 
group mean FEC for Day 0 and Day 14 were used to estimate the group FECRT: 
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FECRT % efficacy= 
𝐺𝑟𝑜𝑢𝑝 𝑚𝑒𝑎𝑛 𝑝𝑟𝑒 − 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝑐𝑜𝑢𝑛𝑡𝑠 –  𝐺𝑟𝑜𝑢𝑝 𝑚𝑒𝑎𝑛 𝑝𝑜𝑠𝑡 − 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝑐𝑜𝑢𝑛𝑡𝑠
𝐺𝑟𝑜𝑢𝑝 𝑚𝑒𝑎𝑛 𝑝𝑟𝑒 − 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡
 × 100 
(Equation 4.1) 
In addition, 95% lower confidence limits (LCL) were calculated from the standard 
error (se) of the mean individual % FECR (Equation 4.2). These calculations were 
based on the actual number of eggs seen before back transforming to EPG. 
95% LCL = mean % FECR - (1.96 x se) 
(Equation 4.2) 
4.3.1.2 Method 2 (arcsine transformation) 
Method 2 was used to estimate the group mean % FECR from arcsine transformed 
individual proportional reductions (Pook et al., 2002, Method 2). The % FECR was 
estimated for each individual and the arcsine square root of each individual FECR 
proportion calculated. The group mean % FECR was calculated using Equation 4.3. 
Group mean % FECR = 100 x (sin(transformed group mean))2 
(Equation 4.3) 
 
The 95% LCL were estimated from the standard error of the transformed mean % 
FECR 
95% LCL = 100 x (sin(transformed mean % FECR - (1.96 x se) )2 
(Equation 4.4) 
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4.3.1.3 Method 3 (non-parametric bootstrapping) 
 
Monte Carlo stochastic simulation (Ripley, 1987) was used for non-parametric 
bootstrapping as a means of estimating % FECR. The bootstrap approach involved 
generating new datasets by sampling the original data with replacement (Efron and 
Tibshirani, 1986). Here, the individual % FECR from each horse was re-sampled with 
replacement. For example, on a yard of 6 horses, the individual % FECR may be 92%, 
88%, 95%, 89%, 90% and 87%. The bootstrap data set was constructed by randomly 
generating six new % FECR from the original dataset with replacement (for example, 
88%, 92%, 88%. 90%, 88%, 87%), and a new average % FECR calculated. The newly 
generated bootstrap dataset was then used to generate 10,000 simulated % FECR to 
obtain estimates of the yard mean % FECR, and upper and lower 2.5-percentiles were 
taken as the 95% confidence limits (Efron, 1979; Hilborn and Mangel, 1997). PopTools 
software (CSIRO, Australia) was used for bootstrapping (Hood, 2010). 
4.3.2 Definition of anthelmintic resistance 
 
The thresholds chosen for defining resistance were mean % FECR of <95% for 
IVM/MOX and <90% for BZD/PYR (Kaplan and Nielsen, 2010). Also, 95% LCL 
thresholds of <90% and <80% were selected for classifying resistance for IVM/MOX 
and FBZ/PYR, respectively. Accordingly, if both % mean FECR and the LCL fell below 
the designated cut-offs, anthelmintic resistance was indicated. Alternatively, if either 
the % mean FECR or the LCL fell below these cut-offs, resistance was suspected (Table 
4.1). 
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4.3.3 Simulation model 
 
The diagnostic performance of the WAAVP recommended FECRT method was explored 
through a Monte Carlo simulation approach (Efron and Tibshirani, 1986). The 
simulation model was used to investigate FECRT factors that can be controlled (see 
above) and factors that cannot be so easily controlled (see above). In theory, some of 
these factors can be manipulated by modifying selection criteria (Kaplan and Nielsen, 
2010), and the simulation included these factors in order to explore their effect more 
thoroughly. The effect of each of these factors on the classification of efficacy was 
investigated to define the application and limitations of FECRT design in detecting 
anthelmintic resistance. 
4.3.3.1. Justification of parasitological parameters: factors that cannot be 
controlled 
 
Strongyle egg shedding is usually highly over-dispersed amongst horse populations 
(Relf et al., 2013; Wood et al., 2013). The most widely used distribution chosen to 
represent parasite count data (nematodes and nematode eggs) is the negative binomial 
distribution (NBD) and previous studies in other host species have shown that the NBD 
adequately models helminth FEC aggregation (Grenfell et al., 1995; Shaw et al., 1998; 
Morgan et al., 2005; Dobson et al., 2009; Calvete and Uriarte, 2013). However, other 
distributions such as the gamma-Poisson (Wilson and Grenfell, 1997), the lognormal 
distribution (Elston et al., 2001), the Weibull distribution (Gaba et al., 2005) and zero-
inflated distributions (Jell et al., 2008; Walker et al., 2009; Denwood et al., 2010) have 
all been used for modelling parasite aggregation. Here, the NBD (k) was used because 
its use in describing the distribution of parasite data is well published and it is 
relatively straightforward to apply. The model simulated eight levels of k (0.5, 1.0, 1.5, 
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2.0, 2.5, 3.0, 3.5, 4.0 and 5.0) and nine levels of mean pre-treatment FEC (EPG) (50, 100, 
150, 200, 250, 300, 350, 400 and 500). These values were selected on the basis of the 
range of k and mean pre-treatment FEC values estimated from pre-treatment FEC 
collected from 26 sets of empirical FECRT datasets (these data were originally 
presented in Chapter 3, Section 3.4.2.2), 13 of which were generated by a CF method, 
with an egg detection limit (dl) of down to 1 EPG (Section 2.3.2) and 13 generated by 
the modified McM method, with an egg dl of 50 EPG (McM50) (Section 2.2.1). From 
these data, estimates for k ranged between 0.67 and 6.7 and mean Day 0 FEC between 
173 and 1900 EPG (Table 4.2 and 4.3). True efficacy was fixed at 70, 90 or 95%. These 
values were selected to reflect resistance (70%), borderline resistance/efficacy if PYR 
or FBZ were used (90%) and borderline resistance/efficacy if IVM or MOX were used 
(95%). 
4.3.3.2 Justification of parasitological parameters: factors that can be controlled 
 
The effect of the FEC method used to generate FECRT data was included in the model 
as a continuation of the findings reported in Chapter 2. FECRT datasets were compiled 
from simulated FEC generated by either the CF method or the McM method. For FECRT 
datasets generated by the McM method, the egg dl could be changed (5, 15, 30, 50 and 
100 EPG) based on the volume of faecal suspension examined in the McM slide (Section 
2.2.1). The number of horses included in the FECRT was explored and n ranged from 1 
to 20 horses. These numbers were selected to reflect the empirical FECRT datasets 
collected, where FECRT group sizes ranged from 3 to 18 horses (Table 4.2). When 
simulating across the range of method-related parameters, the mean pre-treatment 
FEC was fixed at 200 EPG, k at 2.2, n at 10 and the egg dl for McM at 50 EPG. These 
values were selected as they represented the average mean pre-treatment FEC, n and k 
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observed from the empirical FECRT datasets, and the McM egg dl of 50 EPG as 
recommended by the WAAVP (Coles et al., 1992; 2006). 
4.3.4 Simulation of FEC data 
 
4.3.4.1. CF model 
 
A total of 20 individual FEC were simulated from set m, k and efficacy (eff) to give a 
simulated true range of FEC (EPG1). Efficacy (eff) represented the level at which 
anthelmintic efficacy was set in the model. Each true FEC (EPG1) was converted to the 
actual number of eggs observed (egg1), by dividing EPG by the egg detection limit (dl). 
Due to the nature of the CF method, dl is determined by egg density (Section 2.3.2.2); as 
such, if EPG1 was ≥200 EPG then EPG1 was divided by 9, if EPG1 ≥50 EPG, EPG1 was 
divided by 3 and if EPG1 was <50 EPG then no conversion was required. From the 
values of egg1, a new value was drawn (egg2) from the Poisson distribution, to 
represent different aliquots of suspension so that the number of eggs observed should 
follow a Poisson distribution. The observed values for egg2 were multiplied by the 
relevant dl to give the observed EPG (EPG2). The derived EPG2 values were used as the 
pre-treatment FEC. The post-treatment FEC (PtxEPG1) were generated from EPG1 using 
the following formula; 
PtxEPG1 = EPG1*(eff/100) 
(Equation 4.5) 
PtxEPG1 was then converted to the actual number of eggs seen (Ptxegg1) by dividing 
PtxEPG1 by dl. From the values obtained for Ptxegg1, a new value was drawn (Ptxegg2) 
from the Poisson distribution. Ptxegg2 was then converted back to EPG (PtxEPG2) to 
give the post-treatment FEC. 
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Individual %FECR was estimated using the following formula: 
 
Individual FECR = ((EPG2- PtxEPG2)/ EPG2) x 100 
 
(Equation 4.6) 
 
4.3.4.2. McM model 
 
The simulated FEC for generated by the McM method were drawn from the same true 
FEC (EPG1) that were generated in the CF model, the difference being that the egg dl 
used for the McM method was fixed for the pre-treatment and post-treatment counts, 
whereas with CF, the egg dl was dependent on egg density. The egg dl investigated for 
McM were 5, 10, 15, 30, 50 and 100 EPG, and were representative of how the egg dl of 
McM can be manipulated by counting 1 grid of a McM slide (100 EPG dl); counting 2 
grids (50 EPG dl); counting 1 chamber (30 EPG dl); counting 2 chambers (15 EPG dl), 
counting 3 chambers (10 EPG dl) or counting 6 chambers (5 EPG dl). 
4.3.5 Simulation of FECRT data 
 
The model was populated with the values of m, k and eff to generate individual values 
of EPG2 and PtxEPG2. Depending on n, the arithmetic mean EPG2 and arithmetic mean 
PtxEPG2 were used to estimate observed mean % FECR (4.8) for FEC generated by CF 
and McM. 
Mean % FECR = ((EPG2- PtxEPG2)/ EPG2) x 100 
(Equation 4.7) 
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4.3.6 Simulated data generation and evaluation of the diagnostic 
performance of FECRT depending on which FEC method was used 
 
Initially, Monte Carlo simulations were generated by fixing m at 200 EPG, n at 10 and 
efficacy at 70%, but simulating over a range of k (0.5 – 5). The simulations were 
repeated with efficacy fixed at 90% and then at 95%. The effect of mean Day 0 FEC was 
then explored by fixing k at 2.2 and n at 10 and simulating across a range of m (50 - 500 
EPG), with efficacy fixed at 70, 90 and 95%. The effect of n was investigated by fixing m 
at 200 EPG, k at 2.2 and simulating across a range of n (1 - 20 horses) with efficacy 
fixed at 70, 90 and 95%. Finally, the effect of the egg dl of McM was investigated by 
fixing m at 200 EPG, k at 2.2 and n at 10, and simulating across a range of egg dl’s (5 – 
100 EPG), with efficacy fixed at 70, 90 and 95%. In order to investigate co-variation of 
m and k, six values of mean Day 0 FEC and Day 0 k from empirical FECRT datasets were 
used to populate the model and simulations using these values were performed over a 
range of n (2 - 20 horses) and efficacies (70, 90 and 95%). For each simulation, 100 sets 
of simulated FECRT data were generated, and from these, data misclassification rates 
were calculated. The thresholds used to calculate the misclassification rates are 
described in Table 4.1 and reflect the thresholds widely used to discriminate between 
efficacy and resistance (i.e. 90% for FBZ and PYR and 95% for IVM and MOX). 
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Table 4.1. The classification (false positive or false negative) of the simulated faecal 
egg count reduction test results when a 90% (i.e. fenbendazole (FBZ)/pyrantel (PYR)) 
or 95% (i.e. ivermectin (IVM)/moxidectin (MOX)) threshold was applied and efficacy 
was set at 70, 90 or 95% 
 
 
Set efficacy 
(%) 
Classification of results for 
90% threshold 
 (i.e. FBZ/PYR) 
Classification of results for 
95% threshold 
(i.e. IVM/MOX) 
70 >90% = False negative >95% = False negative 
90 <90% = False positive >95% = False negative 
95 <90% = False positive <95% = False positive 
 
The relationship between mean and distribution (k) Day 0 FEC, and the number of 
horses included in the test on the misclassification rate was investigated through a 
generalised linear modelling (GLM) approach using Poisson regression. All analyses 
were performed using RStudio 12.15.1. 
4.3.7 Model validation 
 
Field validation of the model is not possible in a pure sense, as true efficacy is not 
known and cannot be measured in living horses using a gold standard. Nevertheless, 
simulation outputs were compared with field FECRT data to assess whether 
simulations were able to predict measured FECR. A good match between simulated and 
observed FECR would show that the simulation adequately captures the most 
important sources of variation in observed FECR. To examine this, 26 sets of equine 
FECRT data (Section 3.4.2.2) were used to validate the model; 13 sets of data had been 
generated using the CF FEC method and 13 using the McM50 method (Tables 4.3 and 
4.4). The CF and McM50 generated FECR data were generated from the same animals 
on the same yard at the same time. For each set of data generated by each FEC method, 
mean pre-treatment and post-treatment, mean % FECR and k were calculated. In total, 
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four sets of FBZ FECRT data, seven sets of PYR FECRT data and two sets of IVM FECRT 
data were used. The NBD was fitted to 26 sets of empirical Day 0 FEC data (Yards 1 to 
9, 13 sets generated by the CF method and 13 sets by the McM50 method) by maximum 
likelihood estimation (MLE, Williams and Dye, 1994; Shaw et al., 1998; Morgan et al., 
2005) to give estimates of the mean, m, and the aggregation factor, k. The chi-square 
goodness of fit test was used to assess whether these data adequately fitted the NBD 
(Chapter 2, Section 2.4.1). These values were then used to simulate predicted FECRT 
data as above to compare with the measured FECRT data (Section 3.4.2.2) and hence 
validate the model. Thus, the empirical mean pre-treatment FEC and corresponding k 
values from FEC performed by the CF method were used to populate the model and 
generate 100 Monte Carlo simulated predicted mean pre-treatment and post-treatment 
FEC and expected mean % efficacy as estimated by FECRT. An average of the 100 
simulations was taken for the predicted values. The chi-squared (χ2) test was used to 
compare predicted (O) and measured (E) pre-treatment FEC as follows (Equation 2.4, 
Section 2.4.2). Predicted (O) and measured (E) post-treatment counts were compared 
in the same way. The same method was followed using pre-treatment and post-
treatment FEC data generated by the McM50 method. A lack of a significant difference 
was taken to indicate that the error structure in FEC distribution and the FEC process 
was adequately captured by the simulation and associated assumptions. The χ2 for FEC 
performed by CF and McM50 was compared with the chi-squared distribution, a 
significant difference between the predicted and measured mean pre-treatment and 
mean post-treatment EPG (p<0.05) indicated that the model did not generate realistic 
FEC based on the empirical FEC data generated by the CF method and McM50 method. 
The relationship between the predicted mean % FECR and the measured mean % FECR 
was investigated by linear regression. 
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4.4 Results 
 
4.4.1. Comparison of three different methods for estimating faecal 
egg count reduction 
 
For all 18 datasets included in the analysis, the mean % FECR was below 90% (LCL 
<80%) when FBZ was administered regardless of the method used to estimate FECR 
(Figure 4.1). For 15 datasets, Method 2 could not be used and for four datasets, Method 
3 could not be applied because too many individuals were shedding more eggs at Day 
14 than at Day 0 (Figure 4.1). For 14 out of 21 PYR FECRT datasets, Method 2 
estimated the mean % FECR to be higher compared to Methods 1 and 3 (Figure 4.2). 
For one dataset (COO), Method 1 estimated mean % FECR below 90%, LCL >80% 
(Figure 4.2). For this dataset, Methods 2 and 3 estimated mean % FECR above 90% and 
LCL <80%. For another (LAS), Methods 2 and 3 estimated mean % FECR below 90%, 
LCL <80%, compared to Method 1, where resistance was suspected (% FECR >90% LCL 
<80%). For the WHW dataset, the mean % FECR estimated by Methods 1 and 3 was 
<90%, LCL >80%, compared to Method 2, where the % FECR and LCL were >90% and 
80% respectively (Figure 4.2). In 11 out of 16 IVM FECRT datasets, Methods 1, 2 and 3 
generated the same result (mean % FECR 100%) (Figure 4.3). For 3 out of 5 datasets 
where the % efficacy was not 100%, Method 2 generated the highest estimation of 
mean % FECR compared to the other methods and for two datasets, Method 3 gave the 
lowest % FECR compared to the other methods (Figure 4.3). Results from the MOX 
FECRT demonstrated that for 13 out of 19 datasets, all methods generated the same 
mean % FECR (Figure 4.4). For four datasets, Method 3 generated the lowest mean % 
FECR compared to the other two methods, and on two occasions, Method 1 generated 
the lowest mean % FECR (Figure 4.4). In summary, for FBZ, IVM and MOX, all analytical 
methods generated the same outcome (Table 4.2). For FBZ, all methods classified the 
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test populations as ‘resistant’ and for IVM and MOX, all methods classified the test 
populations as ‘sensitive’. For the PYR FECRT dataset for 3/21 (14%) tests, there was 
disagreement between methods in the interpretation of the data (Table 4.2). 
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Figure 4.1. The estimated mean percentage faecal egg count reduction (% FECR) and lower 95% confidence limits (LCL), (which have been 
truncated at zero) derived using three different methods for estimating FECR when applied to 18 sets of fenbendazole (FBZ)-FECR data. The 
black dashed line represents the 90% threshold for acceptable efficacy and the solid grey line represents the 80 % threshold set for the 
lower confidence interval. For 15 datasets, Method 2 could not be applied as the Day 14 faecal egg count (FEC) exceeded those calculated on 
Day 0. For three datasets, only Method 1 was applied as the FEC data precluded the application of Methods 2 and 3. For all datasets and each 
method, the % FECR and LCL fell below the designated thresholds, suggesting that resistance was present 
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Figure 4.2. The estimated mean percentage faecal egg count reduction (% FECR) and lower 95% confidence limit (LCL) derived from three 
different methods for estimating FECR when applied to 21 sets of pyrantel (PYR) FECR data. The black dashed line represents the 90% 
threshold for acceptable efficacy and the solid grey line represents the 80 % threshold set for the lower confidence interval. On 18 yards, all 
methods were in agreement (i.e. mean % FECR ≥90% and LCL ≥80%). 
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Figure 4.3. The estimated mean percentage faecal egg count reduction (% FECR) and lower 95% confidence limits (LCL) derived from three 
different methods for estimating FECR when applied to 16 sets of ivermectin (IVM) FECR data. The black dashed line represents the 95% 
threshold for acceptable efficacy and the solid grey line represents the 90% threshold set for the LCL 
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Figure 4.4. The estimated mean percentage faecal egg count reduction (% FECR) and lower 95% confidence limit (LCL) derived from three 
different methods for estimating FECR when applied to 19 sets of moxidectin (MOX) FECRT data. The black dashed line represents the 95% 
threshold for acceptable efficacy and the solid grey line represents the 90 % threshold set for the LCL 
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  FBZ PYR IVM MOX 
Yard Method 1 Method 2 Method 3 Method 1 Method 2 Method 3 Method 1 Method 2 Method 3 Method 1 Method 2 Method 3 
BNK R R R S S S S S S S S S 
BRE R R R S S S S S S NP NP NP 
CC R R R S S S S S S S S S 
COO 
 
R 
 
R 
 
R 
 
SR  
(86.8%) 
S 
(93.2%) 
SR 
(89.9%) 
S 
 
S 
 
S 
 
S 
 
S 
 
S 
 
CRA R R R S S S S S S S S S 
HTH R R R S S S S S S NP NP NP 
JAR R R R S S S S S S S S S 
KING NP NP NP S S S NP NP NP S S S 
LAS 
 
R 
 
R 
 
R 
 
SR  
(92.2%) 
R 
(84.5%) 
R 
 (84.9%) 
S 
 
S 
 
S 
 
S 
 
S 
 
S 
 
MTL R R R S S S NP NP NP S S S 
OWL R R R S S S S S S S S S 
OXD R R R S S S S S S S S S 
PEN R R R S S S S S S S S S 
PTN R R R S S S S S S S S S 
RDG R R R S S S S S S NP NP NP 
SEA R R R S S S S S S S S S 
SGT R R R S S S S S S S S S 
SWA NP NP NP S S S NP NP NP S S S 
TRE R R R S S S S S S S S S 
WDH R R R S S S NP NP NP S S S 
WHW 
 
NP 
 
NP 
 
NP 
 
SR 
 (87.2%) 
S 
(92.5%) 
SR 
 (89.4%) 
NP 
 
NP 
 
NP 
 
S 
 
S 
 
S 
 
WHW-GS NP NP NP NP NP NP NP NP NP S S S 
Table 4.2. A summary the faecal egg count reduction test (FECRT) when three methods of estimating mean percentage faecal egg count reduction 
(% FECR) were applied to sets of FECRT data collected from yards following administration of either fenbendazole (FBZ), pyrantel (PYR), 
ivermectin (IVM) and moxidectin (MOX). The outcome of the FECRT was classified as either susceptible (S), suspected resistance (SR) or resistant 
(R). For FECRT results that were classified as SR or R, the mean % FECR is recorded. Not all anthelmintics were administered on all yards (NP). 
Tests for which methods disagreed in terms of anthelmintic resistance classification are highlighted by grey shading 
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4.4.2. Simulated FECRT results to assess the performance of Method 
1(WAAVP) when FECRT data were generated using CF and McM50 
 
4.4.2.1. Model validation using raw FECRT data 
 
The FECRT data obtained using CF methodology and used for model validation covered 
a range of mean pre-treatment EPG (177 - 512 EPG) and k (0.67 - 4.4), and the number 
of horses included in the test (3-18 horses) (Table 4.3). The FECRT data obtained using 
McM50 methodology also covered a range of mean pre-treatment EPG (462 - 1900 
EPG) and k (0.69 -6.7), the number of horses included was the same as with the CF 
method (Table 4.4). The measured mean pre-treatment EPG, k, n and mean % FECR 
from the actual FECRT dataset were used to populate the model. The pre-treatment 
EPG, post-treatment EPG and mean % FECR from the measured results were compared 
to the predicted pre-treatment EPG, post-treatment EPG and mean % FECR generated 
by the model for both the CF and McM50 generated counts. The chi-squared test 
statistic (χ2) was used to measure how close the measured mean pre-treatment EPG 
and mean post-treatment EPG were to the predicted pre-treatment EPG and mean 
post-treatment EPG when FEC were generated by the CF, and no significant difference 
between measured mean pre-treatment EPG and predicted mean pre-treatment EPG (p 
= 0.83) was observed and no significant difference between the observed and expected 
mean post-treatment EPG (p = 0.91) were noted, indicating that the model was able to 
generate adequate mean pre- and post-treatment FEC in comparison to measured data 
generated by the CF method (Table 4.3). The same process was followed to assess FEC 
generated by McM50, and there was no significant difference between the measured 
and predicted mean pre-treatment EPG (p = 0.36) and no significant difference 
between the measured and predicted mean post-treatment EPG (p = 0.69) (Table 4.4). 
The relationship between measured and predicted % efficacy when FEC were 
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performed by the CF method was explored by linear regression (Figure 4.5). Here, 
there was a significant positive relationship between measured and predicted % 
efficacy (Pearson – r2=0.99, p=<0.001). The regression equation was: measured % 
efficacy = 0.7 + 0.99 x predicted % efficacy. The intercept was not significantly different 
from 0 and the slope was not significantly different from 1 (Figure 4.5a). For FECRT 
performed using the McM50 method, there was a significant positive relationship 
between measured and predicted % efficacy (Pearson – r2=0.99, p=<0.001). The 
regression equation for McM50 was: measured % efficacy = -0.67 + 1 x predicted % 
efficacy. The intercept was negative, but not significantly so, suggesting that predicted 
efficacy may be lower than measured efficacy (Figure 4.5b). 
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Table 4.3. The measured and predicted mean pre-treatment (pre-tx) and post-treatment (post-tx) faecal egg count (FEC) and measured 
and predicted mean % efficacy derived from 13 sets of faecal egg count reduction test (FECRT) data collected from Yards 1 to 9 when FEC 
performed by centrifugal-flotation (CF). For each yard dataset, pre and post-treatment FEC were performed by CF. The measured mean pre-
treatment eggs per gram (EPG), k and the % efficacy were used to populate the model. The chi-squared test statistic (χ2) was used to 
measure how close the predicted (E) mean pre- and post-treatment EPG was to the measured (O) pre- and post-treatment EPG for each 
yard dataset. The χ2 for CF was compared with the chi-squared distribution, a significant difference between the predicted and measured 
number of eggs was observed if p<0.05 
 
Yard Drug N 
Mean 
Day 0 
FEC 
(EPG) k 
Measured 
mean pre-
tx FEC 
(EPG) 
Predicted 
mean pre-
tx FEC 
(EPG) 
 
(𝑶 − 𝑬)𝟐
𝑬
 
 
Measured 
mean 
post-tx 
FEC 
(EPG) 
Predicted 
mean 
post-tx 
FEC 
(EPG) 
 
(𝑶 − 𝑬)𝟐
𝑬
 
 
Measured 
% 
efficacy 
Predicted 
% 
efficacy 
1 FBZ 8 324 0.67 324 332 0.198 209 218 0.388 35.5 34.3 
1 PYR 6 262 0.81 227 229 0.018 2 3 0.500 99 98.6 
2 FBZ 4 173 0.96 251 265 0.781 106 118 1.358 57.8 55.6 
2 PYR 3 310 0.89 183 178 0.137 3 2 0.333 98.4 98.9 
3 PYR 8 238 2.5 238 258 1.681 31 40 2.613 87 84.5 
3 IVM 13 345 2 345 347 0.012 0 0 0.000 100 100 
4 FBZ 6 365 1.8 365 364 0.003 261 256 0.096 28.5 29.7 
5 IVM 8 177 4.4 177 154 2.989 0 0 0.000 100 100 
6 PYR 4 484 3.7 484 477 0.101 19 18 0.053 96.1 96.2 
7 PYR 5 252 1.8 242 253 0.500 5 6 0.200 98 97.6 
8 FBZ 18 512 2.3 512 516 0.031 263 259 0.061 48.6 49.8 
8 PYR 15 319 2.1 319 320 0.003 5 4 0.200 98.5 98.8 
9 PYR 4 229 0.92 229 244 0.983 11 9 0.364 95.2 94.9 
            χ2 7.435    χ2 6.165    
            p 0.830   p 0.910    
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Table 4.4. The measured and predicted mean pre-treatment (pre-tx) and post-treatment (post-tx) egg counts and measured and predicted 
mean % efficacy derived from 13 sets of faecal egg count reduction test (FECRT) data collected from Yards 1 to 9 when faecal egg counts 
(FEC) performed by McMaster with an egg detection limit of 50 eggs per gram (EPG) (McM50). For each yard dataset, pre and post-
treatment egg counts were performed by McM50. Measured mean pre-treatment FEC, k and % efficacy were used to populate the model. 
The chi-squared test statistic (χ2) was used to measure how close the predicted mean pre- and post-treatment FEC was to the measured 
pre- and post-treatment FEC for each yard dataset. The χ2 for centrifugal-flotation (CF) was compared with the chi-squared distribution, a 
significant difference between the measured and predicted number of eggs was observed if p<0.05 
 
Yard Drug n 
Mean 
Day 0 
FEC 
(EPG) k 
Measured 
mean pre-
tx FEC 
(EPG) 
Predicted 
mean 
pre-tx 
FEC 
(EPG) 
 
(𝑶 − 𝑬)𝟐
𝑬
 
 
Measured 
mean post-
tx FEC 
 (EPG) 
Predicted 
mean post-
tx FEC 
 (EPG) 
 
(𝑶 − 𝑬)𝟐
𝑬
 
 
Expected 
% 
efficacy 
Observed 
% 
efficacy 
1 FBZ 8 1263 0.69 1263 1200 3.143 863 860 0.010 31.7 28.3 
1 PYR 6 1150 0.75 968 960 0.066 0 0 0.000 100.0 100.0 
2 FBZ 4 563 1.38 450 455 0.056 410 404 0.088 8.9 11.2 
2 PYR 3 1050 0.88 350 350 0.000 0 0 0.000 100.0 100.0 
3 PYR 8 1183 1.1 1183 1255 4.382 125 144 2.888 89.4 88.5 
3 IVM 13 462 3.5 462 450 0.312 4 0 0.000 99.1 100.0 
4 FBZ 6 742 1.1 742 771 1.133 442 490 5.213 40.4 36.4 
5 IVM 8 306 2.2 306 318 0.471 13 14 0.000 95.8 95.6 
6 PYR 4 1900 6.7 1900 1973 2.805 88 94 0.409 95.4 95.2 
7 PYR 5 920 2.7 920 938 0.352 50 55 0.500 94.6 94.1 
8 FBZ 18 867 2.4 867 877 0.115 497 490 0.099 42.7 44.1 
8 PYR 15 553 1.4 553 560 0.089 13 13 0.000 97.6 97.7 
9 PYR 4 625 0.99 625 637 0.230 50 50 0.000 92.0 92.2 
      χ2 13.153  χ2 9.207   
      p 0.36  p 0.69   
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Figure 4.5. Measured and predicted % efficacy when faecal egg counts (FEC) were 
performed by (a) centrifugal-flotation (CF) (Pearson – r2=0.99, p=<0.001) or (b) 
McMaster with an egg detection limit of 50 eggs per gram (McM50) (r2=0.99, 
p=<0.001). Measured efficacy values were derived from 13 sets of faecal egg count 
reduction test datasets for which pre- and post-treatment egg counts were generated 
from both CF and McM50. Trend lines represent a linear regression with a zero 
intercept between the predicted and measured % efficacies. The regression equations 
for CF and MCM50 were measured % efficacy = 0.7 + 0.99 x predicted % efficacy and 
measured % efficacy = -0.67 + 1 x predicted % efficacy, respectively 
 
 
 
 
 
 
 
 
CF McM50 A. B. 
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4.4.2.2. Simulated FECRT results: the effect on the underlying pre-treatment 
FEC distribution (k) on misclassification 
  
There were no false negative results when the CF method was used and efficacy was 
set at 70% (Figure 4.6 a-b, Table 4.5), compared to the McM50 method where the 
percentage of FECRT results that were >90% efficacy ranged from 5 – 9% (Figure 4.6a, 
Table 4.5). There was no obvious trend and the % misclassification (>90%) did not 
decrease as k increased across the tested range (Table 4.7). The percentage of 
simulated FECRT results that exceeded 95% efficacy ranged from 0 - 5% and tended to 
decrease as k increased (Figure 4.6b). 
When efficacy was set at 90%, the percentage of false positive results (<90%) ranged 
between 26 - 35% by the CF method and the % misclassification tended to decrease as 
k increased (Figure 4.6c, Table 4.5) but this was not significant (Table 4.6). There were 
no false negative results and none of the simulated FECRT results exceeded >95% 
efficacy (Figure 4.6d). with McM50, the percentage of FECRT results that were <90% 
ranged between 23 – 37% and the % misclassification tended to decrease as k 
increased (Figure 4.6c, Table 4.5) and the percentage of simulated FECRT that 
exceeded 95% ranged from 33 - 54%. Generally, the false negative misclassification 
rate increased as k increased when simulated FEC were generated by McM50 but this 
was not significant (Figure 4.6d, Table 4.7). 
At 95% efficacy, there were no false positive results (<90%) by the CF method (Figure 
4.6e, Table 4.5) and the percentage of false positive results (<95%), ranged between 14 
- 25% (Figure 4.6f, Table 4.5) and increasing k did not reduce the misclassification rate 
(Table 4.6). The results generated by McM50 showed that the percentage of FECRT 
results that were <90% ranged between 7 – 1% (Figure 4.6e, Table 4.5) and the 
percentage of results the percentage of simulated FECRT results that were <95% 
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ranged from 2 - 28% (Figure 4.6f, Table 4.5). Generally the misclassification rate 
decreased as k increased but this was not significant (Table 4.7). 
Overall, CF tended to produce fewer misclassified results compared to McM50. 
However, for both CF and McM50 when drug efficacy and the threshold for 
determining efficacy/resistance were the same misclassification was observed. While 
increasing k generally reduced the misclassification rate for CF and McM50 this was 
not significant and was not the case for McM50 when efficacy was set at 90% the false 
negative misclassification rate increased as k increased, indicating that as k increased, 
the number of FECRT results that were >95% increased. 
Table 4.5. The effect of the pre-treatment faecal egg count (FEC) distribution (k) on the 
misclassification rate (% of false positives or negatives) using 90% and 95% efficacy 
thresholds to classify resistance when efficacy was set at either 70%, 90% or 95% and 
when simulated FEC were generated by either the centrifugal-flotation method (CF) or 
the McMaster method with an egg detection limit of 50 eggs per gram (McM50) 
 
   
Pre-treatment FEC distribution (k) 
  
Drug 
efficacy 
FEC 
method Misclassification rate 0.5 1 1.5 2 2.5 3 4 5 
70% 
CF 
False negative (>90%) 0 0 0 0 0 0 0 0 
False negative (>95%) 0 0 0 0 0 0 0 0 
McM50 
False negative (>90%) 6 8 5 6 7 9 6 8 
False negative (>95%) 4 5 4 2 3 4 1 0 
90% 
CF 
False positive (<90%) 35 31 29 26 29 30 26 27 
False negative (>95%) 0 0 0 0 0 0 0 0 
McM50 
False positive (<90%) 33 27 37 33 33 27 29 23 
False negative (>95%) 33 33 34 41 39 34 43 54 
95% 
CF 
False positive (<90%) 0 0 0 0 0 0 0 0 
False positive (<95%) 21 17 25 20 21 18 20 14 
McM50 
False positive (<90%) 7 6 5 2 2 4 2 1 
False positive (<95%) 28 20 15 10 5 7 5 2 
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Table 4.6. The effect of k on the Faecal Egg Count Reduction Test (FECRT) 
misclassification rate when faecal egg counts (FEC) were performed by centrifugal-
flotation using a Poisson generalised linear model. Presented are the slope estimates 
(b) and the associated p values (p) 
Misclassification Efficacy Factor b p 
False Negative >90% 70% k na na 
False Negative >95% 70% k na na 
False Negative >95% 90% k na na 
False Positive <90% 90% k 3.5553 <0.001 
  
1.0 -0.1214 0.62 
  
1.5 -0.1881 0.45 
  
2.0 -0.297 0.251 
  
2.5 -0.1881 0.46 
  
3.0 -0.154 0.54 
  
4.0 -0.297 0.251 
  
5.0 -0.256 0.311 
False Positive <90% 95% k na na 
False positive <95% 95% k 0.0345 <0.001 
  
1.0 -0.0211 0.517 
  
1.5 0.0174 0.556 
  
2.0 -0.04879 0.879 
  
2.5 0.01245 1 
  
3.0 -0.0542 0.631 
  
4.0 -0.04879 0.876 
  
5.0 -0.04055 0.24 
Table 4.7. The effect of k on the Faecal Egg Count Reduction Test (FECRT) 
misclassification rate when faecal egg counts were performed by McMaster using a 
Poisson generalised linear model. Presented are the slope estimates (b) and the 
associated p values (p) 
Misclassification Efficacy Factor b p 
False Negative >90% 70% k 0.00179 <0.001 
  
1.0 0.0287 0.594 
  
1.5 -0.182 0.763 
  
2.0 0.05294 1 
  
2.5 0.01542 0.783 
  
3.0 0.0455 0.442 
  
4.0 0.0145 0.752 
False Negative >95% 70% k 0.0138 0.006 
  
1.0 0.0223 0.739 
  
1.5 -0.0024 1 
  
2.0 -0.0693 0.423 
  
2.5 -0.0288 0.706 
  
3.0 -0.0026 1 
  
4.0 -0.021 0.06 
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Misclassification Efficacy Factor b p 
False Negative >95% 90% k 0.03497 <0.001 
  
1.0 0.0014 1 
  
1.5 0.0299 0.9 
  
2.0 0.0217 0.35 
  
2.5 0.0167 0.48 
  
3.0 0.0296 0.903 
  
4.0 0.0358 0.06 
False Positive <90% 90% k 3.553 <0.001 
  
1.0 -0.121 0.623 
  
1.5 -0.1881 0.454 
  
2.0 -0.2973 0.251 
  
2.5 -0.1881 0.454 
  
3.0 -0.1542 0.536 
  
4.0 -0.2973 0.251 
  
5.0 -0.2595 0.311 
False Positive <90% 95% k 1.9459 <0.001 
  
1.0 -0.154 0.782 
  
1.5 -0.3365 0.566 
  
2.0 -1.2528 0.118 
  
2.5 -1.2528 0.118 
  
3.0 -0.56 0.372 
  
4.0 -1.2528 0.118 
  
5.0 -1.9459 0.07 
False positive <95% 95% k 0.3045 <0.001 
  
1.0 -0.2113 0.517 
  
1.5 0.1744 0.556 
  
2.0 -0.0487 0.876 
  
2.5 0.01245 1 
  
3.0 -1.542 0.631 
  
4.0 0.04879 0.876 
  
5.0 -0.0405 0.24 
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Figure 4.6. Effect of k on the misclassification rate (%) when mean eggs per gram 
(EPG) was set at 200 EPG, n =10, and when egg counts were performed by centrifugal-
flotation (CF) (blue dots) and McMaster using an egg detection limit of 50 EPG 
(McM50) (red dots). A and B represent the % of false negative simulated faecal egg 
count reduction test (FECRT) results (i.e. the % of simulated FECRT results that were 
>90% efficacy and >95% efficacy, respectively) when drug efficacy was set at 70%. C 
and D represent the % of false positive simulated FECRT results (<90% efficacy) and 
false negative results (>90% efficacy), respectively, when efficacy was set at 90% and E 
and F the % false positive simulated FECRT results (<90% and 95%, respectively) 
when drug efficacy was set at 95% 
F 
A B 
C 
E 
70% efficacy 
False negative rate 
 
 
 
70% efficacy 
False negative rate 
 
 
 
90% efficacy 
False positive rate 
 
 
 
90% efficacy 
False negative rate 
 
 
 
D 
95% efficacy 
False positive rate 
 
 
 
95% efficacy 
False positive rate 
 
 
 
F 
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4.4.2.3. Simulated FECRT results: the effect of the underlying mean pre-
treatment EPG on misclassification (%) when FEC performed by CF or McM50 
 
At 70% efficacy there were no false negative results and none of the simulated FECRT 
exceeded 90% or 95% efficacy when simulated FEC were generated by the CF method 
(Figure 4.7 a-b, Table 4.8). With McM50, the percentage of FECRT results that were 
>90% efficacy ranged between 0 – 31%; the false negative misclassification rate 
decreased as mean FEC increased (Table 4.10) and there was no misclassification when 
mean FEC was 350 EPG or more (Figure 4.7a, Table 4.8). When simulated FEC were 
generated by McM50 the false negative misclassification rate decreased as mean FEC 
increased (Table 2.10) and there was no misclassification when mean FEC was 250 
EPG or more (Figure 4.7b, Table 4.8). 
At 90% efficacy, the false positive rate for CF and McM50 ranged between 25 - 36% and 
18 - 37%, respectively (Figure 4.7c and d, Table 4.8). Increasing the mean did not 
significantly reduce the misclassification rate (Table 4.9). For McM50, the false positive 
rate decreased between 50 and 150 EPG then increased (Figure 4.7c).  There were no 
false negative (>95%) results for CF when mean EPG was ≥100EPG, compared to 
McM50, where the false negative rate decreased as mean increased (Table 4.10) but 
there were still 8% false negative results when mean EPG was 500 EPG (Figure 4.7d, 
Table 4.8).  
When efficacy was set at 95% there were no false positive results (<90%) for CF. For 
McM50, the false positive rate (<90%) decreased from 63% to 10% between 50 and 
100 EPG and was less than ≥3% between 150 – 500 EPG (Figure4.7e, Table 4.8). 
Increasing mean did not significantly reduce the false positive rate (<95%) for CF 
(Table 4.9), and at 500 EPG 11% of results were false positive, compared to the McM50 
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results where the false positive rate decreased between 50 and 200 EPG then increased 
with the incremental mean increases (Figure 4.7f, Table 4.10) 
Overall, CF tended to produce fewer misclassified results compared to McM50. 
However, for both CF and McM50 when drug efficacy and the threshold for 
determining efficacy/resistance were the same misclassification was observed. While 
increasing the mean generally reduced the misclassification rate for CF this was not the 
case for McM50, whereby the misclassification rate increased. 
 
Table 4.8. The effect of the mean pre-treatment faecal egg count (FEC) measured in 
eggs per gram (EPG) on the misclassification rate (%) using 90% and 95% efficacy 
thresholds to classify resistance when efficacy was set at either 70%, 90% or 95% and 
when simulated FEC were generated by either the centrifugal-flotation method (CF) or 
the McMaster method with an egg detection limit of 50 EPG (McM50) 
 
   
Pre-treatment mean (EPG) 
Efficacy 
FEC 
method Misclassification rate 50 100 150 200 250 300 350 400 500 
70% 
CF 
False negative (>90%) 0 0 0 0 0 0 0 0 0 
False negative (>95%) 0 0 0 0 0 0 0 0 0 
McM50 
False negative (>90%) 31 23 13 11 4 3 0 0 0 
False negative (>95%) 28 18 6 2 0 0 0 0 0 
90% 
CF 
False positive (<90%) 35 25 34 35 36 28 25 29 29 
False negative (>95%) 3 0 0 0 0 0 0 0 0 
McM50 
False positive (<90%) 57 18 18 31 35 38 38 38 46 
False negative (>95%) 43 79 57 47 24 25 11 16 8 
95% 
CF 
False positive (<90%) 0 0 0 0 0 0 0 0 0 
False positive (<95%) 30 14 22 21 18 23 19 14 11 
McM50 
False positive (<90%) 63 10 3 1 2 1 3 1 2 
False positive (<95%) 63 11 4 5 14 14 19 24 25 
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Table 4.9. The effect of Mean eggs per gram (EPG) on the Faecal Egg Count Reduction 
Test misclassification rate when faecal egg counts were performed by centrifugal-
flotation using a Poisson generalised linear model. Presented are the slope estimates 
(b) and the associated p values (p). 
Misclassification Efficacy Factor b p 
False Negative 
>90% 70% Mean na na 
False Negative 
>95% 70% Mean na na 
False Negative 
>95% 90% Mean na na 
False Positive 
<90% 90% Mean 0.03219 <0.001 
  
100  0.0365 0.2 
  
150  0.0307 0.24 
  
200  0.0365 0.19 
  
250  0.0346 0.16 
  
300  0.0133 0.68 
  
350  0.0102 1 
  
400  0.0148 0.59 
  
500  0.0145 0.59 
False Positive 
<90% 95% Mean na na 
False positive 
<95% 95% Mean 0.0269 <0.001 
  
100 -0.0621 0.019 
  
150 0.0452 0.186 
  
200 0.0455 0.2399 
  
250 0.2513 0.481 
  
300 0.0496 0.143 
  
350 0.0354 1 
  
400 0.0249 1 
  
500 -0.0241 0.55 
na  = model not performed as there were no misclassifications 
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Table 4.10. The effect of k on the Faecal Egg Count Reduction Test (FECRT) 
misclassification rate when faecal egg counts were performed by McMaster using a 
Poisson generalised linear model. Presented are the slope estimates (b) and the 
associated p values (p). Significant effects are highlighted in grey 
Misclassification Efficacy Factor b p 
False Negative 
>90% 70% Mean 3.1355 <0.001 
  
100  -0.129 0.1 
  
150  -0.571 0.1 
  
200  -0.736 0.04 
  
250  -1.749 0.001 
  
300  -2.034 <0.001 
False Negative 
>95% 70% Mean 0.0289 <0.001 
  
100  -0.0482 0.02 
  
150  -0.0199 0.01 
  
200  -0.0217 0.003 
False Negative 
>95% 90% Mean 4.3694 <0.001 
  
100 -0.608 0.001 
  
150 -0.326 0.06 
  
200 -0.5193 0.005 
  
250 -1.1914 <0.001 
  
300 -1.1506 <0.001 
  
350 -1.9716 <0.001 
  
400 -1.5969 <0.001 
  
500 -2.29 <0.001 
False Positive 
<90% 90% Mean 0.0321 <0.001 
  
100 -0.0336 0.04 
  
150 -0.0336 0.04 
  
200 0.365 1.99 
  
250 0.364 0.0161 
  
300 0.0113 0.68 
  
350 0.01017 1 
  
400 0.01484 0.587 
  
500 0.01484 0.587 
False Positive 
<90% 95% Mean 2.3026 <0.001 
  
100 -1.841 <0.001 
  
150 -1.204 0.05 
  
200 -2.3026 0.03 
  
250 -1.609 0.04 
  
300 -2.3026 0.03 
  
350 -1.204 0.05 
  
400 -2.306 0.03 
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Misclassification Efficacy Factor b p 
  
500 -1.609 0.04 
False positive 
<95% 95% Mean 0.0264 <0.001 
  
100 -0.7621 0.02 
  
150 -0.452 0.186 
  
200 0.4055 0.2399 
  
250 0.2513 0.4807 
  
300 0.4964 0.1431 
  
350 0.3054 0.3859 
  
400 0.7621 1 
  
500 0.2412 0.5495 
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Figure 4.7. Effect of mean pre-treatment eggs per gram (EPG) on the misclassification 
rate (%) when k was set at 2.2 and n at 10, and when egg counts were performed by 
centrifugal-flotation (CF) (blue dots) and McMaster using and egg detection limit of 50 
EPG (McM50) (red dots). A and B represent the % of false negative simulated faecal egg 
count reduction test (FECRT) results (i.e. the % of simulated FECRT results that were 
>90% efficacy and >95% efficacy, respectively) when efficacy was set at 70%. C and D 
represent the % of false positive simulated FECRT results (<90% efficacy) and false 
negative results (>90% efficacy), respectively, when efficacy was set at 90% and E and 
F the % false positive simulated FECRT results (<90% and 95%, respectively) when 
drug efficacy was set at 95% 
A B 
C D 
E F 
70% efficacy 
False negative rate 
 
 
 
70% efficacy 
False negative 
rate 
 
 
 
90% efficacy 
False positive rate 
 
 
 
90% efficacy 
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4.4.2.4. Simulated FECRT results: the effect of number of horses included in the 
FECRT on misclassification (%) when FEC were performed by CF or McM50 
 
The results indicate that the number of horses included in a FECRT affects the 
misclassification rate. At 70% efficacy there were no false negative results and none of 
the simulated FECRT exceeded 90% or 95% efficacy when simulated FEC were 
generated by the CF method (Figure 4.8 a-b, Table 4.11). With McM50, the percentage 
of FECRT results that were >90% efficacy ranged between 16 – 1%; the false negative 
misclassification rate decreased as n increased (Figure 4.8a, Table 4.13). The false 
negative rate (>95%) decreased as n increased and there was no misclassification 
when ≥10 horses were included (Figure 4.8b, Table 4.13).  
At 90% efficacy, the false positive rate (<90%) for CF and McM50 ranged between 24 - 
53% and 27 - 68%, respectively (Figure 4.8c and d, Table 4.11). Generally, the false 
positive rate significantly decreased (Table 4.12) as n increased but even when 20 
horses were included the false positive rate for CF was 24% (Figure 4.8c). There were 
no false negative (>95%) results for CF, compared to McM50, where the false negative 
rate did not significantly decrease as n increased (Table 4.13) and there were still 26% 
false negative results when 20 horses were included (Figure 4.8d).  
When efficacy was set at 95% there were no false positive results (<90%) for CF when 
≥2 horses were included. For McM50, the false positive rate (<90%) decreased from 
67% to 10% between 1 and 10 horses and was 0% when 15 or more horses were 
included. (Figure4.8e, Table 4.11). The false positive rate (<95%) significantly 
decreased as n increased for CF (Table 4.12) and McM50 (Figure 4.8f, Table 4.13). 
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CF tended to produce fewer misclassified results compared to McM50. However, for 
both CF and McM50 when drug efficacy and the threshold for determining 
efficacy/resistance were the same misclassification was observed.  
Table 4.11. The effect of the number of horses (n) included in the faecal egg count 
reduction test (FECRT) on the misclassification rate using 90% and 95% efficacy 
thresholds to classify resistance when drug efficacy was set at either 70%, 90% or 95% 
and when simulated faecal egg counts (FEC) were generated by either the centrifugal-
flotation method (CF) or the McMaster method with an egg detection limit of 50 eggs 
per gram (McM50) 
   
Number of horses (n) 
Efficacy FEC method Misclassification rate 1 2 5 10 15 20 
70% 
CF 
False negative (>90%) 0 0 0 0 0 0 
False negative (>95%) 0 0 0 0 0 0 
McM50 False negative (>90%) 16 11 10 5 2 1 
False negative (>95%) 14 8 6 0 0 0 
90% 
CF 
False positive (<90%)  53 41 27 25 24 24 
False negative (>95%) 0 0 0 0 0 0 
McM50 
False positive (<90%)  68 55 33 27 37 29 
False negative (>95%) 30 41 45 36 23 26 
95% 
CF 
False positive (<90%)  15 2 0 0 0 0 
False positive (<95%) 53 37 26 22 14 12 
McM50 
 
False positive (<90%)  57 31 6 3 0 0 
False positive (<95%) 58 33 10 6 5 4 
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Table 4.12. The effect of the number of horses (n) on the Faecal Egg Count Reduction 
Test (FECRT) misclassification rate when faecal egg counts were performed using 
centrifugal-flotation using a Poisson generalised linear model. Presented are the slope 
estimates (b) and the associated p values (p). Significant effects are highlighted in grey 
Misclassification Efficacy Factor b p 
False Negative 
>90% 70% n na na 
False Negative 
>95% 70% n na na 
False Negative 
>95% 90% n na na 
False Positive 
<90% 90% n 3.9703 0.001 
  
2 -0.257 0.21 
  
5 -0.675 0.004 
  
10 -0.75 0.002 
  
15 -0.7922 0.001 
  
20 -0.7922 0.001 
False Positive 
<90% 95% n na na 
False positive 
<95% 95% n 3.9703 <0.001 
  
2 -0.3994 0.09 
  
5 -0.7122 0.003 
  
10 -0.897 <0.001 
  
15 -1.3312 <0.001 
  
20 -1.485 <0.001 
 
Table 4.13. The effect of the number of horses (n) on the Faecal Egg Count Reduction 
Test (FECRT) misclassification rate when faecal egg counts were performed using 
McMaster using a Poisson generalised linear model. Presented are the slope estimates 
(b) and the associated p values (p). Significant effects are highlighted in grey 
Misclassification Efficacy Factor b p 
False Negative >90% 70% n 2.7726 <0.001 
  
2 -0.3747 0.34 
  
5 -0.47 0.244 
  
10 -1.1632 0.02 
  
15 -2.079 0.006 
  
20 -2.773 0.007 
False Negative >95% 70% n 2.6391 <0.001 
  
2 -0.559 0.02 
  
5 -0.847 0.04 
False Negative >95% 90% n 3.4012 <0.001 
  
2 -0.312 0.461 
  
5 -0.405 0.09 
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Misclassification Efficacy Factor b p 
  
10 -0.182 0.46 
  
15 0.26 0.336 
  
20 -0.1431 0.59 
False Positive <90% 90% n 3.9703 <0.001 
  
2 -0.257 0.217 
  
5 -0.6745 0.004 
  
10 -0.7514 0.002 
  
15 -0.7922 0.001 
  
20 -0.7922 0.001 
False Positive <90% 95% n 4.043 <0.001 
  
2 -0.6091 0.006 
  
5 -2.2513 <0.001 
  
10 -2.944 <0.001 
False positive <95% 95% n 3.9703 <0.001 
  
2 -0.3594 0.09 
  
5 -0.7122 0.003 
  
10 -0.8792 <0.001 
  
15 -1.3312 <0.001 
  
20 -1.4854 <0.001 
 
 
 
 
 
 
 
 
 
 
207 
 
 
 
 
Figure 4.8. Effect of n on the misclassification rate (%) when k was set at 2.2 and mean 
pre-treatment eggs per gram (EPG) at 200 EPG, and when egg counts were performed 
by centrifugal-flotation (CF) (Blue dots) and McMaster using an egg detection limit of 
50 EPG (McM50) (red dots). A and B represent the % of false negative simulated faecal 
egg count reduction test (FECRT) results (i.e. the % of simulated FECRT results that 
were >90% efficacy and >95% efficacy, respectively) when efficacy was set at 70%. C 
and D represent the % of false positive simulated FECRT results (<90% efficacy) and 
false negative results (>90% efficacy), respectively, when efficacy was set at 90% and E 
and F the % false positive simulated FECRT results (<90% and 95%, respectively) 
when efficacy was set at 95% 
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4.4.2.5. Simulated FECRT results: the effect the egg detection limit (dl) on 
misclassification (%) when simulated FEC were generated by the McM method 
  
The egg detection limit affected the misclassification rate for McM50. When efficacy 
was set at 70%, the >90% and >95% false negative rate increased as the egg detection 
limit (dl) increased (Table 4.14, Figure 4.9). When the efficacy and the threshold for 
classifying efficacy/resistance were the same, the false positive misclassification rate 
increased as the egg detection limit increased (Table 4.14, Figure 4.9). 
 
Table 4.14. The effect of the egg detection limit (dl) of the McMaster method on the 
misclassification rate using 90% and 95% efficacy thresholds to classify resistance 
when efficacy was set at either 70%, 90% or 95% 
 
  
Egg detection limit (dl) 
 
Efficacy 
Misclassification 
rate 5 10 15 30 50 100 
70% 
False negative 
(>90%) 0 0 1 2 2 18 
False negative 
(>95%) 0 0 0 1 2 4 
90% 
False positive 
(<90%) 28 38 42 38 33 10 
False negative 
(>95%) 2 6 11 30 37 79 
95% 
False positive 
(<90%) 0 2 6 10 3 0 
False positive 
(<95%) 34 30 52 27 10 0 
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Figure 4.9. Effect of the egg detection limit (dl) on misclassification rate (%) when k 
was set at 2.2 and mean pre-treatment egg per gram (EPG) at 200 EPG, and when egg 
counts were performed by McMaster (McM). A detection limit of 100 EPG represents 
counting 1 grid of a McMaster slide; 50 EPG represents counting 2 grids; 30 EPG 
represents counting one chamber; 15 EPG represents counting two chambers, 10 EPG 
represents counting chambers and 5 EPG represents counting six chambers. A and B 
represent the % of false negative simulated faecal egg count reduction test (FECRT) 
results (i.e. the % of simulated FECRT results that were >90% efficacy and >95% 
efficacy, respectively) when drug efficacy was set at 70%. C and D represent the % of 
false positive simulated FECRT results (<90% efficacy) and false negative results (> 
90% efficacy), respectively, when drug efficacy was set at 90% and E and F the % false 
positive simulated FECRT results (<90% and 95%, respectively) when drug efficacy 
was set at 95% 
A B 
D 
E F 
70% efficacy 
False negative rate 
 
 
 
70% efficacy 
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90% efficacy 
False positive rate 
 
 
 
C 90% efficacy 
False negative rate 
 
 
 
95% efficacy 
False positive rate 
 
 
 
95% efficacy 
False positive rate 
 
 
 
 
 
210 
 
4.4.2.6. Simulated FECRT results: the effect of the underlying mean pre-
treatment FEC, the distribution of FEC (k), the number of horses included in the 
FECRT on the misclassification of resistance when simulated FEC were 
generated either by the CF method or the McM50 method 
 
When efficacy was fixed at 70%, there were no false negative results and none of the 
simulated FECRT results exceeded >90% or 95% efficacy when FEC were generated by 
the CF method and all simulated FECRT results were identified as resistant regardless 
of mean, k and n (Figure 4.10). When FEC were generated by the McM50 method, the 
number of simulated FECRT that were >90% (false negative rate) ranged from 1 to 
17% (Figure 4.10). Generally, the false negative misclassification rate decreased as 
mean, k and n increased. When the mean FEC was >300 EPG and 5 or more horses were 
included, the false negative misclassification rate was less than 5% (Figure 4.10). The 
percentage of simulated FECRT results that were >95% (false negative rate) ranged 
from 1 to 14% when FEC were generated by the McM50 method (Figure 4.10). When 
pre-treatment mean FEC was between 319 EPG and 340 EPG and if 10 horses were 
included, there were no false negative misclassifications (>95% efficacy) and when 
pre-treatment mean was >388 EPG there were no false negative misclassifications 
(>95% efficacy) when 5 or more horses were included (Figure 4.10). 
When efficacy was fixed at 90% and the simulated FECRT were generated by the CF 
method, the false positive misclassification rate (<90% efficacy) ranged between 22 
and 55% (Figure 4.11). The false positive misclassification rate (<90%) decreased with 
FECRT results generated by the CF method, as m, k and n increased, but even when m = 
512 EPG, k = 2.3 and n=20, 30% of simulated FECRT results were <90% (i.e. falsely 
identified resistance) (Figure 4.11). The percentage of simulated FECRT results that 
were >95% (false negative) when FECRT results were generated by the CF method was 
0% across all m, k and n values investigated when more than two horses were included 
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(Figure 4.11). When FECRT results were simulated using the McM50 method, the % of 
FECRT results that were < 90% (false positive rate) ranged from 25 to 68% across the 
range of m, k and n values investigated (Figure 4.11). The % of FECRT results that were 
>95% FECR (false negative rate) ranged between 3 and 55% and tended to decrease as 
m and n increased (Figure 4.11). 
When efficacy was fixed at 95% and the simulated FECRT results were generated by 
the CF method the percentage of FECRT results that were <90% (false positive) ranged 
from 0  to 18% (Figure 4.12). When the mean Day 0 FEC was 120 EPG, k was 1.2 and 2 
horses were included, 18% of the simulated FECRT results were <90% and therefore 
falsely identified resistance. This decreased to 1% when 5 horses were included and 
there was no misclassification observed when 10 or more horses were included 
(Figure 4.12). As m, k and n increased, the percentage of FECRT that were <90% (false 
positive) decreased, and when the mean pre-treatment FEC was >388 EPG, there was 
no misclassification (Figure 4.12). The % of simulated FECRT that were <95% (false 
positive) when FECRT results were generated by the CF method ranged between 5 and 
45% (Figure 4.12). The percentage of FECRT that were <95% generally decreased as m 
and n increased, but even when the pre-treatment FEC was 512 EPG and 20 horses 
were included, 10% of the simulated FECRT results were <95% (Figure 4.12). When 
simulated FECRT data were generated by McM50, the % of results that were <90% 
(false positive) ranged between 0 and 62%. Generally, the false positive 
misclassification rate decreased as m, k and n increased (Figure 4.12). When more than 
10 horses were included, the percentage of simulated FECRT results that were <90% 
was <5%, with the exception of when the mean pre-treatment FEC was 319 EPG and k 
was 0.67. Here, the percentage of FECRT results that were <90% increased when 10 
horses were included (Figure 4.12). The percentage of simulated FECRT results that 
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were <95% (false positive) when the McM50 method was used to generate the 
simulated FEC, ranged from 2 to 64% (Figure 4.12). When the mean pre-treatment FEC 
was 120 EPG, k was 1.5 and 2 horses were included, 64% of the simulated FECRT were 
<95% (false positive). This decreased when 20 horses were included, and the false 
positive misclassification rate was less than 5% (Figure 4.12). However, when the 
mean pre-treatment FEC was 512 EPG, k was 2.3 and 20 horses were included, 30% of 
the simulated FECRT results fell below 95% (Figure 4.12). 
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Figure 4.10. The effect of the mean pre-treatment faecal egg count (FEC) measured in eggs per gram (EPG), the pre-treatment FEC 
distribution (k) and the number of horses included (n) on the false negative misclassification rate (%). Simulated FECRT results that were 
>90% and 95% efficacy of simulated FECRT results when efficacy was set at 70%. The grey bars represent the simulated faecal egg count 
reduction test (FECRT) results when FEC were generated by the McMaster method using an egg detection limit of 50 EPG (McM50). None of 
the simulated FECRT results exceeded 90% or 95% when FEC data were generated by the centrifugal-flotation (CF) method 
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Figure 4.11. The effect of the mean pre-treatment faecal egg count (FEC) measured in eggs per gram (EPG), the pre-treatment FEC 
distribution (k) and the number of horses included (n) on the false positive misclassification rate (%) (<90%) and the false negative 
misclassification rate (>95%) of simulated faecal egg count reduction test (FECRT) data when drug efficacy was set at 90%. The grey bars 
and the blue bars represent simulated FECRT results that were generated by the McMaster method (50 EPG detection limit) (McM50) 
method and the centrifugal-flotation (CF) method, respectively 
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Figure 4.12. The effect of the mean pre-treatment faecal egg count (FEC) measured in eggs per gram (EPG), the pre-treatment FEC distribution (k) and 
the number of horses included (n) on the false positive misclassification rate (%) (<90%) and the false negative misclassification rate (>95%) of 
simulated faecal egg count reduction test (FECRT) data when drug efficacy was set at 90%. The grey bars and the blue bars represent simulated FECRT 
results that were generated by the McMaster method (50 EPG detection limit) (McM50) method and the centrifugal-flotation (CF) method, respectively 
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4.5 Discussion 
 
Despite the limitations of the FECRT, it currently remains the most practical method for 
assessment of anthelmintic efficacy in equids. The work presented here compared 
three different statistical methods for estimating anthelmintic efficacy using the FECRT 
data presented in Chapter 3 to investigate if the method used to estimate mean FECR 
had any bearing on the outcome and interpretation of the data in terms of classifying 
resistance. Secondly, the performance of the FECRT method currently recommended 
by the WAAVP (Coles et al., 1992) was investigated through a simulation approach. The 
effect of the egg counting method used for pre-treatment and post-treatment samples, 
the egg dl of the FEC method, the underlying mean pre-treatment FEC, the underlying 
distribution of the Day 0 FEC (negative binomial parameter, k), the number of horses 
included in the test and the true efficacy of the anthelmintic on the performance of the 
WAAVP method for estimating efficacy were investigated. Such information is essential 
to help improve understanding of how to best utilise FECRT methodologies to more 
accurately diagnose anthelmintic resistance. 
Three methods of estimating percentage FECR were applied to 18, 21, 16 and 19 sets of 
FBZ, PYR, IVM and MOX FECRT data, respectively. When efficacy was low (i.e. following 
FBZ administration), all three statistical FECRT methods generated the same 
assumption (i.e. mean percentage FECR was <90%, with <80% LCL). When efficacy was 
high (i.e. following IVM and MOX administration) all FECRT methods generated the 
same output (i.e. mean % FECR was ≥95 mean % reduction, ≥90% LCL). On 14% of 
yards where efficacy was close to the 90% threshold (i.e. following PYR 
administration), the statistical methods generated different results regarding efficacy. 
Here, Method 2 tended to generate higher estimates of percentage FECR compared to 
the other methods, and Method 3 was more likely to indicate resistance compared to 
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the other methods. These data would suggest that when efficacy is high or low, the 
method used to estimate % FECR is not as critical, but when efficacy is on the threshold 
of resistance/sensitivity, then the analytical method used is highly relevant to the 
calculated FECR. A study conducted by Pook et al. (2002) compared three methods of 
estimating anthelmintic efficacy against strongyles in horses, including Methods 1 and 
2 used here. The third method these authors employed was the WAAVP-recommended 
method that includes an untreated control group (Coles et al., 1992). The authors 
applied the three methods to seven sets of oxbendazole (OBZ) and morantel (MOR) 
FECRT data. The chemical OBZ belongs to the benzimidazole class of anthelmintics, and 
MOR belongs to the tetrahydropyrimidine class. In the Pook (2002) study, the 
estimated efficacy of OBZ and MOR was comparable to FBZ and PYR, respectively, in 
the present study, and Methods 1 and 2 calculated different assumptions regarding 
efficacy. For example, following OBZ administration, on 6/7 yards Method 1 made a 
calculation of BZ resistance and on 5/7 yards Method 2 calculated resistance. 
Following MOR administration, 2/7 yards were classed as MOR resistant and on 3/7 
yards, resistance was suspected when Method 1 was used to estimate percentage 
FECR, compared to when Method 2 was used and 1/7 yards were classed as resistant 
(Pook et al., 2002). These findings are similar to those in the present study and suggest 
that Method 1 tends to generate lower estimates of percentage FECR compared to 
Method 2, which tended to generate higher estimates of anthelmintic efficacy. Pook et 
al. (2002) concluded that, based on a 90% threshold for anthelmintic 
sensitivity/resistance, Method 2 should be used as it reveals fewer cases of resistance 
compared to Method 1. However, since the drug efficacy was unknown, Method 1 may 
be more likely to generate false positive results (i.e. falsely declare resistance) or 
Method 2 may be more likely to generate false negative results (i.e. falsely declaring 
efficacy). It could be argued that Method 1 is preferable as it tends to generate more 
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conservative estimates of efficacy, particularly in the absence of knowledge of the true 
efficacy of the anthelmintic under study. A conservative estimate could provide an 
early warning of a lack of efficacy. However, by not including 95% confidence intervals 
to account for the variance in the FECRT data and not interrogating the FECRT data for 
outliers using a single threshold to classify the outcome of a FECRT is not a robust 
approach and misclassifications are likely to occur, leading to falsely classifying 
resistance and leading to false reports of widespread resistance.  
A further study compared the WAAVP method (Coles et al., 1992) to four other 
methods for estimating anthelmintic efficacy, including two which required untreated 
control groups and two that utilised geometric means to assess efficacy following 
treatment with FBZ, PYR or IVM on 56 Danish horse farms (Craven et al., 1998). These 
authors used the modified McM FEC method with an egg dl of 50 EPG for all pre- and 
post-treatment FEC. The authors found that the WAAVP method, using a cut-off <95% 
FECR and <90% LCL, similar to Method 1 used here, classified more FECRT results 
resistant compared to the other methods (Craven et al., 1998), consistent with the 
findings here. The problem of using statistical methods which include an untreated 
control group lies in the fact that equine strongyle egg shedding is highly aggregated 
between horses and so it is often difficult to find enough horses shedding high enough 
numbers of eggs to divide them into adequately sized treatment and control groups. 
This is exacerbated by the fact that usually horses are usually kept together in small 
groups. Furthermore, leaving horses that are shedding a significant number of eggs in 
their faeces untreated will lead to significant egg output onto pasture and could lead to 
clinical disease. 
In the present study, estimates of percentage FECR generated by non-parametric 
bootstrapping (Method 3) were comparable to the estimates generated by Method 1. 
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Non-parametric bootstrapping is useful when the underlying distribution of the FEC 
data is unknown, but assumes that the data are fully representative of the distribution 
describing the population. The latter assumption is potentially violated when a small 
sample size is used (Denwood et al., 2010). By computing the mean of each bootstrap 
dataset, this generates an empirical sampling distribution of the mean (Cabaret and 
Berrag, 2004), so that the mean is not mathematically estimated but empirically 
reconstructed from the original FECRT data. Vidyashankar et al. (2007) aimed to 
develop a theoretical framework that was free from the distributional assumptions of 
egg count distributions. Further, they developed bootstrap-based algorithms to assess 
efficacy and compared their bootstrap models to a standard t-test, a t-test on FECRT 
data transformed using arcsine transformation and on FECRT data that had been log 
transformed using an extensive simulation approach. The performance of the different 
methods for estimating efficacy was assessed by calculating the Type I error rate (i.e. 
false positive rate) and power analysis. The authors reported that, for the bootstrap 
methods, even when the pre-treatment FEC was low (<50 EPG), these yielded lower 
Type I error rates when true efficacy was less than or equal to 95% compared to the 
other statistical methods, and that the bootstrap methods demonstrated substantial 
power to detect changes close to the null hypothesis (i.e. marginal changes in true 
efficacy) compared to the other statistical methods (Vidyashankar et al., 2007). Their 
approach differed to that of the present study as the authors constructed two novel 
bootstrap-based algorithms, which they compared to existing approaches using 
extensive simulations using different pre-treatment FEC distributions, compared to the 
present study where a standard non-parametric bootstrap method was applied to sets 
of empirical data. Also, they did not compare the bootstrap FECRT results to the 
standard WAAVP FECRT methodology. Further, they compared the results generated 
by the different methodologies using a t-test to compare the different Type I error rates 
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for each method. This approach was not applicable for use with the empirical FECRT 
datasets used here as only one result for each FECRT set was generated using each of 
the three methods. The other major difference between the Vidyashankar et al. (2007) 
study and the present study is that, in the former, all the FECRT methods studied 
require a high degree of statistical knowledge, and none of the approaches would be 
practical for use in practice, whereas the standard WAAVP recommended method is 
practical and easy to utilise. 
Markov Chain Monte Carlo (MCMC) methods for estimating anthelmintic efficacy have 
also been suggested (Denwood et al., 2010). This approach takes into consideration 
many of the statistical caveats arising with equine FECRT data, including the 
distribution of pre-treatment FEC between horses. The limitation of these methods is 
that they require an advanced knowledge of statistics and ability to use statistical 
programmes such as R. Recently a web-interface has been built allowing researchers to 
enter pre- and post-treatment FEC data, along with the egg dl of the FEC method used 
to generate the counts, which then estimates percentage FECR using Bayesian 
hierarchical models via MCMC sampling 
(http://www.math.uzh.ch/as/index.php?id=calc Torgerson et al., 2014). This approach 
aims to account for variation that arises through sampling, variation between animals 
and provides access of the layperson to more robust methods of computing FECR to 
take into account the likely spread of the FEC dataset. However, currently, the interface 
is not particularly user-friendly in that there is no simple way to input FEC, and the 
form needs to be populated by typing in each individual count. This may not be a 
problem when small numbers of animals are being assessed, but this approach would 
be laborious if 20 or more animals were being tested. 
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A study performed in sheep, aimed to gauge the repeatability of the FECRT (Miller et 
al., 2006) and involved the recruitment of two sheep farms previously recorded as 
having nematodes present in which there was <95% efficacy after IVM or albendazole 
(ABZ) administration. From each individual sheep, a faecal sample was collected and 
analysed by the McM method with an egg dl of 50 EPG. The sheep were then split into 
three groups of 80 based on their FEC; Group 1 had high FEC, Group 2 had moderate 
FEC and Group 3 had low FEC. Each group of 80 sheep were further divided into four 
replicates of 20, each having the same mean FEC. Each group of 20 was split again into 
two groups of 10, one treated group and an untreated group. Sheep in the treated 
groups were administered IVM or ABZ. Faecal samples were collected from all sheep 
pre- and post-treatment, and efficacy estimated using three different methods, all of 
which used arithmetic mean pre- and post-treatment FEC; Method 1 included an 
untreated control group (Presidente, 1985), Method 2 was similar to the method 
described by Coles et al. (1992), but was used in conjunction with results of faecal 
larval cultures (McKenna, 1990) and Method 3 was the standard WAAVP method 
(Coles et al., 1992, Method 1 in the present study). The three different methods 
generated different assumptions regarding efficacy. Across low, moderate and high FEC 
groups of sheep that received IVM, when efficacy was estimated by Methods 1 and 3, 
9/12 populations were classed as resistant, compared to Method 2 where 12/12 
populations were classed as resistant. In the groups that received ABZ, 2/12 
populations were classed as resistant by Method 1, 5/12 populations were classed as 
resistant by Method 2 and 0/12 populations classed as resistant by Method 3. In this 
study, there were many more disagreements in the classification between the different 
methods compared to the present study. This may be due to the fact that the sheep 
were infected with multiple helminth species, all of which may have different levels of 
susceptibility to anthelmintics and different levels of fecundity. However, in the Miller 
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et al. (2006) study, Method 3 (Method 1 in the present study) classed fewer 
populations as resistant compared to the other methods, which is comparable to the 
results here. The results presented by Miller et al. (2006) demonstrated that the FECRT 
was not highly repeatable within groups of sheep with the same pre-treatment mean, 
residing on the same farm. Unless efficacy is 100%, there will be variability in the 
measurement of post-treatment FEC in animals (Vidyashankar et al., 2007). Observed 
efficacy is not a fixed value, and it has a range of possible outcomes, which are 
dependent on an array of factors including Poisson associated variability arising in FEC 
(Vidyashankar et al., 2007), the FEC method used (Levecke et al., 2012), the 
pharmacokinetic and pharmacodynamics of the anthelmintic within an individual 
(Kaplan and Nielsen, 2010), the age and immune status of the host (Lyons et al., 2011), 
the composition of parasite species and their relative susceptibility to the anthelmintic 
tested (Vidyashankar et al., 2012), all leading to heterogeneity in the data.  
Here, the diagnostic performance of the FECRT in terms of misclassifying anthelmintic 
resistance/susceptibility was investigated using Monte Carlo simulation. The 
parameters investigated included distribution of pre-treatment FEC between horses, 
the pre-treatment mean EPG, the sample size and the egg dl of the FEC method used to 
generate the FEC data. The simulation approach was primarily one-dimensional with 
each factor investigated in isolation. Further work is required to look at the interaction 
between sample size, mean, k and the sensitivity of the FEC method on the 
misclassification rate of FECRT. 
Generally, in the present study, the performance of the FECRT in terms of 
misclassifying resistance increased when the pre-treatment mean FEC and the number 
of horses included were low and the egg dl was high. When the egg dl was low (i.e. CF 
method) and efficacy was low (i.e. set at 70%), the level of pre-treatment mean FEC did 
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not affect the ability to correctly identify resistance, as there were no false negative 
results regardless of the threshold used to classify anthelmintic resistance/sensitivity. 
When the egg dl was 50 EPG (standard egg dl used for McM), then the pre-treatment 
mean did influence the false negative misclassification rate when efficacy was low 
(70%) and a 90% threshold was used, and the misclassification rate decreased as mean 
EPG increased and there were no false negative results recorded when the mean FEC 
was set at 350 EPG or more. However, when true efficacy was set at 90% and a 90% 
threshold applied, then the false positive misclassification rate ranged between 25% - 
36% and 25% - 49%, for CF and McM generated FECRT, respectively, and did not 
decrease when the mean EPG was increased, which suggests that when the threshold 
and true efficacy are the same, then the negative misclassification rate increases 
regardless of the pre-treatment mean, and between 25% - 49% of FECRT results falsely 
identify resistance regardless of FEC method used. Similarly, when both the efficacy 
and the threshold were set at 95%, then the false positive misclassification rate for CF 
and McM was between 11% - 30% and 4% - 63%, respectively. However, the 
misclassification rate did decrease when mean FEC increased when the CF method was 
used, but increasing the mean EPG increased the misclassification rate when McM was 
used to generate the results. These findings are similar to those reported by Levecke et 
al. (2012a), who set out to empirically assess the impact of sample size, the egg dl of the 
FEC method used and the level of egg excretion (mean EPG) and distribution (k) of the 
FEC on the interpretation of FECRT data when the WAAVP FECRT method was applied 
to FECRT data generated using a Monte Carlo simulation approach. Similarly, they used 
90% and 95% thresholds to indicate acceptable efficacy. In Levecke et al. (2012a), the 
authors classified the outcome of the simulated FECRT data as sensitive (i.e. reduced 
efficacy detected ≥95% of simulated results (true negative)), insensitive (i.e. reduced 
efficacy detected <95% of simulated results (false negative)), specific (i.e. when true 
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efficacy was detected in ≥95% of simulated FECRT results (true positive)) and aspecific 
(i.e. when true efficacy was detected in <95% of simulated FECRT results (false 
positive)). This differed to the approach of the present study. Here, true efficacy was 
set at 70, 90 or 95%, and the false positive and negative misclassification rate for 
simulated FECRT results were calculated for each set of parameter combinations 
studied, which was a more simple approach compared to the Levecke et al. (2012a) 
study. However, the both studies aimed to calculate misclassification rates given set 
thresholds for defining acceptable efficacy when exploring a combination of 
parameters that influence the outcome of FECRT. In the study by Levecke et al. 
(2012a), when a 90% threshold was applied, simulated FECRT results were affected by 
the mean pre-treatment FEC, with lower sensitivity and specificity observed when 
mean pre-treatment FEC was <200 EPG. However, the impact of mean EPG on the 
detection of reduced (true efficacy <90%) and normal efficacy (true efficacy ≥90%) 
decreased as the egg dl of the FEC method decreased, and when the egg dl was 1 or 2 
EPG, reduced and normal efficacy could be reliably detected when true efficacy was 
<87.5% and >95%, respectively, regardless of the pre-treatment mean. The findings 
described in the Levecke (2012a) study, and those in the present study, suggest that 
the combination of the egg dl and pre-treatment mean have a profound impact on the 
outcome of FECRT. In another study conducted by Uriarte and Calvete (2013), their 
aim was to improve the FECRT by performing an extensive Monte Carlo simulation 
study across a range of parameters, including pre-treatment mean FEC and FEC 
distribution, egg dl, the number of animals included and drug efficacy. They used a 
threshold of 95% to classify resistance/efficacy. These authors reported that as mean 
pre-treatment FEC increased, the misclassification rate decreased when efficacy was 
low (i.e. <80%) and a threshold of 95% was applied, but when efficacy and the 
threshold were the same (95%), then increasing the mean did not reduce the 
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misclassification rate, which is in agreement with the present study and the findings of 
Levecke et al. (2012a). 
In the present study, the misclassification rate was profoundly affected by the egg dl 
used to generate the FECRT data. The analysis suggests that, as egg dl increases, the 
percentage of results that are recorded <90% decreases (false positive rate), but the 
percentage of results that are greater than 95% increases (false negative rate). This 
observation may be explained by the Poisson process, which leads to variability in FEC 
data. Using a FEC method with a high egg dl artificially inflates the variance when 
transforming the raw egg counts into the EPG estimate (Torgerson et al., 2012). For 
example, if the number of eggs seen in a McM chamber was 4 and the egg dl was 50, 
this would give a FEC of 200 EPG. If five further subsamples from the same faecal 
sample were taken, the actual number of eggs seen could be 2, 0, 7, 3, 2 (these numbers 
were drawn randomly from a Poisson distribution), giving FEC of 100, 0, 350, 150 and 
100 EPG, respectively, demonstrating the range of FEC that theoretically be generated 
from the same faecal sample due to the Poisson process. The effect of the egg dl and the 
Poisson process appears to be most apparent when values for efficacy and the 
threshold for classifying resistance/efficacy are the same. As the egg dl increases, the 
test is insufficiently sensitive to detect eggs when they are at a low density, therefore, 
there a fewer false positive results and more false negative results and efficacy is 
overestimated. It could be argued that false negative FECRT results are of greater 
concern than false positive results as, if a false positive result is obtained, then from 
this outcome one would be aware that there may be a possible reduction in efficacy of 
the anthelmintic tested and one could repeat the FECRT to make sure that the outcome 
was correct, or chose to use a more sensitive FEC method for counting pre- and post-
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treatment FEC. This is opposed to a false negative result, where the outcome of the 
FECRT would appear to be satisfactory, when in fact it is not. 
The results from this study, and those of others (Levecke et al., 2012a; Calvete and 
Uriarte, 2013) suggest that, to accurately detect anthelmintic resistance in veterinary 
nematodes using the WAAVP recommended-FECRT protocol, a FEC method with a low 
egg dl (for example, ≤ 10 EPG) should be used. This is particularly important when the 
group sizes included in the test are low. Levecke et al. (2012a) found that when the egg 
dl was 1 or 2 EPG then m, k and n values had a minimal effect on increasing the 
reliability of detecting resistance when true efficacy was low (i.e. <90%) and a 90% 
threshold was used to discriminate between resistance/efficacy. These findings are in 
agreement with those in the present study. Likewise, in other studies where ML 
efficacy in cattle was tested, it was found that the egg dl was an important factor and 
unless the error associated with using a multiplication factor in the FEC test is 
accounted for, then false positive results were more likely to occur (El Abdellati et al., 
2010). As discussed in Chapter 2, (Section 2.4) even when faeces have been mixed to 
ensure that eggs are evenly distributed, a FEC method offering an analytical sensitivity 
of 1 EPG, when the FEC is 1 or 2 EPG, the test has a diagnostic sensitivity of 63% and 
86%, respectively, due to Poisson error (Torgerson et al., 2012). Further, when an 
observed FEC of 0 is obtained using a McM test with an egg dl of 50 EPG, 95% lower 
and upper confidence limits of 0 and 184.5 EPG, respectively, are calculated (Torgerson 
et al., 2012). The confidence intervals decrease when a lower egg detection limit is 
used, such that a 0 EPG count derived using a multiplication factor of 10 gives lower 
and upper 95% CL of 0 and 36.9 EPG, respectively (Torgerson et al., 2012). Thus, 
erroneous declarations of efficacy are more likely when using a single McM count with 
an egg detection limit of 50 EPG. This has implications when assessing efficacy, as 
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negative counts of Day 14 post-treatment may not actually be negative, thus falsely 
declaring an anthelmintic to be efficacious. 
Here, the FECRT results were generated across a range of k values, which were taken 
from empirical FECRT datasets. In the study by Levecke et al. (2012a), when a 90% 
threshold was applied, the level of aggregation of pre-treatment FEC amongst animals 
did not have an effect on increasing the sensitivity or specificity of the FECRT, in 
agreement with the findings of the present study when true efficacy was set at 90%. 
Conversely, in the study by Levecke et al. (2012a), when a 95% threshold was applied 
to the simulated FECRT data to discriminate between resistance/efficacy, the level of 
aggregation of pre-treatment FEC did affect the FECRT result. Moreover, when FEC 
were highly aggregated (k<0.1) and the egg dl was between 50 – 100 EPG, reduced 
efficacy (true efficacy <95%) and normal efficacy (true efficacy ≥95%) could not be 
reliably detected (Levecke et al., 2012), which agrees with the findings of the present 
study. 
The number of horses included in the FECRT had a large influence on the 
misclassification of resistance/efficacy. The results suggest that the effect that a small 
sample size (n <10) has on false negative misclassification rate can be negated by using 
a FEC method with a lower egg dl (i.e. <10 EPG). This was not the case when true 
efficacy and the value for the threshold used to classify an anthelmintic as efficacious 
were set at the same value. In this scenario, increasing sample size did reduce false 
negative misclassification rate but did not eliminate it. These findings are similar to 
those reported by Levecke et al. (2012a), where they found that when the sample size 
was small (6 – 10 animals), the egg dl was the most important factor. A study by 
Torgerson et al. (2005), looked to test the efficiency of the FECRT (method by Coles et 
al., 1992) for falsely assigning anthelmintics as effective by a simulation approach 
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similar to that used here, where FEC data were simulated from a NBD, where k was set 
at 1.5, the mean pre-treatment FEC was 4,600 EPG, which were values drawn from 
empirical sheep FECRT datasets. The authors simulated these fixed parameters across 
a range of sample sizes (n = 5 – 20), and used a threshold of 95% to classify 
resistance/efficacy. They found that when the sample size was small (5 animals), there 
was a 5% chance of falsely declaring the anthelmintic as efficacious when the true 
efficacy was less than 84.5%, and when 20 animals were included, there was a 5% 
chance that an anthelmintic would falsely declare efficacy when true efficacy was 
90.2%. Thus, when the sample size was large, there was a significant chance of 
classifying an anthelmintic as effective when it was not, in contrast to the results found 
here. In the study by Torgerson et al. (2005), they did not consider the egg dl, and the 
mean from which the pre-treatment FEC were simulated from was higher than that of 
the present study and the value used for k was lower in their study. These variable 
factors may be the reason for the differences observed. 
Vidyashankar et al. (2007) who developed a theoretical framework for equine FECRT 
used novel bootstrap-based algorithms to estimate efficacy using simulated datasets. 
These authors reported that it was difficult to distinguish between a true FECR of 95% 
to 90% when a small number of horses (i.e. n = 8) were included, and, even on farms 
where pre-treatment mean FEC was 100 - 200 EPG, detection of a 5% drop in efficacy 
in 8 horses lead to a substantial difference between observed and actual efficacy 
(Vidyashankar et al., 2007). These authors suggest that as many horses as possible are 
included, even those with a low FEC, and that a FEC method with a low egg dl be used. 
The results from the present study, clearly demonstrate that when true drug efficacy is 
low (i.e. 70%) and a FEC method with a low egg dl is used (<10 EPG) then the WAAVP 
FECRT is able to accurately identify resistance when a 90% or 95% threshold is 
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applied. However, when efficacy and the threshold for classifying an anthelmintic as 
efficacious are similar, then the false positive misclassification rates were high across a 
range of parameters. These observations can be explained in part by the Poisson 
process. For example, if the mean pre-treatment FEC was 200 EPG and the anthelmintic 
used was 90% efficacious, then it would be expected that the post-treatment FEC 
would be 20 EPG. However, the lower and upper 95% Poisson confidence intervals 
around 20 EPG are 12 EPG and 31 EPG, respectively, which means that the FECRT 
result could lie between 84.5% and 94%. Therefore, it could be argued that regular 
monitoring of FECR would be a more valuable tool than a single test based on a cut-off 
of 90 or 95%. Further, such thresholds are generally selected as they reflect efficacy of 
the anthelmintics measured in drug-sensitive populations when the products were first 
licensed (Kaplan and Nielsen, 2010), but using such an approach is based on the 
presumed efficacy of the anthelmintic being tested rather than the true efficacy, which 
is unknown (Vidyashankar et al., 2007). Using a set threshold for defining efficacy is 
not statistically sound as the spread of the FECRT data is not considered or the impact 
of outliers on the subsequent classification. Thus, researchers have included upper and 
lower 95% confidence limits to address this (Vidyaskankar et al., 2007; Stratford et al., 
2014b). Lind et al., 2007 used resistance criteria for IVM and FBZ (FECR 95%, LCL 
90%) to describe ‘suspected’ or ‘considered’ resistance; and FECR 90%, LCL 80% for 
PYR. Tarigo-Martinie et al. (2001), classed an anthelmintic as ‘effective’ if the FECR was 
greater than 90%, ‘equivocal’ if between 80% and 90%, and ‘ineffective’ if less than 
80%, This lack of standardisation makes direct comparison between studies difficult, 
therefore, if thresholds and LCLs are to be used for cross-sectional surveys, there needs 
to be a consensus reached between researchers and sensible values selected and 
agreed upon and published in up-to-date guidelines.  
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From the results obtained here and from other published studies, it is clear that when 
performing a FECRT, increasing the pre-treatment mean and the number of horses and 
using a more sensitive FEC method will reduce the likelihood of misclassification, but 
the current thresholds are not fit for purpose and are not able to discriminate between 
resistance and efficacy. FECRT remain the only method for routine evaluation of 
anthelmintic efficacy under field conditions and further guidelines for conduct and 
interpretation are warranted. In the absence of validated in vitro and molecular tests, 
which could be used in tandem, the FECRT is not fit for identifying resistance but can 
be used as a tool for identifying efficacy or a suspected lack of efficacy.  
4.6. Conclusions 
 
The results presented in this Chapter clearly demonstrate the effect of mean pre-
treatment FEC, the distribution of pre-treatment FEC, the number of horses included in 
the FECRT and the egg dl on the performance and subsequent interpretation of the 
FECRT. The most critical factors affecting the outcome of the FECRT were the mean 
pre-treatment mean FEC and the egg dl. The misclassification rate could be reduced by 
using a FEC method with a low egg dl (<10 EPG). However, when drug efficacy and the 
threshold for classifying an anthelmintic as resistant/efficacious were close together 
then the false positive misclassification rates were high, regardless of increasing the 
pre-treatment mean FEC, the number of horses included or lowering the egg dl, 
indicating that when a single threshold is applied then there is a greater chance of 
misclassifying the outcome of a FECRT. As such, current thresholds are not fit for 
purpose and none of the statistical FECRT methods are good enough to discriminate 
between resistance and efficacy. To aid interpretation, 95% CL should be included; 
however, in the absence of validated in vitro and molecular tests, FECRT will not be 
able to definitively identify resistance.  
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The results from this Chapter will help to create evidence-based recommendations for 
conducting equine FECRT to reduce the likelihood misclassification and optimise the 
usefulness of the FECRT in monitoring anthelmintic efficacy. 
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CHAPTER 5: Distribution and prevalence of 
equine parasites, factors affecting shedding 
and egg shedding consistency 
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5.1 Introduction 
 
To inform best practice helminth control for horses, it is essential to understand the 
epidemiology of strongyle infections in terms of parasite distribution and prevalence, 
and to appreciate factors that influence strongyle egg shedding. Helminths are typically 
over-dispersed in their host populations, where relatively few individuals harbour a 
significant parasite burden (Crofton, 1971; Anderson and May, 1978; Shaw and 
Dobson, 1995; Shaw et al., 1998; Calabrese et al., 2011). In horses, the vast majority of 
animals within populations shed low numbers or no eggs in their faeces (Relf et al., 
2013; Wood et al., 2013). Such distributions underpin the rationale behind targeting 
anthelmintic treatments at horses that shed a moderate-to-high number of eggs 
(Gomez and Georgi, 1991; Kaplan and Nielsen, 2010; Lester and Matthews, 2014). As 
the work published in this area is limited, it is important to undertake research into 
factors that affect egg shedding, and identify potential risk factors that are associated 
with high egg shedding. Such are thought to include host-related factors (i.e. age, 
immunity, breed, sex), parasite-related factors (i.e. stage of lifecycle, age, fecundity, 
resistance status), management-related factors (i.e. anthelmintics used, treatment 
frequency, regularity of removing faeces from pasture) and environment-related 
factors (i.e. temperature, rainfall, location). 
Recent studies have aimed to quantify consistency of strongyle egg shedding in 
individual horses over time (Dopfer et al., 2004; Nielsen et al., 2006; Becher et al., 
2010; Wood et al., 2013), with the rationale being, that if horses generally stay within 
the same shedding category (if not treated with an anthelmintic), they need not need 
be faecal egg count (FEC) tested as regularly. This could act as an incentive to horse 
owners to adopt targeted deworming programmes as it may be associated with 
reduced costs and effort. Past studies investigating strongyle egg shedding consistency 
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focussed on estimates of strongyle FEC using McMaster (McM) methods with egg 
detection limits (dl) between 20 and 50 EPG (Dopfer et al., 2004; Nielsen et al., 2006, 
Lloyd, 2009; Becher et al., 2010; Wood et al., 2013). As observed in Chapter 2, (Section 
2.5.5) FEC generated using the McM method tend to generate higher EPG estimates and 
greater variance compared to those generated using a centrifugal-flotation (CF) 
method that has an egg dl down to 1 EPG. In addition, using a FEC method with a higher 
egg dl (i.e. multiplication factor), the methodology will not be particularly sensitive to 
relatively low changes in egg abundance (Morrison, 2004), and larger multiplication 
factors will artificially inflate variance, potentially leading to more varied results 
(Torgerson et al., 2012). This may potentially lead to an observed lower consistency 
between egg counts from the same individual over time because of the greater degree 
of variation in FEC. 
5.2 Aims of Chapter 
Here, using the equine FEC data collected and presented in Chapter 3, the distribution 
and prevalence of strongyle egg shedding at yard level and individual level was 
explored, along with factors affecting strongyle egg shedding and the consistency of 
strongyle egg shedding in individual horses over time were investigated. Such 
information will underpin the framework presented in Chapter 6 as current knowledge 
on the prevalence and distribution of strongyles and factors that affect egg shedding 
will inform control programmes that aim to promote sustainable parasite control.  
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5.3 Materials and methods 
 
5.3.1 Data collection 
 
Equine FEC data were collected from 28 horse yards across England and Scotland 
between 2011 and 2012. All samples were collected as previously described in Section 
3.3.3 and analysed by the CF technique described in Section 3.3.4. 
5.3.2 Questionnaire 
 
Each yard that participated in the study was supplied with a questionnaire (Appendix 
1) to collect information on management practices. The questionnaire consisted of 42 
questions divided into 5 sections: 1) general yard information, 2) worm control 
practices in adult horses, 3) worm control practices in foals and horses <2 years old, 4) 
grazing and pasture management and 5) the use of FEC analysis. The response rate was 
100%, but the questionnaire completion rate was relatively poor with several answers 
omitted, particularly with regards to information about grazing area. 
5.3.3 Data analysis 
 
5.3.3.1 Prevalence 
 
Descriptive statistics (mean FEC, and prevalence (%)) were calculated using Microsoft 
Excel (2007). The prevalence of strongyle egg shedding was calculated using Equation 
5.1 at individual level and yard level, where P denotes prevalence (%), n denotes the 
number of positive yards/individuals and N denotes the sample size (total number of 
yards/individuals). 
 
𝑃 =
𝑛
𝑁
 
Equation 5.1 
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For each individual yard prevalence proportion, the exact upper and lower 95% 
confidence intervals were calculated using Equation 5.2 a and b, respectively, where N 
denotes the sample size, n, the number of positive individuals. Betainv, represents the 
inverse of the beta distribution. The upper and lower 95% confidence intervals have 
been included to determine the statistical uncertainty associated with the given 
prevalence estimates. 
 
95% 𝑈𝐶𝐿 =  1 − 𝐵𝑒𝑡𝑎𝑖𝑛𝑣(
1.96
2
 , 𝑛 − 𝑘, 𝑘 + 1) 
Equation 5.2a 
 
95% 𝐿𝐶𝐿 =  1 − 𝐵𝑒𝑡𝑎𝑖𝑛𝑣(1 −
1.96
2
 , 𝑛 − 𝑘, 𝑘 + 1, 𝑘) 
Equation 5.2b 
 
For the overall individual prevalence and yard prevalence, stratified 95% intervals 
were included to account for the heterogeneity between yards (Thrusfield, 2007). 
Where P denotes prevalence, y represents the number of yards samples; N represents 
the total number of animals sampled. V denotes variability between yards where n 
represents the number of animals sampled in each yard and m represents the number 
of animals with a positive FEC: 
V = P2(∑n2) – 2P(∑nm) + (∑m2) 
Equation 5.3a 
 
95% 𝑈𝐶𝐿 = 𝑃 + 1.96 {
𝑦
𝑁
√
𝑉
𝑦(𝑦 − 1)
 
Equation 5.3b 
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95% 𝐿𝐶𝐿 = 𝑃 − 1.96 {
𝑦
𝑁
√
𝑉
𝑦(𝑦 − 1)
 
 
Equation 5.3c 
 
5.3.3.2 Distribution 
 
The negative binomial distribution (NBD) was fitted to each set of yard FEC data by 
maximum likelihood estimation (MLE) (Williams and Dye, 1994; Shaw et al., 1998; 
Morgan et al., 2005) to give estimates of the mean, m, and the aggregation factor, k 
(Section 2.4.1, Equation 2.2). The chi-square goodness of fit test was used to assess 
whether the data adequately fitted the NBD (Section 2.4.1, Equation 2.3). The 
relationship between m and k was investigated by a negative binomial generalised 
linear model (GLM) using the ‘MASS’ package (Venables and Ripley, 2002) in RStudio 
2.15.1 as the mean follows a negative binomial distribution, and the relationship 
between prevalence and k was investigated using a GLM with binomial errors. 
 
5.3.3.3 Factors affecting strongyle egg shedding 
 
To investigate factors affecting strongyle egg shedding, the first screening sample 
collected from each horse was used. Only horses of known age and yards with more 
than 10 horses were included in the analysis. Individuals were classified as foals (<2 
years), youngsters (≥2 and <5 years), adults (≥5 and <18 years) and geriatric (≥18 
years). Response data for the last anthelmintic administered before sampling 
(ivermectin (IVM), moxidectin (MOX), pyrantel (PYR)), the country (England or 
Scotland) and region (southeast England (SE), southwest England (SE), northeast 
Scotland (SNE), southeast Scotland (SSE) and southwest Scotland (SSW)) in which the 
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yard was based, the month (March-September) in which the sample was collected 
(2011 or 2012), the yard type (Competition (CTN), Dealers (DLR), Livery (LVY), 
Sanctuary (STY) and Stud (STD)), the anthelmintic treatment frequency (2 times/year, 
4 times/year and based on FEC) applied on the yard, whether or not the yard enforced 
poopicking (Yes/No) and the quarantine of new arrivals (Yes/No), the number of 
weeks after the strongyle egg reappearance period (ERP) for the last administered 
anthelmintic that the sample was collected (the expected ERP used for MOX was 13 
weeks, IVM 8 weeks, 5d FBZ and PYR was 6 weeks,) and the area of grazing that each 
horse had access to (Table 5.1). Information was provided by each yard on all factors 
with the exception of grazing area, for which on 6 yards (201 horses) these details 
were missing. 
Table 5.1. A summary of the different factors and responses included in the analyses to 
determine factors affecting strongyle egg shedding 
Factor Responses 
 
Yard type Competition, dealers, livery, private, 
sanctuary, stud 
Region NE, SE, SW 
Age category Foal, youngster, adult, geriatric  
Last anthelmintic administered IVM, MOX, PYR 
No. of weeks post the expected ERP Weeks* 
Anthelmintic treatment frequency 2/year, 4/year, FEC 
Year sample collected 2011, 2012 
Month sample collected March-September 
Season sample collected Spring, Summer, Autumn 
Poo pick? Yes, No 
Quarantine new arrivals? Yes, No 
Use FEC for targeted treatment? Yes, No 
Area of grazing/horse Acres* 
* continuous variable 
 
Because these data were collected from multiple yards and each horse was nested 
within yard, it was necessary to investigate this with the aim of partitioning variance 
between yards through a mixed-modelling approach. Generalised linear mixed models 
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(GLMM) are an extension of generalised linear models (GLM) and combine link 
functions and exponential-family variation with random effects (Bolker, 2008). 
Random effects quantify the variation of regression intercept or slopes amongst the 
levels of an explanatory variable by a probability distribution instead of estimating a 
fixed regression coefficient for each level (Thiele and Markussen, 2012). As counts for 
equine FEC are typically over-dispersed, a negative binomial GLMM (NBGLMM) was 
used as the NBD is used most commonly to describe parasite count data (Anderson and 
May, 1978; Wilson and Grenfell, 1997; Shaw and Dobson, 1995; Shaw et al., 1998). The 
NBGLMM is a modification of GLMM to include an estimation of theta (k) (Venables and 
Ripley, 2002). All GLMM were run in RStudio 2.15.1 using the ‘glmer.nb function in the 
‘lme4’ package (Bates et al., 2015). 
Before any modelling commenced, the distribution of FEC was plotted (Figure 5.2); the 
resulting histogram revealed that these data were highly aggregated. Next, 
relationships between variables were explored using violin plots because of the 
underlying distribution using ‘ggplot2’ package in R. Univariate analysis of each factor 
was performed using NBGLMM to identify factors where egg shedding was significantly 
higher (p<0.05).  
Initially, the multivariate model was populated with all explanatory variables; non-
significant factors were removed and the factor with the lowest z value (the ratio of the 
estimated slope to its standard error) was dropped from the models in turn until only 
significant factors (p≤0.05) remained and the minimal adequate model was achieved. 
The significance of removing factors from the model was evaluated using log-likelihood 
ratio tests (LRTs, Zuur et al., 2010; Crawley, 2013). To confirm that the minimal 
adequate model was reasonable, all dropped terms were sequentially reintroduced 
back into the final model to ensure a lack of significant change in explanatory power as 
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confirmed by LRTs. Inspecting the model residuals and plotting them against the fitted 
values and against each significant factor allowed model checking. Grazing area was 
not included in the model due to the high proportion of incomplete answers. Country 
was confounded by year, so country was not included. Interactions between covariates 
were not investigated as the decision was made to follow a simple modelling approach 
here. 
5.3.3.4 Factors affecting strongyle egg shedding consistency 
 
In total, 573 horses were included in the analysis to examine the consistency of egg 
shedding in individual horses over time (Table 5.2). Only horses that had had an initial 
screening sample collected on more than one occasion were included. 
Egg shedding consistency in individual horses over time was investigated. Each FEC 
from each horse on each screening occasion (S1 = first screen, S2 = second screen, S3 = 
third screen and S4 = fourth screen) was assigned to a shedding category ranging from 
1 (0 - 49 EPG) to 7 (>500 EPG) (Table 5.3). 
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Table 5.2. A summary of the number (n) of horses screened on each yard, the last 
anthelmintic administered on the yard, the year and month in which the first faecal egg 
count (FEC) screening, the yard type (Competition = CTN, Livery = LVY, Stud = STD, 
Sanctuary = STY) and the number of occasions the yard was screened (S1 – S4) 
 
Yard n Last 
treatment 
Year first 
Screening 
FEC 
collected 
Month 
first 
screening 
FEC 
collected 
Yard 
type 
Screening 
occasions 
3 31 MOX 2012 APR LVY S1-S3 
5 14 NA 2012 MAY LVY S1-S3 
6 14 PYR 2011 MAY LVY S1-S4 
7 17 MOX 2012 MAY STY S1-S3 
8 15 MOX 2012 APR LVY S1-S3 
10 8 NA 2011 JUL LVY S1-S3 
11 13 IVM 2012 APR LVY S1-S3 
12 21 MOX 2012 JUN LVY S1-S3 
13 8 MOX 2012 MAY LVY S1-S3 
14 20 IVM 2012 MAR STD S1-S3 
15 36 MOX 2011 MAR LVY S1-S4 
16 72 MOX 2011 MAY LVY S1-S3 
17 13 MOX 2010 JUL LVY S1-S2 
18 10 MOX 2011 MAY CTN S1-S3 
19 15 MOX 2012 APR LVY S1-S3 
20 35 MOX 2011 JUN LVY S1-S3 
21 21 MOX 2010 MAY LVY S1-S2 
22 21 MOX 2012 MAY LVY S1-S3 
23 19 NA 2012 MAY LVY S1-S2 
24 27 IVM 2011 AUG LVY S1-S3 
25 20 MOX 2012 FEB LVY S1-S3 
27 47 MOX 2010 JUL LVY S1-S4 
30 31 MOX 2012 MAR LVY S1-S3 
31 7 MOX 2011 JUL LVY S1-S2 
33 28 MOX 2012 APR LVY S1-S2 
34 10 MOX 2012 AUG DLR S1-S2 
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Table 5.3. Strongyle egg shedding categories used for the analysis based on the eggs 
per gram (EPG) estimate for each faecal egg count (FEC) sample as determined by the 
centrifugal-flotation (CF) method. For each horse, two FEC were performed and the 
mean of the two counts was taken as the EPG estimate 
 
EPG range Strongyle egg 
shedding category 
0 - 49 EPG 1 
50 - 99 EPG 2 
100 - 199 EPG 3 
200 - 299 EPG 4 
300 - 399 EPG 5 
400 - 499 EPG 6 
 >500 EPG 7 
 
In addition to shedding category, each sample was assigned a treatment category; <200 
EPG (0, no treatment) or ≥200 EPG (1, treatment). To assess shedding consistency, the 
rank change in shedding category between S1 and S2, S1 and S3 and S1 and S4 samples 
was calculated. For example, if the shedding category was ranked as 1 for S1 and 6 for 
S2, the rank change would be 5. Conversely, if the category was measured as 6 for S1 
and 3 for S3, the rank change would be -3. If the shedding category remained the same 
it was assigned as 0. Treatment category consistency was determined across S1 and S2, 
S1 and S3 and S1 and S4 samples. Similarly, if a category changed from <200 EPG to 
≥200EPG between two sampling points, the rank assigned was 1. Conversely, if the 
category changed from ≥200EPG to <200EPG it was assigned as -1, and if it remained 
consistent it was assigned as 0. Each horse was assigned to an age category: foals (<2 
years), youngsters (≥2 and <5 years), adults (>5 and < 18 years) and geriatric (≥18 
years). For each sampling occasion, the number and percentage of horses that fell into 
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each shedding and each treatment category was calculated. Further, the number and 
percentage of horses that fell into each rank change category of shedding (-6 to 6) and 
treatment (-1, 0 or 1) between S1 and each subsequent screening occasion was 
calculated. The same analysis was performed on 304 horses that had not received any 
anthelmintic during the entire study to assess if no treatment was associated with 
rising egg counts in individuals over time. All analyses were performed in Rstudio, 
version 2.15.1 (The R Foundation for Statistical Computing, 2012).  To test if there was 
a significant difference (p<0.05) in the proportion of horses falling into each shedding 
and treatment category between screening occasions, a binomial test was performed 
using the prop.test function in RStudio. 
The effect of age, last anthelmintic administered and the number of weeks after the 
expected ERP of each anthelmintic on the likelihood of a horse changing shedding or 
treatment category was assessed using multivariate binary logistic regression. 
Regression analyses were performed using the GLM function in R, specifying the family 
as binomial, linked to logit transformation, g, where P is the probability of a horses 
changing egg shedding category or treatment category, βi are the model (slope) 
coefficients and Xi are the explanatory variables (Equation 5.4). 
g = ln[P/(1-P)] = β0+ β1 X0+...+ βk Xk 
Equation 5.4 
The probability of a change in egg shedding category and treatment category was 
estimated using Equation 5.5. 
P=exp[β0+ β1 X0+...+ βk Xk]/(1+exp[β0+ β1 X0+...+ βk Xk]) 
Equation 5.5 
 
 
244 
 
Regression models were initially populated with all potential explanatory variables and 
the least significant removed in turn until a model with only significant terms 
remained. The significance of removing factors from the model was evaluated using 
log-likelihood ratio tests (LRT) (Zuur et al., 2009; Crawley, 2013). P-values of ≤0.05 
indicated factors that had a significant influence on changing shedding or treatment 
category in the final model. The Hosmer-Lemeshow test (Hosmer and Lemeshow, 
2005) was used to assess overall model fit using the ‘ResourceSelection’ package (Lele 
et al., 2009). The Hosmer-Lemeshow test is commonly used to assess the goodness of 
fit of multivariate logistic regression models. It is similar to the chi-square goodness of 
fit test, but has the advantage of partitioning observations into groups of 
approximately equal size, reducing the likelihood of there being groups with very low 
observed or expected frequencies (Bewick et al., 2005). 
5.4 Results 
 
5.4.1 Prevalence and distribution of equine parasites as measured 
by FEC 
 
The prevalence of strongyle egg shedding at yard level was 100% (88.7 - 100%, 95% 
CL) (Table 5.4). For P. equorum and tapeworm, the yard prevalence was 14.3 (4/28 
yards, 4 - 33% CL) and 3.6% (1/28 yards, 0 - 18.4% CL), respectively (Table 5.5). At 
individual horse level, the prevalence of strongyle egg shedding ranged between 21.1 
(11.4 - 34% CI, Yard 3) and 93% (80.9 - 98.5% CI, Yard 24, (Table 5.4)). The mean EPG 
per yard ranged from 5 to 327 EPG and individual FEC ranged from 0 to 2972 EPG 
(Table 5.5). Values for aggregation parameter, k ranged between 0.05 and 0.38 (Table 
5.4). There was no significant relationship observed between mean strongyle EPG and 
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k (Figure 5.1A, Figure 5.2), but there was a significant positive relationship between 
strongyle prevalence and k (r2=0.8, p<0.0001) (Figure 5.1B) 
Table 5.4. The prevalence of strongyle eggs at individual level for each yard. Included 
is the number of horses resident at each yard (n), the mean eggs per gram (EPG) and 
range as estimated by faecal egg count (FEC) taken on the first screening occasion, 
estimates of distribution of FEC (k), the prevalence (%) and the lower (LCL) and upper 
(UCL) exact binomial 95% confidence limits of prevalence 
 
Yard n 
Mean 
EPG 
Range 
 [EPG] k 
Prevalence 
[%] LCL UCL 
1 18 39 0-513 0.08 38.9 17.3 64.3 
2 16 270 0-1341 0.19 92.7 48 93 
3 57 5 0-107 0.05 21.1 11.4 34 
4 28 5 0-126 0.06 25.0 11 45 
5 47 59 0-537 0.1 46.8 32.1 61.9 
6 28 123 0-1284 0.1 50.0 30.7 69.4 
7 23 60 0-378 0.27 87.0 66.4 97.2 
8 33 37 0-555 0.06 33.3 18 51.8 
9 31 71 0-450 0.17 58.1 39.1 75.5 
10 28 153 0-690 0.22 71.4 51.3 86.8 
11 28 94 0-1179 0.12 57.1 37.2 75.5 
12 44 51 0-474 0.17 63.6 48 77.6 
13 29 16 0-155 0.07 31.0 15.3 50.8 
14 8 12 0-33 0.4 87.5 47.4 99.7 
15 69 199 0-2927 0.19 76.8 65.1 86.1 
16 32 95 0-1530 0.1 46.9 29.1 65.3 
17 18 130 0-1233 0.2 66.7 41 86.7 
18 14 197 0-963 0.16 85.7 57.2 98.2 
20 25 84 0-698 0.14 64.0 42.5 82 
21 23 327 0-1137 0.2 73.9 51.6 89.8 
22 18 90 0-675 0.23 83.3 58.6 96.4 
23 26 60 0-927 0.06 23.1 9 43.7 
24 43 114 0-513 0.38 93.0 80.9 98.5 
25 22 27 0-306 0.1 36.4 17.2 59.3 
26 32 102 0-761 0.06 78.1 60 90.7 
27 48 46 0-525 0.23 75.0 60.4 86.4 
28 14 293 0-1067 0.27 78.6 49.2 95.3 
Total 802 472 0-2927 0.16 58.9 51.6 66.2 
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Table 5.5. The prevalence (%) of strongyle spp., P. equorum and tapeworm eggs as 
identified by faecal egg count at yard level. Included are the lower (LCL) and upper 
(UCL) stratified 95% confidence limits 
 
Species 
No. of 
yards 
No. of 
yards 
positive 
Prevalence 
(%) LCL UCL 
Strongyle 
spp. 28 28 100 87.7 100 
P. equorum 28 4 14.3 4 33 
Tapeworm 28 1 3.6 0 18.4 
 
Figure. 5.1. The relationship between strongyle mean eggs per gram (EPG) and k (A) 
and the relationship between strongyle prevalence and k (Pearson r2=0.8 (95% CI: 0.6-
0.9), n=28, p <0.0001) (B) 
k k 
A.  B.  
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Figure. 5.2. The relationship between log10 strongyle mean eggs per gram (EPG) and 
k. Negative binomial generalised linear model.  Model intercept = 0.64, standard error 
(se) = 0.29, z-value= 1.61, p=0.11. The slope for k = 0.79, se = 1.49, z = 0.53, p = 0.6 
 
The prevalence of P. equorum eggs at individual horse level ranged between 2 (1/50 
horses, Yard 27) and 23% (23/32 horses on Yard 21, Table 5.6). Mean EPG for P. 
equorum ranged between 1 and 32 EPG, with individual counts ranging between 0 to 
269 EPG. 
Table 5.6. The prevalence of P. equorum eggs at individual level for each yard where P. 
equorum eggs were identified in screening samples. Included is the number of horses 
resident at each yard (n), the mean eggs per gram (EPG) and range as estimated by 
faecal egg counts (FEC) taken on the first screening occasion, estimates of distribution 
of FEC (k), the prevalence (%) and the lower (LCL) and upper (UCL) stratified 95% 
confidence limits 
 
Yard n 
Mean 
EPG 
Range 
[EPG] 
Prevalence 
[%] LCL UCL 
15 69 3 0-86 7.3 2.4 16.1 
21 23 32 0-269 23 7.5 43.7 
22 18 3 0-47 6 1 27 
27 50 1 0-41 2 0 10.7 
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5.4.2 Factors affecting egg shedding in horses at screening 
 
In total, 27 yards completed the questionnaire and supplied samples for FEC analysis. 
In total, samples from 728 horses were analysed. Of the yards, three were competition 
yards, 20 were livery yards, two were non-Thoroughbred studs farms and five were 
sanctuaries/welfare establishments (Table 5.7). The number of horses per yard ranged 
between 10 and 69. In total, 12 of the yards were FEC screened in 2011 and 15 in 2012, 
while 16 were based in England and 11 in Scotland. Thirteen yards were based in 
southeast England, three in southwest England, one in northeast Scotland, nine in 
southeast Scotland and one in southwest Scotland (Table 5.7). Of the yards tested, 
three were first FEC screened in March, seven in April, six in May, three in June and 
July, four in August and one in September, which, by season, meant that 16 were 
sampled in the spring, 10 during the summer and one in autumn. On six yards, IVM was 
the last administered anthelmintic before FEC screening, 20 had last received MOX and 
one, PYR. Time (at initial FEC sampling) since the expected ERP of the last 
administered anthelmintic ranged from 0 to 27 weeks. On 18 yards, anthelmintics were 
administered twice a year, and on six, four times a year. Owners at three yards 
reported that they followed a FEC directed treatment programme with anthelmintics 
administered according to individual FEC. Seventeen yard owners said they imposed 
quarantine measures and 10 did not; while 23 reported that they systematically 
removed faeces from pasture, four yards did not (Table 5.7). 
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Table 5.7. A summary of yard information collected by questionnaire, including yard type (CTN=competition; DLR=dealers; LVY=livery; 
STD=stud; STY=Sanctuary), the year, month and season (1=Spring; 2=Summer; 3=Autumn) the faecal samples were collected, the country 
(E=England; S=Scotland) and region (SE= southeast England; SW=southwest England; SNE=northeast Scotland; SSE=southeast Scotland; 
SSW=southwest Scotland) where the yard was, the last anthelmintic administered, anthelmintic treatment frequency (2=2 times/year; 4=4 
times/year; Faecal egg count (FEC)= as directed by FEC), the number of weeks after the expected strongyle egg reappearance period (ERP) 
for each anthelmintic that the sample was collected, whether or not the yard imposed quarantine measures for new arrivals, whether they 
remove faeces from pasture and the grazing area per horse (1 = < 1 acre/horse; 2 = 1-1.9 acres/horse; 3 = >2 acres/horse; NA= no 
information provided) 
Yard ID Yard 
type 
Year Month Season Region Country N Last 
anthelmintic 
Treatment 
frequency 
Post 
ERP 
Quarantine? Poopick? Grazing 
area/horse 
2 STD 2011 JUN 2 SSW S 18 IVM 4 2 N Y 1 
3 LVY 2012 APR 1 SE E 32 MOX 4 3 Y Y 2 
4 CTN 2012 AUG 2 SE E 14 IVM 2 5 Y Y 2 
5 LVY 2012 MAY 1 SE E 17 MOX 2 4 N N NA 
6 LVY 2011 APR 1 SSE S 15 PYR 2 7 Y Y 1 
7 STY 2012 MAY 1 SE E 14 MOX 2 5 Y Y 2 
8 LVY 2012 APR 1 SE E 17 MOX 2 3 Y Y 3 
9 STY 2011 JUL 2 SSE S 63 IVM 2 7 N N NA 
11 LVY 2012 APR 1 SE E 14 MOX 2 4 N Y 3 
12 CTN 2012 JUN 2 SE E 25 MOX FEC 3 Y Y NA 
14 STD 2012 MAR 1 SE E 18 IVM 2 3 Y Y 1 
15 LVY 2011 MAR 1 SSE S 28 MOX FEC 2 Y Y NA 
16 LVY 2011 MAY 1 SSE S 47 MOX 2 5 Y N NA 
17 LVY 2011 SEP 3 SSE S 20 MOX 4 7 Y Y 2 
18 CTN 2011 MAY 1 SW E 10 MOX 2 1 N Y 1 
19 LVY 2012 APR 1 SE E 18 MOX 4 3 N Y 2 
20 LVY 2011 JUN 2 SSE S 30 MOX 2 2 N Y 2 
21 LVY 2011 AUG 2 SSE S 21 MOX 2 5 Y Y 2 
22 LVY 2012 MAY 1 SE E 22 MOX 4 2 Y N NA 
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Yard No. 
Yard 
type Year 
 
 
Month Season Region Country N 
Last 
anthelmintic 
Treatment 
frequency 
Post 
ERP Quarantine? Poopick? 
Grazing 
area/horse  
23 LVY 2012 MAY 1 SE E 43 MOX 4 3 N Y 2 
24 LVY 2011 AUG 2 SSE S 28 IVM 2 5 Y Y 2 
25 LVY 2012 APR 1 SE E 24 MOX 2 3 Y Y 2 
27 LVY 2011 JUL 2 SSE S 44 MOX FEC 3 Y Y 2 
30 LVY 2012 MAR 1 SW E 32 MOX 2 1 N Y 2 
32 STY 2011 JUL 2 SNE S 69 IVM 2 3 Y Y 2 
33 STY 2012 APR 1 SW E 31 MOX 2 1 Y Y 3 
34 STY 2012 AUG 2 SE E 14 MOX 2 7 N Y 1 
MOX = moxidectin, IVM = ivermectin, PYR = pyrantel 
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The distribution of horse age on each yard is shown in Table 5.8. In total, 518 adults, 31 
foals, 122 geriatric horses and 73 youngsters comprised the overall population. The 
number of adult horses per yard ranged from 7 to 45, the number of foals, 0 - 12, 
geriatric horses, 0 - 17 and youngsters, 0 - 12 (Table 5.8). Yards 32 and 33 had the 
highest number of youngsters present (n = 12) and yard 32, the highest number of foals 
(n = 12). Adult horses were present on every yard, foals on 6 yards, geriatrics on 19 
yards and youngsters on 23 yards (Table 5.8). 
Table 5.8. The distribution horses by age category; (Foals = <2 years old; Youngsters = 
≥2 - <5 years old; Adults = ≥5 - <18 years old; Geriatric = ≥18 years old) in each yard 
Yard Yard Adults 
 
Foals 
 
Geriatric 
 
Youngster 
 
Total 
 
2 STD 10 0 4 4 18 
3 LVY 14 0 16 2 32 
4 CTN 14 0 0 0 14 
5 LVY 15 0 0 2 17 
6 LVY 9 1 0 5 15 
7 STY 7 0 5 2 14 
8 LVY 13 0 3 1 17 
9 STY 41 1 17 4 63 
11 LVY 9 0 5 0 14 
12 CTN 21 0 0 4 25 
14 STD 11 5 0 2 18 
15 LVY 20 0 8 0 28 
16 LVY 38 0 4 5 47 
17 LVY 12 0 7 1 20 
18 CTN 10 0 0 0 10 
19 LVY 10 0 7 1 18 
20 LVY 20 0 8 2 30 
21 LVY 27 7 2 1 37 
22 LVY 16 0 5 1 22 
23 LVY 41 0 1 1 43 
24 LVY 25 0 0 3 28 
25 LVY 17 0 6 1 24 
27 LVY 31 0 10 3 44 
30 LVY 21 0 9 2 32 
32 STY 41 12 4 12 69 
33 STY 14 5 0 12 31 
34 DLR 11 0 1 2 14 
 
Total 518 31 122 73 744 
CTN = competition, DLR = dealers, LVY = livery, STD = stud 
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Details of the distribution of age according to the last anthelmintic administered, the 
year, month and season in which the sample was collected, the country and region 
where the horse resided, whether or not quarantine measures were implemented on 
the yard, anthelmintic treatment frequency, the grazing area for each horse and 
whether or not there was faecal removal from pasture are presented in Appendix 2 as 
is the distribution of horses according to yard type by age, last anthelmintic 
administered, the year, month and season that the samples were taken, the country and 
region where the horse resided, whether quarantine measures were employed, 
anthelmintic treatment frequency, grazing area and whether or not the horse came 
from a yard where there was faecal removal from pasture to check for autocorrelation 
between covariates. The distribution of strongyle FEC (EPG) between all horses 
included in this analysis was highly over-dispersed (Figure 5.2). Violin plots and 
univariate analysis of each explanatory variable revealed that strongyle egg shedding 
(EPG) was significantly higher in foals (p = 0.001) and youngsters (p = 0.0001) 
compared to adult and geriatric horses (Figure 5.3 and Table 5.9). Egg shedding was 
significantly higher in horses for which a greater number of weeks had elapsed 
between the expected ERP of the previously administered anthelmintic and the time of 
sampling (p = 0.002) (Figure 5.4 and Table 5.9). Egg shedding was significantly lower 
in horses that were based on yards that administered anthelmintics four times a year 
(p = 0.02) and in horses that were based on yards that followed a FEC directed targeted 
treatment protocol (p = 0.04) compared to horses that were treated twice a year 
(Figure 5.5 and Table 5.9). Horses from Dealers yards and sanctuaries shed 
significantly more eggs at the initial sampling time point (p = 0.01 and p = 0.0004, 
respectively) compared to the other yard types (Figure 5.7 and Table 5.9). Egg 
shedding was significantly higher in July (p = 0.03) compared to the other months in 
which samples were analysed (Figure 5.6). There was no significant difference in egg 
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shedding detected between last treatment (Figure 5.8), years (Figure 5.9), seasons 
(Figure 5.10), on yards that quarantined their horses (Figure 5.11), on yards that 
removed faeces from pasture (Figure 5.12) nor the area grazed (Figure 5.13).  
 
  Figure 5.3. A histogram of the distribution of strongyle faecal egg counts as 
measured in eggs per gram (EPG) in all horses tested at screening 
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Figure 5.4. Violin plot of strongyle faecal egg count (SFEC) measured in eggs per gram 
[EPG] by age (A = adults, F = foals, G = geriatrics, Y = youngsters).  
 
Figure 5.5. Violin plot of strongyle faecal egg count (SFEC) measured in eggs per gram 
[EPG] by the number of weeks past the expected strongyle egg reappearance period 
(weeks) 
A. 
C. 
ERP (weeks) 
Age Category 
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Figure 5.6. Violin plot of strongyle faecal egg count (SFEC) measured in eggs per gram 
[EPG] by treatment frequency (2 = twice per year; 4 = four times per year; FEC = FEC 
used to direct treatments) 
 
Figure 5.7. Violin plot of strongyle faecal egg count (SFEC) measured in eggs per gram 
[EPG] by month 
Treatment  frequency 
Month 
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Figure 5.8. Violin plot of strongyle faecal egg count (SFEC) measured in eggs per gram 
[EPG] by Yard type (CTN = competition; DLR = dealers yard; LVY = livery; STD = stud; 
STY = sanctuary) 
 
Figure 5.9. Violin plot of strongyle faecal egg count (SFEC) measured in eggs per gram 
[EPG] by Last treatment (IVM = ivermectin; MOX = moxidectin; PYR = pyrantel)  
Last treatment 
Yard Type 
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Figure 5.10. Violin plot of strongyle faecal egg count (SFEC) measured in eggs per 
gram [EPG] by Year 
Figure 5.11. Violin plot of strongyle faecal egg count (SFEC) measured in eggs per 
gram [EPG] by Season 
Year 
Spring Summer Autumn 
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Figure 5.12. Violin plot of strongyle faecal egg count (SFEC) measured in eggs per 
gram [EPG] by Quarantine (N = no; Y = yes) 
 
Figure 5.13. Violin plot of strongyle faecal egg count (SFEC) measured in eggs per 
gram [EPG] by poopick (N = No; Y = yes) 
Quarantine 
Poopick 
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Figure 5.14. Violin plot of strongyle faecal egg count (SFEC) measured in eggs per 
gram [EPG] by Grazing area per horse (1 = <1 acre/horse; 2 = ≥1 -<2 acres per horse; 3 
= > 2 acres per horse; NA = data not provided) 
 
Table 5.9. Results from univariate analysis of each factor using negative binomial 
generalised linear models (NBGLMM). Included are the estimated effects (b), the 
standard error (se) and associated z scores (z), the p-value for each factor. Significant 
factors (p<0.05) are highlighted in grey 
 
Explanatory 
variable 
Factor 
 
b 
 
se 
 
z 
 
p 
 
Age Model 0.76 0.32 2.42 0.015 
 
Foal 1.79 0.56 3.20 0.001 
 
Geriatric -0.02 0.31 -0.63 0.95 
 
Youngster 2.89 0.36 8.03 <0.0001 
Last treatment Model 1.82 0.65 2.81 0.005 
 
MOX -1.02 0.74 -1.38 0.17 
 
PYR 1.08 1.76 0.61 0.54 
Post ERP Model 0.02 0.46 0.04 0.97 
 
Post ERP 0.12 0.04 3.06 0.002 
Year Model 1.14 0.50 2.30 0.02 
 
2012 -0.09 0.65 -0.13 0.89 
Month Model 0.69 0.57 1.22 0.22 
 
March 0.18 1.03 0.18 0.86 
 
May 0.62 0.84 0.74 0.46 
 
June -1.18 1.03 -1.41 0.25 
Grazing area  
 
 
260 
 
 
Explanatory 
variable 
Factor 
 
b 
 
se 
 
z 
 
p 
 
 
July 2.10 0.99 2.13 0.03 
 
August 0.48 0.96 0.51 0.61 
 
September 1.39 1.60 0.87 0.38 
Season Model 0.96 0.42 2.28 0.023 
 
Summer 0.25 0.67 0.38 0.70 
 
Autumn 1.13 1.72 0.66 0.51 
Yard type Model -0.61 0.84 -0.73 0.47 
 
DLR 4.22 1.65 2.56 0.01 
 
LVY 1.31 0.90 1.45 0.15 
 
STD 2.03 1.30 1.57 0.12 
 
STY 3.80 1.06 3.57 0.0004 
Country Model 1.06 0.43       2.48 0.01 
 
Scotland 0.09 0.65 0.13 0.90 
Region Model 0.92 0.46 2.00 0.05 
 
SNE 1.32 1.61 0.82 0.41 
 
SSE 0.27 0.70 0.39 0.70 
 
SSW -1.57 1.74 -0.90 0.37 
 
SW -0.73 1.05 -0.63 0.49 
Quarantine Model 1.68 0.49 3.40 <0.001 
 
Yes -0.97 0.64 -1.52 0.13 
Poopick Model 1.72 0.74 2.34 0.02 
 
Yes -0.77 0.82 -0.94 0.35 
Treatment 
frequency Model 1.44 0.37 3.86 <0.001 
 
4 x/year -0.49 0.74 -0.66 0.51 
 
FEC -2.04 0.97 -2.10 0.04 
Area Model 2.30 0.71 3.25 0.001 
 
2 -1.13 0.79 -1.42 0.16 
 
3 -1.97 1.07 -1.83 0.07 
 
 
 
Factors affecting egg shedding were first explored through NBGLMM, where all eligible 
explanatory variables were fitted and the least significant removed sequentially until t
he minimal adequate model was achieved in which only significant terms remained (p<
0.05). In the first model, slope estimates and associated values were not generated for s
outhwest Scotland due to singularities, indicating autocorrelation between covariates. 
Quarantine and last treatment were dropped from the model as they were not significa
nt factors and their removal did not significantly affect the model (Quarantine: χ2 = 0.45
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, p = 0.51; Last treatment: χ2 = 1.01, p = 0.62) (Table 5.10). The terms retained in the fin
al model that had a significant effect on strongyle egg excretion were age, time since sta
ndard ERP, year, month, treatment frequency and faecal removal from pasture.  Foals (
b = 1.84, p = 0.0001) and youngsters (b = 3.02, p<0.0001) were identified as excreting s
ignificantly more eggs compared to adult and geriatric horses (Table 5.10). A weak but 
significant positive effect on strongyle egg excretion was observed between the numbe
r of weeks after the expected ERP for each anthelmintic that the sample was collected (
b = 0.22, p<0.0001). Strongyle egg excretion levels were significantly higher in 2012 co
mpared to 2011 (b = 1.02, p = 0.02). Egg excretion levels were significantly higher in M
arch (b = 2.32, p<0.001), May (b = 1.12, p = 0.03) and July (b = 3.37, p<0.0001) with less
 egg excretion in August (b =-0.66, p = 0.35) and September (b = -2.25, p = 0.09) (Table 
5.10). Strongyle egg excretion levels were significantly lower in horses that received an
thelmintics according to FEC analysis (b = -2.49, p<0.0001) (Table 5.10). Faecal remova
l from pasture was identified as a significant factor with horses that came from yards w
here this practice was performed measured as excreting higher levels of strongyle eggs 
compared to those where this practice was not undertaken (b = 1.57, p = 0.01) (Table 5.
10). The model residuals are presented in Appendix 3. 
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Table 5.10. Generalised linear mixed model (GLMM) of strongyle faecal egg counts 
(FEC) including Yard and individual observation as random effects and year and age 
included as fixed factors. Included are the estimated effect (b), standard error (se) and 
associated z scores (z) plus log-likelihood ratio test statistics (LRT) for terms dropped 
(‘dropped terms’). The dropped terms are presented in the order that they were 
removed. The ‘retained terms’ form the final adequate model. Significant terms are 
highlighted in grey 
        
  
b se z p LRT P 
Dropped terms 
       Quarantine Y -0.38 0.43 -0.87 0.38 0.45 0.51 
Last treatment MOX -0.55 0.56 0.98 0.33 1.01 0.62 
 
PYR 1.29 1.54 0.84 0.4 
  Retained terms 
 
       Age Foal 1.84 0.56 3.27 0.0001 
  
 
Geriatric -0.17 0.32 -0.52 0.60 
  
 
Youngster 3.02 0.36 8.28 <0.0001 
  Post ERP 
 
0.22 0.04 6.09 <0.0001 
  Year 2012 1.02 0.44 2.32 0.02 
  Month March 2.32 0.62 3.76 <0.001 
  
 
May 1.12 0.50 2.23 0.03 
  
 
June 0.80 0.65 1.24 0.22 
  
 
July 3.37 0.63 5.36 <0.0001 
  
 
August -0.66 0.71 -0.94 0.35 
  
 
September -2.25 1.32 -1.70 0.09 
  Treatment 
frequency 4 times/year 0.42 0.45 0.92 0.36 
  
 
FEC -2.49 0.55 -4.52 <0.0001 
  Poo pick  Y 1.57 0.61 2.55 0.01 
  
 
5.4.3 The consistency of strongyle egg shedding in individual horses 
over time 
5.4.3.1 The consistency of strongyle egg shedding in horses regardless of 
anthelmintic treatment status 
 
The analysis of strongyle egg shedding consistency over time revealed that on the first 
screening occasion (S1), 70% (401/573) of horses were shedding less than 50 EPG. 
This decreased slightly on S2 and S3: 65 (306/468) and 64% (279/417), respectively 
(Table 5.11). At S2 and S3, a greater percentage of horses fell into shedding categories 
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2 and 3 compared to S1, and the proportion of horses in categories 4 to 6 remained at 
similar levels (Figure 5.15a). The percentage of horses in the highest egg shedding 
category (7, >500 EPG) decreased on each screening occasion from 5.8 (33/573) on S1 
to 0% (0/63) on S4 (Table 5.11). The number of horses sampled at each screening 
occasion decreased over time from 573 at S1 to 63 at S3 (Table 5.11). This was due to 
horses leaving yards and the fact that on the majority of yards, horses were only faecal 
sampled three times during the course of the study. On each occasion, the percentage 
of horses that were calculated as shedding <200 EPG ranged from 84 (479/573) at S1 
to 91.6% (76/83) at S4 (Table 5.12). The proportion shedding <200 EPG increased 
over time across the study (Figure 5.15b), whilst the percentage shedding ≥200 EPG 
ranged from 16 (94/573) at S1 to 8.4% (7/83) at S4 (Table 5.12) and decreased over 
time (Figure 5.15b). 
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Table 5.11. The number (n) and percentage (%) of horses that fell into each strongyle egg shedding category (1-7) as defined by eggs per 
gram (EPG) on each screening occasion (S1-S4) 
  Strongyle egg shedding category  
  1 2 3 4 5 6 7   
Screening 
occasion  (0-49EPG) (50-99EPG) (100-199EPG) (200-299EPG) (300-399EPG) (400-499EPG) (500EPG+) Total 
S1 
n 401 38 40 23 23 15 33 573 
% 70 6.6 7 4 4 2.6 5.8 100 
S2 
n 306 51 37 17 20 13 24 468 
% 65 10.8 7.9 3.6 4.3 2.8 5 100 
S3 
n 276 39 43 20 10 11 18 417 
% 64 9.4 10.3 4.8 2.4 2.6 4.3 100 
 n 65 8 3 3 2 2 0 83 
S4 % 78 9.6 3.6 3.6 2.3 2.3 0 100 
No statistical differences (p<0.05) in proportions between screening occasions as determined by the binomial test were observed 
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Table 5.12. The number (n) and percentage (%) of horses that were calculated as 
shedding <200 eggs per gram (EPG) (category 0, no treatment) or ≥200 EPG (category 
1) at each screening occasion (S1-S4, treatment required) 
   Treatment category  
Sampling 
occasion 
 0 
 (<200 EPG) 
1 
(≥200 EPG) 
Total 
S1 n 479 94 573 
 % 84 16 100 
S2 n 394 74 468 
 % 84.2 15.8 100 
S3 n 358 59 417 
 % 85.9 14.1 100 
S4 n 76 7 83 
 % 91.6 8.4 100 
No statistical differences (p<0.05) in proportions between screening occasions as 
determined by the binomial test were observed 
 
Figure 5.15. The percentage of horses that fell into each strongyle egg shedding 
category (1-7) on each screening occasion (S1-S4), with category S1 represented by the 
darkest shade of grey and subsequent categories in lighter shades (A). The percentage 
of horses that were either shedding <200 eggs per gram (EPG) (Category 0, dark grey) 
or ≥200 EPG (Category 2, light grey) as measured by faecal egg count (FEC) on each 
screening occasion (B). The width of the bars is proportional to the number of 
observations per screening occasion 
 
B. A. 
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The majority of horses remained in the same shedding category (Figure 5.16.a) over 
time. From S1 to S2, 61.5% horses (288/468) remained in the same category (Table 
5.13). The percentage decreased to 58.3% (243/417) between S1 and S3, then 
increased to 73% (61/83) from S1-S4 (Table 5.13). Between S1 and S2, 16.6% 
(77/468) moved into a lower shedding category and 22% (103/468) to a higher 
shedding category (Table 5.13). The percentage of horses that moved to a lower 
shedding category increased at S3 (23.7%; 99/417) compared to S2 and fewer (18%; 
75/417) moved to a higher category. Overall, from S1 to S4, 14.5% (12/83) of horses 
moved into a lower shedding category and 8.3% (10/83) moved to a higher shedding 
category (Table 5.13). 
Similarly, the majority of horses remained in the same treatment category at each 
sampling occasion; however, more changed from requiring, to not requiring, treatment 
between S1 and S3 compared to S2 (Figure 5.16b). Between S1 and S2, 81.8% 
(383/468) remained in the same treatment category, 7.8% (36/468) went from 
requiring treatment to not and 10.5% (49/468) went from not requiring treatment to 
exceeding the threshold for anthelmintic administration (Table 5.14). The percentage 
of horses remaining in the same category increased on S3 to 82.7% (345/417), and the 
percentage of horses that changed to not requiring treatment increased to 10.1% 
(42/417), while the percentage of horses changing to requiring treatment decreased to 
7.2% (30/417) (Table 5.14). From S1 to S4, 94% (78/83) horses remained in the same 
treatment category, 8.4% of these moved to the not requiring treatment category, 
while only 1.2% moved from no treatment required to treatment required (Table 
5.14). 
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Table 5.13. The number (n) and percentage (%) rank change in the shedding category 
(-6 to 6) from the first screening (S1) to the following screening occasion. 
 Screening occasion 
  S1-S2 S1-S3 S1-S4 
Rank change 
in egg 
shedding 
category n % n % n % 
-6 6 1.3 6 1.4 1 1.2 
-5 3 0.6 1 0.2 0 0 
-4 9 2 12 2.9 2 0.5 
-3 9 2 17 3.6 0 0 
-2 19 4.1 26 6.2 6 7.2 
-1 31 6.6 37 8.9 3 3.6 
0 288 61.5 243 58.3 61 73 
1 35 7.5 28 6.7 8 9.6 
2 26 5.6 20 4.8 1 1.2 
3 12 2.6 8 1.9 1 1.2 
4 12 2.6 6 1.4* 0 0* 
5 8 1.7 3 0.7* 0 0* 
6 10 2.1 10 2.4 0 0 
Total 468 100 417 100 83 100 
* statistical difference  (p<0.05) in proportions between screening occasions as 
determined by the binomial test 
 
Table 5.14. The number (n) and percentage (%) rank change in treatment category (-1 
(change from ≥ 200 eggs per gram (EPG) to <200 EPG), 0 (stayed in the same category) 
or 1 (change from <200 EPG to ≥200 EPG)) on each screening occasion 
 Screening occasion 
 S1-S2 S1-S3 S1-S4 
Rank change 
in treatment 
category N 
 
 
% n % n % 
-1 36 7.8 42 10.1 7 8.4 
0 383 81.8 345 82.7 78 94 
1 49 10.5 30 7.2 1 1.2* 
* statistical difference  (p<0.05) in proportions between screening occasions as 
determined by the binomial test 
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Figure 5.16. The rank change in egg shedding category and treatment category 
between sampling occasions (S1 and S2, S1 and S3 and S1 and S4). The percentage of 
horses either remained in the same egg shedding category (0), increased egg shedding 
category (1 to 6) or decreased egg shedding category (-1 to -6), with a rank change in -
6 categories represented by the darkest shade of grey and subsequent ascending 
categories in lighter shades (A). The percentage of horses that were either remained in 
the same treatment category (0, mid-grey), increased in treatment category (1, light 
grey) or decreased in treatment category (-1, dark grey) (B) as measured by faecal egg 
count (FEC) on each screening occasion. The width of the bars is proportional to the 
number of observations per screening occasion 
 
5.4.3.2 Consistency of egg shedding in horses that did not receive anthelmintic 
treatment 
 
Here, the egg shedding consistency in a sub-cohort of horses that did not receive any 
anthelmintic treatment (n =304) during the course of the study was investigated. The 
majority tested on each screening occasion (S1 - S3) were shedding <50 EPG (Figure 
5.17a), with few shedding 200 EPG or more (Figure 5.17b). On the first screening 
occasion, 97.3% (296/304) horses shed <50 EPG. This dropped to 84.9% (258/304) at 
the second screening then increased to 85.5% (213/249) at S3 (Table 5.15). A total of 
99.3% (302/304), 95.5% (290/304) and 95.1% (248/249) horses tested at S1, S2 and 
B. A. 
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S3, respectively, shed <200 EPG and fell into the no treatment category (Figure 5.17b). 
Overall, egg shedding in individuals over time was consistent (Figure 5.18a). Between 
S1 and S2, 92.1% (280/304) remained in the same shedding category, 0.3% (1/304) 
decreased shedding category and 7.9% (23/304) increased in shedding category 
(Table 5.16). Between S1 and S3, the percentage of horses that remained in the same 
shedding category decreased slightly to 90.4% (225/304) and the percentage of horses 
that increased shedding category increased to 9.6% (24/304) (Table 5.16). There was 
a high level of consistency in terms of treatment category in the non-treated horse 
cohort (Figure 5.18b). Between S1 and S2, 98.7% (300/304) of horses remained in the 
same treatment category and, between S1 and S3, 95.6% (238/304) remained in the 
same category. (Table 5.17; Figure 5.18b). 
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Table 5.15. The number (n) and percentage (%) on horses that fell into each shedding category (1 – 7) as defined by eggs per gram (EPG) 
on each sampling occasion (S2 to S3) in animals that had not received anthelmintic treatment over the course of the study 
 
  
Egg shedding category 
 Screening 
occasion 
t 
 
1 2 3 4 5 6 7   
 
(0-49EPG) (50-99EPG) (100-199EPG) (200-299EPG) (300-399EPG) (400-499EPG) (500EPG+) Total 
S1 
n 296 2 6 0 2 0 0 304 
% 97.3 0.7 2 0 0.7 0 0 100 
S2 
n 258 19 13 4 3 4 3 304 
% 84.9 6.3 4.3 1.3 1.0 1.3 1.0 100 
S3 
n 213 14 10 4 2 3 3 249 
% 85.5 5.6 4.0 1.6 0.8 1.2 1.2 100 
No statistical differences (p<0.05) in proportions between screening occasions as determined by the binomial test were observed 
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Figure 5.17. The percentage of horses that did not receive anthelmintic treatment that 
fell into each strongyle egg shedding category (1-7) on each screening occasion (S1-
S3), with Category 1 represented by the darkest shade of grey and subsequent 
categories in lighter shades (A). The percentage of horses that were either shedding 
<200 eggs per gram (EPG) (Category 0, dark grey) or ≥200 EPG (Category 1, light grey) 
as measured by faecal egg count (FEC) on each screening occasion (B). The width of the 
bars is proportional to the number of observations per screening occasion 
 
 
 
 
 
 
 
 
 
 
 
A. B. 
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Table 5.16. The number (n) and percentage (%) of horse that changed egg shedding 
status from one sampling occasion to the next by either increasing egg shedding (1 to 
6) or decreasing (-1 to -6) or staying the same (0) in horses that did not receive 
treatment 
 
 
Screening occasion 
  S2 S3 
Rank change in 
egg shedding 
category n % n % 
-6 0 0 0 0 
-5 0 0 0 0 
-4 0 0 0 0 
-3 0 0 1 0.4 
-2 3 1.0 1 0.4 
-1 3 1.0 7 2.8 
0 255 83.9 206 82.7 
1 20 6.6 13 5.2 
2 11 3.6 10 4.0 
3 3 1.0 3 1.2 
4 3 1.0 2 0.8 
5 4 1.3 3 1.2 
6 2 0.7 3 1.2 
Total 304 100 249 100 
No statistical differences (p<0.05) in proportions between screening occasions as 
determined by the binomial test were observed 
 
Table 5.17. The number of horses that changed treatment category from one sampling 
occasion to the next by either falling into the no treatment category (-1) or increasing 
to the treatment category (1). The 0 category represents no change in treatment status 
 
 
Screening occasion 
 
S2 S3 
Rank change 
in treatment 
category n % n % 
-1 2 0.5 1 0.4 
 0 288 95 237 95 
 1 14 4.6 11 4.6 
No statistical differences (p<0.05) in proportions between screening occasions as 
determined by the binomial test were observed 
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Figure 5.18. The rank change in egg shedding category and treatment category 
between S1 and S2, S1 and S3. The percentage of horses either remained in the same 
egg shedding category (0), increased egg shedding category (1 to 6) or decreased egg 
shedding category (-1 to -6), with a rank change in -6 categories represented by the 
darkest shade of grey and subsequent ascending categories in lighter shades (A). The 
percentage of horses that were either remained in the same treatment category (0, 
mid-grey), increased in treatment category (1, light grey) or decreased in treatment 
category (-1, dark grey) (B) as measured by faecal egg count (FEC) on each screening 
occasion. The width of the bars is proportional to the number of observations per 
screening occasion 
 
5.4.3.3 Factors affecting egg shedding and treatment group consistency; factors 
associated with the likelihood of a horse changing strongyle egg shedding 
category or treatment category over time 
 
Only horses whose age and last treatment were known were included to ensure that 
the analysis was robust. In total, 346 horses were included here. These had been 
screened at S1 and S3. Whether the horse had changed egg shedding category and 
treatment category between these two time points was determined and expressed as a 
binary outcome. Firstly, factors that influenced the likelihood of a change in egg 
A. B. 
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shedding category were investigated. Initially, the model was populated with all 
explanatory variables (Model 1, Table 5.18). In the final model, age (youngsters) and 
last treatment (MOX) were identified as significant explanatory variables (Table 5.18). 
Young horses were 3.3 times more likely to change shedding category compared to 
other age categories, while horses that had received MOX as their last anthelmintic 
treatment were less likely to change shedding category compared to the other 
treatments (OR=0.9, p = <0.0001)(Table 5.18). 
Table 5.18. Significant factors affecting the likelihood horses changing egg shedding 
category of between sampling occasions (S1 and S3) assessed by logistic regression. 
Model fit was assessed using the Hosmer and Lemeshow test 
Model (fit) Significant 
variable 
Factor Logit 
coefficient 
(SE) 
se OR 
(95% CI) 
p 
1 (0.11)   1.44 0.27 na <0.0001 
 Age Youngsters 1.20 0.55 3.3 
(1.22 – 8.46) 
0.02 
 Last 
treatment 
 
MOX 
 
-1.90 
 
0.31 
 
0.15 
(0.05 – 0.17) 
 
<0.0001 
MOX = moxidectin 
Secondly, factors affecting the likelihood of a horse changing treatment category 
between S1 and S3 was investigated. Initially the model was populated with all 
explanatory variables (Model 2, Table 5.19). In the final model, age (youngsters) and 
the last treatment (MOX) were identified as significant explanatory variables (Table 
5.19). Young horses were 2.8 times more likely to change treatment category compared 
to other age categories, while horses that received MOX as their last treatment were 
significantly less likely to change treatment group (OR = 0.15, p = <0.0001) (Table 
5.19). 
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Table 5.19. Significant factors affecting the likelihood of a horse changing from one 
treatment group to another from the first screening (S1) to the last screening (S3) 
assessed by logistic regression. Model fit was assessed using the Hosmer and 
Lemeshow test 
Model 
(fit) 
Significant 
variable 
Factor Logit 
coefficient 
se OR 
(95% CI) 
p 
2 (0.38)   1.48 0.22 na <0.0001 
 Age Youngsters 1.04 0.47 2.8 
(1.1 – 6.3) 
0.028 
 Last 
treatment 
 
MOX 
 
-1.89 
 
    0.61 
 
0.15 
(0.1 – 0.4) 
 
<0.0001 
       
MOX = moxidectin 
 
 
5.5 Discussion 
 
Here, strongyle eggs were the most prevalent helminth eggs detected, and were 
present on 100% of yards. At horse level on each yard, prevalence ranged from 21 to 
93%, confirming that strongyle eggs are the most abundant helminth eggs shed in 
equine faeces, thus justifying the deployment of current control strategies focussed at 
controlling these types of parasite, with the exception of control in foal populations, in 
which the most important where the most important helminth is P. equorum. In the 
horses tested here, P. equorum egg prevalence was 14.3% at yard level and ranged 
between 0 and 23% at individual level. Tapeworm egg prevalence was measured at 
3.6% at yard level. 
These findings were consistent with a recent study in the UK where 737 horses from 
51 yards were screened for the presence of strongyle eggs in their faeces and 100% 
yard prevalence and an average 63% prevalence at individual horse level was reported 
(Traversa et al., 2009). A recent study, which investigated 1221 Thoroughbred horses 
residing at 22 UK stud farms, recorded a mean prevalence of 56% FEC-positive horses 
across farms and a farm level prevalence of 100% (Relf et al., 2013). Similar prevalence 
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data have been reported from other EU countries. In Germany, Hinney et al., (2011) 
performed FEC analysis on 1407 horses from 126 yards and reported a 98.4% yard 
level prevalence and a 67.4% horse level prevalence (Hinney et al., 2011). In other 
German studies, 100% yard prevalence and a mean 48% individual prevalence values 
were reported (Traversa et al., 2009). Wirtherle et al. (2004) reported a 92% yard 
prevalence and 62% individual prevalence, while Fritzen at al. (2010) found yard 
prevalence to be 99% and an average prevalence of 55% at individual horse level 
(Fritzen et al., 2010). Similar prevalence data have been reported in Sweden, where 
yard prevalence was observed as 100% and individual horse prevalence as 78% 
(Osterman-Lind et al., 1999). The prevalence data from the present study and other 
recent studies vary to a degree at individual horse level, and, to a lesser extent, at yard 
level. This could be due to factors including FEC method used to estimate strongyle 
EPG, heterogeneity amongst populations (i.e. individual susceptibility or age of the 
horses sampled), environmental conditions (i.e. time of year of sampling, local climate 
conditions), management practices (i.e. extent of faecal removal from pasture, clipping 
or harrowing), frequency of anthelmintic treatments, anthelmintic products used (and 
their efficacy) and the time since last treatment to sampling.  
P. equorum egg prevalence in the present study were similar to two recent studies 
conducted in Germany, where Hinney et al., (2011) reported P. equorum prevalence as 
16.7% at yard level and 2% at horse level and Fritzen et al. (2010) found that P. 
equorum eggs were prevalent on 21% of yards and in 2% of horses. These values are 
low compared those of Relf et al. (2013) who reported a site prevalence of 58% and an 
overall mean prevalence of 9% in 1221 UK Thoroughbred horses, with, as would be 
expected, the highest prevalence seen in horses <1 old (38%). The reason why 
prevalence was higher in the latter is that the population studied were Thoroughbred 
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breeding stock, with a higher proportion of animals <2 years old compared to the 
present study. Protective immunity to P. equorum is claimed to develop after 6 months 
of age (Clayton and Duncan, 1979a), and patent infections are seldom measured in 
horses >2 years old (Reinemeyer, 2012). However, older horses can harbour patent 
ascarid infections at a low level (Gawor, 1996; Fritzen, 2010; Kornaś et al., 2007; 
Hinney et al., 2011). A further reason for the apparent low prevalence could be that 
ascarid eggs are not reliably detected by the FEC method used here. Recently, a study 
investigating the prevalence of parasites in horses necropsied in Germany reported a 
discrepancy between the number of horses harbouring ascarids and the number 
shedding eggs (Rehbein et al., 2013). The main reason for this is likely to be the 
proportion of the overall worm burden that comprises adult female worms shedding 
eggs. If this is low, then fewer eggs will be detected even though there are worms 
present. Thus, prevalence estimations by faecal examination, especially when using 
dilution techniques, might underestimate the true level of P. equorum, as is the case for 
all helminth species, emphasing the caveats of FEC analysis. 
Here, tapeworms were detected at a low level (3.6% at yard level). This likely 
underestimates the true prevalence as traditional FEC methods do not reliably detect 
tapeworm eggs (Nilsson et al., 1995). This is partly because tapeworm eggs are shed 
intermittently (Dunn, 1978). Counts performed by McM methodology have been 
reported to provide relatively low sensitivity (8 – 61%) for tapeworm eggs (Proudman 
and Edwards, 1992; Abbott and Barrett, 2010). Modifications to traditional methods 
have been suggested; i.e. using a larger volume of faeces (30 - 40 g) (Proudman and 
Edwards, 1992; Ihler et al., 1995; Nilsson et al., 1995; Meana et al., 1998; Kjaer et al., 
2007), or adopting centrifugal-flotation methods (Proudman and Edwards, 1992). The 
sensitivity of tests using these modifications has been reported to range between 37 
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and 61%, indicating that even then, the test is not particularly effective at detecting 
tapeworm infection (Proudman and Edwards, 1992; Ihler et al., 1995; Nilsson et al., 
1995; Meana et al., 1998). In the study by Relf et al. (2013), the authors reported a 
mean prevalence of A. perfoliata eggs of 4% at individual horse level and 41% at yard 
level; markedly higher compared to the present study. The same FEC method was used 
in both the study by Relf et al. (2013) and the present study. Possible reasons for the 
difference measured in prevalence could be the time of year that the samples were 
collected. There is evidence to suggest that the prevalence of A. perfoliata varies with 
season: a recent study on 400 horses at necropsy in Germany reported prevalence as 
significantly higher (p<0.001) in autumn (36.1%) and winter (36.5%) compared to 
spring (17.3%) and summer (15.9%) (Rehbein et al., 2013). The variation was 
attributed to the seasonal exposure of horses to orbatid mites, which are the 
intermediate hosts in the tapeworm lifecycle (Bashkirova, 1941). Another possible 
explanation for the difference in prevalence between the present study and that of Relf 
et al. (2013) could be differences in prevalence of orbatid mites between study 
locations. Orbatid mites are ubiquitous, but their abundance is affected by temperature 
and moisture (Mitchell, 1979). The mites prefer warmer, drier climatic conditions and 
open pasture environments (Mitchell et al., 1979). In the present study, the majority of 
yards were based in southeast Scotland, which is relatively cold and wet, compared to 
Suffolk, where the majority of the stud farms were based (Relf et al., 2013). Further, 
Suffolk is a large arable area, with a high density of arable farming compared to 
southeast Scotland. How the environment influences the abundance of orbatid mites 
was reported by Proudman et al. (1998), where tapeworm prevalence was found to be 
lower in horses kept on dry, sandy pastures. A further reason for the differences in 
prevalence could be variation in praziquantel (PRZ) efficacy against A. perfoliata. The 
population in the Thoroughbred study were administered PRZ frequently: 
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approximately 60% of stud farm managers had administered IVM combined with PRZ, 
50% had administered MOX combined with PRZ and 40% had administered PRZ on its 
own, in the preceding 12 months, as often as every 6 – 8 weeks (Relf et al., 2012), thus 
exerting strong selection pressure for resistance. To date, there have been no reports A. 
perfoliata resistance to PRZ, but there have been reports of a suspected lack of PRZ 
efficacy against the trematode, Schistosoma mansoni (Fallon et al., 1995; Ismail et al., 
1996; Wang et al., 2012), where PRZ has been used prophylactically for many years. 
However, the reported lack of efficacy is associated with heavy infections pre-
treatment and acceptable efficacy has been achieved by administering two doses 
(Picquet et al., 1998). This is an area that warrants further investigation; however, 
testing of PRZ efficacy by use of the FECRT would be difficult due to a lack of sensitivity 
of standard FEC methods in detecting tapeworm eggs (see above), and the 12-13 kDa 
antigen ELISA would be insensitive due to the relatively long half-life of antigen-
specific IgG(T) in equine serum (Abbott and Barrett, 2010). 
Here, strongyle FEC were highly over-dispersed (OD) between horses from the same 
yard, and the NBD adequately described the observed distribution. The NBD is a 
discrete probability distribution that is used to describe the amount of aggregation or 
OD in data, where decreasing values of k correspond to increasing levels of OD (Lloyd-
Smith, 2007). In the present study, the mean value for the aggregation parameter k was 
0.16. The k values obtained here are comparable to values reported in the recent 
Thoroughbred study, in which strongyle FEC were highly OD (k = 0.111) (Relf et al., 
2013). The k values for both studies were smaller than those observed in horses 
managed for conservation purposes in England, where values for k ranged between 
0.43 and 1.61 (Wood et al., 2013). In the study by Wood et al. (2013), the five 
populations of ponies sampled were not regularly treated with anthelmintics. It is not 
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surprising that regular anthelmintic intervention serves to increase aggregation, 
although there are few published studies on this.  
Here, no significant positive relationship between mean FEC and k was observed, even 
when the FEC data were log transformed, in contrast to Relf et al. (2013), who found 
that k tended to track the mean (m) FEC, indicating that FEC become less aggregated 
between individuals with a high mean FEC, and tend to become more clumped between 
individuals with a low group mean FEC. A possible reason for the findings of the 
present study may be the fact that horses within yards were different ages, leading to 
greater heterogeneity in observed FEC. In the analysis of Thoroughbred breeding stock, 
k was estimated for each age group (Relf et al., 2013) and was found to track the mean 
in all age groups except yearlings (Relf et al., 2013). Here, analysis was performed on 
the whole population because of low numbers of foals and yearlings, which may have 
resulted in outliers, explaining why no relationship was observed between mean FEC 
and k. However, a significant positive relationship between mean FEC and prevalence 
was observed (r2 = 0.8 (95% CI: 0.6-0.9), n = 28, p<0.0001), with yards with higher 
mean FEC having a higher prevalence of egg shedding. A similar relationship was 
observed by Relf et al. (2013) who reported a similar significant positive relationship 
(r2 = 0.95, n = 6, p = 0.004). 
The factors associated with parasite aggregation among host species have been 
described (Crofton, 1971; Anderson, 1976; Anderson and May, 1978; Shaw and 
Dobson, 1995; Shaw et al., 1998; Calabrese et al., 2011; Morril and Forbes, 2012; 
Poulin, 2013), and have been mostly attributed to heterogeneity amongst hosts, in 
particular an individual’s exposure to parasitic challenge and its susceptibility to 
infection (Poulin, 2013). Any host population is unlikely to be homogeneous and will 
differ in age, sex, immune status and susceptibility (Morril and Forbes, 2012) leading to 
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variation in FEC (Morgan et al., 2005). Factors related to parasite biology and 
epidemiology may also play a role; for example, the distribution of infective stages in 
the environment (Quenouille, 1949; Shaw et al., 1998), which is likely to be temporally 
and spatially uneven relative to hosts (Poulin, 2013), climatic and temperature 
dependent effects on parasite development (Shaw et al., 1998) and density dependent 
effects within the host (Poulin, 2013).  
The NBGLMM found that age, strongyle ERP, year, month and treatment frequency all 
had a significant effect on strongyle egg shedding. 
Strong associations between shedding levels and horse age were identified in the 
current study. Strongyle egg shedding was significantly higher in younger horses 
(under 5 years) compared to adult and geriatric horses and this is consistent with the 
findings of other studies. The recent study on UK Thoroughbred stud farms used 
logistic regression analyses to identify significant predictors of strongyle prevalence 
and strongyle egg shedding (≥200 EPG) and reported that age had a significant effect 
on strongyle prevalence and that yearlings were three times more likely to be positive 
for strongyle eggs in their faeces compared to the other age groups (Relf et al., 2013). 
Hinney et al., (2011) also analysed equine FEC data from 1407 German horses (126 
farms in one region) and reported that having young horses on a yard was a significant 
risk factor for a population of horses to have a high proportion of animals shedding 
≥200 EPG. It is likely that these age effects are related to the acquisition of immunity 
against strongyle infections over time. Here, the number of weeks after the expected 
strongyle ERP for the last administered anthelmintic that the sample was collected had 
a significant positive effect on strongyle egg shedding. Wood et al. (2013) also reported 
that strongyle egg shedding increased significantly beyond each anthelmintics ERP, and 
found that when the ERP effect and weeks since treatment was included in a 
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generalised additive mixed effects model (GAMM), this removed the effect of month, 
which strongly dominated egg shedding (Wood et al., 2013). 
The results here showed a clear fluctuation in strongyle FEC depending on month 
tested and found that strongyle FEC were significantly higher in 2012 compared to 
2011. Egg excretion was significantly higher in July with FEC levels lower in August and 
September, consistent with other studies (Herd, 1985; Lloyd, 2009; Wood et al., 2013). 
Climatic parameters such as rainfall and temperature play an important role in the 
epidemiology of cyathostomin infections, leading to seasonal fluctuations in strongyle 
egg output (Poynter, 1954; Duncan, 1974; Lloyd, 2009; Wood et al., 2013). In the study 
of Wood et al. (2013), a clear seasonal trend in egg shedding was also observed, where 
average FEC increased from a minimum in February to a peak in May, after which there 
was a plateau until September before a decline in autumn and winter (Wood et al., 
2013). In that study, the effects of year, month and local rainfall were identified as 
playing significant roles in the dynamics of strongyle egg excretion and year-to-year 
variation was attributed to annual variation in climate, while local temperature and 
rainfall were postulated to be associated with most of the monthly variation in FEC 
(Wood et al., 2013). The approach by Wood et al. (2013) differed from that of the 
present study as they investigated the effect of climate, rainfall and age on strongyle 
egg excretion using longitudinal data from five different populations, where in the 
present study, climate and rainfall were not considered and only the first screening 
FEC samples were included in the models. The rationale for the present studies 
approach was to enable a simple method of capturing the effects of factors that affect 
egg shedding at one point in time, to reduce the effects of pseudo-replication. Wood et 
al. (2013) were able to account for pseudo-replication and heterogeneity between 
yards by using generalised additive mixed models (GAMMs) (Pinheiro and Bates, 
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2000). Further, in the present study, the effects of rainfall and temperature was not 
considered, because of the spatial distribution of the yards tested, data would have had 
to be gathered from many different weather stations. 
In the present study, a reduction in strongyle egg shedding was observed in August and 
September. It has been reported that during autumn, a large proportion of ingested 
cyathostomin L3 encyst in the large intestinal wall (Ogbourne, 1976; Eysker et al., 
1984), leading to a reduction in egg excretion during the winter months. This has been 
confirmed in horses in France, where 42 post mortem examinations of horses between 
October and March found that EL represented the majority of the total cyathostomin 
burden (83%) (Collobert-Laugier et al., 2002). In this the UK, it has been reported that 
up to 90% of the total cyathostomin burden may exist as EL, with several million 
present in individual horses in the autumn/winter (Murphy and Love, 1997; Dowdall 
et al, 2002), serving as a potential reservoir for future transmission. The emergence of 
larvae from the intestinal wall is thought to be influenced by environmental conditions, 
host immunity and/or worm population density, and may also coincide with the 
removal of adults from the lumen following anthelmintic dosing (Gibson, 1953; Smith, 
1976). The emergence of encysted stages has been proposed as responsible for the 
spring rise of FEC observed in April and May in temperate climates (Reinemeyer, 
1986). The study looking at factors that that affect helminth egg excretion in 
Thoroughbreds (Relf et al., 2013) reported that horses that had access to grazing 
during winter had a were 7.61 times more likely to shed ≥200EPG in their faeces 
(OR=7.61, p=0) possibly due to milder autumn/winters (van Dijk et al., 2010), which 
will ensure the survival of eggs and larvae on pasture. This requires further study as it 
may have implications on levels of infections (and hence disease) and treatment 
applications.  
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Lloyd (2009), examined strongyle faecal egg shedding in 267 horses that had 
previously been managed under three different control programmes; one group had 
previously received no anthelmintic treatments, another received two anthelmintic 
treatments/year and the other had been treated 5 - 7 times a year. FEC were 
performed in February, May, August and November. In all groups, mean EPG peaked in 
August, slightly later than observed here, which is probably attributable to differences 
in local temperature and rainfall, which could have influenced the epidemiology. In an 
earlier study faecal samples were collected every two weeks from 10 untreated ponies 
in Newmarket, UK reported two peaks in strongyle egg  shedding were observed in 
April and September, both of which led to peak rises in L3 on pasture two weeks later, 
coincidental with abundant rainfall (Herd, 1985).  
In the present study, horses from yards where anthelmintic treatment was directed by 
FEC were shedding significantly fewer eggs compared to horses that were treated 
twice or four times per year. The number of yards and horses following a FEC directed 
worming protocol in the study population was small (three yards; 97 horses) and the 
questionnaire did not request information on how long the horses had been following a 
targeted treatment plan. Despite this, a significant effect was seens, indicating that the 
majority of high egg shedders were being identified and treated when following a FEC 
directed treatment plan. Further studies are warranted to examine the effect that FEC 
directed targeted programmes have on strongyle egg shedding and pasture 
contamination, in particular data should be captured to inform on the optimum testing 
frequency and proportion of horses to be tested at each sampling. This should be 
performed using different treatment regimes on horses with access to the same 
paddock and management practices. 
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In a study similar to the current one, Hinney et al. (2011) investigated risk factors 
associated with strongyle egg excretion in 1,407 horses from 126 farms using 
multivariate logistic regression analyses. These authors found that horses treated with 
anthelmintic less than three times a year were 3.24 (p = 0.011) times more likely to be 
shedding >200 EPG (Hinney et al., 2011). In the study by Lloyd (2009) the effect of 
previous control programmes on strongyle egg shedding was investigated (as outlined 
above). The yard managers were asked to withdraw anthelmintic treatments during 
the study period. Unsurprisingly, there was a significant difference in strongyle egg 
shedding between the yard that had previously administered frequent treatments 
(mean 99 EPG) and the yard that had not administered any treatments (1200 EPG) 
(Lloyd, 2009). It is not clear whether the horses grazed the same pastures that they 
were on before the study started. If they were, then the results are likely explained by 
the level of pasture infectivity, which one would expect to be much higher on pasture 
grazed by untreated horses. These results demonstrate that frequent effective 
anthelmintic treatments reduce parasite transmission via reduced egg excretion, but 
on the flipside, increased treatment frequency is linked to the selection of anthelmintic 
resistance (van Wyk, 2001).  
In the current study, the last anthelmintic administered prior to the start of the study, 
did not have a significant effect on the level of strongyle egg shedding. A likely reason 
for this observation could be that horses were sampled at least two weeks after the 
expected ERP of each anthelmintic, thus minimising any persistent effects on reducing 
strongyle egg shedding. It could be hypothesised that egg shedding would be lower in 
horses that had been previously treated with MOX due to its persistent effect against 
strongyle infections (Cobb and Boeckh, 2009). MOX has an elimination half-life of 23.11 
days compared to IVM (4.25 days) and PYR (13.43 hours) (Cobb and Boeckh, 2009). 
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This means that parasites are exposed to the active drug for longer periods and 
underpins the longer strongyle ERP of 13 weeks or more observed after MOX 
treatment (Cobb and Boeckh, 2009). Furthermore, MOX exhibits high larvicidal activity, 
whereas, IVM and PYR do not (Xiao et al., 1994; Bairden at al., 2006; Schumacher and 
Taintor, 2010). Administering an anthelmintic with adulticidal activity will only 
eliminate the luminal stages (L4 and adults), and this stimulates the EL to mature, 
leading to downstream contamination of pasture. By eliminating encysted stages, the 
strongyle ERP in increased (Schumacher and Taintor, 2010). Relf et al. (2013) reported 
that horses were 31 times more likely to be shedding ≥200 EPG if they had last been 
treated with FBZ. This was unsurprising given the high level strongyle resistance to 
FBZ.  
Here, horses from yards that imposed appropriate quarantine measures did not have 
significantly lower strongyle FEC compared to those that did. Possible reasons for this 
observation could be that the yards do not have new horses arriving frequently; 
therefore, the effect of quarantine on strongyle FEC would be minimal. However, in a 
study looking into parasite control practices on 61 UK Thoroughbred studs, 47% of 
respondents applied quarantine measures (Relf et al., 2011), while 57% of 193 horse 
yards in Scotland quarantined new arrivals (Stratford et al., 2014a), indicating that 
quarantine measures are not widely practiced. 
The regular removal of equine faeces from pasture has been advocated to reduce 
contamination (Herd, 1986; Herd and Coles, 1995; Duncan and Love, 1991), by 
removing parasite eggs before they hatch and develop to L3 (Mathee et al., 2004). In 
the present study, FEC of horses grazed on pastures from which faeces was removed 
were significantly higher compared to horses grazing pastures that did not have faeces 
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removed. This result contrasts to studies carried out at the UK Donkey Sanctuary, 
where a significant reduction in FEC in donkeys grazing pastures where dung was 
removed twice weekly (mechanically or manually) compared to pastures where dung 
was not removed (Corbett et al., 2014) was observed. This conflicting result may 
highlight the fact that in the questionnaire the response was a binary ‘yes’ or ‘no’, and 
did not provide information of frequency, hence a respondent that ticked ‘yes’ may 
have removed faeces from pasture once a year or twice a week. Also, there may be an 
element of respondent ‘prestige’ bias, 23/28 respondents stated that they removed 
faeces from pasture and this may be because it is generally regarded as best practice 
(Waltner-Toews, 1983; Houe et al., 2004). Future questionnaires should ask specific 
questions on frequency of dung removal and method of removal (i.e. manually or by 
machine) to assess if this practice is significantly associated with lower levels of 
strongyle egg shedding in faeces. Dung removal could reduce levels of refugia, 
potentially increasing the risk of anthelmintic resistance (Nielsen et al., 2007), 
therefore further research is required to investigate this phenomenon. 
Alternatives to the NBD have been used to describe parasite population distributions. 
FEC datasets are dominated by zero counts, which can lead to biased parameter 
estimates and OD (Zuur et al., 2009). Zero-inflated distributions are useful when zero 
observations arise from either count data (such as Poisson, lognormal-Poisson or 
gamma-Poisson distributions) or from a truly zero individual (Martin et al., 2005). 
Zero-inflated models involve predicting the number of true zeros from the distribution 
of observed counts and it is also possible to use a zero-inflated distribution to 
approximate a sub-population, which has a very low mean rather than a mean of zero 
(Martin et al., 2005; Zuur et al., 2009). The application of zero-inflated models to 
equine FEC would be useful to estimate the true number of zero egg counts. A zero FEC 
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result could mean that there were truly no eggs shed, or it could mean that eggs were 
not detected because the FEC method used was not sensitive enough to reliably detect 
eggs at a low abundance, or that the worm population within the host was comprised 
of immature stages only, therefore no eggs were detected. To counter these possible 
scenarios, in the present study, a sensitive FEC method was used, reducing the 
likelihood of a false negative result and the faecal samples were collected from horses 
between March and September, when there are likely to be fewer encysted stages in 
the host. However, it would be useful to explore the use of zero-inflated models for 
analysing equine FEC data. 
Knowledge that horses consistently shed similar levels of strongyle eggs over time can 
help establish evidence-based control strategies (Nielsen et al., 2014a). Here, horses 
were screened up to four times a year and shedding consistency in all horses tested 
was found to be relatively consistent over time, and encouragingly, egg shedding was 
highly consistent in horses that did not receive anthelmintic treatment during the 
course of the study. The results also revealed that young horses were more likely to 
change egg shedding or treatment category compared to the other age groups. A total 
of 61.5% of horses remained in the same shedding category between the first and 
second screen, and 58.3% between the first and third screen, while 81.8 and 82.7% 
remained in the same treatment category between the first and second screen and the 
first and third screen, respectively. In horses that did not receive anthelmintic 
treatment during the study, 92.1% remained in the same egg shedding category 
between the first and second screening and 90.4% between the first and the third 
screening. In terms of treatment category, 98.7% remained in the same category 
between the first and second screen and 95.6% between the first and the third screen, 
suggesting high levels of consistency. These results were similar to those of previous 
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studies that measured strongyle egg shedding consistency. In one, Nielsen et al. (2006) 
performed FEC analysis on 424 horses from 10 yards, twice a year for three years. In 
the first year, horses that shed >200 EPG were treated with anthelmintic chosen by the 
horse owner, and in the second and third years, horses received PYR and IVM, 
respectively. The authors reported that if the first two FEC were 0 EPG, there was an 
82% probability that the third FEC would be 0 and a 91% chance that it would be <200 
EPG. If the first two counts were <200 EPG, there was an 84% chance that the next FEC 
would be <200 EPG. Finally, if the first two FEC were ≥200 EPG, they reported a 59% 
probability that the next FEC would be ≥200 EPG (Nielsen et al., 2006). These results 
suggest a tendency for horses in low egg shedding categories to remain in this category 
on subsequent occasions. In the study of Nielsen et al. (2006), factors affecting 
shedding consistency were not examined. In another study, 129 horses from 19 yards 
were sampled every 4 weeks between March and October (9 samples/horse) (Becher 
et al., 2010). FEC were analysed by modified McM (30 EPG egg dl). Horses were treated 
with anthelmintics (PYR on the first occasion, IVM on the second occasion and MOX on 
the third occasion) when FEC were measured ≥250 EPG. Only horses that had not 
received anthelmintic treatment were included in the subsequent analysis. The authors 
reported that if the first two samples were FEC 0 EPG, there was a 62% probability that 
the maximum FEC of the next seven samples would be 0 EPG, and if the first two 
samples were FEC 0, there was an 88% probability that the maximum FEC of the next 
seven counts would be < 200 EPG, and a 92% probability of the next FEC being <250 
EPG. They concluded that for individual horses, the magnitude of the initial FEC was 
significantly correlated to the maximal FEC of the subsequent eight counts (Becher et 
al., 2010). An earlier study examined strongyle egg shedding consistency over tighter 
sampling frame (two samples over 6 weeks) in 484 horses from 18 yards (Dopfer et al., 
2004). Here, FEC analysis was performed by modified McM (50 EPG egg dl), and horses 
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were categorised as high egg shedders (HES, ≥100 EPG) or low egg shedders (LES, 
<100 EPG). A total of 55.2% of horses remained consistently low and 32% remained 
consistently high and did not move from one category to another. The remaining 12.8% 
went from low-to-high or high-to-low (Dopfer et al., 2004). As the threshold for a HES 
was only 100 EPG compared to 200 or 250 EPG in other studies (Nielsen et al., 2006; 
Becher et al., 2010), this could account for the reported lower level of consistency. One 
thing in common between these studies and the current one is that all horses received 
anthelmintic treatments at defined intervals or by FEC directed targeted treatment. A 
recent study that examined strongyle egg shedding consistency in ponies managed for 
conservation purposes found that shedding consistency at individual level was 
generally weak (Wood et al., 2013). In this study, FEC data were collected from the 
populations up to 11 years and four out of the five populations did not receive 
anthelmintic treatment. These data were analysed using GAMMs to estimate 
repeatability of FEC at individual level and to test for differences in mean FEC amongst 
populations and age classes. Climate and season were found to exert a significant effect 
on FEC in the populations that did not receive anthelmintic treatments. They reported 
a strong interaction between age and climate, suggesting that the highest FEC would be 
expected in young horses living in a warmer and wetter climate (Wood et al., 2013). 
The lack of individual consistency observed in this study (Wood et al., 2013) compared 
with others (Dopfer et al., 2004; Nielsen et al., 2006; Becher et al., 2010) could be due 
to the length of time the data were collected, the absence of anthlemintic treatments 
and the type of statistical analysis undertaken. In the anthelmintic treated horses, 
climatic effects were not detectable (Wood et al., 2013), supporting the impact of 
anthelmintic treatment on parasite distribution, as discussed above. Taken together, 
the evidence presented here and elsewhere (Dopfer et al., 2004; Nielsen et al., 2006; 
Becher et al., 2010), it is important to monitor FEC shedding patterns over time, and 
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not categorise shedding status over a short sampling time as factors such as 
management, immunity, anthelmintic use and climate that may affect longitudinal egg 
shedding patterns (Lloyd, 2009; Wood et al., 2013). Here, egg shedding and treatment 
consistency was higher in adult and geriatric horses compared to youngsters and foals, 
and youngsters were 3.3 (p=0.03) times more likely to change egg shedding category 
and 2.8 (p=0.028) times more likely to change treatment category between the first 
and third screening occasion compared to other age groups. Wood et al. (2013) also 
found that younger animals were more likely to shed more strongyle eggs compared to 
older animals and another study reported that mean FEC was negatively correlated to 
age (r = -0.328, p<0.01), with younger horses more likely to shed more strongyle eggs 
in their faeces (Becher et al., 2010).  
Overall, the results indicate that there is a high probability of a horse measured as 
having a negative or low FEC having a low FEC on subsequent occasions and a high 
probability that a horse not requiring treatment based on a 200 EPG threshold, will not 
on subsequent occasions (Section 5.4.3.1 – 5.4.3.2). However, climatic factors will 
influence the number of larvae that survive on pasture, so if horses are exposed to a 
greater parasitic challenge then their strongyle egg shedding potential may increase. 
Further, changes in management practices such as cessation of regular dung removal 
from pasture (potentially leading to an increased number of infective larvae on 
pasture), or the introduction of a new horse that has not undergone quarantine 
measures and may increase the likelihood of a LES becoming a high egg shedder HES. 
Another reason for an increase in strongyle egg shedding could be if the horse became 
immunocompromised due to an underlying illness or pregnancy. By using FEC analysis, 
horses can be categorised as LES (i.e. if FEC are consistently <50 EPG over three 
sampling occasions), medium egg shedders (MES, i.e. FEC are consistently ≥50 EPG but 
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<200 EPG) and HES (i.e. if consistently shedding >200 EPG on three sampling 
occasions). In practice, this means that LES could be checked less frequently (1 – 2 
times per year) saving time and money. Since in this population, only 15% of horses 
excreted 80% of strongyle eggs over the three sampling points, and on average, 18% of 
the horses screened would have required anthelmintic treatment on the basis of a 200 
EPG threshold for treatment, the majority of adult horses are likely to be LES. However, 
further analysis revealed that young horses (≥2 - <5 years of age) were 3.3 times more 
likely to change egg shedding category compared to the other age groups and were 2.8 
times more likely to change treatment group. This is likely to be due to younger horses 
being more susceptible to infection due to a lack of acquired immunity (Klei and 
Chapman, 1999), so that after treatment they are more likely to become infected and 
shed strongyle eggs. As their FEC are more likely to change, as well as be higher in 
count, FEC monitoring of young horses should be carried out more frequently than in 
older horses. If a horse has three or more consecutive FEC that measure <50 EPG using 
a FEC method with and egg dl of <10 EPG, the horse may be classified as a LES. 
However, further studies are warranted to ensure that these thresholds are suitable, 
and that there is no risk to horse health. 
Here, egg shedding and treatment status consistency at individual level was relatively 
high, especially in adult horses. However, FEC data were collected over one grazing 
season, so wider temporal effects were not accounted for. There is a lack of published 
information on long term patterns strongyle egg shedding in populations, especially in 
those managed under a FEC-driven treatment programme and this should be assessed 
in future, and include the analysis of various species of nematode. 
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5.5 Conclusions 
 
These data on helminth prevalence, distribution patterns and factors that affect egg 
shedding will inform improved methods of parasite control, which are less reliant on 
regular anthelmintic treatments. The results confirm that strongyle eggs are the most 
prevalent helminth egg found in the faeces of horses, confirming that strongyle control 
should be the main objective of most control programmes, and that egg shedding is 
highly over-dispersed amongst individuals, supporting the application of FEC directed 
anthelmintic treatments to those individuals shedding moderate-to-high numbers of. In 
terms of factors that affect strongyle egg shedding, age, time since last anthelmintic 
treatment, time of year and anthelmintic treatment frequency all affect the level of 
excretion. Such information informs the basic epidemiology of cyathostomin infections, 
which will ultimately underpin improved control programmes. Further, there was 
evidence to suggest that there is a high level of consistency in the level of strongyle egg 
shedding in individuals over time, which, will help to build guidelines for FEC directed 
targeted programmes. 
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CHAPTER 6: A framework for a decision 
support system for sustainable equine parasite 
control 
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6.1 Introduction 
 
The frequent and indiscriminate usage of anthelmintics in horses has contributed to 
the development of widespread drug resistance in cyathostomins and Parascaris 
equorum (Kaplan, 2004; Kaplan and Nielsen, 2010; Matthews, 2008, 2011, 2014), and 
recent evidence suggests that resistance in Oxyuris equi to macrocyclic lactones (MLs) 
is emerging (Wolf et al., 2014). With a limited option of effective anthelmintics, and 
increasing reports of resistance/lack of efficacy in multiple parasite species, chemical 
options for control are becoming restricted. With no new anthelmintic classes likely to 
be licensed for use in equids in the short to medium term, it is essential to preserve 
efficacy of the currently effective anthelmintics; in particular, moxidectin (MOX), which 
has larvicidal activity against cyathostomin species (Bairden et al., 2001). One primary 
aim of helminth control programs must be the preservation of anthelmintic-sensitive 
nematode populations by maximising levels of parasite refugia thus providing a pool of 
susceptible parasites, coupled with minimising the risk of parasite-associated disease. 
Such an approach could usefully employ targeted strategic dosing, which relies on 
administering anthelmintics at the most appropriate time of year, while considering 
the life cycle and epidemiology of the associated parasites, as well as taking into 
account variation in nematode egg excretion amongst individuals. This approach 
involves the measurement of individual faecal egg counts (FEC) of horses at specific 
times of year to facilitate targeting anthelmintics to only those horses excreting 
moderate-to-high levels of nematode eggs in their faeces (Duncan and Love, 1991; 
Gomez and Georgi, 1991). While this was suggested almost a quarter of a century ago, 
many horse owners in the UK continue to administer anthelmintics prophylactically at 
defined intervals. For example, a recent questionnaire study conducted on 61 UK 
Thoroughbred stud farms (Relf et al., 2012), reported that 100% of respondents 
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administered treatments to all individuals on a treatment interval basis. While 58% 
said that they had conducted faecal egg counts (FEC), 100% of those said that FEC 
analysis was not used regularly and usually only if parasite-associated disease was 
suspected. Further, 68% of respondents were not aware of the faecal egg count 
reduction test (FECRT, Relf et al., 2012). These figures are concerning, particularly as 
stud farms contain high numbers of young stock whose helminth burdens are likely to 
be higher (Relf et al., 2014) and they are known to frequently administer anthelmintics, 
in particular ML (Comer et al., 2006). Such practices are likely to exert a strong 
selection pressure for anthelmintic resistance. Another recent questionnaire study 
looking at control measures on 193 Scottish equine livery/leisure yards (Stratford et 
al., 2014a) found that 40% of respondents believed that they were following a targeted 
treatment programme however, this was not associated with delaying treatment 
beyond the standard strongyle egg reappearance period (ERP), and the pattern of use 
of products did not specifically ‘target’ encysted cyathostomin larvae. This indicated 
that the respondents were unsure of the definition of ‘targeted’ worming. In total, only 
19% of respondents administered anthelmintics based on FEC analysis and 61% were 
aware of the FECRT, but only 16% had performed a FECRT on their yard (Stratford et 
al., 2014a). Similarly, results from an earlier questionnaire study conducted in Ireland 
reported that of 55 yard owners questioned, none of the respondents left any animals 
untreated (O’Meara and Mulachy, 2002). A total of 72% of the respondents 
administered anthelmintics based on a treatment interval of <8 weeks, indicating that 
if they were administering MLs, they would be treating horses within the standard 
strongyle ERP (O’Meara and Mulachy, 2002). An online study performed in the UK 
targeting the general horse owning population (Allison et al., 2011) found that <60% of 
respondents (n = 574) believed that their current deworming programme was not as 
effective as it could be. In this study, 49% of the horses were kept on livery yards and 
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the owner’s indicated that they followed a deworming regime imposed by the yard 
manager. In total, 40% of these owners indicated that were ‘not happy’ with the 
imposed programme. Further, while 94% of respondents believed their horses were 
reasonably or well protected from worms, only 25% wanted to reduce the amount of 
anthelmintic they used and, only 31% followed a FEC directed control programme 
(Allison et al., 2011). The results suggested that while the horse owners were aware of 
anthelmintic resistance and felt well informed about targeted treatment, the vast 
majority were not following a targeted treatment protocol (Allison et al., 2011). 
The results from the aforementioned studies demonstrate gaps in knowledge about 
equine parasite control. Overall, the leisure yard owners appeared to be more aware of 
evidence-based control methods compared to the Thoroughbred stud farm sector. 
Generally, the results indicate that horse owners find parasite control confusing, 
particularly with regard to which species should be targeted at what time of year, and 
which anthelmintic should be used against which parasite species or stage. The need to 
take time to define prevalence (i.e. egg shedding status) and drug sensitivity by 
performing FEC analysis and FECRTs can disincentivise owners to practice evidence-
based control. Thus, a decision support system (DSS) aiding evidence-based steps for 
control would be a useful tool for horse owners, and those that prescribe anthelmintics 
for horses: veterinary surgeons, veterinary pharmacists and Suitably Qualified Persons 
(SQPs). Decision support tools have been used to support definitive disease diagnosis 
in human and veterinary medicine, where they incorporate sets of rules for solving 
problems, and use details such as clinical signs, laboratory results and opinions of 
experts to guide decision making (Thrusfield, 1995). A DSS does exist for equine 
parasites, Parasietenwijzer (www.parasietenwijzer.nl), written by the University of 
Utrecht. This resource provides decision trees for equine parasite control and is a 
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passive tool that provides suggestions based on risk. It advocates the use of FEC 
directed anthelmintic treatments, but does not suggest a plan for taking faecal samples 
over time, nor does it advocate performing FECRT. The aim of this chapter is to build 
an evidence-based framework for a more prescriptive DSS, using the results from 
earlier chapters, as well as existing published expert opinion to provide a relatively 
simple, informative system to aid horse owners and managers in adopting sustainable 
approaches to control. Furthermore, as there is a lack of published information on the 
resource implications of adopting targeted treatments, a cost-comparison analysis was 
performed to assess the impact of applying targeted anthelmintic treatments in 
populations of horses in the UK. 
6.2 Aims and objectives 
 
The aim of this Chapter is to apply the major findings of the earlier chapters, together 
with that of other published data, to build an evidence-based framework for helminth 
control in horses. A small study on the financial implications of adopting targeted 
based treatment regimes is also presented. 
6.3 Methods 
 
6.3.1. The framework for an evidence-based approach to sustainable 
parasite control 
 
Here, a framework for evidence-based parasite control is developed, based on the 
information and results generated in the earlier chapters, and using published 
evidence from other studies. This framework will be used to create rules that will be 
incorporated into a decision-based process, which will guide users through a set of 
questions regarding treatment decisions for helminth control. Four frameworks have 
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been constructed; the first is a simple framework, which considers three factors (last 
anthelmintic administered, when it was administered and the time of year) and guides 
the user through a set of questions relating to these factors, each with a set rules and 
recommendations, which will ultimately advise the user whether or not to perform a 
FEC and what to do if the FEC is ≥200 EPG. The second builds in the level of strongyle 
egg shedding in individual horses, includes performing FECRT analysis, surveillance of 
large strongyle infection and recommendations for tapeworm treatment. The third 
considers control in horses under the age of three years, and the fourth, control in 
foals. 
6.3.2 A cost-comparison of performing FEC directed targeted 
treatment protocols compared to interval dosing strategies 
 
Targeted treatment control programmes are underpinned by FEC analysis, which are 
likely to incur extra costs to the horse owner. The perceived benefit may be 
outweighed by concerns regarding the cost of performing routine FEC analysis. There 
is a lack of published information on the financial implications of adopting FEC directed 
targeted treatments compared to regular (interval) treatments with anthelmintics. 
Here, a cost-comparison analysis was performed to assess the financial impact of 
applying targeted treatments in 16 populations of horses across the UK. This analysis 
was applied to data collected from 368 horses on 16 yards that were part of the 
anthelmintic efficacy studies described in Chapter 3. Faecal samples from all horses 
were screened for the presence of strongyle eggs using a modification of the salt 
flotation method (Christie and Jackson 1982), with an egg detection limit (dl) of down 
to 1 EPG as described previously in Section 2.2.2.2. Each horse was screened three 
times (February/March, June/July, and September/October). Horses with a FEC 
measured at 50 EPG or more were treated in February/March and in June/July with 
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PYR and with IVM in September/October. Anthelmintics were administered per os at 
the following dose rates; PYR (Strongid-P™, Elanco Animal Health, UK) (19mg/kg), IVM 
(Eqvalan® oral paste for horses, Merial Animal Health, UK) (0.2mg/kg). Each horse 
received a dose appropriate for 110% of each individual’s body weight, as estimated by 
weigh tape, to minimise the risk of under-dosing (Stratford et al., 2014b). In December, 
all horses were treated with moxidectin (MOX)/praziquantel (PRZ)(PramoxTM, Zoetis) 
at a dose rate of 0.4 mg/kg (MOX) and 2.5 mg/kg (PRZ) to target encysted small 
strongyle larvae and tapeworm, which are most prevalent during the winter. The 
protocol was designed around findings from a recent questionnaire study, which 
identified that 92% of respondents had administered MOX or MOX/PRZ anthelmintic 
combination to their horses in the last 12 months (Stratford et al., 2014a). For the 
purpose of this study, each yard was asked to provide information regarding 
management practices; 94% of respondents had used a ML in the previous 6 months 
(19% IVM, 81% MOX). These products were administered at intervals that varied: 
12.5% (2/16) of respondents reported using them every 6 - 7 weeks, 68.8% (11/16) 
every 2 - 4 months and 18.8% (3/16) every 6-12 months. Since the majority of horse 
owners administered an anthelmintic every 2 - 4 months, and, with 81% administering 
MOX, the comparison here was based on each horse receiving two treatments of MOX 
and two treatments with MOX/PRZ during the course of the year (calculated as £55 per 
horse per year, assuming each horse received one dose/syringe and based on the 
average retail price of MOX, which was compared across five different retailers 
(average £10.62/dose for MOX and £16.65/dose of MOX/PRZ). The average cost of 
each FEC analysis was estimated to be £7 (based on the average of five commercial 
online FEC services (£7.29), with the average cost of an adulticidal treatment of PYR, £5 
(price compared across five different online retailers (average £5.34)) and IVM, £8 
(price compared between five different online retailers (average £8.23)). Included in 
 
 
301 
 
the analysis was the cost of two further FECs, using samples collected 14 days 
following treatment with PYR, after the first FEC screening occasion, and following 
treatment with IVM, on the third screening occasion, to assess efficacy of the 
anthelmintic used. 
6.4 Results 
6.4.1. Development of a framework for sustainable parasite control 
in equids 
Results contained within this thesis and other published studies have been collated 
into Table 6.1, which inform the recommendations and rules that will be used in the 
framework. Factors that have not been discussed previously are briefly introduced 
here. 
6.4.1.1. Recommendations for responsible anthelmintic use 
It is proposed that PYR and IVM should be used for controlling adult strongyles at the 
appropriate time of year (i.e. March - November) and reserve MOX for strategic use 
over the winter months to target cyathostomin EL (Matthews, 2014).  
Table 6.1. A list of recommendations for evidence-based control linked to 
specific areas 
Factor 
 
Recommendations Thesis 
Section/ 
Reference 
1. Recommendations 
for faecal sample 
collection and 
storage 
 
 Wait a minimum of four weeks after the 
standard ERP of the last administered 
anthelmintic before taking performing FEC 
analysis. 
 Freshly voided faeces should be used (sample 
within 12 hours of excretion). 
 Collect at least three faecal balls to ensure 
representative material is obtained. 
 Place samples into a zip-lock bag (or similar) 
and remove as much air as possible before 
Nielsen et 
al., 2010 
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sealing. 
 If not processed immediately, samples should 
be refrigerated at the laboratory as soon as 
possible. 
 All samples should be processed and eggs 
counted within five days. 
 
2. Recommendations 
for performing 
faecal egg counts 
 
 Thoroughly mix faecal samples before taking 
subsamples for analysis. 
 Use a FEC method with a low egg detection 
limit (dl) (≤10 EPG). 
 Ensure specific gravity of medium solution is 
correct (i.e. 1.2 for saturated NaCl solution). 
 
Sections: 
2.4.1,  
2.4.3 
2.4.5 
Lester and 
Matthews, 
2014 
3. Recommendations 
for performing a 
faecal egg count 
reduction test 
 
 Collect and handle pre- and post-treatment 
sample in a consistent manner. 
 Use a FEC method with an egg dl ≤10 EPG. 
 Include more than 10 horses. 
 Perform the FECRT method according to Coles 
et al. (1992) (as referred to as Method 1 in this 
thesis). 
 Calculate 95% lower confidence limits when 
calculating % FECR. This will take into 
consideration spread of individual FECR 
results and give a more accurate indication of 
sensitivity if especially if % efficacy is close to 
that of the threshold used to discriminate 
sensitivity and resistance. 
 Alternatively, a web-based tool (Torgerson et 
al., 2014) is freely available to generate FECRT 
estimates: 
http://www.math.uzh.ch/as/index.php?id=cal
c. This accounts for variation arising through 
sampling and variation between animals and 
now provides access of the layperson to more 
robust methods of computing FECR to take 
into account the likely spread of the FEC 
dataset. 
 Examine the FECRT dataset to identify 
shedding patterns post-treatment. If one or 
two individuals are shedding eggs post-
treatment consider retesting in case of 
administration error in the first test. 
Sections: 
4.4.1 
4.4.2.3 
4.4.2.4 
4.4.2.5 
4.5 
4. Anthelmintic use  FBZ is not recommended for small strongyle 
control. 
 FBZ is recommended to target P. equorum. If 
MLs are used to control this species, test 
efficacy. 
 PYR or IVM can be used during the grazing 
season to target adult strongyles. Efficacy of 
PYR should be tested. 
 MOX should be used strategically to target 
Section 3.5 
Matthews, 
2014 
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encysted cyathostomin larvae in the 
autumn/winter. 
 PRZ should be used annually to target 
tapeworm in the autumn/winter. 
 
5. Equine helminth 
prevalence 
 
 Cyathostomins are the most prevalent 
helminths, therefore, apart from foals, parasite 
control programmes should be focussed on 
this group. P. equorum is the major target of 
control programmes in foals. 
 If following a FEC directed targeted treatment 
programme, annual coproculture is 
recommended for surveillance of S. vulgaris or 
administration of an ML once a year to break 
the parasite lifecycle. 
 O. equi eggs are not routinely detected by FEC 
methods. If tail-rubbing is observed, perform a 
tapetest. 
 Tapeworm eggs are not reliably detected by 
common FEC methods; perform a tapeworm 
ELISA or treat prophylactically with PRZ in 
autumn/winter. 
 If co-grazing pastures with ruminants, ensure 
ruminants are free of liver fluke. Treat with an 
effective flukicide before turnout.  
Section 5.4.1 
Matthews, 
2014 
Nielsen et 
al., 2014 
6. Cyathostomin 
distribution 
 Strongyle egg shedding amongst populations 
of horses is highly over-dispersed.  
 Use FEC analysis to identify horses that are 
shedding ≥200 EPG and treat these animals 
only. 
Section 5.4.1 
Matthews, 
2014 
7. Factors affecting 
egg shedding 
 Young horses (<5 years) shed significantly 
more strongyle eggs in their faeces compared 
to adult horses therefore, young horses should 
be targeted appropriately to reduce pasture 
contamination. 
 Strongyle egg shedding is significantly higher 
during the summer months. 
 In the spring, target treatments at high egg 
shedders to reduce the peak observed in the 
summer months. 
Section 5.4.2 
8. Consistency of egg 
shedding 
 Here, young horses are more likely to change 
egg shedding category over the course of a 
grazing season (i.e. February to November). 
 If a horse has three or more consecutive FEC 
that measure >50 EPG and <200 EPG using a 
FEC method with and egg dl of ≤10 EPG the 
horse may be classified as a medium egg 
shedder (MES). 
 If a horse has three or more consecutive FEC 
that measure <200 EPG using a FEC method 
Section 5.4.3 
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with and egg dl of less than 10 EPG the horse 
may be classified as a low egg shedder (LES). 
 Once an individual is identified as an LES, 
perform FEC analysis once or twice per year in 
spring and in summer to ensure that the FEC 
has not risen significantly. Treat with 
MOX/PRZ in late autumn/winter to target 
encysted small strongyles and tapeworm 
regardless of egg shedding status. 
 For MES and HES perform FEC analysis at 
more regular intervals and treat if FEC >200 
EPG. Treat with MOX/PRZ in late 
autumn/winter to target encysted small 
strongyles and tapeworm regardless of egg 
shedding status. 
 
9. Recommendations 
for young horses 
(<3 years) 
 For horses > 12 months but < 3 years, perform 
FEC analysis every 4 – 6 weeks between 
February and November  
 Treat all youngsters with a FEC of ≥200 EPG 
with an ML. 
 Perform FECRT to ensure treatment efficacy. 
 Treat with MOX in late autumn/early winter to 
target encysted cyathostomin larvae. 
 Perform tapeworm ELISA in autumn and treat 
if necessary, otherwise treat with PRZ in late 
autumn/early winter. 
Section 5.4.2 
Matthews, 
2014 
10. Recommendations 
for foal 
management 
 Between 0 and 1 month treat with FBZ to 
target migrating ascarid larvae. 
 Between 2 and 4 months perform FEC analysis 
and treat with FBZ if ascarid eggs are present. 
Perform FECRT to ensure treatment efficacy. 
 Perform FEC at 6 months (weaning). Treat 
with FBZ if only ascarids are present and treat 
with an ML if strongyles are present. Perform 
FECRT to ensure treatment efficacy. 
 Perform FEC at 9 – 12 months. Treat with FBZ 
if only ascarids are present and treat with an 
ML if strongyles are present. Perform FECRT 
to ensure treatment efficacy. Perform 
tapeworm ELISA or treat with PRZ to target 
tapeworm. 
AAEP,2013 
 
6.4.1.2. Non-cyathostomin species 
 
Here, small strongyles were identified as the most prevalent species in the populations 
examined (Section 5.4.1), thus, cyathostomins should be the main focus of control 
programmes in adult horses, but it is important to consider other helminth species 
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when designing a tool for equine parasite control. In populations of horses that do not 
receive any broad-spectrum anthelmintic treatments, there is a risk that Strongylus 
vulgaris may re-emerge (Nielsen et al., 2012). Therefore, yard owners that follow a FEC 
directed targeted programme should be encouraged to perform an annual coproculture 
to monitor large strongyle prevalence. Alternatively, owners could consider treating 
with MOX annually in the late autumn. This will reduce the likelihood of S. vulgaris 
infection because MOX is highly effective against all stages of S. vulgaris (Monahan et 
al., 1995) and due to the long prepatent period observed with S. vulgaris (6 – 7 months) 
(Duncan and Pirie, 1972) transmission of this parasite species can be broken. In 
addition, treating with MOX in late autumn will also target encysted cyathostomins.  
O. equi eggs were not detected on any yards or in any horses tested during this study. 
There is no validated method for the detection of O. equi in horse faeces,. An inadequate 
method for the detection of O. equi eggs renders efficacy testing problematic. It has 
been suggested that once O. equi eggs have been detected using the tapetest, an 
anthelmintic is administered and the perianal area washed with warm soapy water 
immediately after treatment to remove all eggs. A tapetest should be performed every 
week for a month after treatment to ensure that no further eggs are shed. If eggs are 
detected within a month, this may suggest reduced efficacy (Reinemeyer and Nielsen, 
2013). However, the use of this test for determining anthelmintic efficacy against O. 
equi has not been validated, and further work is required to ensure that it is fit for 
purpose. The best prevention is to regularly wash the perianal area with mild 
detergent using disposable cloths and ensure that stables and grooming equipment are 
regularly cleaned and are not shared. 
Stongyloides westeri eggs were not detected in any horses tested during this study. S. 
westeri is typically found in foals as somatic larvae can become mobilized from the 
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ventral abdominal wall of the dam and infect the foal through milk (Greer et al., 1974). 
Since the population studied was biased towards adult horses, this finding is not 
surprising. Many worming protocols for foals recommend treating with MLs in the first 
month of life to target S. westeri, however, since this is mildly pathogenic at most, this 
practice has been questioned (Reinemeyer, 2009). For the control of S. westeri, it has 
been suggested that treatment of the mare with IVM within 24 h of parturition 
significantly reduces vertical transmission (Ludwig et al., 1982). 
As tapeworm eggs are not reliably detected by routine FEC analysis (Nilsson et al., 
1995), the only way to target anthelmintic treatment is to perform regular ELISA tests, 
otherwise it is recommended that owners treat their horses prophylactically once a 
year, in the autumn, as this is when adult tapeworm are thought to be most prevalent 
(Rehbein et al., 2013). 
6.4.1.3. Young horses and foals 
 
Horses under the age of five were measured as having significantly more strongyle 
eggs in their faeces compared to horses of 5 years and over (Section 5.4.2). Young 
horses are more susceptible to cyathostomin infection and are at greater risk of 
cyathostominosis (Reid et al., 1995). On this basis, the AAEP does not recommend 
targeted treatment programmes for horses under three years of age (AAEP, 2013) and 
they recommend that foals are treated a minimum of four times during their first year. 
FBZ is recommended at 2 – 3 months to target ascarids, and  a FEC is recommended 
just before weaning (approximately six months) to determine which species are 
present (i.e. ascarids or strongyles) and then using an appropriate anthlemintic to 
target either or both species. The recommendations are then to treat again at nine and 
12 months, targeting strongyles and tapeworm with a FECRT performed after each 
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treatment to ensure efficacy. It is also recommended that newly weaned foals are 
turned out onto ‘clean’ pasture and that yearling and two year olds should be treated 
three to four times a year with ML because of high strongyle egg shedding potential 
and their increased risk of larval cyathostominosis (Reid et al., 1995). It is feasible that 
younger horses (<3 years old) could follow a FEC directed treatment plan; however, 
FEC analysis should be performed at more regular intervals  because of the reduced 
strongyle ERP observed in younger horses (Lyons et al., 2008; Lyons et al., 2009). This 
would ensure adequate surveillance to identify horses that need treatment. 
Recommendations for ascarid control suggest not treating foals before 2 months of age 
and to use FBZ at a dose rate of 10mg/kg (Reinemeyer, 2009) to minimise the use of 
MLs. However, the larval stages of P. equorum are pathogenic as they can cause 
pathology to the liver and bronchitis during hepato-tracheal migration (Nichols et al. 
1987); therefore if P. equorum has been detected on a yard in the past, then it would be 
prudent to treat foals within their first month, as it takes approximately one month 
from the time the egg is ingested to the arrival of the L4 to the small intestine (Clayton 
and Duncan, 1977). Further, advice to treat P. equorum with FBZ at a dose rate of 
10mg/kg is problematic, as the administration of FBZ at this dose rate is not licensed in 
the UK. Treatment at this dose rate would only be allowed by a veterinary surgeon 
under the ‘cascade’ option, a legal flexibility that allows veterinary surgeons to 
administer a licensed product to a particular target species at an unlicensed dose rate 
or, an unlicensed product to a particular species in the absence of a suitable licensed 
product in order to treat a condition or disease to reduce animal suffering (refer to: 
‘Guidance note on the use of the cascade’ available at: www.vmd.defra.gov.uk). 
6.4.1.4. The envisaged framework for the decision support system 
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Figure 6.1 builds on the evidence above, and shows a schematic representation of the 
factors requiring consideration when arriving at a decision whether to treat or not, and 
how these factors interact with one another other. In summary, the FEC result of an 
individual will depend on host age, and host age will have a bearing on which 
nematode species are more likely to be present. Further, host age will also have an 
effect of whether or not the horse is a high egg shedder or a low egg shedder. Thus, 
host age and parasite species present will affect anthelmintic choice. This also depends 
on season, the anthelmintic sensitivity status of the nematode population, and activity 
of the anthelmintic. The choice of anthelmintic will have an impact on 
recommendations for when to perform the next FEC, based on the strongyle ERP 
(Figure 6.1).
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Figure 6.1. A schematic presentation of factors to consider in arriving at a decision of whether or not to treat, and their interaction with one 
another as represented by the blue circles and the envisaged outputs, represented by the green circles. Host age will affect the faecal egg 
count result (FEC), the infection history, whether or not the horse is a low egg shedder (LES) or a high egg shedder (HES) and the worm 
species present. The season in which the sample is taken, the worm species present, anthelmintic (AM) activity, the strongyle egg 
reappearance period (ERP) and resistance status of the helminth population will determine which anthelmintic (AM) should be 
administered. The season will also have an effect on the stage and species needing to be targeted and the FEC result
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Using the evidence above (Table 6.1), an annual framework is presented (Figure 6.2). 
This is primarily designed for use with adult horses. Horses should be FEC tested as a 
group: here, recommended in March, based on the assumption of a MOX treatment in 
the previous autumn. Typically, in the UK, horses that have been stabled over-winter 
are grazed for longer periods in spring. Strongyle L3 that have survived on pasture 
over-winter can act as a source of infection. Further, any cyathostomin EL that are 
present are likely to resume development (Herd, 1985), leading to pasture 
contamination with eggs. Horses measured at this test point as having a FEC of ≥200 
EPG should be treated with an anthelmintic with licensed (and preferably known) 
efficacy against adult strongyles. Effective treatment of moderate-to-high FEC shedders 
will help reduce the build up of strongyle larvae on pasture during the following 
months. This will be dependent on active ingredient used and the anthelmintic 
sensitivity of the population of worms present. Horses should then be tested in June 
and September to ensure that individual FEC have not increased. Again, anthelmintic 
treatments should be administered to horses with a FEC of ≥200 EPG with the same 
anthelmintic that was administered earlier in the year (i.e. either IVM or PYR). IVM or 
PYR, if identified as effective, should be used exclusively over the course of the year, 
and one FECRT performed to ensure that the drug remains effective. Thus, any 
reduction in efficacy can be identified and not masked by the use of another class of 
anthelmintic. In late autumn/early winter, all horses should be treated with MOX and 
PRZ to target strongyle species (including larval stages) and A. perfoliata respectively. 
Once three FEC samples have been analysed for an individual, the animal can then be 
categorised as a high egg shedder (HES - >200 EPG), medium egg shedder (MES – ≥50 - 
≤200 EPG) or low egg shedder (LES - <50 EPG). These results support categorising 
horses into strongyle egg shedding categories, and demonstrate that a low egg 
shedding horse, is highly likely to remain a LES over the course of a grazing season 
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(February – November), and that young horses (<3 years) should be treated separately 
because of their tendency to change egg shedding category and treatment category. 
Based on the annual framework (Figure 6.2), it is recommended that LES should be 
FEC analysed at least twice a year (March and June) to ensure that their strongyle egg 
shedding status remains low and that they do not require anthelmintic treatment. MES 
and HES should be FEC tested in March as this is the time that egg shedding increases 
after any EL present in the gut wall will start to mature and adults females will begin to 
lay eggs (Ogbourne, 1972; 1973; Herd, 1985; Reinemeyer, 1986) and in June/July, as 
this is the time when peak egg excretion was observed in this study (Section 5.4.2., 
Tables 5.10 and 5.11) and in August/September to identify any horses that are still 
shedding ≥200 EPG to reduce pasture contamination with infective larvae, which if 
ingested at or after this time of year, are likely to become encysted in the gut wall 
(Ogbourne, 1975; Eysker et al., 1984). The rationale behind treating MES and HES the 
same here is that more research is required to investigate how consistent strongyle egg 
shedding is in these groups and that adequate surveillance of the MES is undertaken to 
ensure that they do not become HES. 
The efficacy of each anthelmintic should be examined on an annual basis by performing 
a FECRT (Table 6.2). The FECRT should be conducted early in the year as this will guide 
decisions on which anthelmintic to use in the future. Only horses that require 
treatment (i.e. those with a FEC of ≥200 EPG) should be included in the FECRT. 
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Figure 6.2. Proposed framework for faecal egg count directed strongyle control in adult horses. The blue and grey boxes indicate when 
faecal egg count (FEC) analysis should be performed. The blue boxes indicate that high egg shedders (HES), medium egg shedders (MES) 
and low egg shedders (LES) should be tested and the grey box indicates that only HES and MES should be tested. Horses with a strongyle 
FEC of 200 eggs per gram (EPG) or more at these time points should be treated with either ivermectin (IVM) or pyrantel (PYR) to control 
the adult strongyle burden. * If PYR is administered, then efficacy should be examined by FECRT – state when and indicate on figure. The 
red box indicates all horses should be treated with MOX/PRZ** to target strongyles (including encysted stages) and A. perfoliata. The green 
arrow represents the likely seasonal peak in strongyle egg excretion (Herd, 1985; Lloyd, 2009), the blue arrow represents the time of year 
when adult tapeworm are likely to be most abundant (Rehbein et al., 2013) and the red arrows represent when cyathostomin encysted 
stages are likely the most abundant (Ogbourne, 1975; Murphy and Love, 1997; Dowdall et al, 2002) 
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Figure 6.3 presents a simple decision tree. The first step explores which anthelmintic 
was previously administered, and then asks when the last treatment was administered, 
followed by the season. This then leads to a recommendation on whether or not to 
perform FEC analysis. Based on the FEC result, recommendations for treatment are 
indicated. The decision tree is based on four questions, and their respective responses. 
For each response there are rules based on current evidence (Table 6.3). For example, 
if the last treatment was FBZ, the recommendation is to perform a FEC to ensure that 
the FEC is <200 EPG because of widespread FBZ resistance in small strongyles. If the 
response is PYR, IVM or MOX, the next question prompts the time elapsed since last 
treatment. FEC analysis should be performed a minimum of four weeks beyond the 
strongyle ERP of the last administered anthelmintic (AAEP, 2013). The next step 
explores season and based on this and/or FEC result data and a treatment 
recommendation is given. 
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Which anthelmintic was used for the last 
treatment? 
FBZ PYR IVM MOX 
Do not FEC test – 
wait until a 
minimum period of 
four weeks past the 
expected ERP of the 
last administered 
anthelmintic has 
passed. 
Treatment less than 
10 weeks ago? 
Treatment less than 
12 weeks ago? 
Treatment less than 
17 weeks ago? 
 
Winter 
(Y/N) 
 
Perform FEC 
Do not FEC test 
If a minimum of 4 
weeks has passed 
beyond the ERP 
for the last drug 
used – Treat with 
MOX/PRZ  
 
FEC 
< 200 EPG? 
No need to treat  – 
re-test in 6-8 weeks 
time. 
Treat with IVM or PYR  
Figure 6.3 Framework for a simple decision support system for strongyle and tapeworm control 
in adult horses using faecal egg counts (FEC) to guide decisions whether or not to treat with 
anthelmintic. The red lines represent a ‘No’ answer,  the green lines represent a ‘Yes’ answer, grey 
lines represent a multiple choice and blue lines take the user back to the start  
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Table 6.3. The questions, responses and rules underpinning the simple decision tree 
for strongyle and tapeworm control in adult horses 
 
 
 
Question Response Rule 
 
Have all new arrivals been 
quarantined? 
Yes The risk of a newly introduced horse 
shedding strongyle eggs of unknown 
resistance status is minimised 
No This poses a greater risk as newly 
introduced horses could be shedding 
resistant strongyles onto pasture. 
Perform a FEC immediately and treat 
with MOX if necessary 
When was the horse was last 
treated? 
Date Used for determining whether horse is 
within ERP 
What was the horse last treated 
with? 
FBZ Perform FEC to check efficacy and treat 
with anthelmintic if >200 EPG 
PYR If <10 weeks do not FEC 
If >10 weeks recommend FEC 
depending on season 
IVM If <12 weeks do not FEC 
If >12 weeks recommend FEC 
depending on season 
MOX If <17 weeks do not FEC 
If >7 weeks recommend FEC depending 
on season 
What is the current season? Spring A minimum of 4 weeks has passed 
beyond the ERP for the last drug used – 
perform FEC analysis 
Summer A minimum of 4 weeks has passed 
beyond the ERP for the last drug used – 
perform FEC analysis 
Autumn A minimum of 4 weeks has passed 
beyond the ERP for the last drug used – 
perform FEC analysis 
Winter A minimum of 4 weeks has passed 
beyond the ERP for the last drug used – 
Treat with MOX/PRZ to target encysted 
larvae and tapeworm 
What is the FEC result? <200 EPG Do not treat – re-rest in 6 - 8 weeks 
time 
≥200 EPG Treat with IVM or PYR to target adult 
small strongyles 
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Tables 6.4 and 6.5 provide a more comprehensive framework for a decision support 
system, incorporating individual strongyle egg shedding status, anthelmintic efficacy 
testing and surveillance for S. vulgaris. The framework outlined in Table 6.4 is based on 
questions, responses and rules, which guide the user and prompt them to, perform a 
FEC test or to treat with anthelmintic. It also explores the use of faecal culture for large 
strongyle identification. Table 6.4 is for horses for which their egg shedding status is 
unknown and for known HES and MES horses. Table 6.5 is for LES status horses 
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Table 6.4. Questions, responses and rules for a decision support tool for adult 
horses that have been identified as high strongyle egg shedders (HES). 
 
 
 
 
 
Question Response Rule 
 
Have all new arrivals been 
quarantined? 
Yes The risk of a newly introduced horse 
shedding strongyle eggs of unknown 
resistance status is minimised 
No This poses a greater risk as newly 
introduced horses could be shedding 
resistant strongyles onto pasture. 
Perform a FEC immediately and treat 
with MOX if necessary 
When was the horse was last 
treated? 
Date Used for determining whether horse is 
within ERP 
What was the horse last treated 
with? 
FBZ Perform FEC to check efficacy and treat 
with anthelmintic if >200 EPG 
PYR If <10 weeks do not FEC 
If >10 weeks recommend FEC 
depending on season 
IVM If <12 weeks do not FEC 
If >12 weeks recommend FEC 
depending on season 
MOX If <17 weeks do not FEC 
If >17 weeks recommend FEC 
depending on season 
What is the current season? Spring A minimum of 4 weeks has passed 
beyond the ERP for the last drug used – 
perform FEC analysis 
Summer A minimum of 4 weeks has passed 
beyond the ERP for the last drug used – 
perform FEC analysis 
Autumn A minimum of 4 weeks has passed 
beyond the ERP for the last drug used – 
perform FEC analysis 
Winter A minimum of 4 weeks has passed 
beyond the ERP for the last drug used – 
Treat with MOX/PRZ to target encysted 
larvae and tapeworm 
What is the FEC result? < 200 EPG Do not treat – re-rest in 6 - 8 weeks 
time 
≥ 200 EPG Treat with IVM or PYR to target adult 
small strongyles 
 
 
318 
 
Table 6.5. Questions, responses and rules for a decision support tool for adult  
horses that have been identified as low strongyle egg shedders (LES) 
 
 
 
Helminth control in young horses (i.e. >1 year <3 years) and foals (≤1 year) are 
considered in Tables 6.6 and 6.7, respectively. The decision support framework 
outlined in Table 6.6 is similar to the framework for the HES. The differences being that 
the interval for performing FEC analysis in young horses has decreased to every 4 – 6 
weeks. This is to ensure that any animals with a high strongyle FEC are treated 
promptly. Further, whether or not ascarids are present is considered as patent 
Question Response Rule 
 
1. What is the current season? Spring Go to Question 2 
Summer Go to Question 2 
Autumn Go to Question 2 
Winter A minimum of 4 weeks has passed 
beyond the ERP for the last drug used – 
Treat with MOX/PRZ to target 
encysted larvae and tapeworm 
2. When was the horse last 
FEC tested? 
Don’t know Perform FEC analysis at least twice a 
year during the spring and summer 
months to ensure egg count does not 
rise 
>4 months ago Perform FEC analysis at least twice a 
year during the spring and summer 
months to ensure egg count does not 
rise 
<4 months ago If performed in spring and FEC analysis 
was <50 EPG test again in summer to 
ensure egg count does not rise. If 
performed in spring and summer and 
both counts below 50 EPG no need to 
FEC again – treat horse in winter with 
MOX/PRZ 
3. Has a faecal culture been 
performed this year? 
Yes If large strongyle larvae present treat 
all horses with IVM in summer or MOX 
in winter 
No Perform faecal culture at least annually 
if horses are following a targeted 
treatment programme to check for 
large strongyles 
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infections may be seen in young horses under the age of three years (Reinemeyer, 
2012). The framework for young horses has been built on evidence presented in Table 
6.1. The framework for helminth control in foals (Table 6.7) is based primarily on the 
age of the foal and on the recommendations made by the AAEP (AAEP, 2013). 
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Table 6.6. Questions, responses and rules for young horses (<3 years) 
Question Response Rule 
 
1. What was the horse last 
treated with? 
FBZ Perform FEC to check efficacy 
and treat with anthelmintic if 
>200 EPG 
PYR If <10 weeks do not FEC 
If >10 weeks recommend FEC 
depending on season 
IVM If <12 weeks do not FEC 
If >12 weeks recommend FEC 
depending on season 
MOX If <17 weeks do not FEC 
If >17 weeks recommend FEC 
depending on season 
2. What is the current 
season? 
Spring/Summer/Autumn A minimum of 4 weeks has 
passed beyond the ERP for the 
last drug used – perform FEC 
analysis 
Winter A minimum of 4 weeks has 
passed beyond the ERP for the 
last drug used – Treat with 
MOX/PRZ to target encysted 
larvae and tapeworm 
3. What is the FEC result? < 200 EPG Do not treat – re-rest in 4 - 6 
weeks time 
≥ 200 EPG Treat with adulticidal 
anthelmintic – go to Question 6 
4. Were any ascarid eggs 
present? 
Yes Treat with an ML to target 
strongyles. Perform a FECRT 
No Treat with an ML to target the 
adult strongyles 
5. In the last year, has a faecal 
egg count reduction test 
(FECRT) been undertaken 
to determine efficacy? 
Don’t know Treat with IVM or MOX and 
perform FECRT once a year to 
ensure de-wormer is working 
No Treat with IVM or MOX and 
perform FECRT once a year to 
ensure de-wormer is working 
Yes Go to Question 7 
6. What was the last FECRT 
result for: 
PYR If less than 90% do not use; if 
≥90% use during summer 
months 
IVM If less than 95% do not use; if 
≥95% use during summer 
months 
MOX If less than 95% do not use; if 
≥95% use annually during 
autumn/winter to target 
encysted larvae 
7. Has a faecal culture been 
performed this year? 
Yes If large strongyle larvae present 
treat all horses with IVM in 
summer or MOX in winter 
No Perform faecal culture at least 
annually to check for large 
strongyles 
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Table 6.7. Questions, responses and rules for a decision support tool for foals 
 
Question Response Recommendation 
How old is the foal? 0 -1 month  Treat with FBZ to target 
migrating ascarid larvae  
3 – 4 months Perform FEC. Treat with FBZ if 
ascarid eggs present. Perform 
follow-up FEC to ensure 
treatment efficacy 
6 months (or weaning age) Perform FEC. If only ascarids 
present, treat with FBZ. If only 
strongyles present, treat with 
ML. If both species present, 
treat with an ML and perform 
a FECRT to ensure treatment 
efficacy. If ascarids still 
present treat with FBZ. 
9 – 12 months Perform FEC. If only ascarids 
present, treat with FBZ. If 
strongyles only present, treat 
with ML. If both species 
present, treat with an ML and 
perform a FECRT to ensure 
treatment efficacy. If ascarids 
still present treat with FBZ. 
For tapeworm, either perform 
ELISA or treat with PRZ. 
 
6.4.2 Resource implications of FEC directed targeted treatment 
protocols compared to interval dosing 
 
The average number of horses per yard (n = 16) in the study was 23 (range 10 - 47). 
The average saving calculated of adopting an anthelmintic-targeted treatment 
programme was calculated to be £294.44 (range £57 - 568, Table 6.8). On the basis of 
the analysis here, a financial saving was calculated for every yard included in the study. 
Costs associated with the time taken and labour used for collecting samples, 
administering anthelmintic, and postage costs were not included in the analysis. A  
linear regression model with a zero intercept with savings as the response variable and 
the number of horses of the yard (n) as the explanatory variable yielded a maximum 
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likelihood model of Savings = 6.3 + 0.06 x n . The r2 value was 0.76 indicating that the 
model accounted for 76% of the variance. These findings show a significant positive 
relationship (p<0.001) between the number of horses per yard and the overall saving 
that could be achieved, indicating that the more horses present on a yard and 
undergoing targeted treatment, the greater the savings (Figure 6.4), demonstrating the 
additional value of applying targeted anthelmintic treatments in horses. 
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          Yard       
  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 
Number of horses 30 17 10 32 20 14 14 25 23 12 26 19 14 28 47 36 
Estimated cost of interval treatment 
programme(£)a 
1650 935 550 1760 1100 770 770 1375 1265 660 1430 1045 770 1540 2585 1980 
Cost of FEC screening (£)b 630 357 210 672 420 294 294 525 483 252 546 399 294 588 987 756 
Cost of efficacy testing (£)c 31 31 0 47 31 73 0 12 58 37 15 16 28 0 117 22 
Screen 1 - MAR12 210 119 70 224 140 98 98 175 161 84 182 133 98 196 329 252 
No. Horses >200EPG 3 3 0 5 3 3 0 12 9 2 1 2 7 0 5 1 
FECRT (£) 21 21 0 35 21 21 0 84 63 14 7 14 49 0 35 7 
Cost of AM used (£)d  15 15 0 25 15 15 0 60 45 10 5 10 35 0 25 5 
Screen 2 - JUN12  210 119 70 224 140 98 98 175 161 84 182 133 98 196 329 252 
No. Horses >200EPG 0 0 0 11 0 7 0 16 5 7 3 1 4 1 24 3 
Cost of AM used (£)d 0 0 0 55 0 35 0 80 25 35 15 5 20 5 120 15 
Screen 3 - SEP12 210 119 70 224 140 98 98 175 161 84 182 133 98 196 329 252 
No. Horses >200EPG 4 4 0 6 4 10 0 0 7 5 2 2 3 0 16 3 
FECRT (£) 28 28 0 42 28 70 0 0 49 35 14 14 21 0 112 21 
Cost of AM used (£)e 32 28 0 48 32 80 0 0 56 40 16 16 24 0 128 24 
All horses treated with MOX/PRZ (£) 
499 283 167 533 333 233 233 416 383 199 433 316 233 466 783 599 
Total cost of targeted Programme (£) 
1225 732 377 1355 849 713 527 1085 1079 550 1021 769 656 1054 2070 1412 
Overall saving (£) 425 203 173 405 251 57 243 290 186 110 409 276 114 486 515 568 
Table 6.8. Comparative analysis of using faecal egg count (FEC) to determine anthelmintic treatment requirement compared to an 
interval dosing protocol on 16 UK yards. a the estimated cost of interval dosing was £55/horse/year. b the cost of screening all 
horses/yard based on £7/FEC, c total cost of efficacy testing.  Horses were treated with pyrantel (PYR) after the first and second 
screen and received ivermectin (IVM) after the third screen. The cost of anthelmintic used (AM) was d PYR, estimated to cost 
£5/dose and e IVM, estimated to cost £8/dose.  All horses were administered moxidectin+praziquantel (MOX/PRZ) in December.  
 
 
 
324 
 
 
Figure 6.4. Linear regression with zero intercept of the number of horses per yard and 
the overall saving (£) achieved (r2 =0.76, p<0.001). 
 
6.5 Discussion 
 
Presented here are four evidence-based frameworks, using results gathered from 
earlier chapters and existing published opinion, to provide a relatively simple decision 
support system to aid a sustainable approach to equine parasite control. There is no 
uniform way to practice FEC directed targeted control (Nielsen et al., 2014a). Young 
horses need to be considered separately as they may be subject to varying factors that 
affect the epidemiology of the parasites (Matthews, 2014), as do horses in different 
geographic areas (Nielsen et al., 2014b). The frameworks here are based on the 
epidemiology of equine helminths in the UK, using data collected in this study and data 
from other researchers. The framework presented here is primarily for use in older 
horses. A preliminary framework is presented for younger horses and foals. For the 
latter, more data need to be generated to ensure that withholding treatments in young 
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animals in not associated with an increase in the incidence of parasite-associated 
disease. Despite these caveats, the evidence available (Section 5.4.3; Menzel et al., 
2012) support the use of FEC directed therapy in horses by illustrating that strongyle 
egg shedding can be reduced substantially in populations despite leaving up to 84% of 
the population untreated. However, there are no data available on the long term effect 
of FEC directed targeted treatment protocols on the development of anthelmintic 
resistance or on the incidence of parasite-associated disease (Nielsen et al., 2014a). 
The choice of FEC cut-off value used for deciding whether or not a horse requires 
treatment is often arbitrarily set at 200 EPG (Nielsen et al., 2006). The majority of 
studies evaluating FEC directed therapy quote cut-off values in the range of 100 – 300 
EPG (Duncan and Love, 1991; Gomez and Georgi, 1991; Krecek et al., 1994; Mathee and 
McGough, 2004; Nielsen et al., 2006; Hertzberg et al., 2014). Such cut-offs were 
recommended without prior knowledge of the relationship between FEC and worm 
burden in horses (Nielsen et al., 2014a). A study by Nielsen et al. (2010) looked at the 
correlation between strongyle egg counts and adult worm counts obtained at necropsy 
from 700 horses, and found that there was no direct linear relationship between EPG 
and worm burden. They found that horses with FEC between 100 – 500 EPG had 
significantly larger adult strongyle worm burdens, however; some horses with FEC 
<100 EPG were found to have 300,000 luminal adult strongyles (Nielsen et al., 2006). 
This suggests that applying a threshold of 200 EPG may miss some horses with a large 
burden, allowing these animals to serve as a reservoir for egg shedding and pasture 
contamination. This is an area that warrants further investigation in order to further 
understand the impact of selecting specific cut-off values for targeted anthelmintic 
therapy. 
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The impact of management factors have not been considered in this framework. While 
there is evidence that regular removal of dung from pastures can reduce strongyle egg 
shedding (Corbett et al., 2014), there is little information on how dung removal impacts 
refugia. Similarly, nothing is known of the impact that co-grazing pastures with 
ruminants may have on levels of refugia. Further research is required to provide 
quantitative evidence on the utility of these control methods and to provide baseline 
values on which to build practical recommendations (Matthews, 2014). 
An assumption of the proposed framework is that horses spend less time on pasture 
during the winter months, and that pasture contamination during winter is lower. A 
recent study looking at helminth egg excretion on UK Thoroughbred stud farms found 
that horses grazed in December – February shed relatively high levels of strongyle eggs 
(Relf et al., 2013). Milder autumns and winters that have been observed in the UK may 
allow development of nematode larvae from eggs over-winter (van Dijk et al., 2010), 
serving as a source of infection at these times of year. Rainfall and temperature play an 
important role in the transmission of strongyle infections (Poynter, 1954; Duncan, 
1974; Lloyd, 2009; Wood et al., 2013). The results in Chapter 5 showed a fluctuation in 
strongyle FEC depending on month and demonstrated that strongyle FEC were 
significantly higher in 2012 compared to 2011. The generalised linear models in 
Chapter 5 identified significantly higher levels of egg excretion in July, with FEC lower 
in August and September, consistent with other studies (Herd, 1986; Lloyd, 2009; 
Wood et al., 2013). In Wood et al. (2013), a clear seasonal trend was observed in FEC 
shedding in ponies grazed primarily without anthelmintic treatment. In that study, the 
effects of year, month and local rainfall were identified as playing significant roles in 
the dynamics of strongyle egg excretion and year-to-year variation in FEC could be 
attributed to annual variation in climate, while local temperature and rainfall explained 
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most of the monthly variation in FEC (Wood et al., 2013). The current frameworks 
presented in this study, rely on the seasons being consistent, and are based on the egg 
shedding dynamics observed in the general horse population over a two year period. 
The next step in development of the framework here would be to develop steps that 
would allow automatic incorporation of local rainfall and temperature data across 
regions to allow the impact of these parameters to be included in the decision 
structure. 
One of the caveats in FEC directed treatment programmes is that the tests only detect 
patent infections and do not provide an indication of prepatent infection. The larval 
stages of large and small strongyles and P. equorum (in foals) are associated with 
pathology and clinical signs. Diagnostic assays, capable of detecting encysted small 
strongyle larvae and migrating large strongyle and P. equorum larvae, would identify 
horses at risk of developing disease and better aid targeted treatment protocols 
(Andersen et al., 2013). For this reason, the recommendations here are to treat all adult 
horses annually with MOX to target small strongyle EL and any migrating large 
strongyle larvae. If the EL are highly aggregated between horses, then this prophylactic 
treatment may be unnecessary in all horses. Recently, a diagnostic ELISA based on 
detection of antibodies to a cocktail of larval cyathostomin proteins has been described 
(McWilliam et al., 2010). Such an ELISA would help to identify horses harbouring 
encysted larvae to allow treatments to be targeted at these individuals only, which 
could reduce selection pressure for ML resistance and refine anthelmintic treatment 
recommendations. Further, a serum ELISA for detection of migrating S. vulgaris larvae 
may be a useful monitoring tool in the future, but further work needs to be performed 
to validate the sensitivity and specificity of this test (Andersen et al., 2013). 
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Another limitation of FEC methods is that they do not reliably detect tapeworm 
(Nilsson et al., 1995). Further, while there has been a diagnostic tapeworm ELISA 
available for over ten years, a lack of sensitivity observed due to the long half-life of 
antigen-specific IgG(T) in serum in response to previous infection, limits usefulness of 
this test in the field. In the absence of more sensitive tools to identify infected 
individuals, current recommendations are to treat once a year with PRZ in autumn 
winter when adult tapeworms are more prevalent (Rehbein et al., 2013). It is likely that 
tapeworm infections will be highly aggregated in horse populations; therefore, not all 
horses will need treatment. To date, there have been no reports of tapeworm 
resistance to PRZ and this is an area of equine parasitology that warrants further 
investigation. However, testing of PRZ efficacy by use of the FECRT is difficult due to a 
lack of sensitivity of standard FEC methods in detecting tapeworm eggs and the ELISA 
(Abbott and Barrett, 2010). 
A potential hurdle to widespread adoption of FEC directed targeted treatments by 
horse owners and managers may be the perceived cost providing be a disincentive to 
their widespread application. The cost associated with performing regular FEC analysis 
should be viewed as a necessary expense for maintaining horse health (Kaplan and 
Nielsen, 2010). The findings from the cost-comparison study here showed that such a 
strategy has a high chance of reducing the financial cost associated with interval 
dosing. The evidence available supports the exploitation of FEC directed therapy by 
illustrating that strongyle egg shedding can be controlled in populations of horses 
despite leaving up to 84% of the population untreated, and that such a strategy has a 
chance of reducing the cost associated with interval dosing. As many veterinarians and 
horse owners still practice interval treatment control programmes (Stratford et al., 
2014a), the advantage of more evidence-based programmes need to be promoted to 
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ensure further uptake (Matthews, 2014). The development of accessible decision 
support tools based on up-to-date research and utilising available diagnostic tools to 
aid evidence-based management would facilitate such uptake. The frameworks 
presented in this Chapter require further development to be transformed into an 
accessible tool. The envisaged tool would store data for each horse and yard and would 
be able to send automated reminders to prompt further steps. The tool would be able 
to categorise horses to shedding status based on the previous FEC results and alert if 
there were changes in egg shedding status of individuals. Also, the tool could also 
prompt the need to test for large strongyle larvae should ML treatments be reduced 
substantially and would provide guidance on efficacy testing. The tool would need to 
be flexible to account for changes to incorporate new technologies as they were 
developed and validated. Such a tool could be developed using Bayesian networks. 
Bayesian networks offer a flexible graphical way to describe the probabilistic 
relationships between a set of random variables (Yet et al., 2013) allowing predictive 
or diagnostic inferences to be made, and have been used in human and veterinary 
medicine to aid clinical decision making and aid diagnosis (McKendrick et al., 2000; 
Lucas et al., 2004; Geenen and van der Gaag, 2005; Yet et al., 2013). Bayesian networks 
can be constructed using evidence obtained from expert opinion and/or published data 
to form a decision framework based on the probabilistic relationship between a 
particular variable and all possible outcomes (Yet et al., 2013). 
6.6 Conclusions 
 
The aim of this Chapter was to build an evidence-based framework for a DSS, using the 
results gathered from earlier chapters and existing published expert opinion, to 
provide a relatively simple and informative system to aid in the adoption of a 
sustainable approach to parasite control, by utilising FEC directed treatments. The 
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resource implications of following a FEC directed targeted treatment were investigated 
by performing a cost-comparison study. The findings indicate targeting anthelmintic 
treatment at individuals with high FEC can help to reduce selection pressure for 
resistance by reducing treatment frequency but without a substantial increase in 
financial cost. Taken together, these findings demonstrate the value of applying 
targeted anthelmintic treatments in horses. Several frameworks are presented and 
further work is now required to develop these into useable tools. 
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CHAPTER 7: General Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
332 
 
7.1 Discussion 
 
Gastrointestinal helminths present a serious challenge to the health and welfare of 
equids worldwide. With virtually all grazing equids at risk of infection (Nielsen et al., 
2006), there is a need for control strategies to reduce the threat of clinical disease. 
Since the early 1900’s, a number of anthelmintic compounds, which, in chronological 
terms, are of increasing spectrum, efficacy and safety, have been developed (Lyons et 
al., 1999). Currently, there are four broad-spectrum anthelmintics licensed for use in 
horses in the UK; these are fenbendazole (FBZ), pyrantel embonate (PYR) and the 
macrocyclic lactones (ML) ivermectin (IVM) and moxidectin (MOX). Praziquantel 
(PRZ), which is only effective against tapeworm species, is also licensed. The frequent 
administration of anthelmintics has significantly reduced the prevalence of Strongylus 
vulgaris and associated morbidity (Nielsen et al., 2014); however, it has led to the 
development of anthelmintic resistance to FBZ, PYR and MLs in a number of species, in 
particular the cyathostomins, which are now the most prevalent group of equine 
helminths worldwide (Nielsen et al., 2014; Matthews, 2014). The heavy use of 
anthelmintics has also contributed to the development of resistance in Parascaris 
equorum (Boersema et al., 2002; Hearne and Peregrine, 2003; Slocombe et al., 2003), 
and recent evidence suggests that ML resistance in Oxyuris equi may be an issue (Wolf 
et al., 2014). With no immediate prospects for new classes of equine anthelmintics, and 
increasing levels of resistance in various helminth species, chemical options for control 
are becoming limited. For these reasons, it is essential to preserve efficacy of the 
currently effective products (Kaplan, 2004; Kaplan and Nielsen, 2010; Matthews, 2011; 
Matthews, 2014); in particular, moxidectin, which has larvicidal activity against 
cyathostomin encysted larvae (EL) (Bairden et al., 2001), which are a major clinical 
threat to horses (Love et al., 1999). 
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As helminth infections and worm egg excretion are highly over-dispersed in horses 
(Kaplan and Nielsen, 2010; Relf et al., 2013), targeted treatment programmes have 
been advocated to reduce anthelmintic use (Kaplan and Nielsen, 2010; Matthews, 
2014). Targeted protocols encompass the measurement of individual FEC within 
populations at specific times of the year to facilitate targeting of anthelmintics to those 
horses excreting moderate-to-high levels of nematode eggs in their faeces (Duncan and 
Love, 1991; Gomez and Georgi, 1991). The approach aims to reduce the selection of 
anthelmintic resistant strongyles by reducing treatment frequency and maintaining a 
population of parasites in refugia (van Wyk, 2001; Sangster, 2003). The role of refugia 
in slowing the development of anthelmintic resistance has been confirmed in part in 
sheep (Martin et al., 1981; Dobson et al., 2001); however, critically, practical evidence 
in equids demonstrating the effectiveness of this strategy is limited and therefore the 
role of maintaining populations of parasites in refugia to delay the development of 
anthelmintic resistance in equine parasites is currently an unvalidated theory, and 
warrants investigation. One caveat to the application of targeted treatment 
programmes is that many horse owners/managers have insufficient knowledge on 
which to base these protocols. For example, often they have little idea of the relative 
contribution that individual horses make to pasture contamination or of the true 
anthelmintic sensitivity status of the associated parasite population. Furthermore, 
specific advice is infrequently sought from veterinary surgeons and, when it is, the 
information provided can be based on out-dated concepts such as interval dosing 
(Stratford et al., 2014a; Matthews, 2014). Currently, there are no standardised 
guidelines for performing FEC analysis or efficacy testing in horses using the faecal egg 
count reduction test (FECRT). Since these tools underpin targeted treatment protocols, 
there is a need to optimise them and create recommendations for their use to ensure 
that they are fit for purpose. The aim of this thesis has been to build a framework for 
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sustainable helminth control to help horse owners and people who prescribe 
anthelmintics to develop control programmes on an evidence basis. Diagnostic tools 
that will promote the targeted treatment of horses in the field will underpin such a 
system.  
To achieve this, the following areas have been investigated: 
 
1. Sources of variation in equine FEC analysis with the aim of developing 
guidelines that will help reduce variation and improve the diagnostic accuracy 
of these tests. 
2. Efficacy of commonly used anthelmintics in populations of horses to inform the 
current status of the prevalence of anthelmintic resistance in the UK. 
3. Comparison of different FECRT methodologies to determine which is the most 
accurate to ensure that resistance is not misclassified. 
4. Risk factors associated with nematode egg excretion to inform on when to 
perform FEC analysis. 
5. Studying the practical utility of FEC directed protocols in the field. 
The derived information, along with other published research, has been used to build 
four decision trees which form the framework for a decision support system (DSS) to 
facilitate evidence-based helminth control in horses. 
The findings of this thesis support targeted anthelmintic treatment strategies in horses 
based on FEC analysis. However, the use of FEC directed treatment protocols and the 
framework outlined in this thesis need to be validated under field conditions to ensure 
that withholding treatments is not associated with an increased risk of disease 
particularly if low egg shedders (LES) are not administered with MOX to target 
cyathostomin EL. Lack of ML treatments could also be linked to the re-emergence of S. 
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vulgaris (Nielsen et al., 2014), and this needs to considered when following a targeted 
treatment protocol, particularly as large strongyle eggs cannot be differentiated from 
small strongyle eggs during routine FEC screening and given the pathogenicity of the 
large strongyles, this poses a future challenge for equine parasite control. 
Further research into the FEC threshold used for determining anthelmintic treatment 
is required. The current guide of 200 EPG is an arbitrary figure; in younger horses that 
tend to have higher burdens this threshold should perhaps be lowered to reduce 
pasture contamination and the risk of larval cyathostominosis, and, for older horses 
(>5 years), who generally have lower strongyle burdens the threshold could be higher 
especially on premised where good management practices (i.e. regular dung removal) 
are deployed. Because young horses are more susceptible to strongyle infection and 
tend to shed more eggs, animals in this category require closer attention on monitoring 
programmes than adult horses, particularly as horses aged less than three years have 
been associated with are a greater risk of larval cyathostominosis (Reid et al., 1995). 
Thus, FEC can be used to guide treatment options in populations of young horses, but 
FEC analysis needs to be performed more frequently than when dealing with 
populations largely comprising adult horses and the FEC threshold for treatment may 
need to be lowered (e.g. ≥100 EPG) to reduce the infection intensity on pasture. The 
use of FEC directed treatment programmes needs further study in young horses to 
establish an evidence basis for FEC test frequency and thresholds for treatment. 
Further studies are required to examine the effect that FEC directed targeted 
programmes have on strongyle egg shedding and effect on pasture contamination; data 
should be captured to inform on testing frequency and the proportion of horses to be 
tested at each sampling. Ideally, this should be performed using different treatment 
regimes on horses with access to the same paddock and management practices. Here 
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(Chapter 5), practices such as quarantining new arrivals and regular removal of dung 
from pastures did not appear to have a significant association with low FEC shedding. 
Nevertheless, appropriate quarantine is an essential component of best practice 
control programmes and further dissemination of the importance of this is required, 
through education of veterinary surgeons and horse owners through scientific and lay 
publications and through webinars and lectures. Likewise, dung removal from pasture 
is considered an essential component of equine helminth control (Herd, 1986; Herd 
and Coles, 1995; Duncan and Love, 1991; Mathee et al., 2003; Corbett et al., 2014). 
Further research into how management factors fit into and complement targeted 
treatment protocols; in particular how the regular removal of dung impacts on levels of 
refugia are required. 
The ability to categorise horses on the basis of an initial number of FEC tests (taking 
into account age, season and previous anthelmintic treatment) could act as an incentive 
to owners to adopt targeted programmes. However, climatic factors will influence the 
number of larvae that survive on pasture, so if horses are exposed to a greater parasitic 
challenge then their strongyle egg shedding potential may increase. The results from 
the egg shedding consistency analysis are encouraging, however, further research is 
required validate the categorisation of horses into egg shedding categories and to 
explore whether leaving low egg shedders (LES) untreated over several grazing 
seasons leads to an increase in egg shedding overtime, and to ensure that there is no 
increased risk of clinical disease. 
FEC directed treatment strategies incur labour and financial costs, specifically in 
conducting FEC, and this could act as a disincentive to widespread application. Here, a 
cost-comparison analysis was performed to assess the financial impact of applying 
targeted anthelmintic treatments (Section 6.4.2). A saving was achieved on every yard 
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with the average saving of adopting a targeted programme equal to £294.44. Costs 
associated with time taken for collecting samples, administering anthelmintic, and 
postage costs were not included, and should be included in any future analyses. 
Nevertheless, these results demonstrate that an overall saving can be made by 
following a FEC directed targeted approach and that the more horses included in a 
targeted treatment programme, the greater the savings. However, the challenge 
remains convincing horse owners, yard managers, vets and those that prescribe 
anthelmintics that utilising FEC can save them money and help to reduce anthelmintic 
use, which will reduce the selection pressure for resistance and aid sustainable 
parasite control. One way of promoting the value of FEC directed a targeted approach is 
to publish these results in scientific and lay publications, and use social media to target 
appropriate groups of people. Another is to build and promote accessible, robust and 
validated tools, which use diagnostic FEC data and epidemiological knowledge to 
support decisions to treat on an evidence basis. 
To support FEC directed treatment protocols, it is necessary to have laboratory 
services to conduct FEC analyses. In the UK, there are several commercial laboratories 
offering equine FEC analysis. However, at the time of writing this thesis, the majority of 
these labs currently employ the McMaster method with an egg detection limit of 50 
EPG, which as discussed in Chapters 2 and 4 will lead to a greater proportion of horses 
appearing to require treatment based on a 200 EPG threshold and will lead to more 
misclassified FECRT results compared to when a more sensitive egg counting method 
is employed. The challenge now is to convince veterinarians and diagnostic 
laboratories to adopt more sensitive egg counting methods.  
There are several further studies and areas of research to pursue that would 
complement and clarify the work described in this thesis, which include developing 
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standardised guidelines for performing FEC analysis and for performing FECRT against 
all equine helminth species, and to define thresholds for classifying resistance to each 
anthelmintic so that results can be compared across studies and regions. It is clear 
from the results obtained in this study that the current use of thresholds are not fit for 
purpose and currently they are unable to discriminate between efficacy and resistance. 
To aid the interpretation of FECRT data and confirm resistance, there is an urgent need 
to develop rapid and sensitive diagnostic tools to detect anthelmintic resistance to 
complement the FECRT to ensure adequate surveillance of anthelmintic resistance. 
Molecular-based assays offer future promise, as they will be able to detect genotypic 
resistance prior to the occurrence of anthelmintic failure (Kaplan, 2002). However, to 
date, the performance of in vitro assays for detecting anthelmintic resistance in equine 
parasites has been disappointing (Matthews et al., 2012). 
As the results from the FECRT conducted here found that IVM and MOX were 
efficacious on all yards tested, PYR was effective on the 90% of yards tested and FBZ 
resistance was detected on all yards, it was not possible to determine risk factors for 
resistance. Further studies need to be conducted in areas where there are documented 
cases of ML resistance in order to accurately identify risk factors, which will help 
inform evidence-based control strategies. 
A reduction in nematode egg reappearance period (ERP) has been proposed to be an 
earlier indicator of anthelmintic resistance (Sangster, 2001). ERP was not investigated 
here as the focus of this study was on measuring anthelmintic efficacy by the FECRT. 
Further investigation into strongyle ERP after anthelmintic treatment is now 
warranted, and surveillance of ERP should be encouraged as a part of control 
programmes. Further studies are also required to examine efficacy of these products 
against species such as O. equi and P. equorum. 
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A major assumption, when interpreting FECRT data and strongyle ERP is that all 
cyathostomin species respond to an anthelmintic in the same way. There are over 50 
recognised cyathostomin species (Lichtenfels et al., 2008) and the role that individual 
species play in the development of resistance is largely unknown. Several studies 
looking into the species composition of larvae recovered from horses following 
treatment with IVM and MOX indicated that cyathostomin species that belong to the 
genus Cylicocyclus, predominate in cases where there is a shortened strongyle ERP 
(Lyons et al., 2009; van Doorn et al., 2014). This is of particular interest, and requires 
further investigation as knowledge of which species are contributing to any observed 
shortened ERP can help inform future research into molecular and in vitro tools for the 
detection of these species, so that species composition can be taken into consideration 
when performing efficacy testing. 
Peregrine et al. (2014) propose that, even in the face of increased reports of resistance 
in multiple nematode species against all anthelmintic classes, there have been no 
formal links between anthelmintic resistance and an increase in parasite-associated 
disease reported in horses. They believe that this is due to a publication bias, where 
researchers use horses that are in good condition and reside on well-managed 
establishments. Furthermore, they believe that a lack of an accurate validated tool for 
the detection of anthelmintic resistance affects the early identification of resistance 
making associations between clinical cases and resistance difficult. Published data on 
the incidence of larval cyathostominosis or morbidity associated with P. equorum is 
limited so drawing conclusions as to the interaction of increased resistance with 
clinical disease is difficult (von Samson-Himmelstjerna, 2012). However, it stands to 
reason that if anthelmintics fail to control helminths, the resultant accumulation of 
parasites over time will lead to a greater probability of disease. It could be argued that 
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at the current time, helminth populations are being adequately controlled, despite 
widespread cyathostomin resistance to FBZ. Until the levels of ML resistance reaches 
similar levels, associations between resistance and clinical disease may not be seen. 
The current situation in sheep illustrates the clinical ramifications of multidrug 
resistance, and in some countries resistance to all anthelmintic groups and 
combinations is widespread (with the exception of the new anthelmintic compounds, 
monepantel and derquantel) (Besier and Love, 2002; Bartley et al., 2004; Waghorn et 
al., 2006; Kaplan and Vidyashankar, 2012; Guerden et al., 2014b). In the UK, sheep 
helminth populations resistant to BZ, levamisole, IVM and MOX have been reported 
(Bartley et al., 2004; Sargison et al., 2005, 2007), and a sheep farm was forced to close 
due to the failure of all anthelmintic classes to adequately control Teladorsagia 
circumcincta (Sargison et al., 2005). In small ruminant production, multidrug 
resistance has been reported to lead to increased mortality and morbidity and 
economic losses such that farm closures or culling of flocks are becoming a reality in 
many countries across the world (Sargison et al., 2005, 2007; Kaplan and Vidyashankar 
et al., 2012; Miller et al., 2012; Leathwick and Besier, 2013; Guerden et al., 2014b). Two 
novel anthelmintics belonging to two new anthelmintic classes have been developed 
and licensed for use against sheep helminths in many countries including the UK. 
Monepantel, an amino-acetonitrile derivative was first licensed in New Zealand in 2009 
and derquantel, a spiroindole, administered in combination with abamectin (a 
macrocyclic lactone) was first licensed in New Zealand in 2010. Worryingly, within two 
years of reaching the market, reduced efficacy following monepantel administration 
against populations of T. circumcincta in New Zealand have been reported (Scott et al., 
2013), further demonstrating that even with new compounds, anthelmintic resistance 
poses a threat to the health and welfare of animals. 
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Epidemiological studies into the prevalence and incidence of parasite-associated 
disease in horses to identify the current baseline, which could then be used an 
indicator for change in incidence rate and to aid surveillance are warranted and multi-
site epidemiological studies to determine the impact of anthelmintic resistant 
helminths on equine health are required. The development and validation of tools that 
detect prepatent infection are needed as the larval stages of cyathostomins and S. 
vulgaris are responsible for major pathology. Therefore, being able to target these 
stages would help to reduce the risk of parasite-associated disease. Further, treatments 
could be targeted at horses with cyathostomin EL so that not all horses receive a dose 
of MOX in the autumn/winter as per current guidelines, thus reducing the selection 
pressure for MOX resistance. The cyathostomin EL ELISA under development shows 
promise as a useful diagnostic tool in the future (McWilliam et al., 2010; Matthews, 
2014). 
Sustainable equine parasite control depends on the development of recommendations 
for helminth control programs that are focussed on reducing anthelmintic use to aid 
the preservation of anthelmintic-sensitive nematode populations while recognising 
that the primary objective is to avoid clinical disease. The evidence currently available 
supports the use of FEC directed therapy (Section 5.5.3), and such a strategy is 
potentially cost effective (Section 6.4.2). The advantage of FEC directed programmes 
needs to be promoted to ensure further uptake and end users must have easy access to 
up-to-date knowledge (Matthews, 2014). This can be achieved through publishing in 
journals that are regularly read by those that prescribe anthelmintics and through 
educating horse owners via publishing accessible articles in specialist magazines, 
through social media and webinars. The development of an online decision support 
tool that advocates the use of appropriate diagnostic tests would provide access to 
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such knowledge, with the ultimate aim of specifically targeting anthelmintic treatments 
that are given, and perhaps, increasing levels of refugia whilst minimising the risk of 
parasite-associated disease. 
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Appendix 1. Questionnaire 
 
An Investigation of Wormer Resistance in UK Horses 
(Funded by the Elise Pilkington Trust) 
 
Yard 
Name: 
 
Yard 
Address: 
 
 
Name of Contact: ___________________________________ 
 
Telephone No: _____________________________________ 
 
Section 1: Basic Information 
 
1.1 Basic function of yard: 
 
(Please tick the boxes that apply to your yard) 
Private use only 
 
 
Livery 
 
 
Competitive 
 
 
Riding school 
 
 
Racing Yard 
 
 
Stud 
 
 
Other: Please give details 
 
 
 
 
1.2 Total number of equines permanently residing at establishment: 
_____________________________ 
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1.3  Of total permanent residents – how many are:     
Stallions - aged 4 years or older 
 
 
Mares or Geldings - aged 4 years or older 
 
 
Youngstock – aged 1-3 years old 
 
 
Foals - aged 0-1 year-old 
 
 
Donkeys – any age 
 
 
 
1.3.a Of these animals – how many are kept at: 
Full livery 
 
 
Working or part livery 
 
 
D.I.Y or grass livery 
 
 
Not applicable – all animals owned by proprietor 
 
 
 
1.4.a On average, how many horses visit your establishment per year (e.g. short-term 
loan): ____________ 
 
1.4.b Of the visiting population, how frequently do they change: (please tick all that 
apply) 
 
Weekly 
 
 
Monthly  
 
Every 3 months or seasonally  
 
Yearly  
 
Varies depending on individual horses (and/or owners)  
 
 
 
1.5.a Do you quarantine new 
arrivals?.......................................................................................YES / NO 
1.5.b Do you perform faecal egg count before deciding to worm? 
..................................................YES / NO 
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1.5.b If YES, which wormer do you use? 
 
Ivermectin (e.g. Eqvalan; Eraquell; Vectin; Noromectin)  
Moxidectin (e.g. Equest)  
Benzimidazoles (e.g Panacur; Panacur 5 Day Guard; Telmin)  
Pyrantel (e.g. Strongid-P; Pyratape-P)  
Praziquantel     (e.g. Equitape)  
Ivermectin/ Praziquantel (e.g. Eqvalan Duo; Equimax)  
Moxidectin/ Praziquantel (e.g. Equest Pramox)  
Other (please state): 
 
1.5.c If YES, for how long after worming are they quarantined before turnout?: 
 
Turned out immediately 
 
 
24 hours 
 
 
48 hours 
 
 
7 days 
 
 
14 days 
 
 
Other (please state) 
 
 
Section 2: Worm control in PERMANENT Equines (aged 1 year and over) 
 
2.1 Name and role of person in charge of wormer 
policy/administration:___________________________ 
 
2.2 How frequently are wormers administered at your establishment? (please tick one) 
 
Every 4 weeks or less 
 
 
Every 4-6 weeks 
 
 
Every 6-8 weeks 
 
 
Every 2-6 months 
 
 
Every 6-12 months 
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Less than every 12 months 
 
 
 
2.3 Which of these wormers have been used at your establishment during the last 12 
months? 
 (please tick all that apply) 
Ivermectin (e.g. Eqvalan; Eraquell; Vectin; Noromectin) 
 
 
Moxidectin (e.g. Equest) 
   
 
Benzimidazoles   (e.g Panacur; Panacur 5 Day Guard; Telmin) 
 
 
Pyrantel (e.g. Strongid-P; Pyratape-P) 
 
 
Praziquantel (e.g. Equitape) 
 
 
Ivermectin/ Praziquantel     (e.g. Eqvalan Duo; Equimax) 
 
 
Moxidectin/ Praziquantel (e.g. Equest Pramox) 
 
 
Other (please state): 
 
2.4 How often do you rotate between wormer classes (e.g. between ivermectin and 
pyrantel)? 
 (please tick all that apply) 
After every application 
 
 
Every 2-3 months 
 
 
Every 6 months 
 
 
Every year 
 
 
At random/infrequently 
 
 
Never 
 
 
 
2.5 How often do you rotate between wormer brands (e.g. between Eqvalan and 
Noromectin)? 
 (please tick all that apply) 
After every application 
 
 
With each change of anthelmintic class 
 
 
Every 2-3 months 
 
 
Every 6 months  
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Every year 
 
 
At random/infrequently 
 
 
Never 
 
 
 
2.6 Reason(s) for choosing which wormer(s) to use: (please tick all that apply) 
 
Brand name 
 
 
Veterinary advice 
 
 
Own experience 
 
 
Price 
 
 
Anthelmintic effectiveness 
 
 
The egg reappearance period 
 
 
Recommendation from associate 
 
 
Rotation between anthelmintics 
 
 
Brand loyalty 
 
 
Other (please state): 
 
 
 
2.7.a Do you use a weightape to estimate the wormer dose for each horse? 
............................... YES / NO 
2.7.b If NO, how is wormer dosage calculated at your establishment? (please tick one) 
Estimation of weight by eye 
 
 
One tube/packet of drug per animal 
 
 
Average weight of animals in a particular age group 
 
 
Average weight of all animals 
 
 
Other (please state): 
 
 
 
2.8 In addition to normal worming procedures; which occasions (or times of the year) do 
you feel are particularly important for administering wormer? (please tick all that 
apply) 
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Spring (March; April; May) 
 
 
Summer (June; July; August) 
 
 
Autumn (September; October; November) 
 
 
Winter (December; January; February) 
 
 
Prior to grazing turnout 
 
 
Prior to introduction of new yard arrivals to existing animals 
 
 
Suspicion of parasite-related illness 
 
 
Other (please state): 
 
 
2.9 Have there been any instances of parasite-related illness at your establishment? 
(please tick all that apply) 
No sign of illness 
 
 
Diarrhoea (lasting less than one week) 
 
 
Diarrhoea (lasting between 1 and 4 weeks) 
 
 
Ill-thrift 
 
 
Colic 
 
 
Weight loss 
 
 
Worms seen in faeces 
 
 
Other (please state): 
 
 
2.9 Have you heard about wormer resistance? 
....................................................................... YES / NO 
 
2.10 Are you concerned about resistance at your establishment 
............................................ YES / NO 
 
 
2.11 If YES have you spoken to your vet or SQP about resistance? 
........................................ YES / NO 
 
 
2.12 If YES, how would you rate their advice? (please tick those that apply) 
Poor 
 
 
Satisfactory 
 
 
Excellent 
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Secti
on 3: Worm control in Foals and Youngstock (please ignore if not applicable) 
 
3.1 At what age are foals first treated with wormer: 
_____________________________________ 
3.2.a Are foals/youngstock treated differently from practices stated in Section 
2?....................YES / NO 
3.2.b If YES, how are they treated and with which wormer(s): (please state) 
 
Section 4: Grazing and Pasture Management 
 
4.0 Approximately what area of grazable land do you have at your establishment? 
 
____________________________________________________ 
 
 
4.2.a Do you poopick? 
.................................................................................................. YES / NO 
 
4.2.b If YES, do you poopick manually or use a machine? (please tick one) 
 
Manually 
 
 
Machine 
 
 
 
4.3 At your establishment do you ever: (Please tick those that apply) 
Other: 
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 YES NO 
Rotate grazing between groups of equines   
Rest paddocks from grazing   
Graze with animals other than equines (e.g. sheep and cattle)   
Harrow and/or clip   
Section 5: Faecal egg counts 
5.1.a Are faecal egg counts carried out on your 
establishment?....................................................YES / NO 
5.1.b If YES, where do you get the faecal egg counts performed? 
Perform it yourself 
 
 
Veterinary Surgery 
 
 
Online service 
 
 
 
5.1.c If YES, how frequently are they carried out? (please tick all that apply) 
Monthly OR every 2-3 months 
 
 
Every six months 
 
 
Yearly 
 
 
Under suspicion of parasite-related illness 
 
 
During Quarantine 
 
 
Infrequently OR at random 
 
 
 
5.1.d If you perform FECs do you: (Please tick the box that applies) 
Treat all horses regardless of FEC 
 
 
Treat all with a positive FEC 
 
 
Treat horses with a FEC of 200 epg or greater 
 
 
Other: 
 
 
 
 
5.2.a Do you know what a faecal egg count reduction test 
is?.....................................................YES / NO 
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5.2.b If YES, have you had one carried out in the last 5 
years?...................................................YES / NO 
 
5.2.c If YES, which wormer(s) were investigated?: 
Wormer 
 
Date  
Ivermectin (e.g. Eqvalan; Eraquell; Vectin; Noromectin) 
 
 
Moxidectin (e.g. Equest) 
 
 
Benzimidazoles  (e.g Panacur; Panacur 5 Day Guard; Telmin) 
 
 
Pyrantel (e.g. Strongid-P; Pyratape-P) 
 
 
Praziquantel    (e.g. Equitape) 
 
 
Ivermectin/ Praziquantel     (e.g. Eqvalan Duo; Equimax) 
 
 
Moxidectin/ Praziquantel (e.g. Equest Pramox 
 
 
Other (please state): 
 
5.2.d If YES, what did the results of the FECRT show? (Please tick the boxes that apply) 
Wormer 
 
Susceptible Resistant 
Ivermectin 
 
  
Moxidectin 
  
  
Benzimidazoles 
 
  
Pyrantel 
   
  
Other (please state):   
 
5.3 Which wormer did you last use and on what date did you administer it? 
Wormer 
 
Date 
Ivermectin (e.g. Eqvalan; Eraquell; Vectin; Noromectin) 
 
 
Moxidectin (e.g. Equest) 
 
 
Benzimidazoles      (e.g Panacur; Panacur 5 Day Guard; Telmin) 
 
 
Pyrantel (e.g. Strongid-P; Pyratape-P) 
 
 
Praziquantel   (e.g. Equitape) 
 
 
Ivermectin/ Praziquantel     (e.g. Eqvalan Duo; Equimax) 
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Moxidectin/ Praziquantel (e.g. Equest Pramox 
 
 
Other (please state): 
 
Completed by: ____________________________(please print name) 
Date:____________ 
 
If you have any specific questions regarding this questionnaire, feel free to 
email me at: hannah.lester@moredun.ac.uk, or telephone: (0131) 44 55 111 
(extension 7479/7465) 
 
Thank you for taking the time 
to complete this 
questionnaire 
 
Please return to: Hannah Lester, Division of Parasitology, Moredun Research 
Institute, Pentlands Science Park, Bush Loan, Penicuik, near Edinburgh, EH26 
0PZ 
or 
hannah.lester@moredun.ac.uk 
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Appendix 2 – Population distribution data from Chapter 5 
 
Appendix 2a. The distribution of age according to the last anthelmintic administered, 
the year, month and season in which the sample was collected, the country and region 
where the horse resided, whether or not quarantine measures were implemented on 
the yard, anthelmintic treatment frequency, the grazing area for each horse and 
whether or not the pasture was poopicked. 
  
No. Yards Adults Foals Geriatric Youngster Total 
Last  
anthelmintic 
IVM 6 142 18 25 25 210 
MOX 20 366 12 97 44 519 
PYR 1 9 1 0 5 15 
Year 
2011 11 274 21 64 40 399 
2012 16 243 10 58 34 345 
Month 
MAR 3 52 5 17 4 78 
APR 7 86 6 37 22 151 
MAY 6 126 0 15 12 153 
JUN 3 51 0 12 10 73 
JUL 3 113 13 31 19 176 
AUG 4 77 7 3 6 93 
SEP 1 12 0 7 1 20 
Season Spring 16 264 11 69 38 382 
 
Summer 10 241 20 46 35 342 
 
Autumn 1 12 0 7 1 20 
Country England 16 243 10 58 34 345 
 
Scotland 11 274 21 64 40 399 
Region SE England 13 199 5 49 19 272 
 
SW England 3 44 5 9 15 73 
 
NE Scotland 1 41 12 4 12 69 
 
SE Scotland 9 223 9 56 24 312 
 
SW Scotland 1 10 0 4 4 18 
Quarantine Y 16 321 29 70 50 470 
 
N  11 196 2 52 24 274 
Treatment 
frequency 2 times/year 18 342 31 64 57 494 
 
4 times/year 6 103 0 40 10 153 
 
FEC 3 72 0 18 77 167 
Grazing area <1 acre/horse 4 41 6 5 13 65 
 
1 - 1.9 
acres/horse 14 289 19 75 32 415 
 
>2 acres/horse 3 36 5 8 13 62 
 
NA 5 151 1 34 15 201 
Poopick Y 3 398 29 96 57 580 
 
N 24 119 2 26 17 164 
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Appendix 2b. Distribution of horses according to yard type by age, last anthelmintic, 
the year, month and season that the samples were taken, country and region, whether 
quarantine measures and poopicking were employed, anthelmintic treatment 
frequency and grazing area 
 
 
Yard type 
 
 
CTN DLR LVY STD STY 
 No. Yards 3 1 17 2 4 
 No. Horses 49 14 468 36 177 
Age  Adults 44 11 338 21 103 
 Foals 0 0 8 5 18 
 Geriatric 0 1 91 4 26 
 Youngster 5 2 31 6 30 
Last anthelmintic 5FBZ 0 0 24 0 0 
 IVM 14 0 28 36 132 
 MOX 35 14 401 0 45 
 PYR 0 0 15 0 0 
Year 2011 0 0 249 18 132 
 2012 49 14 219 18 45 
Month March 0 0 60 18 0 
 April 0 0 120 0 31 
 May 9 0 129 0 14 
 June 25 0 30 18 0 
 July 0 0 44 0 132 
 August 14 14 65 0 0 
 September 0 0 20 0 0 
Season Spring 10 0 309 18 45 
 Summer 39 14 139 18 132 
 Autumn 0 0 20 0 0 
Country England 49 14 219 18 45 
 Scotland 0 0 249 18 132 
Region SE England 39 14 187 18 14 
 SW England 10 0 32 0 31 
 NE Scotland 0 0 0 0 69 
 SE Scotland 0 0 249 0 63 
 SW Scotland 0 0 0 18 0 
Quarantine Y 39 0 299 18 114 
 N  10 14 169 18 63 
Treatment  2 times/year 24 14 261 18 177 
Frequency 4 times/year 0 0 135 18 0 
 FEC 25 0 72 0 0 
Grazing area <1 acre/horse 0 14 0 18 0 
 1 to 1.9 acres/horse 22 0 288 0 69 
 >2 acres/horse 0 0 0 0 31 
 NA 27 0 180 18 77 
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Poopick Y 49 14 367 36 114 
 N 0 0 101 0 63 
 
Appendix 3 - Residuals from negative binomial generalised 
linear mixed (NBGLMM) model 
 
Appendix 3a. Residuals and model checking from the final generalise linear mixed 
model (GLMM). A. Plot of model residuals plotted against the fitted values to evaluate 
the constancy of variance. B. Normal quantile-quantile plot to check that the errors are 
normally distributed. C. Plot of the square root of the standardised residuals. D. Plot of 
the standardised residuals as a function of leverage, along with Cook’s distance to 
highlight any y values that have the biggest effect on parameter estimates. 
 
 
 
 
 
 
 
E 
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Appendix 3b. Model residuals for each significant term retained in the final GLMM 
model. A. Residuals for age category. B. Residuals for ERP. C. Residuals for month. D. 
Residuals for year. E. Residuals for treatment frequency. F. Residuals for poopicking. 
 
 
 
 
 
 
 
 
 
 
 
A B 
C D 
E F 
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